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In the past decades, tremendous advances have been made in both the imaging and 
interventional fi eld of clinical cardiology. Dedicated imaging techniques such as multi-slice 
computed tomography have been introduced and enable detailed non-invasive evaluation 
of cardiac anatomy. Furthermore, conventional techniques such as echocardiography have 
been improved and nowadays allow a more comprehensive assessment of cardiac morphol-
ogy and function. At the same time, percutaneous interventional procedures for arrhythmias 
and valvular heart disease have been further explored. While conventional invasive treatment 
of these conditions requires open-heart surgery, nowadays it has become feasible to perform 
these procedures with minimal-invasive techniques. 
These advances allow a more integrative approach to cardiac imaging and interventions. 
The combination and integration of diff erent imaging modalities and subsequent use of these 
techniques during interventional procedures will further enhance the evaluation and treat-
ment of cardiac arrhythmias and valvular heart disease. In this thesis, the role of multimodality 
imaging to guide cardiac interventional procedures is investigated. In particular, catheter abla-
tion for atrial fi brillation (AF), cardiac pacing and resynchronization therapy, and percutaneous 
valve procedures are explored. 
CATHETER ABLATION FOR ATRIAL FIBRILLATION
Atrial fi brillation is the most commonly encountered cardiac arrhythmia. It is characterized by 
rapid, irregular activity of the atria. In the general population, the prevalence of AF is approxi-
mately 1% (1). Since the prevalence of AF increases with age, it may become ‘epidemic’ in the 
coming decades, with an estimated 3.3 million patients in the United States in 2020 (Figure 1). 
Importantly, AF is associated with an increased risk of both cardiac morbidity and mortality (2). 
The most important goals in the treatment of AF are: reduction of the risk of thrombo-
embolism and control of AF-related symptoms (3). To reduce the risk of thromboembolism, a 
tailored anti-thrombotic regimen (e.g. anticoagulation or aspirin) should be chosen depending 
on clinical characteristics (4). To control symptoms of AF, both ‘rate control’ and ‘rhythm control’ 
strategies can be chosen. Again, an individualized approach is preferred, since the superiority 
of one strategy has not been proven. Large randomized trials have not demonstrated diff er-
ences in mortality or quality of life between the two strategies (5,6). 
If a ‘rhythm control’ strategy is chosen, anti-arrhythmic drugs and/or electrical cardioversion 
are used to restore sinus rhythm. Unfortunately, anti-arrhythmic drugs may have side-eff ects 
and often fail to maintain sinus rhythm. In the past decade, catheter ablation procedures have 
been introduced as a new therapeutic option in the treatment of patients with AF. 
Haissaguerre et al. demonstrated that the pulmonary veins (PVs) are the main source of 
ectopic beats that initiate AF (7). Subsequently, it was shown that electrical isolation of these 
PVs with the use of (radiofrequency) catheter ablation is eff ective for the restoration and 
12
maintenance of sinus rhythm. During the catheter ablation procedure, the PVs are isolated from 
the left atrial (LA) wall by applying radiofrequency current around the PV ostia (Figure 2). Sev-
eral randomized controlled trials have compared anti-arrhythmic drugs and catheter ablation 
procedures regarding the effi  cacy to maintain sinus rhythm during long-term follow-up (8-11). 
From these studies, it has become apparent that catheter ablation may be more eff ective than 
anti-arrhythmic drugs (Table 1). It should be noted however, that serious complications may 
occur in up to 5% of patients undergoing catheter ablation for AF (12). Therefore, at present 
catheter ablation still is considered a second-line therapy, but an excellent treatment option 
Figure 1. Estimated number of patients with atrial fi brillation (AF) in the United States of America (USA). The total number of patients may 
increase up to 2.5-fold in the coming 4 decades. Adapted with permission from Go AS et al., reference (1).
Figure 2. The left panel shows a schematic representation of a catheter ablation procedure. The ablation catheter is introduced into the 
left atrium (LA) through the foramen ovale. Subsequently, radiofrequency current is applied around the ostia of the pulmonary veins (PVs) 
(indicated with the white dots). The right panel shows a volume-rendered reconstruction of multi-slice computed tomography images of the LA 
and PVs that is used to guide the ablation procedure. The red dots indicate the ablation lesions.
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after at least one anti-arrhythmic drug has failed (3). Interestingly, an increasing number of AF 
patients worldwide are treated with catheter ablation (Figure 3). 
The cornerstone of AF ablation procedures is electrical isolation of the PVs. However, ana-
tomical studies have demonstrated that PV anatomy is highly variable (13). In particular, the 
exact number and location of the PVs has large inter-individual variation. Therefore, careful 
identifi cation of the PVs is important both before and during the catheter ablation procedure. 
Several imaging modalities are available to evaluate the anatomy of the LA and the PVs. Multi-
slice computed tomography and magnetic resonance imaging provide excellent images of 
the PVs. However, they do not provide real-time information since the images are acquired 
before the actual ablation procedure. On the other hand, intracardiac echocardiography and 
electroanatomic mapping enable online visualization of the PVs in relation with the ablation 
catheters. However, these techniques are limited by the two-dimensional character and the 
use of reconstructed anatomy, respectively. Ideally, the information of the diff erent imaging 
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Jais et al. (8) 112 112 
paroxysmal 
(100%)
12 months 89% vs. 23%, 
p<0.001
- No diff erences in LA 
diameter and LVEF at 
follow-up
- Greater reduction in 
AF burden in ablation 
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- Improvement in 
quality of life and 





- PV stenosis: 1
AF = atrial fi brillation; AAR = anti-arrhythmic drugs; LA = left atrial; LVEF = left ventricular ejection fraction; PV = pulmonary vein; TIA = 
transient ischemic attack
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techniques is integrated, providing highly detailed on-line anatomical information during the 
catheter ablation procedure. 
Another important issue is the eff ect of catheter ablation procedures for AF on cardiac size 
and function. It has been well recognized that there is a close relation between AF and LA size 
(14). After catheter ablation, the ablation lesions may result in scarring of the LA wall. This may 
negatively aff ect LA size and contractile function. On the other hand, a reduction in LA size 
may result in lower susceptibility to AF (15). In addition, the restoration of sinus rhythm may 
ultimately result in an improved LA function. Furthermore, normalization of heart rhythm may 
result in more effi  cient left ventricular (LV) function. It has been demonstrated that catheter 
ablation results in signifi cant improvement in LV ejection fraction in patients with AF and sys-
tolic heart failure (16). However, the eff ect of catheter ablation on LV function in patients with 
preserved LV ejection fraction is unclear. 
Multimodality imaging and image integration may enhance AF ablation procedures by 
improved visualization of cardiac structures, and may result in better understanding of the 
eff ects of catheter ablation on cardiac function. Accordingly, the aims of the studies described 
in this thesis are to test the feasibility of image integration to guide catheter ablation proce-
dures and to assess the eff ects of catheter ablation procedures on LA and LV function. 
Figure 3. World-wide number of catheter ablation procedures for AF between 1995 and 2002. A clear increase in the annual number of 
procedures is noted. Adapted with permission from Cappato R et al. Worldwide survey on the methods, effi  cacy, and safety of catheter ablation 
for human atrial fi brillation. Circulation 2005;111:1100-5.
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VENTRICULAR PACING AND DYSSYNCHRONY
In 1958, the fi rst pacemaker implantation was performed in a patient with high degree atrio-
ventricular block. Since then, cardiac pacing has been an eff ective treatment in the manage-
ment of patients with symptomatic brady- and tachy-arrhythmias. The annual number of new 
pacemaker implantations in the Netherlands is about 6000, and is steadily increasing (17). High 
degree atrioventricular block and sick sinus syndrome are the most important indications for 
implantation of a conventional pacemaker (Figure 4). 
Typically, the endocardial ventricular pacing lead is positioned at the right ventricular (RV) 
apex. However, large randomized trials have revealed a possible association between RV apical 
pacing and deterioration of cardiac function (18,19). In the Mode Selection Trial (MOST), it was 
demonstrated that a high percentage of ventricular pacing is associated with an increased risk 
of heart failure hospitalization (Figure 5). Furthermore, other studies have shown that RV apical 
pacing results in changes in myocardial perfusion (20) and ventricular remodeling (21). At the 
same time, minimizing RV apical pacing with dedicated algorithms can prevent harmful eff ects 
of cardiac pacing (22). 
The deleterious eff ects of conventional RV apical pacing may be associated with the abnor-





Figure 4. Indications for new pacemaker implantations in the World Survey of Cardiac Pacing and Cardioverter Defi brillators 2001. 
High degree atrio-ventricular (AV) block (40%) and sick sinus syndrome (SSS, 30%) remain the most important indications for pacemaker 
implantation. Less frequently, atrial fi brillation (AF, 12%) and other indications (e.g. bundle-branch block, cardiomyopathy) result in 
implantation of a pacemaker. Adapted from Mond HG et al., reference (17).
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pacing, the electrical wave front propagates through the myocardium, rather than through the 
His-Purkinje conduction system. Due to the diff erences in conduction velocity, heterogeneity 
in electrical activation of the cardiac chambers occurs (23). Simultaneously, changes in the 
mechanical activation pattern are noted. In particular, the onset and magnitude of mechanical 
contraction of various LV walls change (24). The temporal occurrence of peak strain of diff erent 
ventricular segments exhibits an asynchronous pattern during RV apical pacing. This is referred 
to as ‘ventricular mechanical dyssynchrony’ (Figure 6). 
Mechanical dyssynchrony can be assessed with various non-invasive imaging modalities. 
Already in 1977, Gomes et al. noticed the asynchronous contraction pattern of the LV during RV 
apical pacing with the use of transthoracic echocardiography (25). A signifi cant delay between 
the (early) posterior motion of the interventricular septum and the (delayed) contraction of the 
posterior wall was observed immediately after onset of pacing. Nowadays, additional echocar-
diographic techniques are available for assessment of ventricular dyssynchrony (26). With the 
use of tissue Doppler imaging, myocardial velocities of diff erent ventricular segments can be 
assessed throughout the cardiac cycle (Figure 6). Off -line analysis of the regional time-to-peak 
systolic velocity enables quantifi cation of ventricular mechanical dyssynchrony (27). Speckle-
tracking strain analysis is another echocardiographic technique that allows assessment of 
regional timing of peak strain (28). The assessment of myocardial strain permits diff erentiation 
Figure 5. In the MOST trial, >40% cumulative percentage of ventricular pacing (Cum%VP) in the DDDR pacing group (n=707) signifi cantly 
increased the risk of heart failure hospitalization compared with <40% pacing (hazard ratio 2.60; 95% CI 1.05 - 6.47; p<0.05). This fi gure 
demonstrates the Kaplan-Meier plots relating time to fi rst heart failure hospitalization (event) by cumulative percentage of ventricular pacing. 
Reprinted with permission from Sweeney MO et al., reference (18).
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between active contraction and passive motion of the myocardium. Again, by calculating dif-
ferences in time-to-peak systolic strain of various segments, ventricular dyssynchrony can be 
assessed (29). 
Importantly, it has been demonstrated that the presence of mechanical dyssynchrony has 
prognostic value in heart failure patients (30). However, the association between mechanical 
dyssynchrony and the deterioration of cardiac function and functional class in pacemaker 
patients has not been fully elucidated yet. Furthermore, in the past decade cardiac resynchro-
nization therapy has become a well-established therapeutic option for patients with severe 
drug-refractory heart failure and signs of electrical or mechanical dyssynchrony (31,32). In 
cardiac resynchronization therapy, an LV pacing lead is added to a conventional pacing system, 
allowing simultaneously pacing of the RV and LV to re-synchronize the cardiac chambers. It 
may well be that cardiac resynchronization therapy is able to (partly) reverse the detrimental 
eff ects of conventional RV apical pacing. 
New imaging techniques may be valuable tools for the detection of mechanical dyssyn-
chrony, and may help in monitoring patients with conventional pacemakers and selecting 
potential candidates for upgrade of RV pacing to biventricular pacing. Accordingly, the cur-
rent studies explore the possible association between deterioration of cardiac function and 
ventricular mechanical dyssynchrony after onset of RV pacing, and reversal of the detrimental 
eff ects and LV dyssynchrony with cardiac resynchronization therapy. 
Figure 6. Mechanical dyssynchrony. The left panel is a schematic representation of mechanical dyssynchrony. Two diff erent regions of the 
heart contract with similar force (myocardial stiff ening), but one region has a delay in contraction relative to the other. The net diff erence 
between the two regions determines the extent of discoordination in contraction, or mechanical dyssynchrony. The right panel shows 
echocardiographic dyssynchrony assessment with tissue Doppler imaging. Sample areas are placed at the basal parts of the septum and 
lateral wall of the LV. The diff erence in time-to-peak systolic velocity of the two regions (indicated with white arrows) represents mechanical 




Valvular heart disease is an important entity in clinical cardiology. Aortic stenosis (AS) and mitral 
regurgitation (MR) are the most common native single-valve disease. In the general population, 
the prevalence of AS is estimated between 2 and 7% (33). Various pathophysiologic processes 
can attribute to the development of AS or MR, but most frequently the etiology is degenerative 
(Table 2). Importantly, the presence of severe AS (34) or MR (35) is associated with a substan-
tially increased risk of cardiac morbidity and mortality. The poor natural history of untreated 
AS and MR emphasizes the importance of treatment of patients with these conditions (36,37). 
Surgical aortic valve replacement is the treatment of choice in severe, symptomatic AS. 
Operative mortality is about 3-5%, and good long-term survival has been reported (Figure 7) 
(38). Importantly, the severity of symptoms, LV ejection fraction and age are important predic-
tors of good outcome after surgical aortic valve replacement (39). For MR, surgical treatment 
is more complex, due to its variety in etiologies. Mitral valve repair using undersized mitral 
annuloplasty is most frequently used for degenerative and ischemic MR (40). The outcome of 
surgical mitral valve repair depends largely on the etiology of MR, but also severity of symp-
toms, LV ejection fraction and age are important predictors of outcome (33). In particular for 
organic MR (e.g. mitral valve prolapse), good long-term results have been reported (41). 
Despite the good outcome after surgical treatment of AS and MR, a large proportion of 
patients does not undergo surgery. The Euro Heart Survey on Valvular Heart Disease explored 
the characteristics, treatment and outcome of 5001 patients with valvular heart disease from 25 
countries in Europe (42). From this Euro Heart Survey, it has become apparent that up to 30% 
Table 2. Results from the Euro Heart Survey on Valvular Heart Disease on the etiology and surgical treatment of aortic stenosis and mitral 
regurgitation. 
Aortic stenosis Mitral regurgitation
Etiology *
Degenerative, % 82 61
Rheumatic, % 11 14
Endocarditis, % 1 4
Infl ammatory, % 0 1
Congenital, % 5 5
Ischaemic, % 0 7
Other, % 1 8
Surgical intervention †
Mechanical prosthesis, % 49 43
Bioprosthesis, % 50 10
Valve repair, % 0 47
Other, % 1 0
* Data on etiology from 1197 patients with aortic stenosis and 877 patients with mitral regurgitation. † Data on surgical intervention from 512 
patients with aortic stenosis and 155 patients with mitral regurgitation. Adapted from Iung et al., reference (42).
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of patients with severe symptomatic valvular disease do not undergo surgical intervention, 
while a clear indication exists. Most frequently, this is because of co-morbidity and age (42). 
Obviously, there is a need for a less invasive approach, in particular in elderly patients with 
co-morbidity and severe valvular heart disease. 
In recent years, various new percutaneous procedures for the treatment of AS and MR have 
been introduced. The implantation of an aortic valve prosthesis through the femoral artery or 
the LV apex has become feasible (Figure 8). The feasibility of a balloon-expandable (43) and 
a self-expanding valve (44) for the percutaneous treatment of severe AS have been demon-
strated. Importantly, large multi-center studies (45) and mid-term follow-up studies (46) have 
demonstrated the safety and effi  cacy of these procedures. 
Furthermore, new percutaneous devices have been introduced for the percutaneous 
treatment of MR (Figure 8). The feasibility of a mitral valve clip mimicking edge-to-edge repair 
has been demonstrated (47), and diff erent prostheses that target mitral annulus remodeling 
through the coronary sinus have been introduced (48,49). The safety and mid-term effi  cacy of 
these procedures have also been demonstrated (50,51). 
However, percutaneous valve procedures still have limitations and severe complications 
can occur. An important issue is failure of the procedure as a result of unfavorable cardiac 
anatomy. For example, the close relation between the native valve leafl ets, valve annulus 
and the coronary arteries may preclude save percutaneous implantation of a device. In the 
Mitral Annuloplasty Device European Union Study (AMADEUS), the coronary sinus device was 
Figure 7. Long-term outcome after primary surgical aortic valve replacement in 2227 patients with severe aortic stenosis. The observed 
(open circles) and relative (solid circles) survival is shown in patients who survived the fi rst postoperative month. Reprinted with permission 
from Kvidal P et al., reference (38).
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recaptured because of potential coronary compromise in up to 30% of the non-implanted 
patients (51). Furthermore, acute coronary occlusion during percutaneous aortic valve implan-
tation has been reported (43). 
Imaging may be of great value in the percutaneous treatment of valvular heart disease. It 
may improve the selection of patients and may enhance real-time guidance of the procedures. 
In the studies described in the present thesis, the potential role of multi-slice computed tomog-
raphy in the selection for candidates for new percutaneous valve procedures for AS and MR is 
explored.  
OUTLINE OF THE PRESENT THESIS
The aim of this thesis is to evaluate the role of multimodality imaging to guide cardiac interven-
tional procedures. In particular, catheter ablation procedures for AF, conventional pacing and 
cardiac resynchronization therapy, and percutaneous valve procedures are studied. Therefore, 
the present thesis consists of three distinct parts. 
PART I: Catheter ablation for atrial fi brillation
In the fi rst part, catheter ablation procedures for AF are studied. These procedures are considered 
a good treatment option in patients with drug-refractory AF, after at least one anti-arrhythmic 
drug has failed. Visualization of the PVs with diff erent imaging modalities, the integration of 
various imaging techniques, and the eff ect of catheter ablation on LA and LV function are 
important issues in AF ablation. Chapter 2 and Chapter 3 provide two extensive reviews on 
the role of multimodality imaging in the assessment of PV and LA anatomy, and in catheter 
ablation procedures for AF. In Chapter 4, the fi rst clinical experience with a new image integra-
tion system that allows integration of MSCT images and electroanatomic mapping is described. 
Subsequently, the integration of intracardiac echocardiography with electroanatomic mapping 
and multi-slice computed tomography is studied in Chapter 5. The assessment of PV anatomy 
with multi-slice computed tomography, and its impact on the outcome of catheter ablation 
procedures is explored in Chapter 6. 
In the next chapters, the eff ect of catheter ablation for AF on LA and LV function is studied. 
In Chapter 7, conventional transthoracic two-dimensional echocardiography is used to assess 
the eff ect of catheter ablation on LA size. The fi ndings of this study are further extended in 
the following chapters. In Chapter 8, real-time three-dimensional echocardiography is used to 
assess LA function after catheter ablation. Subsequently, the eff ect of catheter ablation on LA 
systolic and diastolic strain is investigated in Chapter 9. Furthermore, the predictive value of LA 
strain for LA reverse remodeling is studied. Finally, the eff ect of sinus rhythm maintenance after 
catheter ablation on LV function is studied in Chapter 10. 
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PART II: Ventricular pacing and dyssynchrony
In the second part, conventional RV apical pacing, cardiac resynchronization therapy and ven-
tricular mechanical dyssynchrony are studied. In particular, the association between dyssyn-
chrony and the deterioration of LV function after long-term RV apical pacing, and the reversal 
of the negative eff ects with cardiac resynchronization therapy are investigated. In Chapter 11, 
an extensive review of the available evidence on the eff ects of RV apical pacing on LV function 
is provided. Chapter 12 describes the initial observation that long-term RV apical pacing can 
induce LV mechanical dyssynchrony assessed with conventional echocardiography and tissue 
Doppler imaging. Subsequently, the acute eff ects of RV apical pacing on ventricular dyssyn-
chrony are studied with speckle-tracking echocardiography in Chapter 13. Furthermore, the 
eff ects of RV apical pacing on LV strain and LV twist are investigated in this study. Subsequently, 
speckle-tracking echocardiography is used to assess ventricular dyssynchrony, and in particular 
the site of latest activation in a cohort of patients with long-term RV apical pacing in Chapter 
14. Importantly, the eff ect of upgrade to biventricular pacing is investigated in this study. In 
Chapter 15, the eff ect of RV apical pacing and ventricular dyssynchrony on myocardial oxida-
tive metabolism and effi  ciency is studied with the use of positron emission tomography scan-
ning. Finally, the prevalence of ventricular dyssynchrony in patients with arrhythmogenic right 
ventricular dysplasia/cardiomyopathy is studied in Chapter 16. 
PART III: Percutaneous valve procedures 
In the third part, the role of cardiac imaging in percutaneous valve procedures is explored. 
Recently, various percutaneous procedures for aortic valve and mitral valve disease have been 
introduced. The background of these procedures and the diff erent prostheses are reviewed in 
Chapter 17. The relation between the mitral annulus, the LA posterior wall and the coronary 
arteries determines the feasibility of percutaneous mitral annuloplasty. The assessment of this 
critical relation with the use of multi-slice computed tomography is described in Chapter 18. 
Figure 8. Percutaneous valve procedures for aortic stenosis (AS) and mitral regurgitation (MR). The left panel shows the percutaneous 
implantation of a balloon expandable aortic valve prosthesis. The catheter with the balloon and prosthesis is inserted retrograde through the 
femoral artery and aorta. The right panel shows a coronary sinus device that attempts to remodel the mitral valve annulus in severe MR. The 
device is inserted antegrade through the right atrium.
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Subsequently, multi-slice computed tomography is used for the assessment of the mitral valve 
itself, and exploration of the anatomical mechanism underlying functional MR in Chapter 19. 
For percutaneous aortic valve procedures, other anatomical considerations are important. In 
particular, the extent and location of aortic valve calcifi cations, and the relation between the 
aortic valve annulus and the coronary arteries are important issues. The role of multimodality 
imaging in the selection of patients and performing percutaneous aortic valve procedures is 
discussed in Chapter 20. Furthermore, the clinical experience with percutaneous aortic valve 
procedures is extensively reviewed in this chapter. In Chapter 21, a systematic analysis with the 
use of multi-slice computed tomography of the aortic valve and the relation with the coronary 
arteries is performed in a large cohort of patients. Finally, this methodology is used in patients 
undergoing percutaneous aortic valve implantation in Chapter 22. 
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INTRODUCTION
The left atrium (LA) anterior-posterior diameter was one of the fi rst standardized echocar-
diographic parameters. However, the clinical importance of LA size assessment has been 
neglected for a long time. Recent population-based studies have demonstrated the prognostic 
value of LA size for long-term outcome. Furthermore, with new dedicated techniques such as 
tissue Doppler imaging, it has become feasible to assess (regional) LA function. In addition, the 
introduction of catheter ablation procedures has changed the treatment of patients with drug-
refractory atrial fi brillation (AF) dramatically. New image integration systems have become 
available for these catheter ablation procedures. With the use of image integration systems, 
a real anatomical ‘roadmap’ of the LA is provided for catheter ablation procedures. All these 
factors may explain the renewed interest in LA anatomy. 
In the present manuscript, the importance of assessment of LA size and LA anatomy is 
discussed. Furthermore, the various imaging modalities that are available for the non-invasive 
visualization of the LA will be reviewed. In addition, the role of these imaging techniques in 
catheter ablation procedures for AF will be discussed. 
CAUSES AND MECHANISMS OF LA DILATATION
In large population-based studies, it has been demonstrated that LA size is an important 
predictor of cardiovascular outcome (1-3). Tsang et al (3) recently demonstrated that a larger 
indexed LA volume predicted a higher risk of cardiovascular events after adjustment for age, 
gender and other covariates. Patients with a severely increased left atrium (≥40 ml/m2) had the 
highest risk for the development of cardiovascular events (hazard ratio 6.6) (3). 
Left atrium dilatation can occur in a broad spectrum of cardiovascular diseases including 
hypertension, left ventricular dysfunction, mitral valve disease and AF. In general, two major 
conditions are associated with LA dilatation: pressure overload and volume overload (4). LA 
volume overload frequently occurs in the setting of mitral regurgitation. Pressure overload is 
most frequently caused by an increased LA afterload, secondary to mitral valve disease or LV 
dysfunction (4). Pritchett et al (5) demonstrated a close correlation between LA volume and the 
severity of diastolic dysfunction after adjusting for the presence of covariates including age, 
gender, cardiovascular disease, ejection fraction and left ventricular mass. Accordingly, it has 
been suggested that whereas LA volumes represent long-term exposure to elevated pressures, 
Doppler measures of fi lling pressures rather represent the actual LV fi lling pressures at one 
point in time (6). 
Atrial fi brillation is another important factor associated with LA dilatation. Atrial fi brillation 
is the most commonly encountered cardiac arrhythmia, and the association of LA enlargement 
and AF has been well recognized (1,7-10). However, whether AF causes LA dilatation or vice 
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versa still remains controversial. Several studies suggest that LA enlargement may cause AF 
(1,7,8). In the Framingham Heart Study (7), M-mode derived LA size was an independent risk 
factor for development of AF. More recently, Tsang et al (1) demonstrated that LA volume 
(assessed with a modifi ed biplane method) was a strong predictor of AF, incremental to clinical 
risk factors (1). However, other studies have revealed that LA enlargement may be the conse-
quence of AF (9,10). Dittrich et al (10) demonstrated that AF was an independent predictor of 
LA size in a large cohort study with 3465 patients with AF. 
THE IMPORTANCE OF LA SIZE AND ANATOMY ASSESSMENT
Assessment of LA size is important since it has been shown to provide strong prognostic infor-
mation. The incremental value of LA size over conventional risk factors has been demonstrated 
in several studies (3,11-13). In the Framingham Heart study (13) it was demonstrated that LA 
enlargement was a signifi cant predictor of death in both men and women. The relative risk of 
death per 10 mm increment in LA size was 1.3 for men (95% CI 1.0-1.5) and 1.4 for women (95% 
CI 1.1-1.7). 
In particular, assessment of LA size is important in patients with AF. The guidelines on 
management of patients with AF recommend a standard 2-dimensional and Doppler echocar-
diogram, with assessment of LA size and function, in the clinical evaluation of all patients with 
AF (14). Osranek et al (12) demonstrated the predictive value of LA dilatation in patients with 
lone AF. In this population-based study with a median follow-up of 27 years, it was noted that 
in patients with lone AF, LA volume was a strong predictor of adverse events (cerebrovascular 
event/ acute myocardial infarction/ heart failure hospitalization/ death), independent of age 
and clinical risk factors (12). 
The assessment of LA anatomy is important in the setting of catheter ablation procedures 
for AF. Although there is still debate concerning the best ablation strategy and the exact lesion 
set, knowledge on LA and pulmonary vein anatomy is mandatory, both before and during the 
ablation procedure. Both anatomical (15) and in vivo studies with diff erent imaging modali-
ties (16-18) have shown that LA and pulmonary vein anatomy is highly variable. Diff erent 
non-invasive imaging modalities are available for assessment of LA size and anatomy. The 
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MULTI-MODALITY IMAGING OF THE LEFT ATRIUM
Echocardiography
For assessment of LA size various echocardiographic techniques are available, including trans-
thoracic, transesophageal and intracardiac echocardiography. Transthoracic echocardiography 
is most commonly used in daily clinical practice to assess LA size. Both transesophageal and 
intracardiac echocardiography are mainly used during interventions for AF, such as cardiover-
sion (transesophageal echocardiography) and catheter ablation procedures (intracardiac 
echocardiography).
Transthoracic echocardiography Feigenbaum was the fi rst to demonstrate the correlation 
between LA dimension assessed with one-dimensional M-mode echocardiography and angio-
graphic LA size (19). Afterwards, the development of two-dimensional echocardiography has 
expanded the insight in LA size and morphology. Nowadays, various established parameters 
for assessment of LA size are available (20). The LA anteroposterior diameter of the left atrium 
as assessed with M-mode is most commonly used in daily clinical practice and in large stud-
ies. However, it is not suffi  cient to determine true LA size, since M-mode represents only one 
dimension of the LA (21). In particular in LA enlargement, which may result in an asymmetrical 
geometry of the LA, M-mode echocardiography may underestimate LA size. Therefore, optimal 
assessment of LA size should include LA volume measurements (20,21). Various methods for 
the assessment of LA volume with two-dimensional echocardiography are available, including 
the cubical method, area-length method, ellipsoid method, and Modifi ed Simpson’s rule (Table 
1 and Figure 1). In a prospective study including 631 patients (22), it was demonstrated that the 
biplane area-length method and the biplane Simpson’s method compared closely (mean LA 
volume 39 ± 14 ml/m2 and 38 ± 13 ml/m2, correlation coeffi  cient 0.98) , whereas the ellipsoid 
method systematically underestimated LA volume (mean LA volume 32 ± 14 ml/m2).  Recently, 
Table 1. Methods for left atrial volume quantifi cation with two-dimensional echocardiography
Method Parameter View Equation Assumption
Cube Anterior-Posterior diameter (APD) PSLAX 4/3 π (APD/2)3 LA has a spherical shape
Ellipsoid Anterior-Posterior diameter (APD)







LA has an ellipsoid 
geometry
Area-length LA area planimetry (A2C)













Summation of discs Total volume can be 
calculated from sum of 
smaller volumes
LA = left atrium; PSLAX = parasternal long-axis; 2CH = 2-chamber view; 4CH = 4-chamber view
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three-dimensional echocardiography has been introduced (Figure 2). A number of studies have 
demonstrated the feasibility of three-dimensional echocardiography for the assessment of LA 
volumes (23,24), and it has been validated against magnetic resonance imaging (25). Jenkins 
et al (23) have demonstrated that three-dimensional echocardiography allows accurate LA 
volume assessment, with a low test-retest variation, and a lower intra-and inter-observer vari-
ability as compared to two-dimensional echocardiography. However, there still remain some 
technical limitations such as the spatial and temporal resolution. In addition, since a relatively 
constant RR interval is needed, three-dimensional echocardiography may not be feasible in 
patients with AF and a high ventricular response rate. 
Transesophageal echocardiography Transesophageal echocardiography (TEE) provides good 
views on the LA and the left atrial appendage (LAA). However, visualizing the complete left 
atrium to determine LA size with TEE may be hampered by the close proximity of the probe 
to the LA and the variable position of the esophagus to the posterior LA. As a result, measure-
ments of LA size with TEE have not been standardized. Only few studies have compared the 
assessment of LA size with TEE and TTE. Block et al (26) assessed diff erent LA dimensions with 
TEE and TTE in 109 patients. The authors noted that the 30- to 60-degree short-axis equivalent 
at the level of the aortic valve was the only view in which the entire LA dimension could be 
reliably obtained. Although TEE slightly underestimated LA size, it provided good correlation 
with TTE (26). 
TEE is considered the procedure of choice for assessment of thrombi in the LA cavity or LAA. 
It can detect thrombi with a high degree of sensitivity and specifi city varying from 93 - 100% 
(27). In addition, TEE is helpful in assessment of LAA emptying velocities, which are correlated 
with thrombus formation (velocities <20 cm/s) and with maintenance of sinus rhythm after 
cardioversion (velocities >40 cm/s) (28). Furthermore, TEE may be of great value in performing 
transseptal punctures in AF ablation procedures. 
Figure 1. Measurement of LA volumes with transthoracic echocardiography using the modifi ed biplane Simpson’s rule. The maximum LA 
volume is assessed during ventricular systole in the apical 2-chamber (left panel) and apical 4-chamber (right panel) views. Maximal LA volume 
was 46 ml, minimal LA volume was 22 ml, resulting in an LA ejection fraction of 53%.
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Intracardiac echocardiography  Intracardiac echocardiography (ICE) is only used during inter-
ventional procedures, such as percutaneous closure of atrial septal defects and catheter abla-
tion procedures. Therefore, no standardized measurements of LA size or volume are available. 
During these interventional procedures, ICE can accurately visualize LA anatomy and related 
structures (29). Furthermore, it allows visualization of intracardiac devices and catheters, and 
it is helpful in monitoring potential complications during catheter ablation procedures (30). 
Examples of intracardiac echocardiograms are shown in Figure 3. 
In addition, the Doppler capacities of ICE allow for monitoring of pulmonary vein narrow-
ing and may predict the recurrence of AF after ablation (31). Furthermore, LA function can be 
assessed with ICE. Rotter et al (32) demonstrated a good correlation between ICE and TEE for 
measurement of mitral E wave velocity (correlation coeffi  cient 0.759, mean diff erence 6.9 cm/s) 
and LAA emptying velocity (correlation coeffi  cient 0.991, mean diff erence 0.7 cm/s). Although 
ICE is limited by the monoplane character and the lack of standardized measurements of LA 
size, it is a valuable tool for interventional procedures. 
Multi-slice computed tomography
The application of multi-slice computed tomography (MSCT) in cardiac imaging has rapidly 
expanded in the past few years. Since MSCT has an excellent spatial and temporal resolution, 
Figure 2. Real-time three-dimensional echocardiogram for the assessment of LA volumes. Panels A to C represent the coronal, sagittal 
and transverse planes, respectively. With the use of a 5-point tracing algorithm, LA volumes can be obtained throughout the cardiac cycle, 
represented by the ‘shell’ in panel D. In this example, LA maximum volume was 53 ml.
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it can accurately quantify LA volumes, by using the modifi ed Simpson’s method (33). However, 
because of the radiation exposure and the use of contrast agents, MSCT is not routinely used 
for the assessment of LA size. 
For AF ablation procedures, MSCT is a valuable tool to depict LA anatomy (34). With the use 
of volume-rendered reconstructions, MSCT can provide detailed information on LA and pulmo-
nary vein anatomy (Figure 4). Since LA and pulmonary vein anatomy is highly variable, MSCT 
may off er a ‘road-map’ for ablation. The exact role of MSCT in ablation procedures is discussed 
in one of the following paragraphs. 
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is considered the most accurate technique for the non-
invasive assessment of atrial volumes, because of the high spatial resolution and the excellent 
myocardial border detection. Detailed information of LA size and volumes throughout the 
cardiac cycle can be acquired with MRI (Figure 5). Anderson et al (35) recently reported fi ndings 
on LA dimensions and LA area assessed with MRI in 20 healthy controls and in 20 patients with 
cardiomyopathy. It was noted that a LA systolic area <24 cm2 was the upper 95th percentile 
of the normal range, and best discriminated normal from abnormal hearts (35). Similar to 
MSCT, a modifi ed Simpson’s method can be used to determine LA volumes. However, due to 
its relatively long acquisition times and the cumbersome data analysis, LA volume assessment 
with MRI is not performed in daily clinical practice. MRI can provide detailed information on LA 
and pulmonary vein anatomy before catheter ablation procedures, and is a useful tool in the 
follow-up of patients after the ablation procedure. This will be discussed in more depth in one 
of the following paragraphs. 
Several studies have compared the value of the diff erent imaging modalities for the assess-
ment of LA size and volumes (23-26,36). Two-dimensional transthoracic echocardiography 
Figure 3. Intracardiac echocardiography during a catheter ablation procedure for AF. Panel A: The transseptal puncture is guided by ICE to 
gain access to the LA. The white arrow indicates the transseptal sheath aimed at the fossa ovalis, which is the preferred site for the transeptal 
puncture. The ‘tenting’ of the septum (open arrow) indicates stable contact of the sheath with the fossa ovalis. Panel B: The anatomy of the 
pulmonary veins can be assessed with ICE during the ablation procedure. In this patient, the left inferior pulmonary vein (LIPV) and the left 
superior pulmonary vein (LSPV) have a single insertion in the LA, a so-called ‘common ostium’ of the left-sided pulmonary veins.
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(using the biplane methods) may underestimate true LA size, as compared with computed 
tomography (36) or magnetic resonance (25). However, these three-dimensional techniques 
are not preferred for LA size assessment in daily clinical practice. In this respect, new three-
dimensional echocardiography is a promising technique that is widely available and provides 
accurate information on LA size (24).
Figure 4. Volume-rendered three-dimensional reconstruction of a 64-slice MSCT scan. The dorsal view clearly demonstrates the anatomy 
of the LA and pulmonary veins. In this patient, normal pulmonary vein anatomy is present including four pulmonary veins, all with their own 
insertion into the LA. LIPV = left inferior pulmonary vein; LSPV = left superior pulmonary vein; RIPV = right inferior pulmonary vein; RSPV = 
right superior pulmonary vein.
Figure 5. Assessment of LA volumes with MRI. The 2-chamber (left panel) and the 4-chamber (right panel) views are used to delineate the 
endocardial border of the LA, as well as the maximal diameter.
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ASSESSMENT OF REGIONAL LA FUNCTION 
Regional LA function is not routinely assessed, and therefore no standardized parameters for 
regional LA function are available. This can be partly explained by the fact that non-invasive 
evaluation of regional LA function may be hampered by the relative thin LA walls. However, 
assessment of regional LA function may provide more insight in atrial electromechanical 
remodeling and may be helpful in the management of AF with surgical or catheter ablation. 
New echocardiographic techniques, such as tissue Doppler imaging and strain (rate) imaging, 
allow non-invasive measurement of regional function of the myocardium. Tissue Doppler imag-
ing quantifi es regional tissue velocities of the myocardium. Strain and strain rate represent local 
tissue deformation and the rate (speed) of local deformation, respectively (37). Both techniques 
have been well validated for the assessment of regional left ventricular function. Recently, 
several studies (38-42) have applied these new techniques to the left atrium. 
Tissue Doppler imaging allows quantifi cation of regional myocardial velocities, and assess-
ment of the timing of peak systolic and diastolic velocities of the myocardium (Figure 6, panel 
A). Thomas et al (38) used tissue Doppler imaging in 92 healthy volunteers to evaluate regional 
LA function. The authors noted that atrial contraction velocities were signifi cantly increased in 
the annular segments, compared with the more superior segments. 
Tissue Doppler imaging also provides information on the timing of regional velocities of 
the myocardium. Therefore, it may quantify regional electromechanical LA function, such as the 
total electromechanical activity of the atria (represented by the interval between the onset of 
the P-wave on the ECG to the end of the A’ wave on the tissue Doppler images) (39). However, 
the clinical relevance and the exact correlation of these new tissue Doppler derived parameters 
of regional LA function with conventional parameters, such as mitral infl ow A wave velocity and 
LA volumes, needs further investigation. Furthermore, a limitation of tissue Doppler imaging 
for evaluation of regional LA function is the angle dependency of the technique. Therefore, 
careful adjustment of the beam and gain settings should be made to avoid aliasing and to allow 
reliable measurement of tissue velocities of the LA. 
Strain imaging and strain rate imaging are new tools for the assessment of regional myocar-
dial deformation of the LA (40). An example of strain rate imaging of the LA is shown in Figure 
6, panel B. In contrast to tissue Doppler imaging, strain imaging is not hampered by myocardial 
tethering. Furthermore, strain imaging allows for diff erentiation between active contraction 
and passive motion (37). However, the thin atrial walls may not generate clear strain curves 
and therefore require careful interpretation. Several studies have demonstrated the value of 
regional atrial strain in the analysis of patients with AF undergoing cardioversion (41,42). Di 
Salvo et al (41) studied 65 patients with AF and performed tissue Doppler imaging of standard 
apical images of the LA. It was noted that all tissue Doppler imaging derived parameters of the 
LA, including tissue velocities, strain and strain rate, were signifi cantly reduced in patients with 
AF, compared with healthy controls. Of interest, multivariable analysis demonstrated that atrial 
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inferior wall peak systolic strain rate and atrial septal peak systolic strain were the best predic-
tors of maintenance of sinus rhythm after cardioversion (41). The assessment of regional LA 
function by tissue Doppler imaging or strain imaging may be of value in the clinical follow-up 
of patients with AF undergoing catheter ablation or cardioversion. It has been suggested that 
diminished regional atrial strain values may warrant prolonged use of anti-arrhythmic drugs 
and anti-coagulation (41,42). However, more studies are needed to appreciate the value of 
regional left atrial strain and its role to guide use of medication in patients with AF.
Figure 6. Panel A: Color-coded tissue Doppler imaging in the apical 4-chamber view for the assessment of regional LA function. The samples are 
placed in the basal atrial septum and the basal atrial lateral wall. From the myocardial velocity curves, peak systolic and diastolic velocities can be 
assessed. Early diastolic fi lling is indicated by E’ and late diastolic fi lling is indicated by A’. Panel B: Strain rate imaging in the apical 4-chamber view 
in a patient with a history of paroxysmal atrial fi brillation. A sample is placed in the basal atrial septum. From the time-strain curves segmental 
atrial contraction and time-to-peak strain can be derived. The vertical green lines indicate aortic valve opening (AVO) and aortic valve closure (AVC).
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IMAGING OF LA FUNCTION IN THERAPY FOR AF
As previously discussed, the association between LA remodeling and AF has been well rec-
ognized. Restoration of normal sinus rhythm by catheter ablation or cardioversion may result 
in reverse remodeling of the LA, with subsequent improvement of LA function. However, 
electrical or pharmacological cardioversion may cause transient atrial mechanical dysfunction 
or ‘stunning’ (28,43). It has been demonstrated that conventional parameters of LA function, 
such as A wave velocity or A wave velocity time integral, are decreased immediately after 
cardioversion (43). The subsequent depressed LA appendage fl ow velocities increase the risk of 
thromboembolic events after cardioversion. 
With the use of new techniques such as strain imaging, LA dysfunction following cardiover-
sion can also be assessed (42). In 37 patients with chronic AF, it was noted that immediately after 
cardioversion regional LA function was depressed compared with healthy controls. However, 
6 months after successful cardioversion a signifi cant increase in LA strain was observed. The 
maximal increase in regional LA strain occurred within 1 month after cardioversion (42). This 
observation is in concordance with previous studies (43,44) and suggests that ‘atrial stunning’ 
following cardioversion is a function of the preceding AF, rather than the cardioversion itself. 
Catheter ablation has been demonstrated to be successful in the restoration of sinus 
rhythm, and is performed in an increasing number of patients with symptomatic drug-refrac-
tory AF. It has been demonstrated that maintenance of sinus rhythm after catheter ablation is 
associated with a decrease in LA volumes (Figure 7) (45). Reant et al studied 48 patients with 
lone AF treated with catheter ablation (46). Serial echocardiograms up to 12 months after the 
procedure revealed a progressive decrease in LA dimensions. Interestingly, with the use of 
new tissue Doppler derived parameters it was noted that in parallel to the improvement in LA 
function, both LV systolic and diastolic function improved in the patients who maintained sinus 
rhythm (46). Furthermore, with the use of MRI it has been demonstrated that in addition to 
LA reverse remodeling, the area of the pulmonary venous ostia may decrease after successful 
catheter ablation procedures (47).
IMAGING IN CATHETER ABLATION PROCEDURES FOR AF
Multimodality imaging
Catheter ablation procedures are being performed in an increasing number of patients world-
wide. The recent guidelines on management of patients with AF propose catheter ablation 
as a reasonable option when fi rst-line anti-arrhythmic drugs have failed (14). Various ablation 
strategies have been proposed, including segmental ostial ablation and anatomically based 
circumferential ablation, and there is still debate concerning the exact lesion set. Regardless of 
the ablation strategy applied, knowledge on the complex LA and pulmonary vein anatomy is 
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essential during the ablation procedure. The veno-atrial junctions and anatomical landmarks 
in the LA, such as the ridge between the left superior pulmonary vein and the LAA, are critical 
structures to identify during catheter ablation procedures. 
Anatomical studies have demonstrated that LA and pulmonary vein anatomy is highly 
variable (15). Most frequently, two left-sided pulmonary veins and two right-sided pulmonary 
veins drain separately into the LA (Figure 4). Anatomical variations include a single insertion 
or ‘common ostium’ of the pulmonary veins, and an additional pulmonary vein (Figure 8). A 
‘common ostium’ is most frequently found on the left-sided pulmonary veins, whereas an addi-
tional pulmonary vein is most frequently noted on the right side. In 201 patients undergoing 
MSCT scanning, Marom et al (48) noted a left-sided ‘common ostium’ in 14% of the patients, 
and an additional right-sided pulmonary vein in 28% of the patients. In addition, variations in 
LAA morphology and LA roof anatomy may be present in patients with AF (49). Because of the 
complex anatomy of the LA and the variability in pulmonary vein anatomy, a detailed ‘roadmap’ 
for the ablation procedure is mandatory. The various imaging modalities that are available for 
assessment of LA and pulmonary vein anatomy in catheter ablation procedures include MSCT, 
MRI, ICE and electroanatomical mapping systems. 
MSCT and MRI (Figures 8 and 9) provide detailed information on the anatomy of the LA 
and pulmonary veins. With the use of volume-rendered three-dimensional reconstructions and 
cross-sectional images, the number of pulmonary veins and their branching pattern can be 
accurately assessed (Figure 10). Furthermore, the diameters of the pulmonary vein ostia can 
be measured on the diff erent orthogonal planes. In addition, MSCT may identify the presence 
of thrombi in the LAA and provide detailed information on surrounding structures, such as the 
Figure 7. Reverse remodeling of the LA may occur after successful catheter ablation. A signifi cant reduction in LA end-diastolic volume 
(LAEDV) was observed in the patients who maintained sinus rhythm after the catheter ablation procedure (SR group). In contrast, an increase in 
LA volumes was observed in the patients who had recurrence of atrial fi brillation (AF group). * = p<0.01 baseline vs. 3 months of follow-up; † 
= p < 0.05 SR group vs. AF group.
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esophagus and coronary arteries. However, the pre-procedural acquired MSCT and MRI images 
only provide off -line information. 
In contrast to MSCT and MRI, ICE allows real-time assessment of the pulmonary veins and 
the veno-atrial junction during the ablation procedure. The Doppler capacities and the ability 
to monitor the catheter position in relation to the pulmonary veins are great advantages of this 
technique (29). In addition, ICE is helpful in assessment of the transmural extent of the ablation 
lesions (50) and ICE has been used to titrate ablation energy, thereby increasing the safety of 
the ablation procedure (30). Still, the major limitation of ICE is the mono-dimensional char-
acter of the technique. It has been demonstrated that three-dimensional imaging modalities 
Figure 8. Variations in pulmonary vein (PV) anatomy shown on volume-rendered three-dimensional reconstructions of MSCT scans. Panel A 
demonstrates an additional PV on the right side. Panel B shows a ‘common’ ostium of the left-sided PVs.
Figure 9. Maximum intensity projection of a gadolinium enhanced MRI angiogram of the pulmonary veins. LA = left atrium; RIPV = right 
inferior pulmonary vein; RSPV = right superior pulmonary vein
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provide the most accurate information on LA and pulmonary vein anatomy (16,17). In a direct 
comparison between MSCT and ICE (Figure 11), it was noted that MSCT has a higher sensitivity 
for the detection of additional pulmonary veins and that ICE underestimated the size of the 
pulmonary venous ostia (16). 
During the ablation procedure, electroanatomical mapping systems such as CartoTM 
(Biosense-Webster, Diamond Bar, California, USA) are available to assess LA and pulmonary 
vein anatomy. These systems combine on-line electrophysiological data with anatomical 
information, acquired with mapping catheters positioned in the LA (51). When performing the 
actual ablation, the ablation points can be marked on the acquired electroanatomical map. 
The major limitation of these systems is the use of reconstructed anatomy. Ideally, the detailed 
anatomical information acquired with three-dimensional imaging techniques (such as MSCT 
and MRI) could be combined with the on-line electrophysiological information. Recently, image 
integration systems have been introduced that allow the on-line use of MSCT or MRI images 
during the actual ablation procedures. 
Figure 10. The diff erent orthogonal planes (axial, coronal and sagittal) and three-dimensional volume rendered reconstructions of the 
MSCT scan can be used to assess LA and pulmonary vein anatomy. The black arrows indicate the large ‘common ostium’ of the left-sided 
pulmonary veins. LIPV = left inferior pulmonary vein; LSPV = left superior pulmonary vein
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Image integration
With the use of new image integration systems such as CartoMergeTM (Biosense-Webster, 
Diamond Bar, California, USA), it has become feasible to merge pre-procedural acquired three-
dimensional MSCT or MRI images with on-line acquired electroanatomical maps. Before the 
ablation procedure, the MSCT or MRI images are segmented into diff erent structures (Figure 
12). During the ablation procedure, the MSCT or MRI images are ‘registered’ with the use of 
dedicated software algorithms that minimize the distance between the electroanatomical 
mapping points and the three-dimensional MSCT or MRI images (Figure 13). Both pre-clinical 
(52) and clinical studies (53-55) have demonstrated the accuracy of image integration systems. 
Advantages of the image integration systems include the possibility to monitor the exact cath-
eter position in relation to the endocardial border, the pulmonary veins and the surrounding 
structures (Figure 14). Hereby, potential complications such as pulmonary vein stenosis and 
atrio-oesophageal fi stula may be avoided. 
Recently, Kistler et al (54) compared 47 patients treated using conventional mapping alone 
with 47 patients treated using MSCT image integration. In the image integration group, fl uo-
roscopy times were signifi cantly shorter (49 ± 27 minutes vs. 62 ± 26 minutes, p<0.05) and the 
number of patients with maintenance of sinus rhythm without anti-arrhythmic medication was 
signifi cantly higher in the image integration group (83% vs. 60%, p<0.05) (54). However, these 
data have to be confi rmed in larger, randomized trials. 
One of the limitations of the new image integration technique is the time interval between 
the MSCT / MRI scan and the actual ablation procedure. Obviously, diff erences in fl uid status, 
heart rate or rhythm are present between the two procedures, and may result in errors in the 
image fusion process. Furthermore, the accuracy of the image integration process may be 
aff ected by breathing during data acquisition and during the ablation procedure. In addition, 
variation of pulmonary vein location throughout the cardiac cycle may decrease the accuracy 
(56). Nonetheless, the various studies (52-55) have demonstrated the accuracy and the value 
Figure 11. Comparison of MSCT and ICE to evaluate LA and pulmonary vein anatomy. In this patient, both techniques clearly visualize 
the ‘common ostium’ of the left-sided pulmonary veins (indicated with the white arrow). Whereas MSCT may provide more detailed three-
dimensional information, ICE also provides on-line information on the relation between the ablation catheter and the pulmonary veins during 
the actual ablation. LIPV = left inferior pulmonary vein; LSPV = left superior pulmonary vein; RA = right atrium
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of image integration systems in guiding AF ablation procedures. By merging on-line acquired 
electrophysiological data with detailed anatomical information, these image integration sys-
tems are valuable tools in the invasive treatment of patients with AF.
SUMMARY
Assessment of LA size, anatomy and function is important in various clinical settings and can 
be performed with diff erent imaging techniques. The assessment of LA size provides important 
prognostic information and is routinely performed with transthoracic echocardiography. Infor-
mation on regional LA function can also be provided by transthoracic echocardiography and 
is important in the setting of treatment of atrial fi brillation. Catheter ablation procedures for 
AF require accurate imaging of LA and surrounding structures. Intracardiac echocardiography, 
MSCT and MRI provide detailed information on LA and pulmonary vein anatomy. New image 
integration systems allow the on-line use of pre-procedural acquired images and may facilitate 
the ablation procedures and potentially improve the outcome. 
Figure 12. Segmentation of the MSCT scan into the diff erent structures using the CartoMergeTM Image Integration Module. From the raw 
MSCT data, a three-dimensional volume is created. This volume is divided in the diff erent chambers by placing anatomical landmarks and 
applying a dedicated software algorithm. The chamber of interest (LA in case of atrial fi brillation ablation) can then be used during the actual 
ablation procedure. LA = left atrium; LV = left ventricle; PA = pulmonary artery; RA = right atrium; RV = right ventricle
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Figure 13. Image integration. The upper left panel demonstrates the conventional electroanatomical map with the reconstructed anatomy of 
the LA. The blue, purple, red and green ‘tubes’ represent the pulmonary veins. The lower left panel shows the segmented LA derived from MSCT 
(see also Figure 12). With the use of dedicated software, the CartoMergeTM Image Integration Module integrates the both modalities (right panel).
Figure 14. After the fusion process, the ‘real’ anatomy provided by the MSCT scan can be used to guide the actual catheter ablation. With the 
use of dedicated tools, such as a ‘clipping plane’ (represented by the dotted line), the ostium of the left-sided pulmonary veins (lower left panel) 
and the right sided pulmonary veins (lower right panel) can be visualized. The relation between the ablation catheter and the ostium of the 
pulmonary veins can be monitored constantly. In this patient, a ‘common ostium’ of the left-sided pulmonary veins is present. The white arrows 
indicate the ridge between the left-sided pulmonary veins and the left atrial appendage (LAA). LIPV = left inferior pulmonary vein; LSPV = left 
superior pulmonary vein; RIPV = right inferior pulmonary vein; RSPV = right superior pulmonary vein.
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ABSTRACT
Atrial fi brillation (AF) is the most common cardiac arrhythmia, and is associated with an increased 
risk of cardiac morbidity and mortality. In this review, the role of multimodality imaging in the 
evaluation and treatment of AF is discussed in two main parts. First, an overview of the initial 
assessment of an AF patient is provided, including the role of diff erent imaging techniques. 
Conditions that are associated with AF (coronary artery disease, heart failure, valvular heart 
disease and left ventricular hypertrophy), and the assessment with various imaging modali-
ties will be reviewed. Furthermore, left atrial size assessment and the screening for thrombus 
formation are addressed. Second, the role of imaging in the invasive treatment of AF with 
catheter ablation is reviewed. Issues that should be considered before the procedure including 
contra-indications and pulmonary vein and left atrial anatomy will be discussed. Furthermore, 
the integration of diff erent imaging modalities during catheter ablation is explored. Finally, an 




aging and atrial fi brillation
53
INTRODUCTION
Atrial fi brillation (AF) is the most commonly encountered arrhythmia, and its prevalence 
increases with advancing age. The prevalence of AF in the general population is estimated to 
be 0.4 to 1% (1). Importantly, AF is associated with an increased risk of cardiac morbidity and 
mortality (2). The ‘Euro Heart Survey on Atrial Fibrillation’ that included 5333 AF patients from 
35 European countries, demonstrated that the evaluation and treatment of AF is associated 
with considerable costs (3). Therefore, continuous eff orts are made to optimize the evaluation 
and treatment of AF patients (4). 
The treatment of AF patients depends on various factors including but not limited to the 
type of AF, age and co-morbidity. These issues should therefore be evaluated in the initial 
assessment of a patient presenting with AF. In daily clinical practice, a ‘rhythm control’ strategy 
using anti-arrhythmic drugs is chosen in the majority of the patients (5). However in a large 
proportion of patients, anti-arrhythmic drugs fail to control AF. In these patients, the invasive 
treatment of AF with catheter ablation is a good option (6). The cornerstone of catheter abla-
tion procedures is the electrical isolation of the pulmonary veins (PVs), since these are the main 
source of triggers initiating AF (7). In this review, we will explore the role of various imaging 
techniques in the evaluation and treatment of patients with AF. The manuscript will focus on 
relevant questions for daily clinical practice. The role of imaging in both the initial assessment of 
AF patients, and the invasive treatment of AF patients with catheter ablation will be reviewed. 
CLINICAL EVALUATION OF PATIENTS WITH AF 
Since the prevalence of AF is steadily increasing, an ever-growing number of patients in the 
outpatient clinic will present with AF. In the following paragraphs, we will focus on the role of 
imaging while answering the question ‘What should be evaluated in patients presenting in the 
outpatient clinic with AF?’ 
First, important factors associated with AF should be evaluated. A large number of (clinical) 
conditions, including structural heart disease, hypertension, surgery, hyperthyroidism and 
drugs are associated with AF. In order to diagnose these clinical conditions, medical history, 
physical examination and blood tests are often suffi  cient. However, other conditions associated 
with AF require (non-invasive) imaging for appropriate assessment. One of these conditions is 
underlying structural heart disease. Hence, an important question in the initial clinical evalua-
tion of an AF patient is: ‘Is there any underlying heart disease present?’ Subsequently, the question 
arises: ‘Which imaging techniques can be used to detect the underlying heart disease?’
54
Underlying heart disease
In the clinical evaluation of patients with AF, it is essential to evaluate underlying structural 
heart disease that may cause, or is associated with AF. Since the presence of ‘true’ lone AF is 
controversial, a potential reversible cause of AF (such as myocardial ischemia) should be 
excluded in the fi rst assessment of a patient presenting with AF. In the Euro Heart Survey on 
Atrial Fibrillation, 90% of the AF patients had at least one associated medical condition (5). Most 
frequently, hypertension (up to 66%), coronary artery disease (up to 36%), heart failure (up to 
49%), and valvular heart disease (up to 40%) was present. The prevalence of structural heart 
disease was highest in patients with persistent or permanent AF. 
In daily clinical practice, conventional transthoracic echocardiography is most often used to 
detect underlying heart disease (5). However, other imaging modalities may provide important 
information that cannot be obtained with echocardiography. In the following paragraphs, the 
various cardiac conditions associated with AF, and the diff erent imaging modalities to assess 
these conditions will be discussed.  
Coronary artery disease The presence of coronary artery disease should be assessed in 
patients presenting with AF. Large cohort studies have reported a high prevalence of coronary 
artery disease among patients with AF (8). In 2768 patients with fi rst detected AF, the incidence 
of coronary ischemic events was 31 per 1000 person-years (9). Furthermore, it has also been 
suggested that AF may be the fi rst manifestation of cardiac ischemia (10). Typically, a stepwise 
approach starting with the evaluation of individual risk factors and exercise stress tests is 
applied when screening for coronary artery disease. However, non-invasive imaging modalities 
may have incremental value over traditional risk factors (11). 
Various imaging modalities are available for the assessment of coronary artery disease in 
patients with AF. Conventional angiography remains the gold standard for detection of sig-
nifi cant coronary artery stenosis. In recent years, non-invasive assessment of coronary artery 
disease with multi-slice computed tomography (MSCT) has become available. This technique 
enables non-invasive detection of signifi cant coronary artery stenosis with a high sensitivity 
and specifi city (12). It should be noted however that the diagnostic accuracy of MSCT may be 
limited in patients with AF during data acquisition (13). In addition, MSCT still is limited by 
higher radiation exposure as compared with conventional angiography. New techniques, such 
as the use of dose modulation during scanning may reduce radiation exposure. In a recent 
study, the presence of coronary artery disease was evaluated with MSCT in 150 patients with 
AF and 148 patients with similar age, gender, symptomatic status and pretest likelihood, but 
without a history of AF (14). Interestingly, a higher prevalence of obstructive coronary artery 
disease was noted in the AF patients, compared with the non-AF patients (41% in AF patients 
vs. 27% in non-AF patients, p=0.01). However, more studies are needed to fully appreciate the 
role of MSCT in the screening for coronary artery disease in AF patients. 
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Nuclear myocardial perfusion imaging provides information on the presence of ischemia, 
a surrogate marker for coronary artery disease; the diagnostic accuracy of nuclear perfusion 
imaging to detect signifi cant coronary artery stenoses is high (15). It has been shown that 
nuclear imaging has similar diagnostic accuracy for detection of coronary artery disease in 
asymptomatic patients with AF as compared with patients without AF (16). Abidov et al. have 
demonstrated the prognostic value of ischemia detection with single-photon emission com-
puted tomography in 384 AF patients and 15.664 patients without AF (17). The cardiac death 
rate was 6.3% per year in the AF patients with mildly abnormal myocardial perfusion scan, 
compared with 1.2% per year in the non-AF group with similar perfusion fi ndings. This fi nding 
further underlines the importance of screening for coronary artery disease in AF patients. 
Heart failure  The presence of left ventricular (LV) systolic dysfunction or heart failure should be 
assessed in AF patients. The close relation between AF and heart failure has been well appreci-
ated (18). In the Euro Heart Survey on Atrial Fibrillation 135 patients (5%) developed new onset 
heart failure during 1-year follow-up, while 314 patients (24.7%) experienced worsening of 
existing heart failure (5). Conversely, the Framingham Heart study demonstrated a 4.5-fold to 
5.9-fold increased risk for the development of AF in men and women with LV systolic dysfunc-
tion (19). The exact pathophysiologic mechanism underlying the association between AF and 
LV dysfunction is only partially understood, but includes electromechanical factors, cellular and 
extra-cellular changes, and neurohumoral modulation (20). 
For the assessment of LV systolic function, conventional two-dimensional transthoracic 
echocardiography is typically used. Using standard apical images, LV volumes can be assessed 
and subsequently LV ejection fraction can be calculated (21). Although conventional echocar-
diography is most frequently used in daily clinical practice, the accuracy of this technique largely 
depends on the operator and LV morphology. Therefore, in general magnetic resonance imag-
ing (MRI) is considered the gold standard for assessment of LV volumes. However, it should be 
noted that pacemakers still are a contra-indication for cardiac MRI. In addition, gadolinium for 
delayed-enhancement MRI should not be used in patients with severely impaired renal function, 
due to the risk of nephrogenic systemic fi brosis. Nuclear imaging and MSCT can also be used 
for the assessment of LV function (12), but these techniques are associated with radiation. Novel 
real-time three-dimensional echocardiography allows accurate assessment of LV volumes and 
systolic function (22), and good agreement between this technique and MRI has been reported 
(23). However, more studies on the accuracy of this technique in patients with AF are needed. 
Valvular heart disease  Another condition that is associated with AF is valvular heart disease. 
In the Euro Heart Survey, about 20% of AF patients had valvular heart disease, with the high-
est prevalence among patients with persistent or permanent AF (5). Most often, mitral valve 
disease is present, resulting in elevated left atrial (LA) pressures and subsequently in a higher 
susceptibility to AF. 
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Transthoracic echocardiography is typically used for the assessment of valvular disease in 
patients with AF. It allows a comprehensive anatomical and functional evaluation of the dif-
ferent valves. Recently, the feasibility of both MRI (24) and MSCT (25) to assess valvular heart 
disease have been demonstrated. However, in daily clinical practice conventional echocardio-
graphy remains the technique of choice to assess valvular heart disease in AF patients. 
LV hypertrophy The presence of LV hypertrophy should be evaluated in the initial assessment 
of AF patients. Long-lasting hypertension may result in LV hypertrophy and may expose the 
LA to elevated pressures. Since hypertension may be present in up to 66% of patients present-
ing with AF (5), screening for LV hypertrophy is essential. In 1924 patients of the Framingham 
Heart Study, increased LV wall thickness was one of the predictors for the development of AF 
over a 7.2-year period (HR 1.28 per 4-mm increment, 95% CI, 1.03 to 1.60) (26). Importantly, it 
has been suggested that antihypertensive therapy targeted at regression or prevention of LV 
hypertrophy may reduce the incidence of new-onset AF (27). 
In addition to conventional criteria using electrocardiography, various imaging modalities 
can be used for the screening for LV hypertrophy in AF patients. In daily clinical practice, trans-
thoracic echocardiography is most frequently used. Using standard echocardiographic images, 
LV wall thickness and LV mass can be assessed (21). However, three-dimensional imaging tech-
niques such as MRI may provide a more accurate quantifi cation of LV hypertrophy (28). Real-time 
three-dimensional echocardiography may overcome the limitations of conventional echocar-
diography and may be comparable with MSCT and MRI for assessment of LV hypertrophy (22).  
Left atrial size
In addition to underlying structural heart disease, LA size should be assessed in the initial evalu-
ation of patients with AF (1). In particular LA dilatation, as a marker of LA remodeling, should 
be identifi ed. The association between AF and LA remodeling is well appreciated (29), but it 
remains controversial whether AF causes LA dilatation, or rather is its consequence. It has been 
demonstrated that LA size is a strong predictor of cardiovascular events in patients with lone 
AF, independent of age and clinical risk factors (30). Therefore, LA size should be assessed in the 
initial evaluation of AF patients, but the question is: ‘How should LA size be assessed?’ 
Magnetic resonance imaging still is considered the gold standard for quantifi cation of LA 
size. Its three-dimensional character and high spatial resolution allow accurate assessment 
of the LA. Typically, the modifi ed Simpson’s rule is applied, using LA areas from subsequent 
cross-sectional images (31). However, MRI is limited by the relatively time-consuming data 
acquisition and cumbersome data analysis. Therefore, in daily clinical practice, MRI is not often 
used for the assessment of LA size. Similarly, MSCT allows three-dimensional assessment of LA 
size, with high spatial and temporal resolution (32). The modifi ed Simpson’s rule and simplifi ed 
linear methods can be used to quantify LA size (33). MSCT however, is not routinely used for 
assessment of LA size, because of radiation exposure and the need for contrast agents. 
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Transthoracic echocardiography is widely used for assessment of LA size in daily clinical 
practice. In randomized clinical trials and large cohort studies, linear methods such as the 
M-mode derived LA diameter are typically used for LA size assessment because of the good 
reproducibility. However, it has been well recognized that the M-mode derived LA diameter 
may underestimate true LA size (34). In particular when LA dilatation is present, resulting in an 
asymmetric shape of the LA, linear methods are not the preferred method. Instead, LA volumes 
should be assessed for quantifi cation of LA size (21). 
Various methods are available for quantifi cation of LA volumes using transthoracic echo-
cardiography (Figure 1). The ellipsoid method and biplane area-length method use various LA 
diameters and/or areas to calculate LA volumes, assuming that the LA has an ellipsoid shape (35). 
The modifi ed biplane Simpson’s rule using planimetry is considered the most accurate method 
and is most frequently used. Good agreement between the biplane area-length method and 
the biplane Simpson’s rule has been demonstrated (36). However, all these methods still use 
geometric assumptions and are operator dependent. Real-time three-dimensional echocar-
diography allows more accurate assessment of LA volumes (Figure 2) (22). In addition, because 
Figure 1. Using transthoracic echocardiography, various methods are available to assess LA size. The standard parasternal long-axis 
view (PSLAX) and the apical 2-chamber (2CH) and 4-chamber (4CH) views are used to assess LA diameters and LA area (using planimetry). 
Subsequently, LA volume can be calculated with the diff erent equations. APD, D, L = LA diameter; A
2CH
 = LA area on 2-chamber view; A
4CH
 = LA 
area on 4-chamber view.
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of its semi-automatic character, resulting in high reproducibility, real-time three-dimensional 
echocardiography is of great value in the follow-up of AF patients (37).
Left atrial thrombus
In addition to underlying structural heart disease and LA size, the presence of thrombus should 
be assessed in selected patients presenting with AF. Although there are various sources of 
embolism in patients with ischemic stroke, the majority of strokes occurring in patients with AF 
can be attributed to the presence of thromboembolism in the LA (1). Therefore, screening for 
thrombus formation is of critical importance, in particular in patients undergoing cardioversion 
or catheter ablation for AF. The question arises: ‘Which imaging technique should be used for the 
screening for LA thrombi?’ 
Figure 2. Real-time three-dimensional echocardiography for the assessment of LA volumes. Automatic border detection can be applied to 
the apical 4-chamber and 2-chamber view (upper panels) for quantifi cation of LA volumes.
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Conventional transthoracic echocardiography can be used to assess LA dilatation and severe 
LV dysfunction, both associated with the presence of LA thrombi and stroke (38,39). However, 
this technique has only moderate sensitivity and specifi city for the detection of LA thrombi 
(40). In contrast, transesophageal echocardiography has a very high sensitivity and specifi city 
for detection of cardiogenic sources of thromboembolism (41). In addition, spontaneous echo 
contrast and reduced LA appendage fl ow velocity, associated with LA thrombus formation, can 
be assessed with transesophageal echocardiography. Importantly, it has been demonstrated 
that the use of transesophageal echocardiography may result in less hemorrhagic complica-
tions after cardioversion, compared with a conventional strategy using anticoagulation prior 
to cardioversion (42). 
Non-invasive three-dimensional imaging techniques such as MRI and MSCT have also been 
used for the detection of thrombi in the LA and LA appendage. However, both techniques 
have low inter-observer agreement, and moderate sensitivity and specifi city compared with 
transesophageal echocardiography (43,44). Therefore, at present transesophageal echocar-
diography is still considered the gold standard for the detection of thrombi in the LA and LA 
appendage in patients with AF (1). 
PATIENTS WITH AF UNDERGOING CATHETER ABLATION 
After the initial assessment as described before, a tailored treatment strategy should be 
planned for each AF patient. Radiofrequency catheter ablation is a good therapeutic option 
when at least one anti-arrhythmic drug has failed (1). A recent study including 1404 AF patients 
undergoing PV isolation demonstrated that 78% of patients with paroxysmal AF and 67% 
of patients with non-paroxysmal AF (p<0.001) maintain sinus rhythm after a single catheter 
ablation procedure (45). Although various ablation strategies exist, the majority of approaches 
target electrical isolation of the PVs (6). In the following paragraphs, the question ‘What is the 
role of imaging in catheter ablation for AF?’ will be answered. Before the procedure, during the 
actual ablation and during follow-up various imaging modalities play a diff erent role (Table 1). 
The diff erent processes and the preferred imaging modalities will be reviewed in the following 
paragraphs. 
Pre-procedural issues: Contra-indications and assessment of anatomy
The fi rst step in the work-up of a patient referred for AF ablation is to exclude any contra-indica-
tion. The most important is to rule out the presence of LA thrombi. In particular in patients with 
persistent AF, or patients who are in AF at the time of the procedure, this is of critical importance 
(6). As discussed previously, transesophageal echocardiography is considered the gold standard 
for detection of LA thrombi. In addition, extreme LA dilatation and long-lasting permanent AF 
are relative contra-indications for AF ablation, since these conditions are associated with a low 
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Table 1. The role of imaging in AF ablation
Process Imaging modality Comment
Before catheter ablation
Assessment of LA / LAA thrombus TEE Considered gold standard for detection of 
thrombi
Assessment of LA size and 
anatomy
TTE Most often used in daily clinical practice
RT3DE New technique allowing accurate assessment of 
LA volumes
MSCT or MRI Allow three-dimensional assessment of LA 
volumes and specifi c anatomic features. 
Considered gold standard for assessment of LA 
volumes
Assessment of PV anatomy MSCT or MRI Provide detailed three-dimensional information 
on PV anatomy as a ‘road-map to ablation’
During catheter ablation
Positioning catheters Fluoroscopy Standard imaging modality in the 
electrophysiology laboratory. Enables 
visualization of catheters and devices. 
Transseptal puncture ICE May enhance safety of transseptal puncture by 
direct visualization of inter-atrial septum and 
puncture needle
Visualization of LA and PVs Fluoroscopy New rotational angiography technique accurately 
identifi es PV anatomy and PV diameters
ICE Allows real-time assessment of PV ostium, but 
underestimates PV diameter
Mapping system Provides real-time electroanatomic information, 
and guides ablation. Limited by the use of 
reconstructed anatomy
Image integration Fluoroscopy & MSCT 
/ MRI
Combines real-time fl uoroscopy with detailed LA 
and PV anatomy from MSCT or MRI
Mapping system & 
MSCT / MRI
Combines electroanatomic map with detailed LA 
and PV anatomy from MSCT or MRI
Mapping system & ICE Combines electroanatomic map with real-time 
anatomic information from ICE
Follow-up after catheter ablation
Assessment of PV stenosis MSCT or MRI Preferably, these three-dimensional techniques 
are correlated with pre-procedural images for 
detection of PV stenosis 
Detection of pericardial eff usion TTE Routine echocardiography should be performed 
before discharge and during follow-up
Esophageal injury MSCT or MRI Should be performed when atrio-esophageal 
fi stula is suspected
Assessment of LA size and 
function
TTE Conventional method for detection of LA volumes 
and function
RT3DE Three-dimensional assessment of LA volumes 
allows detection of LA reverse remodeling
MSCT Three-dimensional assessment of LA volumes 
allows detection of LA reverse remodeling
MRI Preliminary studies demonstrate feasibility of LA 
scar detection with gadolinium enhanced MRI
ICE = intracardiac echocardiography; LA = left atrium/atrial; LAA = left atrial appendage; MRI = magnetic resonance imaging; MSCT = 
multi-slice computed tomography; PV = pulmonary vein; RT3DE = real-time 3-dimensional echocardiography; TEE = transesophageal 
echocardiography; TTE = transthoracic echocardiography.
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probability of successful outcome (46). Therefore, LA size assessment should be performed rou-
tinely, as described in the previous section. After exclusion of any contra-indication, LA and PV 
anatomy should be assessed, since the PVs are the main target during the ablation procedure. 
Therefore, an important question is: ‘How can LA and PV anatomy best be assessed?’ 
From anatomical studies it has become apparent that LA and PV anatomy is highly variable 
(47). Typically, four separate PVs are present: two right-sided and two left-sided PVs. Large in 
vivo studies using MSCT and MRI scanning have demonstrated that a single PV ostium on the 
left side or an additional right-sided PV are the most common variations (Figure 3) (48,49). 
These anatomical variants may be present in up to 30% of patients, and may aff ect the planned 
ablation strategy. In general, three-dimensional imaging techniques such as MSCT and MRI 
are used for assessment of PV anatomy. Using three-dimensional reconstructions and cross-
sectional images, these techniques provide the most detailed information on PV anatomy. 
In addition to the number of PVs, the exact diameter and shape of the PVs should be 





Figure 3. Three-dimensional volume-rendered reconstructions of MSCT images are created to assess LA and PV anatomy. Normal PV 
anatomy includes four PVs draining separately into the LA (upper panel). Variations of PV anatomy include a single (or ‘common’) ostium of 
the left-sided PVs (lower left panel, black double-arrow), and an additional right-sided PV (lower right panel, black arrow). LIPV = left inferior 
pulmonary vein; LSPV = left superior pulmonary vein; RIPV = right inferior pulmonary vein; RSPV = right superior pulmonary vein.
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using balloon-catheters (50). In addition, comparison of PV diameters at baseline and during 
follow-up allows detection of PV stenosis after catheter ablation (51). 
Finally, specifi c anatomical features of the LA, such as the LA appendage, variations in LA 
roof anatomy and the ‘Coumadin ridge’ between the left-sided PVs and the LA appendage, can 
be assessed prior to the ablation procedure (52). Surrounding structures that may be important 
during catheter ablation can be identifi ed including coronary veins, coronary arteries and the 
course of the esophagus (25,53). For these issues, MSCT and MRI are the preferred imaging 
modalities (6). 
During catheter ablation: visualization of structures and image integration 
During the actual catheter ablation procedure, mapping and ablation catheters are introduced 
into the LA after a transseptal puncture. This is typically performed under fl uoroscopy guid-
ance, but intracardiac echocardiography can be used to better visualize the inter-atrial septum 
and puncture needle (54). After gaining access to the LA, the exact location and anatomy of the 
PV ostia is determined, and the position of the mapping/ablation catheters in relation to them. 
For this purpose, various imaging modalities are available. 
Fluoroscopy is the most widely used imaging technique in the electrophysiology labora-
tory. However, correct visualization of cardiac structures may be limited with fl uoroscopy alone. 
In recent years, a new application of conventional fl uoroscopy has been introduced: rotational 
angiography uses a C-arm fl at-panel fl uoroscopy system and contrast medium to create three-
dimensional images of the LA and PVs (55). It has been demonstrated that this technique 
correctly identifi es PVs and provides PV diameters that correlate well with those derived from 
pre-procedural acquired MSCT images (56). 
Intracardiac echocardiography can be used in addition to fl uoroscopy to visualize the PVs. 
This technique provides real-time images of the PVs and neighboring structures. In addition, 
it may be very helpful in avoiding complications during the ablation (57). A limitation of intra-
cardiac echocardiography is its two-dimensional character. As a result, PV diameters may be 
underestimated as compared with three-dimensional imaging techniques (58,59). 
Electroanatomic mapping systems may also be used in addition to fl uoroscopy. These 
systems provide on-line electrophysiologic data, and allow tracking of mapping/ablation cath-
eters and annotation of ablation points (60). A limitation of electroanatomic mapping systems 
however is the use of reconstructed anatomy. Finally, three-dimensional imaging techniques 
such as MSCT and MRI can provide very detailed information on LA and PV anatomy. However, 
scanning is performed before the ablation procedure, and therefore these techniques cannot 
provide real-time images. 
Although the various imaging modalities all provide important information during the 
catheter ablation procedure, each technique has its own limitations. Integration of the diff erent 
modalities may overcome the limitations of each separate modality. Hence, the question is: ‘Is it 
possible to integrate diff erent imaging modalities during AF ablation?’ 
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In recent years, various image integration systems have been introduced, allowing inte-
gration of diff erent imaging modalities. Dedicated software has been developed to integrate 
biplane fl uoroscopy and MSCT or MRI images (61). Angiographic reconstructions of the LA 
and PVs from fl uoroscopy and three-dimensional volume rendered reconstructions from pre-
procedural acquired MSCT or MRI images are merged with the use of calibration, translation 
and rotation processes. Several studies have demonstrated the feasibility of this new technique 
and its value during AF ablation (62,63). 
In the past years, large clinical experience has been obtained with the integration of elec-
troanatomic maps and three-dimensional techniques such as MSCT and MRI (64). This image 
integration strategy uses algorithms that minimize the distance between the reconstructed 
anatomy from the electroanatomic map and the MSCT or MRI image (65,66). Importantly, it has 
been demonstrated that the use of image integration may improve the outcome of the ablation 
procedure (67). In a cohort of 290 patients (145 patients with image integration, 145 patients 
with conventional mapping and ablation approach), the AF-free survival rate was signifi cantly 
higher in patients with image integration (Figure 4) (68). However, this fi nding was not confi rmed 
in a smaller, randomized study: single procedure success after 6 months follow-up was similar 
in patients with image integration and conventional mapping approach (50% vs. 56%, p=0.65) 
(69). More randomized controlled trials are needed to fully appreciate the role of integration of 
electroanatomic maps and MSCT or MRI images in catheter ablation procedures, and the impact 
on procedure/ fl uoroscopy times and outcome. Nonetheless, image integration facilitates AF 




Figure 4. The use of image integration during catheter ablation may signifi cantly improve the outcome of the procedure. In patients treated 
with catheter ablation using image integration, the AF-free survival rate was signifi cantly higher compared with patients who were treated 
with conventional electroanatomic mapping alone (AF-free survival rate 88% vs. 69%, p<0.05). Adapted from Della Bella et al., reference 68.
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More recently, integration of intracardiac echocardiography, electroanatomic mapping and 
MSCT has become available (70) (Figure 5). With the use of an intracardiac echocardiography 
probe that is tracked by the electroanatomic mapping system, a real-time electrophysiologic 
and anatomic reconstruction of the LA and PVs is created. Subsequently, it is integrated with 
MSCT images, adding detailed anatomic information. Although it is a promising strategy, more 
studies are needed to appreciate the role of this new technique and its eff ect on the outcome 
of catheter ablation for AF. 
Follow-up issues: assessment of complications and evaluation of LA function
Immediately after the procedure and during follow-up, patients should be screened for com-
plications. A large survey revealed that serious complications occur in up to 6% of patients (71). 
Therefore, it is important to know: ‘Which complications can be expected and how can they be 
assessed?’ 
Pulmonary vein stenosis is one of the most frequently occurring complications of AF 
ablation (6). Fortunately, the prevalence is decreasing due to more proximal ablation strate-
gies. Asymptomatic PV stenosis may occur in up to 19% of patients, whereas symptomatic PV 
stenosis requiring intervention occurs in less than 1% of patients (72). Conventional invasive 
angiography assessing PV diameters may be used for the detection of PV stenosis. However, 
Figure 5. The feasibility of the integration of electroanatomic mapping, intracardiac echocardiography and MSCT has recently been 
demonstrated. A dedicated intracardiac echocardiography probe provides real-time anatomic images that are integrated with pre-procedural 
acquired MSCT images. On the ECG-gated intracardiac echocardiography images, the anatomy of the LA and PVs can be annotated, creating a 
three-dimensional shell (right panel). Subsequently, the three imaging modalities are integrated with dedicated algorithms (left panel).
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three-dimensional imaging techniques such as MSCT or MRI are recommended for accurate 
assessment of PV stenosis (73). 
Severe pericardial eff usion or cardiac tamponade is another serious complication after AF 
ablation. In a recent meta-analysis with 70 studies including approximately 15.500 AF patients, 
cardiac tamponade was reported in up to 5% of the patients (median from all studies 1%) (72). 
During the procedure, invasive blood pressure measurement, fl uoroscopy, and transthoracic 
echocardiography are helpful tools to detect pericardial eff usion. In addition, intracardiac 
echocardiography can be used during the procedure (74). Conventional transthoracic echocar-
diography is the preferred imaging modality for screening during follow-up (6). 
Finally, injury to the esophagus may occur after ablation, since the esophagus has a close 
relation with the posterior LA wall and PVs. A rare but severe complication is an atrio-esophageal 
fi stula (75). MSCT or MRI should be performed when this complication is suspected (6). 
In addition to the detection of complications, the eff ects of catheter ablation on cardiac 
function may be assessed during follow-up. It has been demonstrated that AF ablation has 
favorable eff ects on LV systolic function in patients with heart failure (76). In contrast, in 
patients with preserved LV systolic function, LV ejection fraction does not change after success-
ful catheter ablation (77). However, it may be that LV ejection fraction is not a sensitive marker 
to detect subtle changes in LV systolic function. Recently, it has been demonstrated that global 
LV systolic strain does improve in patients with preserved LV systolic function who maintain 
sinus rhythm after catheter ablation (78). In contrast, patients who had recurrence of AF did not 
show a signifi cant improvement in LV systolic strain. 
Furthermore, since extensive ablation in the LA may result in scar formation and subse-
quently in changes in LA anatomy, one could wonder: ‘What is the eff ect of catheter ablation 
on LA size and function?’ As previously described, there is a strong association between AF and 
LA enlargement. Interestingly, it has been demonstrated that restoration of sinus rhythm may 
result in reversal of LA enlargement (29). Several studies have demonstrated a decrease in LA 
volumes after successful catheter ablation (79-81). Typically, transthoracic echocardiography 
is used for the follow-up of LA volumes. However, three-dimensional techniques may provide 
more accurate information, as previously described. With the use of real-time three-dimensional 
echocardiography, it has been shown that LA maximum volume decreases in patients who 
maintain in sinus rhythm during follow-up (82). Similarly, LA reverse remodeling has also been 
demonstrated with MSCT (32) and MRI (83). 
Furthermore, AF ablation may aff ect LA function. Three distinct phases can be distinguished 
in LA function: LA reservoir function (during ventricular systole), LA conduit function (during 
early ventricular diastole) and LA booster pump function (during late ventricular diastole). In 
general, LA function parameters are derived from trans-mitral fl ow patterns using Doppler 
echocardiography. However, using real-time three-dimensional echocardiography the diff erent 
phases in LA function can be derived from LA volumes throughout the cardiac cycle. Marsan et 
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al. demonstrated that LA booster pump function signifi cantly improves in AF ablation patients 
who maintain sinus rhythm during follow-up (Figure 6) (37). 
With the use of tissue Doppler echocardiography, LA strain and strain rate can be assessed. 
These parameters represent myocardial mechanical function, allowing quantifi cation of LA seg-
mental function (84). Schneider et al. used this technique to assess LA function in 118 patients 
undergoing AF ablation (85). After 3 months follow-up, an improvement in the diff erent LA 
functions was noted, but only in patients who maintained sinus rhythm during follow-up. 
Finally, the feasibility of LA scar assessment with gadolinium enhanced MRI has recently 
been demonstrated. In 53 patients undergoing AF ablation, MRI images were acquired before 
the procedure and after 3 months follow-up. Interestingly, the extent of LA scar as assessed 
with MRI was a strong predictor of freedom from AF during follow-up (OR 18.5, 95% CI 1.27 to 
268, p=0.032) (86). However, more studies are needed to appreciate the role of LA scar assess-
ment with MRI in the follow-up of AF ablation patients.  
CONCLUSIONS
Multimodality imaging plays an important role in the initial assessment of AF patients, and 
during subsequent invasive treatment with catheter ablation (Figure 7). An important issue to 
consider in the fi rst evaluation of AF patients is the presence of any underlying heart disease 
that is associated with AF: coronary artery disease, heart failure, valvular heart disease and LV 
Figure 6. Left atrial active emptying fraction (representing LA active function) improves in patients who maintain sinus rhythm during 
follow-up (green bars). In contrast, a deterioration of LA active emptying fraction is noted in patients who have recurrence of AF during follow-
up (red bars). Adapted from Marsan et al., reference 37.
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hypertrophy. Any (reversible) underlying disease that causes AF should be treated fi rst. Fur-
thermore, LA size should be assessed in the initial evaluation of AF patients. For the routine 
assessment of LA size transthoracic echocardiography is the technique of choice. Preferably, LA 
volumes are assessed for estimation of LA size. 
After the initial assessment of the AF patient, a treatment strategy is chosen (pharmacologic 
vs. non-pharmacologic). Multimodality imaging is of particular value in the non-pharmacologic 
treatment of AF. In patients undergoing electrocardioversion or catheter ablation, LA thrombi 
should be excluded with transesophageal echocardiography. Before catheter ablation, PV 
anatomy should be evaluated, preferably with three-dimensional imaging techniques such as 
MSCT or MRI. During the actual ablation procedure, diff erent imaging modalities are available 
for visualization of cardiac anatomy. New dedicated systems allow integration of the various 
modalities, further facilitating catheter ablation procedures. After the ablation procedure, 
imaging plays an important role in the detection of complications. Finally, the eff ects of the 
catheter ablation procedure on LA size and function can be assessed with various imaging 
modalities.
Underlying heart disease?
Coronary artery disease Heart failure Valve disease LV hypertrophy
Yes
LA size assessment
Pharmacologic treatment Non-pharmacologic treatment
Thromboembolism Pulmonary vein anatomy
No
Treat reversible cause AF
Figure 7. Multimodality imaging plays an important role in the evaluation of AF patients, and in the management of AF. Various modalities 
are available for screening for underlying heart disease causing AF. For LA size assessment, various methods are available; three-dimensional 
imaging techniques provide the most accurate estimation. In particular in the non-pharmacologic treatment of AF, imaging plays an important 
role in patient selection and guidance of the procedure. See also text for explanation.
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Background: The outcome of catheter ablation procedures of cardiac arrhythmias depends on 
the ability to evaluate the underlying mechanism and to depict target sites for ablation. Fusion 
of diff erent imaging modalities within one system may improve electroanatomic modeling and 
facilitate ablation procedures. 
Objectives: To study the feasibility of fusion of multi-slice computed tomography (MSCT) with 
electroanatomic mapping to guide radiofrequency catheter ablation of atrial arrhythmias. 
Methods: Sixteen patients (15 men, age 54 ± 7 years) with drug-refractory atrial fi brillation (AF) 
underwent 64-slice MSCT within 2 days before radiofrequency catheter ablation. MSCT data 
were imported in the CartoTM electroanatomic mapping system. Using the new CartoMergeTM 
Image Integration Module, the MSCT images and the electroanatomical map were aligned. A 
statistical algorithm provided information about the accuracy of the fusion process. 
Results: In all patients MSCT images could be fused with the electroanatomic map. Mean 
distance between the mapping points and the MSCT surface ranged from 1.7 ± 1.2 mm to 2.8 ± 
1.8 mm. This resulted in an average of 2.1 ± 0.2 mm for the patient group as a whole. 
Conclusion: MSCT images can be fused with the 3D electroanatomic mapping system in an 
accurate manner. Anatomy-based catheter ablation procedures for atrial arrhythmias may be 
facilitated by integration of diff erent imaging modalities. 
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Ectopic beats originating from the pulmonary veins have been identifi ed as a potential cause 
of atrial fi brillation (AF) (1). Catheter ablation focused on isolation of the pulmonary veins is a 
curative treatment modality of AF. Diff erent strategies for pulmonary vein isolation have been 
proposed, including segmental (2) and circumferential (3) ablation. Electrical isolation of the 
pulmonary veins has proved to be a safe technique with a reasonable long-term success rate 
(4,5). To plan and guide these ablation procedures, detailed anatomic information is needed. 
Several imaging modalities are available to visualize the anatomy of the left atrium and the 
pulmonary veins.
Both magnetic resonance imaging and multi-slice computed tomography (MSCT) are 
non-invasive imaging modalities that can provide the requested information and both imag-
ing modalities have been used to provide road maps prior to ablation (6,7). These techniques 
provide detailed information on the precise number, location and anatomy of the pulmonary 
veins and have been demonstrated useful in the planning of ablation procedures (8,9). In addi-
tion, detailed information is also needed during the ablation procedure; fl uoroscopy alone is 
not accurate enough and may result in a prolonged radiation exposure. For this purpose, 3D 
electroanatomic mapping systems that facilitate ablation procedures have been introduced 
(10). However, a realistic anatomical representation of the left atrium and pulmonary veins is 
still diffi  cult to obtain. Therefore, fusion of an anatomical imaging technique (e.g. MSCT) with 
3D electroanatomic mapping may further facilitate ablation procedures. In the current study, 
the feasibility of fusion of MSCT with electroanatomic mapping is demonstrated in patients 
undergoing radiofrequency ablation for AF. 
METHODS
Study population
The study population consisted of 16 consecutive patients (15 men, mean age 54 ± 7 years) 
with symptomatic drug-refractory AF who were admitted for radiofrequency catheter abla-
tion. AF was present for 54 ± 12 months, and was paroxysmal in 5 patients, persistent in 9 
and permanent in 2 patients. Mean number of anti-arrhythmic drugs used was 3.7 ± 1.6 per 
patient. Mean left atrial size was 4.4 ± 0.3 cm; mean left ventricular ejection fraction was 57 ± 
10%. Seven patients were treated for hypertension; none of the patients had clinically relevant 
valvular disease. Six patients underwent coronary angiography for suspected coronary artery 
disease; in none of the patients signifi cant coronary artery stenoses were detected. One patient 




All patients underwent MSCT using a 64-detector row system (Toshiba Medical Systems, 
Otawara, Japan) 2 days prior to the ablation procedure, as previously reported (8). Collimation 
was 64 x 0.5 mm, rotation time 400 ms, and tube voltage 100 kV at 250 mA. Cranio-caudal 
scanning was performed during an inspiratory breathhold, without electrocardiographic gat-
ing. Non-ionic contrast material (Iomeron 400, Bracco Altana Pharma, Konstanz, Germany) was 
infused through the antecubital vein with an infusion rate of 5 ml/s. A total amount of 70 ml 
contrast was given. Automatic detection of the contrast bolus in the ascending aorta was used 
to time the scan. All MSCT images were evaluated by two experienced observers in consensus. 
To assess the number of pulmonary veins, the number of ostia (common or separate ostia), 
and the branching pattern of the pulmonary veins, 2D viewing modes and 3D reconstructions 
were used. Diameters of the pulmonary vein ostia were measured in the anterior-posterior and 
superior-inferior direction, as previously described (8). Furthermore, thrombi in the left atrial 
appendage and extra-cardiac anomalies were excluded. 
Image processing
Before the ablation procedure, raw MSCT data were loaded into the 3D electroanatomic map-
ping system (Carto XPTM, Biosense Webster, California, USA) equipped with the newly devel-
oped CartoMergeTM Image Integration Module. The accuracy of this new technique has been 
validated in animal studies previously (11). To depict the structures of interest (left atrium and 
pulmonary veins) out of the raw data set, a segmentation process was performed manually. 
This process consisted of several phases. First, the borders of the structures of interest 
were delineated by setting the threshold intensity range. The presence of contrast in the left 
atrium allowed diff erentiation between endocardium (low intensity level) and blood pool (high 
intensity level). Subsequently, a 3D volume was created by labeling all volume units of the raw 
MSCT data within the set threshold intensity range. To segment this volume into diff erent 
structures, anatomical markers were placed in the middle of the diff erent areas of the volume. 
An algorithm was then implemented to automatically depict the diff erent structures of interest 
based on the placement of the anatomical markers and the borders (Figure1). Finally, the result 
of the segmentation process was verifi ed on axial slices. When an adequate segmentation of 
the MSCT images was achieved, the surface images were stored in the CartoTM system. 
Mapping and radiofrequency ablation
The aim of the radiofrequency catheter ablation procedure for AF was to obtain an electri-
cal disconnection of all pulmonary veins. With the use of intracardiac echocardiography an 
intracardiac thrombus was excluded and a transseptal puncture was guided (12). Mapping and 
ablation was performed with a 4 mm quadripolar mapping/ablation catheter (7F Thermocool, 
Biosense Webster, California, USA). A 6F reference catheter was placed in the right atrium. 
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After completion of the electroanatomic map, a registration process was performed manu-
ally to fuse the MSCT images and the electroanatomic map. First, the 3D surface image of the 
MSCT was displayed on the CartoTM system next to the electroanatomic map. A landmark 
was then placed on the electroanatomic map on a certain point (e.g. left atrial appendage), 
confi rmed with intracardiac echocardiography and fl uoroscopy. A second landmark was placed 
on the MSCT image at the same location (Figure 2). Next, the surface registration algorithm 
was performed to align the MSCT surface image and the electroanatomic map. This algorithm 
composed the best fi t of the two structures based on minimizing distance between the two 
landmarks and the distance between all mapping points and the MSCT surface image. 
The accuracy of the registration process was then reviewed. The algorithm used for fusion 
provided information about the accuracy of the registration: mean distance, standard deviation 
and range between all mapping points and the MSCT surface image were reviewed. Further-
more, the catheter position in the fused electroanatomic map and MSCT was reviewed using 
intracardiac echocardiography and fl uoroscopy. 
After registration of the MSCT surface image radiofrequency current was applied outside 
the ostia of the pulmonary veins, using the ablation catheter with a 4 mm open loop irrigated 
Figure 1. Multislice computed tomography image after segmentation using the CartoMergeTM Image Integration Module. Segmentation 
included: creation of a 3D volume, placement of anatomical markers on diff erent structures and implementation of an algorithm that creates the 
diff erent structures of interest (see text). LA = left atrium; LV = left ventricle; PA = pulmonary arteries; RA = right atrium; RV = right ventricle.
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tip. The following power and temperature settings were used: irrigation rate 20 mL/min, maxi-
mum temperature 50°C, maximum radiofrequency energy 30 W. At each point, radiofrequency 
current was applied until a voltage <0.1 mV was achieved, with a maximum of 60 seconds per 
point. If a separate pulmonary venous insertion was noted on the MSCT image, radiofrequency 
current was targeted to form separate circles surrounding the pulmonary venous ostia. If a 
common ostium was observed, ablation points were targeted in a large circle surrounding the 
common ostium. The procedure was considered successful when pulmonary vein isolation was 
confi rmed by recording entrance block during sinus rhythm or pacing in the coronary sinus. All 
patients received heparin intravenously (activated clotting time > 300 sec) to avoid thrombo-
embolic complications. 
After the ablation procedure, patients received heparin intravenously until INR was 
adequate with oral anticoagulants. Transthoracic 2D echocardiography was performed within 
24 hours to detect pericardial eff usion. Electrocardiographic monitoring (including 12-lead sur-
face and 24-hour Holter monitoring) was obtained to assess the maintenance of sinus rhythm 
after the ablation procedure. 
Statistical analysis
The statistical algorithm of the new CartoMergeTM Image Integration Module provides statisti-
cal information (mean, standard deviation and range) about the distances between all map-
ping points and the MSCT surface image. All data are presented as mean ± standard deviation 
or number (%). 
Figure 2. During the ablation procedure, a registration process was performed to fuse the electroanatomic map and the MSCT image. After 
completion of the electroanatomic map of the left atrium, landmarks were placed on the electroanatomic map and the MSCT surface image. In 
this case, a landmark (LA) was placed on the left atrial appendage, based on fl uoroscopy and intracardiac echocardiography. Panel A: posterior 
view, Panel B: lateral view.
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MSCT and image processing
In the 16 patients, a total number of 67 pulmonary veins were identifi ed by MSCT (4.2 ± 0.4 per 
patient). In 3 patients (19%), an additional pulmonary vein on the right side was observed. A 
common ostium of the left-sided pulmonary veins was noted in 6 patients (38%), and a com-
mon ostium of the right-sided pulmonary veins in 1 patient (6%). In 9 patients (63%), early 
branching pattern of a pulmonary vein was observed, all in the right inferior pulmonary vein. 
The anterior-posterior and superior-inferior diameters were as follows: left superior pulmo-
nary vein 15.8 ± 2.3 mm and 19.0 ± 2.1 mm respectively, left inferior pulmonary vein 13.2 ± 2.0 
mm and 18.4 ± 1.9 mm, right superior pulmonary vein 17.7 ± 2.7 mm and 20.1 ± 3.3 mm, right 
inferior pulmonary vein 17.3 ± 2.7 mm and 17.6 ± 2.4 mm, respectively. 
Image processing of the raw MSCT data could be performed within 10 minutes in all 
patients. Good contrast timing during the CT scan favored the segmentation process: the 
presence of contrast allowed excellent diff erentiation between the endocardium (low intensity 
level) and the blood pool (high intensity level). In all patients, an adequate segmentation of the 
MSCT was achieved. 
Mapping and radiofrequency ablation
Eventually, all patients were treated with radiofrequency catheter ablation for AF. In all patients 
a transseptal puncture could be performed guided by intracardiac echocardiography. Mean 
mapping time was 43 ± 15 minutes, and a mean of 224 ± 59 mapping points was used to create 
an electroanatomic map of the left atrium and pulmonary veins. There was no diff erence in 
heart rhythm during MSCT scanning and the mapping / ablation procedure. 
After placement of the landmarks, the MSCT image and the electroanatomic map were 
fused. This registration process could be performed within 5 - 7 minutes in all patients. After 
the registration, the distances between all mapping points and the MSCT surface image were 
reviewed. Results of the registration processes are listed in Table 1. Mean distance between the 
mapping points and the MSCT surface ranged from 1.7 ± 1.2 mm to 2.8 ± 1.8 mm. This resulted 
in an average of 2.1 ± 0.2 mm for the patient group as a whole. 
The fused electroanatomic map and MSCT surface image were used to guide the catheter 
during the actual ablation. Exact catheter position and relation to the pulmonary veins and the 
endocardium could be adequately visualized (Figure 3). Radiofrequency current was applied 
outside the ostia of all the pulmonary veins. Mean ablation time was 89 ± 20 minutes, and 
mean fl uoroscopy time was 48 ± 7 minutes. Procedural success was achieved in all patients. No 
complications occurred during the ablation procedures, in 2 patients mild pericardial eff usion 
was observed after the procedure, without hemodynamic consequences. After the ablation 
procedure all patients were in sinus rhythm. 
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DISCUSSION
The results of this study illustrate the feasibility of fusion of MSCT images with 3D electroana-
tomic mapping in patients undergoing catheter ablation for AF. The mean distance between 
the MSCT image and the electroanatomic map was only 2 mm, allowing accurate visualization 
of the catheter position on real surface anatomy during the ablation procedure. The integra-
tion of MSCT images and 3D electroanatomic mapping is a promising technique which may 
facilitate ablation procedures. 
Image processing and registration
The introduction of 3D electroanatomic mapping systems has facilitated the anatomical based 
ablation procedures for AF (10). However, the surrogate anatomy is reconstructed from multiple 
catheter recordings along the endocardium (13). Therefore, the use of reconstructed maps may 
be limited by the complex anatomy of the left atrium and pulmonary veins. 
Registration of previously acquired 3D images is a new technique, which off ers the ability 
of using real surface anatomy to guide anatomical based catheter ablation procedures (14,15). 
Reddy et al (15) demonstrated the feasibility of fusion of magnetic resonance images and 3D 
electroanatomic mapping in an animal study. After manual segmentation of the magnetic reso-
nance image of the left ventricle, the authors performed a similar registration process. Mean 
distance between the electroanatomic map and the surface image of the left ventricle was 4.9 
± 1.8 mm. The registration process was limited by the rotation of the left ventricle around its 
Table 1. Results of the registration process per patient
Distance between mapping points and MSCT (mm)
Patient Age Gender No. of Mapping points Mean SD Range
1 64 M 217 2.2 1.8 0.0 - 9.1
2 56 M 204 2.2 1.7 0.0 - 9.3
3 58 M 185 1.9 1.4 0.0 - 6.7
4 54 M 220 2.8 1.8 0.0 - 8.3
5 43 M 248 2.1 1.5 0.1 - 7.4
6 56 M 328 2.0 1.6 0.0 - 7.1
7 51 M 117 1.7 1.2 0.0 - 4.9
8 58 F 151 1.9 1.3 0.0 - 6.5
9 55 M 165 1.9 1.5 0.0 - 7.1
10 58 M 316 2.2 1.6 0.0 - 9.9
11 35 M 294 2.3 1.7 0.0 - 7.9
12 65 M 219 2.4 1.5 0.0 - 5.6
13 56 M 282 2.1 1.4 0.0 - 6.3
14 56 M 245 1.9 1.2 0.0 - 5.1
15 56 M 205 2.1 1.7 0.0 - 8.9
16 50 M 191 2.0 1.4 0.0 - 6.8
Mean 53.7 224.2 2.1
SD 7.2 59.0 0.2
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symmetric long axis. To assess an accurate registration, part of the ascending aorta had to be 
included in the electroanatomic map (15). In the current study, the mean distance between 
the MSCT image and the electroanatomic map was only 2.1 ± 0.2 mm for the patient group as 
a whole. Furthermore, the specifi c anatomy of the left atrium and the pulmonary veins made 
improper registration due to rotation impossible. The current in vivo study demonstrates that 
fusion of previously acquired MSCT images of the left atrium and 3D electroanatomic mapping 
can be performed accurately. 
Clinical implications 
Anatomy-based catheter ablation for AF is nowadays a safe procedure, and is performed in a 
large number of centers worldwide (5). Infrequent serious complications, such as pulmonary 
Figure 3. After registration, the fused electroanatomic map and MSCT surface image are used to guide catheter ablation. In this view from 
inside the left atrium, the ostium (arrow) of the right superior pulmonary vein (RSPV) is visualized. Radiofrequency current was applied outside 
the ostia of the pulmonary veins. Red tags indicate sites of radiofrequency current delivery. RPV = landmark used for registration; RSPV = right 
superior pulmonary vein; RIPV = right inferior pulmonary vein.
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vein stenosis, have been reported (16). MSCT can accurately depict the anatomy of the left 
atrium and the pulmonary veins (8,17), and complications can be avoided to some extent by 
integration of pre-procedural acquired MSCT images and the 3D mapping images. Furthermore, 
isolation of all pulmonary veins is necessary to achieve good long-term results. The number 
and anatomy of the pulmonary veins can be highly variable (18), and the small right middle 
pulmonary vein has been associated with the initiation of AF (19). Using the electroanatomic 
mapping system alone, additional or small pulmonary veins are diffi  cult to identify. Detailed 
information on number, location and branching pattern of all pulmonary veins (as provided by 
MSCT) during the ablation procedure may improve outcome. 
Furthermore, the use of integration of diff erent imaging modalities may reduce procedure 
time and fl uoroscopy time. The introduction of non-fl uoroscopic systems reduced fl uoros-
copy time during AF ablation procedures. However, incorrect geometry of the reconstructed 
anatomy may limit the use of non-fl uoroscopy systems (20). Recently, stereotactic systems have 
become available to guide ablation procedures (21,22). Although initial results are promising, 
the high costs of stereotactic systems limit their use in clinical practice. Alternatively, fusion 
of MSCT images and 3D electroanatomic mapping is easy to perform as demonstrated in the 
current study and allows visualization of real surface anatomy during the ablation procedure. 
Limitations 
The present study has some limitations. Scanning was performed during breath-hold, whereas 
patients were breathing normally during the ablation procedure. Furthermore, heart rate is 
variable during the ablation procedure. As a consequence, diff erent volumes of the left atrium 
during the MSCT scan and the ablation procedure may limit the fusion process. However, using 
a 64-slice MSCT scanner, data acquisition was completed in only 4 seconds. This short breath-
hold may minimize the possible diff erence in left atrial volumes. Reddy et al (15) also observed 
diff erences in volume between the surface image and the electroanatomic map of the left 
ventricle. This resulted in a mean distance of approximately 5 mm between the magnetic reso-
nance surface image and the electroanatomic map. However, ablation based on the magnetic 
resonance surface image alone resulted in exact ablation lesions in their porcine model (15). 
We speculate that volume diff erences in the left atrium and pulmonary veins may be smaller 
than in the left ventricle, limiting the possible error and allowing precise ablation. Furthermore, 
the mean distance between the MSCT surface image and the electroanatomic map was only 
2.1 ± 0.2 mm for the patient group as a whole. More validation studies in well-controlled animal 
models are needed to fully appreciate the strengths and limitations of this new fusion approach. 
Chapter 4
Im




The current study demonstrates that integration of pre-procedural acquired MSCT images and 
the 3D electroanatomic mapping system can be performed accurately. This new technique 
allows the use of real surface anatomy to guide anatomy-based catheter ablation procedures. 
The fusion of diff erent imaging modalities may facilitate catheter ablation for AF.
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Background: Multi-slice computed tomography (MSCT) integration is commonly used to 
guide radiofrequency catheter ablation (RFCA) for atrial fi brillation (AF). MSCT provides detailed 
anatomical information but lacks the ability to provide real-time anatomy during RFCA. Intra-
cardiac echocardiography (ICE) allows real-time visualization of cardiac structures.
Objective: The purpose of this study was to investigate the feasibility of three-dimensional 
(3D) anatomical mapping of the left atrium (LA) with ICE and integrating the 3D map with MSCT 
to facilitate RFCA for AF. 
Methods: In 17 patients undergoing RFCA for AF, 3D mapping of the LA was performed with 
ICE using a new mapping system (CARTOSOUNDTM, Biosense Webster) which allows tracking of 
a new ICE probe. On each ICE image endocardial contours were traced and used to generate 
a 3D map of the LA and pulmonary veins (PVs). A preprocedural acquired MSCT image of the 
LA was then integrated with the 3D map. Additionally, PV assessment with ICE was compared 
with MSCT.
Results: Accurate 3D mapping could be performed in all patients with a mean number of 31.1 
± 8.5 contours. Integration with MSCT resulted in a mean distance between MSCT and ICE 
contours of 2.2 ± 0.3 mm for the LA and PVs together and of 1.7 ± 0.2 mm around the PV ostia 
specifi cally. Agreement in assessment of PV anatomy and diameters between ICE and MSCT 
was excellent. 
Conclusion: Three-dimensional ICE mapping of the LA is feasible. The 3D map created with ICE 
can be merged with MSCT to facilitate RFCA for AF.
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Ectopic beats originating from the pulmonary veins (PVs) can initiate atrial fi brillation (AF) (1). 
Radiofrequency catheter ablation (RFCA) is considered a reasonable option in the treatment of 
patients with AF, when at least one anti-arrhythmic drug has failed (2). Ablation strategies tar-
geting the PVs are the cornerstone of these RFCA procedures. To plan and guide these ablation 
procedures, non-invasive three-dimensional (3D) imaging modalities like magnetic resonance 
imaging and multi-slice computed tomography (MSCT) are available to visualize the left atrium 
(LA) and PVs (3,4). Electrophysiological navigation systems allowing the integration of MSCT 
with electroanatomical maps combine accurate real-time navigation with detailed anatomical 
information thereby facilitating the ablation procedure (5) and reducing fl uoroscopy time and 
procedural duration (6). 
However, a limiting factor of using MSCT to guide the ablation procedure is the time inter-
val between image acquisition and the ablation procedure which may result in diff erences in 
heart rhythm, heart rate and fl uid status potentially causing an inaccurate registration process. 
Because the quality of the registration process determines the accuracy of navigating (7), this 
could result in less accurate lesion placement during RFCA. Recently, a new electroanatomi-
cal mapping system has been released that allows integration of 3D mapping and real-time 
intracardiac echocardiography (ICE). Using this system, a registered 3D shell of the LA and PV 
anatomy can be generated from two-dimensional (2D) ICE images. 
The aim of this study was to investigate the feasibility of creating a 3D map of the LA and 
PVs with ICE and integrating this map with a MSCT surface image in order to facilitate RFCA for 
AF. In addition, a direct comparison between this new ICE technique and MSCT for the assess-
ment of PV anatomy was performed. 
METHODS
Study population and protocol
The study population comprised 17 consecutive patients with symptomatic drug refractory AF, 
who underwent RFCA in our institution. In all patients a MSCT was acquired two days before the 
ablation. Prior to the procedure, the raw MSCT data was loaded into an electroanatomical map-
ping system (CARTO XPTM, Biosense Webster, Diamond Bar, California) equipped with a newly 
developed image integration module (CARTOSOUNDTM, Biosense Webster). During the ablation 
procedure 3D maps of the LA and PVs were created using an ICE catheter with an imbedded 
CARTO navigation sensor (10Fr SoundstarTM, Biosense Webster) allowing the mapping system 
to detect its position and generate a registered 3D shell from the recorded two-dimensional 
(2D) images. After completion of the mapping procedure a registration process was performed 
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to integrate the MSCT image with the 3D map made with ICE. Thereafter the merged MSCT 
image and 3D maps were used to guide the RFCA procedure. 
Multi-Slice Computed Tomography
The MSCT examination was performed with a 64-slice Toshiba Aquilion 64 system (Toshiba 
Medical Systems, Otawara, Japan) (7 patients) or a 320-slice Toshiba Aquilion One system 
(Toshiba Medical Systems) (10 patients). Craniocaudal scanning was performed during breath 
holding. For the Aquilion 64 system collimation was 64 x 0.5 mm, rotation time 400 ms and tube 
voltage between 100 and 135 kV at 250 to 400 mA. For the Aquilion One system collimation was 
320 x 0.5 mm, rotation time 350 ms and tube voltage 120 kV at 400 to 500 mA. In all patients 
nonionic contrast material (Iomeron 400, Bracco, Milan, Italy; 105 ml for Aquilion 64 and 50 ml 
for Aquilion One scanning) was infused through the antecubital vein at a rate of 5 ml/s followed 
by 50 ml saline solution fl ush. Automatic detection of the contrast bolus was used to time the 
start of the scan. Before the ablation procedure, all MSCT data were analyzed on a dedicated 
workstation (Vitrea 2; Vital Images, Minnetonka, Minnesota). 
Image processing and segmentation
Prior to the ablation procedure, the raw MSCT data were loaded into the image integration 
module of the mapping system (CartoMergeTM, Biosense Webster) and a segmentation process 
was performed. The segmentation process consisted of three phases as described previously 
(5). The fi rst step was to delineate the borders of interest on the MSCT (LA and PVs) by manually 
setting the threshold intensity range. A 3D volume was subsequently created of all structures 
within the set threshold range. The second step was to segment this 3D volume into diff erent 
structures by placing markers in the middle of the diff erent areas. An algorithm was used to 
automatically depict the diff erent structures based on the placement of the markers and the 
border of the 3D volume. Finally, the segmented surface images were exported to the mapping 
system.
Anatomical mapping with ICE 
During the catheter ablation procedure, a 3D anatomical map was created with ICE images. A 
new mapping system was used, equipped with a new image integration module that allows 
the integration of ICE and 3D mapping (CARTOSOUNDTM). This system is able to detect the 
position and direction of a specifi cally designed ICE catheter with an imbedded CARTO navi-
gation sensor located at its tip (SoundstarTM). By positioning the ICE catheter inside the right 
atrium, ECG gated images of the LA and PVs were acquired. To provide ECG gating, either a 
quadripolar electrophysiological catheter placed inside the right atrium or the body surface 
ECG was used as a reference signal in patients with sinus rhythm or AF, respectively. In order to 
correct for respiratory phase, all ICE images were acquired during expiratory breath hold. Intra-
cardiac echocardiography was performed using a Sequoia ultrasound system (Siemens Medical 
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Solutions USA, Mountain View, California) which transferred real-time ICE data to the mapping 
system. On the mapping system, the endocardial contours were traced manually after which 
they were assigned to a map (Figure 1A). All contours within a map were used to generate a 
registered 3D shell (Figure 1B and 1C). For each map a separate shell was generated. Diff erent 
maps were created for the LA and for each of the PVs (Figure 1D).
Registration
After creating a map with ICE, a registration process was performed to integrate the MSCT sur-
face image and the 3D map. First, the MSCT surface image was displayed next to the anatomical 
map (Figure 2A). A landmark was placed at a distinct anatomical structure on the anatomical 
map and at a corresponding point on the MSCT model. Then ‘visual alignment’ was performed 
by minimizing the distance between both landmarks. Next, the maps created during the 
Figure 1. Three-dimensional (3D) mapping with intracardiac echocardiographic (ICE). Ultrasound images of the left atrium (LA) are 
acquired. The endocardial contour of the LA is traced on the ultrasound viewer of the mapping system. After assigning the contour to a map, it 
appears on the map viewer (A). By acquiring more contours and reconstructing them into a registered 3D shell (B), the shape of the LA and 
pulmonary veins (PVs) is depicted. Systematically, the LA and PVs are visualized (C) until a complete 3D map of the LA and PVs is acquired (D). 
Add PV = additional pulmonary vein, LCO = left common ostium, RIPV = right inferior pulmonary vein, RSPV = right superior pulmonary vein.
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mapping procedure were each assigned to the corresponding MSCT surface image and a 
‘surface registration’ was performed. During this process the ICE contours were represented 
as a line of adjacent mapping points. An internal algorithm was used to minimize the distance 
between these points and the MSCT surface image (Figure 2B). 
The accuracy of the registration process was then reviewed. The mean value, standard 
deviation and range of the distance between the points along the ICE contours and the MSCT 
surface were provided by the algorithm. The accuracy of the registration process at the level of 
the PVs was evaluated by measuring the distance between the contours and MSCT surface at 5 
representative points around each PV ostium (Figure 3).
PV anatomy and quantitative measurements
After an accurate registration had been acquired the PVs and their atrial insertion were evalu-
ated on both MSCT and ICE. Pulmonary vein anatomy was classifi ed according to the presence 
or absence of a common ostium/trunk and/or additional veins. As described previously, a com-
mon ostium was defi ned as a PV carina located outside the extrapolated endocardial border 
of the LA (4). A common trunk was defi ned as a clearly recognizable common part in which 
both superior and inferior PV drain before emptying into the LA (8). An additional vein was 
defi ned as a supranumerical vein entering the LA with a separate ostium. The same criteria for 
PV classifi cation were used for MSCT and ICE evaluation. 
Figure 2. After 3D mapping with ICE, the 3D map and multi-slice computed tomography (MSCT) image are displayed next to each other 
(A). Then a manual registration process is performed. This results in the integration of the 3D map and the MSCT image in order to anatomically 
guide the ablation procedure (B).
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Pulmonary vein diameters on MSCT were measured in anterior-posterior (AP) and superior-
inferior (SI) direction inside the PV ostium, as previously described (4). Pulmonary vein diameters 
on ICE were measured at the widest point. Left atrial diameter was measured in AP direction on 
both MSCT and the 3D map created with ICE. 
Radiofrequency catheter ablation
Radiofrequency catheter ablation was performed by creating two circumferential lesions 
around the left and right PV antrum (Figure 4). Additional lesions consisting of a roofl ine, a 
mitral valve isthmus line or sites exhibiting fractionated activity were created if deemed neces-
sary. After excluding an intracardiac thrombus, and in the absence of a patent foramen ovale, 
a transseptal puncture was performed under ICE guidance. All patients received a bolus of 
intravenous heparin (5000 IU) with an additional bolus to maintain an activated clotting time 
between 300-400 s. The ablation procedure was guided by the 3D map created with ICE and 
integrated with the MSCT image. An open loop irrigated 4-mm tip quadripolar mapping/abla-
tion catheter (7Fr NavistarTM, Biosense Webster) was introduced in the LA and used to apply 
radiofrequency current outside the ostia of all PVs. At each point, radiofrequency current was 
applied at 30-35 W (maximum tip temperature 45 °C) until a voltage of <0.1 mV was achieved, 
with a maximum of 60 seconds per point.
Statistical analysis
Data are presented as mean ± SD or as number (percentage). Statistical analysis was performed 
using SPSS 14.0 software (SPSS Inc., Chicago, Illinois). Statistical comparisons were performed 
Figure 3. The quality of the registration process was reviewed at the level of the PV ostium by measuring the distance between the MSCT 
and the 3D map at 5 representative points.
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with two tailed Student’s T-test, paired or unpaired as appropriate. Kappa analysis was used to 
quantify the level of agreement in PV anatomy classifi cation with MSCT and ICE. Bland-Altman 
analysis was used to quantify the level of agreement between measurements of PV diameter 
with ICE and MSCT. A P value <0.05 was considered statistically signifi cant. 
RESULTS
Study population
Seventeen patients were studied (13 men, mean age 56 ± 8 years). Atrial fi brillation was parox-
ysmal in 11 patients and persistent in 6 according to the ACC/AHA/ESC Guidelines defi nition (9). 
Mean duration of AF was 72 ± 58 months and the mean number of anti-arrhythmic drugs used 
was 3.7 ± 1.3 per patient. Mean LA size measured by transthoracic echocardiography was 41.8 
± 5.3 mm; mean left ventricular ejection fraction was 58 ± 7 %. Four patients had undergone 
another radiofrequency catheter ablation procedure for AF previously.
Mapping and registration accuracy
In order to acquire a good geometry of LA and PVs a mean of 31.1 ± 8.5 ICE contours were 
drawn per patient (range 18-43 contours). The mean time needed to make a 3D map with ICE 
was 76 ± 27 minutes (range 25-126 minutes). It was noted that the time needed to make a 
Figure 4. After registration, the 3D map created with ICE and integrated MSCT image were used to facilitate the ablation procedure. 
Circumferential lesions were created outside the PV ostia. Red tags represent the sites of radiofrequency current application.
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map signifi cantly decreased from 97 ± 20 minutes during the fi rst 4 procedures to 39 ± 10 
minutes during the last 13 procedures (p<0.001). After the registration process the mean dis-
tance between the drawn ICE contours and the MSCT surface image ranged from 1.7 to 2.8 mm 
(mean 2.2 ± 0.3 mm). The standard deviation of the ICE-MSCT diff erence ranged from 1.4 mm to 
1.9 mm (mean 1.7 ± 0.2 mm). Individual results of the registration process are given in Table 1. 
The accuracy of the registration process at the level of the PVs was evaluated by calculating 
the mean value of the distance between the contours and MSCT surface at 5 representative 
points around each PV ostium. The mean distance between the drawn contours and the MSCT 
surface image at the level of the PV ostia ranged from 0.7 to 4.4 mm (mean 1.7 ± 1.1 mm) 
and was smallest around the left inferior PV (mean 1.5 ± 1.1 mm) and largest around the left 
superior PV (mean 2.1 ± 1.3 mm) (Table 2).
Table 1. Result of the registration process per patient
Distance between contours and MSCT surface image (mm)
Patient Age (years) Gender No. of contours Mean SD Range
1 46 F 20 2.1 1.6 0.00-8.45
2 55 M 19 1.9 1.4 0.00-8.91
3 61 M 27 2.3 1.6 0.00-8.82
4 72 M 23 2.5 1.9 0.01-10.27
5 57 M 18 2.1 1.7 0.01-10.17
6 40 F 36 1.8 1.4 0.01-7.19
7 58 M 39 2.6 1.9 0.00-9.99
8 48 M 38 2.0 1.5 0.00-7.68
9 61 F 29 1.9 1.4 0.15-6.45
10 47 M 42 1.7 1.4 0.00-7.44
11 68 M 22 2.3 1.5 0.01-7.03
12 50 M 40 2.1 1.6 0.01-9.15
13 53 F 38 1.9 1.7 0.00-12.50
14 58 M 31 2.8 1.9 0.02-11.56
15 60 M 43 2.5 1.8 0.00-8.57
16 54 M 30 2.5 1.7 0.01-8.36
17 58 M 34 2.3 1.6 0.01-8.38
Mean 55.6 31.1 2.2 1.7
SD 8.0 8.5 0.3 0.2
MSCT = multi-slice computed tomography; No. = number; SD = standard deviation.
Table 2. Result of the registration process at pulmonary vein ostia 
Distance between contours and MSCT surface image (mm)
Pulmonary vein (PV) Mean SD Range
Right superior PV 1.7 1.0 0.8-3.2
Right inferior PV 1.6 1.0 0.7-3.2
Left superior PV 2.1 1.3 0.8-4.4
Left inferior PV 1.5 1.1 1.0-2.4
Left common trunk 1.7 1.2 1.3-1.9
Both right PVs 1.7 1.0 0.7-3.2
Both Left PVs 1.8 1.2 0.8-4.4
All PVs 1.7 1.1 0.7-4.4
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Classifi cation of PV anatomy
An equal number of 70 PVs were visualized with MSCT and ICE (4.12 ± 0.49 per patient). The 
most common PV variant consisted of 2 left sided PVs with separate ostia and 2 right sided PVs 
with separate ostia (7 patients, 41%). A common ostium of the left PVs was noted in 8 patients 
(47%) with MSCT and in 10 patients (59%) with ICE. A common trunk of the left superior and 
left inferior PV was recognized in 3 patients (18%) with both MSCT and ICE. An additional PV 
was identifi ed in 5 patients (29%). All additional PVs were located at the right side of the LA. 
Using kappa analysis, an excellent agreement between MSCT and ICE for the classifi cation of 
the left-sided PVs (kappa = 0.77) and the right-sided PVs (kappa = 1.00) was observed. 
Quantitative measurements
Pulmonary vein diameters were measured in two directions on MSCT (AP and SI) and in the direc-
tion of the largest diameter possible on ICE, as previously described (4). Superior-inferior diameters 
measured on MSCT were signifi cantly larger for all PVs compared to the diameters measured on 
ICE (Table 3). The AP diameters of the right superior PV, left superior PV and additional veins mea-
sured on MSCT were not signifi cantly diff erent from the diameters measured on ICE. In contrast, 
the AP diameters of the right inferior PV on MSCT were signifi cantly larger than the PV diameters 
on ICE (Table 3). Bland-Altman analysis demonstrated that there was a good overall agreement 
between ICE and MSCT for the assessment of the PV ostium diameter (Figure 5). 





ICE (mm) SI diameter MSCT 
vs. ICE (p-value)
AP diameter MSCT 
vs. ICE (p-value)
Right superior PV 24.0 ± 3.5 19.2 ± 3.3 18.3 ± 3.3 <0.01 NS
Right inferior PV 20.8 ± 3.0 17.9 ± 3.3 15.3 ± 2.4 <0.01 <0.05
Left superior PV 21.6 ± 3.9 15.4 ± 3.0 15.2 ± 2.2 <0.01 NS
Left inferior PV 19.0 ± 2.1 11.9 ± 2.3 14.6 ± 2.4 <0.01 <0.05
Left common trunk 38.2 ± 3.8 22.4 ± 1.0 28.2 ± 0.4 <0.05 <0.05
Additional PV 9.6 ± 1.9 8.5 ± 2.4 8.5 ± 0.9 <0.05 NS
All PVs 21.5 ± 5.7 16.2 ± 4.5 16.0 ± 4.3 <0.01 NS
Figure 5. Bland-Altman analysis of measurements performed with MSCT and ICE in AP (left panel) and SI (right panel) directions.
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Left atrial diameter was measured in AP direction on both MSCT and ICE. Mean AP diameter of the 
LA on MSCT was 39.6 ± 7.2 mm compared to 35.9 ± 7.2 mm on ICE. The mean diff erence between 
AP diameter on MSCT and ICE was 3.7 ± 5.0 mm (p<0.01) and ranged from 0.3 to 15.6 mm. 
Radiofrequency catheter ablation
Transseptal puncture was performed under ICE guidance in 13 patients. A patent foramen ovale 
existed in 4 patients. The mean ablation time was 80 ± 34 minutes and mean fl uoroscopy time 
was 35 ± 6 minutes. Radiofrequency catheter ablation was targeted at the PVs in all patients. 
No diff erences between heart rhythm during MSCT acquisition and ablation procedure were 
observed. No complications occurred during and after the ablation procedure. 
DISCUSSION
The present study is the fi rst to report on the feasibility of creating a 3D map of the LA and 
PVs with ICE and integrating this map with MSCT in order to facilitate RFCA for AF. This study 
has three main fi ndings: 1) It is feasible to create an anatomical map of the LA and PVs using 
ICE contours; 2) The anatomical map created by ICE can accurately be merged with a MSCT 
surface image and 3) Anatomical ICE mapping is a sensitive imaging modality to visualize PVs 
and classify LA and PV anatomy. 
Three-dimensional mapping with ICE and MSCT integration
In the present study, a novel mapping system was used that enables detection of a specifi cally 
designed ICE catheter with an imbedded CARTO navigation sensor. This mapping system allows 
acquisition of ECG gated ICE images and reconstructs them into a registered 3D shell. With this 
new technology, it has become possible to acquire accurate real-time anatomical information 
of the LA and PVs without entering the left side of the heart. Khaykin et al fi rst reported on 
the use of 3D mapping with ICE during the ablation of a right free wall accessory pathway 
(10). Okumura et al demonstrated the accuracy of navigation based on 3D mapping with ICE in 
animal experiments (11). Both groups subsequently demonstrated the feasibility of creating a 
3D map with ICE to guide RFCA for AF (11-13). The present study supports these fi ndings and 
additionally demonstrates the accuracy of creating a 3D map of the LA and PVs with ICE by 
comparing LA and PV geometry on the 3D ICE map with MSCT. 
In addition, the current study is the fi rst to demonstrate the feasibility of integrating a 
3D map created with ICE and a MSCT image. Integration of MSCT images with conventional 
electroanatomical mapping is commonly used to guide RFCA for AF (14). In an animal study, 
Dong et al (15) demonstrated that the integration of MSCT and electroanatomical mapping 
allows accurate placement of anatomically guided ablation lesions in all cardiac chambers. 
Furthermore, several studies demonstrated the feasibility of the integration of MSCT and 
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electroanatomical mapping to guide RFCA for AF (5,16-18). Importantly, Kistler et al (6) showed 
that the integration of a MSCT image to guide RFCA for AF is associated with reduced fl uoros-
copy time and an improved outcome of the procedure. 
However, the time interval between the MSCT data acquisition and the ablation procedure 
is a limitation of MSCT image integration. This delay may result in diff erences in heart rhythm, 
heart rate and fl uid status which may cause errors in the image integration process, thereby 
compromising the accuracy of lesion placement. By integrating real-time ICE, MSCT and electro-
anatomical mapping, it has become possible to combine real-time anatomical and electrophysi-
ological information with highly detailed anatomical information, thereby potentially increasing 
the accuracy of the placement of ablation lesions. The present study demonstrates the accuracy 
of integrating a MSCT image with a 3D map created with ICE. This was illustrated by a mean 
distance of only 2.2 mm between the MSCT image and the ICE contours, which is comparable 
with the integration results between an electroanatomical map and MSCT (5,16-18). 
However, despite acquiring a good overall match between ICE and MSCT, the distance 
between the represented points along the ICE contours and MSCT ranged from 0.00 to 12.50 mm 
(Table 1). Similar ranges have been reported for the integration of electroanatomical maps and 
MSCT (5,16). This wide range may be related to diff erences in reconstructed LA and PV anatomy 
between MSCT and ICE in areas that are strongly infl uenced by cardiac and respiratory movement.
Pulmonary vein visualization 
Left atrial and PV anatomy are highly variable (3,4,19). Importantly, accurate visualization of the PV 
ostia during RFCA for AF is required to avoid ablation within the PVs (2). In the present study, the 
PV ostia were visualized with ICE and MSCT. Both imaging modalities recorded an equal number 
of PVs, which suggests that 3D mapping with ICE has a high sensitivity for detecting PVs. Further-
more, there was good agreement between ICE and MSCT for classifi cation of the PV anatomy. 
In the present study, ICE slightly underestimated PV diameter, as compared with MSCT. This 
observation is in agreement with a study by Jongbloed et al (4) who found that ICE under-
estimated PV diameter for all PVs by 3.5 mm in SI direction and 0.2 mm in AP direction. An 
explanation for the underestimation of left sided PV diameters on ICE may be the fact that 
these PVs are visualized in longitudinal cross-sections thereby potentially missing the middle 
and widest part of the PVs. In contrast, the underestimation of the right sided PV diameters may 
be due to the fact that the exact PV-LA junction can be challenging to visualize in transversal 
cross-sections. However, since radiofrequency current is typically applied outside the PVs, this 
should have little implications for the safety of the ablation procedure. 
The present study shows that 3D mapping with ICE provides an accurate visualization of 
PV ostia and PV anatomy with a high sensitivity for detecting additional PVs and gives a good 
estimation of PV dimensions, as compared with MSCT.
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The integration of MSCT with electroanatomical mapping allows accurate placement of abla-
tion lesions (15) and has improved the outcome of anatomically guided RFCA targeting the PVs 
(6). However, it is reported that the accuracy of navigating with MSCT integration depends on 
the quality of the registration process (7). With the release of a new electroanatomical mapping 
system that allows integration of ICE it has become possible to acquire calibrated real-time 3D 
anatomical information without performing a manual registration process. 
The ablation procedures in this study were guided by a 3D map made with ICE, integrated 
with a MSCT surface image. Importantly, this study demonstrates that 3D mapping with ICE 
alone provides accurate visualization of the LA geometry and PV ostia which is required to 
safely perform RFCA for AF targeting the PVs. Therefore it should be possible to perform an 
anatomically guided ablation procedure targeting the PVs on 3D mapping with ICE alone. This 
may result in a considerable reduction in radiation exposure for the patient. Further studies are 
therefore needed to fully explore the value of this promising new technique.
Limitations
This study represents an initial experience with 3D mapping using ICE to guide RFCA for AF. The 
time necessary to make a map with ICE was therefore relatively long. However, due to a clear 
learning curve, this time decreased in the later procedures. Therefore, it can be expected that 
the time needed to make a 3D ICE map can be shortened signifi cantly. In this study RFCA was 
guided by the 3D map made with ICE and integrated with the MSCT image. As a consequence 
no data has been acquired on guidance by 3D ICE mapping alone. Furthermore, at present no 
data is available on the outcome of the ablation procedures. 
Intracardiac echocardiography allows real-time visualization of important cardiac struc-
tures. However, some areas of the LA may be challenging to visualize with ICE due to their 
parallel orientation to the ultrasound beam. Examples of these areas are the right sided PV-LA 
junction and the left side of the anterior wall. By positioning the ICE catheter inside the right 
ventricle these structures can be visualized from another angle thereby providing more insight 
in LA and PV anatomy. Additionally, conventional electroanatomical mapping can also be used 
to acquire anatomical information in these and other areas. 
Three-dimensional mapping with ICE is very sensitive to respiratory phase. Small diff erences 
in respiratory phase during image acquisition may result in contours situated outside the inter-
polated continuity of the other contours of the 3D map. However, by acquiring all ICE images 
during expiratory breath hold, consistent sets of contours could be acquired in all patients. 
Three-dimensional mapping with ICE is a very promising but expensive technique. The ICE 
catheters used in this study are single-use only and a dedicated mapping system with image 
integration modules is needed to integrate ICE with the electroanatomical mapping and MSCT 
images. Furthermore this technology is only available on one electroanatomical mapping sys-
tem (CARTO XP) and on limited echocardiographic machines (Sequoia ultrasound system and 
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Cypress ultrasound system, Siemens Medical Solutions). Nonetheless, integration of ICE provides 
accurate anatomical information that could potentially replace MSCT integration in RFCA for AF. 
Replacing MSCT would render the use of ICE cost-effi  cient and would reduce radiation exposure 
to the patient. Furthermore, the ability to acquire registered real-time anatomical information of 
important structures with ICE has a signifi cant additional value compared to MSCT integration.
CONCLUSIONS
Using a novel mapping system that allows integration of ICE and electroanatomical mapping it 
is feasible to create a real-time registered 3D shell of LA and PV anatomy. Furthermore, the 3D 
map created with ICE can accurately be integrated with a MSCT surface image. This approach 
combines real-time anatomy with high detailed anatomy potentially providing highly accurate 
lesion placement during anatomical ablation procedures.
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Background: Multi-slice computed tomography (MSCT) is commonly acquired prior to radio-
frequency catheter ablation (RFCA) for atrial fi brillation (AF) in order to plan and guide the 
procedure. Importantly, MSCT allows accurate measurement of left atrial (LA) and pulmonary 
vein (PV) dimensions and classifi cation of PV anatomy.
Objective: The aim of this study was to investigate the impact of LA dimensions, PV dimensions 
and PV anatomy on the outcome of circumferential RFCA for AF.
Methods: One hundred consecutive patients undergoing RFCA for AF (paroxysmal 72%, persis-
tent 28%) were studied. Left atrial dimensions, PV dimensions and PV anatomy were assessed 
in multiple directions on MSCT. Pulmonary vein anatomy was classifi ed as normal or atypical 
based on the absence/presence of a common trunk or additional vein(s). 
Results: After a mean follow up of 11.6 ± 2.8 months, 65 patients (65%) maintained sinus 
rhythm. Enlargement of the LA in anterior-posterior direction on MSCT was related to a higher 
risk for AF recurrence. No relation was found between PV dimensions and outcome of RFCA. 
In contrast, the presence of atypical right-sided PV anatomy was related to a reduced risk for 
AF recurrence. Multivariate analysis showed that anterior-posterior LA diameter on MSCT 
(OR=1.083, p=0.027), atypical right-sided PV anatomy (OR=0.149, p=0.006), and persistent AF 
(OR=3.004, p=0.035) were independent predictors of AF recurrence after RFCA. 
Conclusions: Enlargement of anterior-posterior LA diameter and presence of atypical anatomy 
of the right PVs are independent risk factor for AF recurrence. 
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Radiofrequency catheter ablation (RFCA) is considered a reasonable treatment option for 
patients with symptomatic drug-refractory atrial fi brillation (AF) (1). However, this treatment 
modality is associated with a considerable recurrence rate and a small risk for serious complica-
tions (2). Identifi cation of pre-procedural risk factors for AF recurrence is mandatory to improve 
the outcome of RFCA. 
Multi-slice computed tomography (MSCT) is nowadays commonly acquired prior to RFCA 
for AF. It provides important information about left atrial (LA) and pulmonary vein (PV) anatomy 
which can be used to plan and guide the RFCA procedure (3). Moreover, MSCT allows accurate 
multidirectional assessment of LA and PV dimensions (4,5). It has been demonstrated that 
LA and PV dimensions are enlarged in patients with AF (6,7). However, whereas LA size is a 
well-known risk factor for AF recurrence after RFCA (8-11), little is known about the prognostic 
importance of PV dilatation. Similarly, the impact of PV anatomy on the outcome of RFCA has 
not been studied extensively. Potentially, diff erent anatomical drainage patterns could be 
accompanied by diff erent tissue characteristics of the surrounding myocardium rendering 
the PV area more or less resistant to electrical isolation. Moreover, certain anatomical variants 
could pose a technical diffi  culty to achieve stable catheter position during ablation thereby 
compromising eff ective lesion formation. The aim of this study was to investigate the impact 
of multidirectional LA dimensions, PV dimensions and PV anatomy assessed by MSCT on the 
outcome of circumferential RFCA for AF.  
METHODS
Study population
The study population comprised 100 consecutive patients with symptomatic drug-refractory 
AF, undergoing circumferential RFCA. After RFCA, all patients were evaluated on a regular basis 
at the outpatient clinic during a 12-month follow-up period. Routine electrocardiograms (ECG) 
were recorded each visit and 24-hour Holter registrations were scheduled at 3, 6 and 12 months 
after the ablation. All medications were continued for at least 3 months. Afterwards, anti-
arrhythmic drugs were discontinued at the discretion of the physician. After a post-ablation 
blanking period of 3 months, recurrence of AF was defi ned as any recording of AF on ECG or an 
episode longer than 30 seconds on 24-hour Holter monitoring (1). After 12-month follow-up, 
the study population was divided into two groups: patients with maintenance of sinus rhythm 
(SR) (non-recurrence group) and patients who had recurrence of AF (recurrence group).
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Multi-Slice Computed Tomography 
Multi-slice computed tomography data were acquired prior to the ablation in order to guide 
the procedure (3). The MSCT scan was performed with a 64-slice Toshiba Aquilion 64 system 
(Toshiba Medical Systems, Otawara, Japan). A bolus of 70 ml nonionic contrast material (Iomeron 
400, Bracco, Milan, Italy) was infused through the antecubital vein at a rate of 5 ml/s followed by 
50 ml saline solution fl ush. Automatic detection of the contrast bolus in the descending aorta 
was used to time the start of the scan. Craniocaudal scanning was performed during breath-
hold, without ECG-gating. Collimation was 64 x 0.5 mm, rotation time 400 ms and the tube 
voltage 100 kV at 250 mA. After acquisition, the raw MSCT data were exported, post-processed 
and analyzed on a dedicated workstation (Vitrea 2, Vital Images, Minnetonka, Minnesota, USA). 
Pulmonary vein ostium dimensions were evaluated using a two-dimensional viewing mode. 
To allow accurate assessment, multiplanar reformatting was used by placing two orthogonal 
planes parallel to the course of the vein (Figure 1, panel A and B). The third orthogonal plane, 
orientated perpendicular to the course of the vein, was then used to measure the diameter of 
the PV ostium in anterior-posterior (AP) and superior-inferior (SI) direction (Figure 1, panel C). 
The ratio between the largest and smallest diameter was calculated in order to obtain informa-
tion on the oval shape of the ostium. Similarly, multiplanar reformatting was used to assess 
LA dimensions in 3 orthogonal directions: AP, longitudinal and transversal direction (Figure 2). 
Pulmonary vein anatomy was analyzed from an external view using a 3D volume-rendered 
reconstruction. Pulmonary vein classifi cation was based on the presence or absence of a com-
mon trunk and/or additional vein(s) (Figure 3). A common trunk was defi ned as a conjoined 
part of more than 5 mm in which both superior and inferior PV drain before entering the LA. An 
additional vein was defi ned as a supernumerary vein directly entering the LA. 
To evaluate the impact of PV anatomy on the outcome of RFCA for AF, left- and right-sided 
anatomy was additionally classifi ed as normal or atypical. Atypical anatomy was defi ned as the 
presence of a common trunk or an additional PV.
Figure 1. To assess pulmonary vein diameters, two orthogonal planes were placed parallel to the course of the vein (panel A and B). A 
third orthogonal plane (panel C), oriented perpendicular to the course of the vein, was then used to measure the anterior-posterior (AP) and 
superior-inferior (SI) pulmonary vein diameter (white arrows).
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Figure 2. The left atrial (LA) dimensions (white arrows) were assessed in three orthogonal directions by using multiplanar reformatting. 
Panel A: LA dimensions in anterior-posterior (AP) (red line) and longitudinal direction (green line). Panel B: LA dimension in transversal 
direction (green line). Panel B is a cross-section of panel A at the level of the crosshair and parallel to the red line.
Figure 3. Panel A: Separate ostia of the left-sided pulmonary veins; Panel B: Separate ostia of the right-sided pulmonary veins; Panel C: 
Common trunk of the left-sided pulmonary veins (defi ned as a conjoined part of more than 5 mm); Panel D: Additional right-sided pulmonary 
vein (defi ned as a supernumerary vein directly entering the left atrium). Add = additional pulmonary vein, LIPV = left inferior pulmonary vein, 
LSPV = left superior pulmonary vein, RIPV = right inferior pulmonary vein, RSPV = right superior pulmonary vein.
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Radiofrequency catheter ablation 
The RFCA procedure was aimed at creating two circumferential lesions around the left- and 
right-sided ipsilateral PVs approximately 1 cm outside the ostia. All patients received intra-
venous heparin to maintain an activated clotting time of 300-400 s. Intracardiac echocardio-
graphy was used to guide the transseptal puncture. To guide the ablation, a non-fl uoroscopic 
electroanatomical mapping system with MSCT integration was used (CARTO XPTM with Car-
tomergeTM, Biosense Webster, Diamond Bar, California, USA). Contact mapping and ablation 
was performed using a 4-mm quadripolar open-loop irrigated mapping/ablation catheter (7Fr 
NavistarTM, Biosense Webster). A 6Fr quadripolar diagnostic catheter placed inside the right 
atrium served as a temporal reference. Radiofrequency current was applied at 30-35 W with 
a maximum temperature of 45°C and an irrigation fl ow of 20 ml/min until a bipolar voltage 
of <0.1 mV was achieved, with a maximum of 60 s per point. The end-point of the procedure 
was PV isolation as confi rmed by recording entrance block during SR or pacing from inside the 
coronary sinus (1). 
Statistical analysis
Data are presented as mean ± SD or as number (percentage). Statistical comparisons for 
continuous variables were performed with the two tailed Student’s t-test, paired or unpaired 
as appropriate. Statistical comparisons for categorical variables were performed with the Chi-
square test. Univariate and multivariate logistic regression analyses were performed to study 
the impact of PV anatomy, PV dimensions, LA dimensions and clinical characteristics on the 
incidence of AF recurrence after RFCA. Variables with a p-value <0.05 in the univariate analyses 
were included into the multivariate analysis. Multivariate analysis was performed using an 
‘enter’ method. All statistical analyses were performed with SPSS software (version 16.0, SPSS 
Inc., Chicago, Illinois, USA). A p-value of <0.05 was considered statistically signifi cant. 
RESULTS
One hundred consecutive patients were included (77 men, mean age 56 ± 9 years), from an 
ongoing clinical registry (12). Atrial fi brillation was paroxysmal in 72 patients and persistent in 
28 patients according to American College of Cardiology/American Heart Association/European 
Society of Cardiology guidelines defi nitions (13). None of the patients had previously undergone 
RFCA for AF. Median duration of AF was 48 months (interquartile range: 24-84) and the mean 
number of anti-arrhythmic drugs used was 3.1 ± 1.3 per patient. The mean AP diameter of the 
LA was 43 ± 6 mm and the mean left ventricular ejection fraction was 58 ± 8% on transthoracic 
echocardiography (Table 1). The procedural end-point of PV isolation was achieved in all patients. 
After a mean follow-up of 11.6 ± 2.8 months, 65 patients (65%) had maintained SR (non-
recurrence group), whereas 35 patients (35%) had recurrence of AF (recurrence group). In 
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the recurrence group a higher prevalence of persistent AF was found compared to the non-
recurrence group (14 [22%] vs 14 [40%], p=0.049). 
Left atrial dimensions
Left atrial dimensions were measured in three orthogonal directions on MSCT: AP, longitudinal 
and transversal (Figure 2). Mean AP diameter was 41 ± 7 mm, mean longitudinal diameter was 
65 ± 8 mm and mean transversal diameter was 59 ± 7 mm. Anterior-posterior LA diameter was 
signifi cantly larger in the recurrence group than in the non-recurrence group (43 ± 6 mm vs. 39 
± 7 mm, p=0.02). Interestingly, no diff erences were found between the recurrence group and 
non-recurrence group in longitudinal (64 ± 7 mm vs. 65 ± 9 mm, p=0.45) and transversal (59 ± 
7 mm vs. 60 ± 7 mm, p=0.57) LA diameter. 
Pulmonary vein dimensions
Pulmonary vein ostial dimensions were assessed in AP and SI direction on MSCT (Table 2). 
Pulmonary vein dimensions were larger in SI direction than in AP direction (21.1 ± 2.3 mm vs. 
16.3 ± 2.5 mm, p<0.001). Overall, right-sided PVs had a larger diameter than left-sided PVs (20.0 
Table 1. Baseline characteristics
Total study population (n = 100)
Age (years) 56.4 ± 8.6
Gender (male/female) 77/23
Body Surface Area (m2) 2.1 ± 0.2
Type of AF (paroxysmal/persistent) 72/28
Duration of AF (months) 64 ± 60
Anti-arrhythmic drugs used per patient 3.1 ± 1.3
Hypertension, n (%) 53 (53)
Coronary artery disease, n (%) 8 (8)
Diabetes, n (%) 8 (8)
Echocardiography
   Anterior-posterior LA diameter (mm) 43 ± 6
   Left ventricular ejection fraction (%) 58 ± 8
AF = atrial fi brillation; LA = left atrium.
Table 2. Pulmonary vein measurements on MSCT
AP diameter (mm) SI diameter (mm) Mean diameter (mm) Ratio
RSPV 18.8 ± 4.2 23.3 ± 4.5 21.0 ± 4.0 0.80 ± 0.11
RIPV 17.7 ± 2.9 20.3 ± 3.2 19.0 ± 2.8 0.87 ± 0.10
LSPV 14.3 ± 2.6 21.1 ± 3.6 17.7 ± 2.4 0.67 ± 0.13
LIPV 12.1 ± 2.7 18.8 ± 2.5 15.4 ± 2.0 0.65 ± 0.15
ADD 8.9 ± 3.1 10.1 ± 2.4 9.5 ± 2.5 0.82 ± 0.11
LCT 19.5 ± 4.5 33.5 ± 4.7 26.5 ± 3.4 0.59 ± 0.15
All RPV 18.2 ± 2.5 21.8 ± 2.8 20.0 ± 2.4 0.83 ± 0.08
All LPV 13.2 ± 2.5 19.9 ± 2.0 16.6 ± 1.6 0.66 ± 0.11
All PV 16.3 ± 2.5 21.1 ± 2.3 18.7 ± 2.2 0.77 ± 0.09
ADD = additional pulmonary vein; AP = anterior-posterior; LCT = left common trunk; LIPV = left inferior pulmonary vein; LPV = left pulmonary 
veins; LSPV = left superior pulmonary vein; RIPV = right inferior pulmonary vein; RPV = right pulmonary veins; RSPV = right superior 
pulmonary vein; SI = superior-inferior
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± 2.4 mm vs. 16.6 ± 1.6 mm, p<0.001). Similarly, superior PVs had a larger diameter than inferior 
PVs (19.6 ± 3.8 mm vs. 17.5 ± 3.1 mm, p<0.001). With regard to the shape of the PV ostium, 
left-sided PVs had a more pronounced oval shape than right-sided PV ostia indicated by a lower 
ratio between the largest and smallest PV diameter (ratio 0.65 ± 0.09 vs. 0.84 ± 0.09, p<0.001). 
In contrast to AP LA dimension, PV dimensions were not related to the recurrence of AF 
during follow-up: no diff erences were found in mean PV diameter between the recurrence and 
non-recurrence group (18.8 ± 2.2 mm vs.18.6 ± 2.2 mm, p=0.74). In addition, a similar oval shape 
of the PV ostia was found in the both groups (non-recurrence group vs. recurrence group: 0.77 
± 0.09 vs. 0.77 ± 0.09, p=0.73).
Pulmonary vein anatomy
Pulmonary vein anatomy was classifi ed based on the presence or absence of a common trunk 
and/or additional PV. A total of 174 left-sided PVs and 226 right-sided PVs were identifi ed on 
MSCT. Separate ostia of the left superior PV and left inferior PV were present in 74 patients 
(74%) and a common trunk of the left PVs was present in the remaining 26 patients (26%). 
Separate ostia of the right superior PV and right inferior PV were observed in 78 patients (78%), 
an additional right-sided PV in 18 patients (18%) and 2 additional right-sided veins in 4 patients 
(4%). Accordingly, atypical anatomy of the left-sided PVs was present in 26 patients (26%) and 
atypical anatomy of the right-sided PVs was observed in 22 patients (22%). 
Atypical anatomy of the right-sided PVs was associated with a signifi cantly lower risk for 
AF recurrence than normal anatomy of the right-sided PVs (unadjusted OR: 0.136, p=0.010). In 
contrast, the presence of atypical anatomy of the left-sided PVs had no signifi cant impact on 
the outcome of RFCA (unadjusted OR: 0.466, p=0.14).
Predictors of AF recurrence 
Univariate logistic regression analyses were performed to study the impact of LA dimensions, 
PV dimensions and PV anatomy, as well as clinical risk factors (e.g. type of AF, hypertension) on 
the outcome of RFCA for AF (Table 3). A large AP LA diameter was related to a higher risk for 
recurrent AF after RFCA (unadjusted OR: 1.082, p=0.021). Similarly, patients with persistent AF 
had a higher risk for AF recurrence (unadjusted OR: 2.429, p=0.049). In contrast, the presence 
of atypical right-sided PV anatomy was related to a lower risk for AF recurrence (unadjusted 
OR: 0.136, p=0.010). Subsequent multivariate analyses demonstrated that AP LA diameter, type 
of AF and right-sided PV anatomy were independent predictors of AF recurrence (OR: 1.083, 
p=0.027, OR: 3.004, p=0.035 and OR: 0.149, p=0.006, respectively) (Table 4). 
Chapter 6
Im
pact of PV anatom




The present study investigated the impact of LA dimensions, PV dimensions and PV anatomy on 
the outcome of circumferential RFCA for AF. The main fi ndings can be summarized as follows: 
enlargement of the LA in AP direction on MSCT is an independent predictor of AF recurrence 
after RFCA. In contrast, PV dimensions are not related to the outcome of RFCA. Finally, atypical 
anatomy of the right-sided PVs is independently associated with less recurrences of AF after 
RFCA. 
Left atrial dimensions 
Left atrial enlargement is an important risk factor for the development of AF in the general pop-
ulation (14) and has been identifi ed as an independent predictor of AF recurrence after RFCA 
(8-11). Heavily dilated atria are thought to contain a large extent of atrial remodeling thereby 
limiting the effi  cacy of RFCA. Multislice CT allows accurate measurement of LA dimensions and 
is commonly acquired prior to RFCA in order to plan and guide the procedure (3). The present 
Table 3. Univariate logistic regression analysis of clinical and anatomical characteristics on MSCT as risk factors for recurrence of AF after RFCA
OR 95% CI P-value
Clinical characteristics
Age (years) 1.027 0.978-1.079 0.28
Male gender 1.012 0.381-2.691 0.98
AF duration (months)  1.032 0.952-1.118 0.45
Failed anti-arrhythmic drugs (n) 1.109 0.802-1.532 0.53
Persistent AF 2.429 0.989-5.963 0.05*
Hypertension 0.908 0.399-2.067 0.82
Left atrial AP diameter (TTE) 1.042 0.966-1.125 0.29
Left ventricular ejection fraction (%) 0.971 0.920-1.026 0.30
MSCT characteristics
Right atypical anatomy 0.136 0.030-0.624 0.010*
Left atypical anatomy 0.466 0.167-1.297 0.14*
Mean PV diameter 1.033 0.856-1.247 0.73
Left atrial diameter
   AP (mm) 1.082 1.012-1.156 0.021*
   Longitudinal (mm) 1.021 0.967-1.078 0.45
   Transversal (mm) 1.018 0.958-1.082 0.57
* included in multivariate logistic regression analysis; ECV = electrocardioversion; TTE = transthoracic echocardiography; other abbreviations as 
in Table 2.
Table 4. Multivariate logistic regression analysis of clinical and anatomical characteristics on MSCT as risk factors for recurrence of AF after RFCA
OR 95% CI P-value
Clinical characteristics
Persistent AF 3.004 1.082-8.345 0.035
MSCT characteristics
Right complex anatomy 0.149 0.038-0.576 0.006
Left atrial AP diameter (mm) 1.083 1.009-1.162 0.027
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study evaluated LA dimensions in three orthogonal directions on MSCT: AP, longitudinal and 
transversal. Anterior-posterior LA diameter on MSCT was identifi ed as an independent predic-
tor of AF recurrence, whereas longitudinal and transversal LA diameters were not. Interestingly, 
atrial dilatation is thought to be predominantly oriented in longitudinal and transversal direc-
tion and not in AP direction (15). A potential explanation for our fi nding is that dilatation of 
the LA in AP direction occurs at a more advanced stage of atrial enlargement and refl ects a 
higher extent of atrial remodeling, thereby explaining its prognostic value. Importantly, AP LA 
diameter was a strong predictor of AF recurrence even after correction for type of AF.
Pulmonary vein dimensions
Similar to LA dimensions, PV dimensions are enlarged in patients with AF (6,7). However, little 
is known about the prognostic importance of PV dilatation in patients undergoing RFCA for 
AF. The present study evaluated the impact of PV ostial dimensions assessed by MSCT on 
the outcome of RFCA for AF. No diff erences were found in PV dimensions or shape between 
patients with AF recurrence and patients without AF recurrence during follow-up. These results 
suggest that PV dilatation has no prognostic importance for the outcome of circumferential 
RFCA. Most likely, PV dilatation is caused by the presence of AF and can be best considered an 
epiphenomenon. 
Pulmonary vein anatomy
The observations by Haïssaguerre et al. that ectopic beats originating from the PVs can initiate 
AF, have led to an increasing interest in the PVs as target for RFCA (16). Nowadays, isolation of 
the PV region is the cornerstone for most ablation strategies (1). However, the relation between 
the anatomy of the PV region and the effi  cacy RFCA for AF has not been studied extensively. 
Several studies have shown that large variations in pulmonary venous drainage pattern into 
the LA exist (5,17-20). Potentially, certain anatomical variants could pose a technical challenge 
to achieve stable catheter position thereby infl uencing the outcome of RFCA. Moreover, diff er-
ent venous drainage patterns could be accompanied by diff erent tissue characteristics of the 
surrounding myocardium rendering the PV area more or less resistant to electrical isolation. 
In the present study, the relation between PV anatomy and outcome of AF ablation was 
studied in 100 consecutive patients undergoing circumferential RFCA. Pulmonary vein anat-
omy was analyzed on MSCT and classifi ed according to the presence or absence of a common 
trunk and/or additional PV as either normal or atypical. Atypical anatomy of the right-sided 
PVs was associated with a decreased risk for AF recurrence after RFCA. After correction for 
AP LA diameter and type of AF, right-sided PV anatomy remained an independent predictor 
of AF recurrence after RFCA. Potential explanations for these results include that an atypical 
PV drainage pattern may be accompanied by an increased susceptibility of the surrounding 
myocardial tissue for electrical isolation or a lower likelihood for PV ectopy originating from the 
right-sided PVs. Furthermore an atypical PV drainage pattern may pose less technical diffi  culty 
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to achieve stable catheter position, resulting in a more eff ective lesion formation and a lower 
risk for electrical reconnection. 
Recently, Hof et al reported on the impact of PV anatomy on the effi  cacy of RFCA in 146 
patients (9). Interestingly, no relation was found between PV anatomy and outcome of RFCA. 
However, several diff erences can be identifi ed between their work and the present study that 
could have caused this discrepancy. Most importantly, the defi nition of outcome used by Hof 
et al included three categories (failure, improvement of AF burden and complete success) (9), 
whereas the present study only considered two (AF recurrence and non-recurrence). The use of 
this defi nition of outcome may also explain why type of AF, which is a commonly accepted risk 
factor for AF recurrence (1) was not related to outcome in their study (9).
Clinical implications
Despite the introduction of new devices to perform PV isolation, circumferential RFCA remains a 
widely used ablation strategy. Multi-slice computed tomography is commonly performed prior 
to these procedures. The present study demonstrates that AP LA dimension and PV anatomy 
on MSCT have an important impact on the likelihood to maintain SR after RFCA. In patients 
undergoing RFCA for AF, information about LA size and PV anatomy on MSCT can be used to 
decide whether circumferential RFCA alone is suffi  cient or additional ablation lesions (e.g. PV 
carina ablation) may be needed to improve outcome.
Limitations
The present study represents a single center experience. In addition, the number of evaluated 
patients is relatively small; nonetheless, statistical signifi cance was reached. The applicability 
of MSCT as a pre-procedural patient selection tool is limited by the radiation exposure of this 
technique. However, since MSCT is commonly acquired prior to RFCA to plan and guide the 
procedure, the present results may help determine whether additional ablation is needed in 
patients who are undergoing circumferential ablation. 
CONCLUSIONS
Right-sided PV anatomy is an independent predictor of AF recurrence after circumferential 
RFCA for AF. In addition, enlargement of the LA in AP direction and type of AF are independent 
pre-procedural risk factors for recurrence of AF after circumferential RFCA. 
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ABSTRACT
Left atrial (LA) remodeling is associated with atrial fi brillation (AF). Radiofrequency catheter 
ablation off ers a good treatment option for AF, with reasonable long-term results. The purpose 
of the current study was to assess whether LA reverse remodeling occurs after successful cath-
eter ablation. Fifty-seven consecutive patients (45 men, age 53 ± 8 years) with symptomatic 
drug-refractory AF were treated with radiofrequency catheter ablation. Patients were divided 
in 2 groups based on recurrence of AF on Holter monitoring and 12-lead ECG at 6 weeks and 
3 months follow-up (SR-group: no recurrence; AF-group: recurrence of AF). At baseline and 
3 months follow-up, 2-dimensional echocardiography was performed to assess LA size and 
dimensions. Furthermore, LA volumes were measured at end-systole (LAESV) and end-diastole 
(LAEDV). After 3 months 39 of 57 patients (68%) maintained sinus rhythm. At 3 months follow-
up, LA anteroposterior diameter showed a signifi cant reduction in the SR-group (4.5 ± 0.3 cm 
vs. 4.2 ± 0.2 cm, p<0.01), whereas a further increase was observed in the AF-group (4.5 ± 0.3 
cm vs. 4.8 ± 0.3 cm, p<0.05). Furthermore, LAESV and LAEDV decreased signifi cantly in the SR-
group from baseline to follow-up (LAESV 59 ± 12 ml vs. 50 ± 11 ml, p<0.01; LAEDV 37 ± 9 ml 
vs. 31 ± 7 ml, p<0.01), whereas a tendency towards an increase in LA volumes was observed in 
the AF-group. In conclusion, this study demonstrates that LA reverse remodeling occurs after 
successful radiofrequency catheter ablation for AF. 
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INTRODUCTION
Radiofrequency catheter ablation off ers a curative treatment modality for patients with drug-
refractory atrial fi brillation (AF) (1). Anatomical based electrical isolation of pulmonary veins 
has proven to be a safe method with reasonable long-term results (2). However, the eff ect of 
radiofrequency catheter ablation on left atrial (LA) size has not been evaluated extensively. 
Accordingly, the purpose of the current study was to assess whether LA reverse remodeling 
occurs after successful radiofrequency catheter ablation for AF.
METHODS
The study population consisted of 57 consecutive patients (45 men, age 53 ± 8 years) with 
symptomatic drug-refractory AF, who were referred for radiofrequency catheter ablation. AF 
was present for 6 ± 5 years and was paroxysmal in 35 (61%), persistent in 18 (32%) and perma-
nent in 4 (7%). In 17 patients ablation of atrial fl utter was performed previously. 
Radiofrequency ablation
The ablation procedure was aimed at electrical isolation of all pulmonary veins from the LA. 
With the use of phased-array intracardiac echocardiography an intracardiac thrombus was 
excluded and a transseptal puncture was guided. Endocardial mapping was performed with 
a 4 mm quadripolar mapping/ablation catheter (7F Thermocool, Biosense Webster, California, 
USA), using a 3-dimensional electroanatomical mapping system (CARTOTM, Biosense Webster). 
A 6F diagnostic catheter placed in the right atrium served as a temporal reference. 
Radiofrequency current was applied outside the ostia of all pulmonary veins, using the 
ablation catheter with a 4 mm open loop irrigated tip. Additional lines were targeted between 
the mitral annulus and the left inferior pulmonary vein (mitral isthmus line) and between the 
ostia of the left and right superior pulmonary veins (roof line). The following power and tem-
perature settings were used: irrigation rate 20 mL/min, maximum temperature 50°C, maximum 
radiofrequency energy 30 W. At each point, radiofrequency current was applied until a voltage 
<0.1 mV was achieved, with a maximum of 60 seconds per point. The procedure was consid-
ered successful when pulmonary vein isolation was confi rmed by recording entrance block 
during sinus rhythm or pacing in the coronary sinus. All patients received heparin intravenously 
(activated clotting time > 300 sec) to avoid thrombo-embolic complications. 
Follow-up
After the ablation procedure rhythm was continuously monitored until discharge. Patients 
received heparin intravenously until INR was adequate with oral anticoagulants. Transthoracic 
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2-dimensional echocardiography was performed within 24 hours after the ablation procedure 
to detect pericardial eff usion. 
Follow-up was scheduled at 6 weeks and 3 months after the ablation procedure. Follow-
up at 6 weeks consisted of an outpatient clinic visit with a 12-lead surface ECG. At 3 months 
follow-up, 24-hour Holter monitoring, a 12-lead surface ECG, and a standard 2-dimensional 
echocardiogram were performed. During the 3 months follow-up all medication, including 
anti-arrhythmic drugs, was continued in all patients. Patients were divided into 2 groups based 
on their rhythm during follow-up. Group 1 maintained sinus rhythm during the 3 months 
follow-up (SR-group) whereas group 2 had recurrence of AF during follow-up (AF-group). 
Echocardiography
Two-dimensional echocardiography was performed 2 days before the ablation procedure, and 
at 3 months follow-up. Two-dimensional images were recorded with patients in the left lateral 
decubitus position using a commercially available system (Vingmed system Seven, General 
Electric-Vingmed, Milwaukee, Wisconsin, USA). Images were obtained using a 3.5-MHz trans-
ducer at a depth of 16 cm in the parasternal and apical views (standard long-axis and 2- and 
4-chamber images). Standard 2-dimensional images and color Doppler data triggered to the 
QRS complex were saved in cine loop format. 
LA measurements were performed off -line using commercial software (Echopac 6.1, 
General Electric-Vingmed). LA anteroposterior diameter was measured at end-systole on the 
M-mode image obtained from the parasternal long-axis view (3). Short- and long-axis of the 
LA were measured on apical 4-chamber views at end-systole. Furthermore, LA volumes were 
measured on apical 2- and 4-chamber views using the biplane Simpson’s rule (4,5). Measure-
ments on LA volumes were acquired from 3 consecutive beats, and subsequently averaged. 
Left atrial end-systolic volume (LAESV) was defi ned as the largest LA volume in ventricular 
systole; left atrial end-diastolic volume (LAEDV) was defi ned as the smallest possible LA volume 
in ventricular diastole (5). Inter- and intraobserver agreement for the assessment of LA volumes 
were 92% and 95%, respectively. 
Statistical analysis
Data are expressed as mean ± SD or number (%), as appropriate. Continuous variables were 
compared using the nonparametric Mann-Whitney U test for unpaired variables or the non-
parametric Wilcoxon signed-ranks test for paired variables. The chi-square test was used to test 
categorical variables. All statistical tests were performed using SPSS 12.0 software for Windows. 
A p-value <0.05 was considered signifi cant. 
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RESULTS
A total number of 57 patients were treated with radiofrequency catheter ablation for AF. 
Immediate success of the procedure was achieved in all patients. In 3 patients (5%) mild peri-
cardial eff usion (<1.0 cm) was observed within 24 hours after the ablation procedure, without 
hemodynamic consequences. No acute complications were observed. Complete rhythm and 
echocardiography follow-up data was available in all patients. 
After 3 months follow-up, 39 of 57 patients (68%) maintained sinus rhythm. The study 
population was divided in 2 groups (with maintained sinus rhythm or relapsed AF). Baseline 
characteristics of the 2 groups are listed in Table 1. There were no signifi cant diff erences in base-
line characteristics between the AF-group and the SR-group. Only the proportion of patients 
with non-paroxysmal AF at baseline was higher in the AF-group as compared to the SR-group 
(72% versus 23%, p<0.05). 
Left atrial dimensions and volumes
The LA dimensions (anteroposterior diameter, short- and long-axis) and volumes at baseline 
and 3 months follow-up are listed in Table 2. Baseline echocardiographic parameters were 
Table 1. Clinical characteristics of patients with maintenance of sinus rhythm (SR-group) and recurrence of atrial fi brillation (AF-group)
Variable SR-group (n=39) AF-group (n=18)
Age (years) 53 ± 9 54 ± 8
Men/Women 32/7 13/5
Body surface area (m2) 2.07 ± 0.16 2.07 ± 0.17
Non-paroxysmal AF 9 (23%) 13 (72%)*
Duration AF (years) 7 ± 5 5 ± 4
Number of anti-arrhythmic drugs per patient 3.5 ± 1.8 4.0 ± 1.5
Left ventricular ejection fraction (%) 55 ± 9 54 ± 6
Valvular disease 4 (10%) 2 (11%)
Hypertension 13 (33%) 4 (22%)
Coronary artery disease 2 (5%) 2 (11%)
* p <0.05 SR-group vs AF-group.
Table 2. Left atrial dimensions and volumes at baseline and 3 months follow-up
Variable SR-group (n=39) AF-group (n=18)
Baseline 
   LA anteroposterior diameter (cm) 4.5 ± 0.3 4.5 ± 0.3
   LA short axis (cm) 4.5 ± 0.3 4.6 ± 0.2
   LA long axis (cm) 5.1 ± 0.3 5.2 ± 0.4
   LAEDV (ml) 59 ± 12 63 ± 7
   LAESV (ml) 37 ± 9 43 ± 7*
3 months follow-up
   LA anteroposterior diameter (cm) 4.2 ± 0.2† 4.8 ± 0.3*‡
   LA short axis (cm) 4.2 ± 0.3† 4.8 ± 0.3*‡
   LA long axis (cm) 4.6 ± 0.4† 5.3 ± 0.3*
   LAEDV (ml) 50 ± 11† 68 ± 8*
   LAESV (ml) 31 ± 7† 47 ± 7*
*p <0.05 SR-group vs AF-group; †p<0.01 baseline vs 3 months follow-up; ‡p<0.05 baseline vs 3 months follow-up.
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similar in both groups, except that the LAEDV was signifi cantly smaller in the SR-group as 
compared to the AF-group (37 ± 9 ml vs. 43 ± 7 ml, p<0.05). 
At 3 months follow-up, the LA anteroposterior diameter had decreased signifi cantly in 
the SR-group (baseline 4.5 ± 0.3 cm vs. follow-up 4.2 ± 0.2 cm, p<0.01). In contrast, in the AF-
group, the LA anteroposterior diameter increased signifi cantly from 4.5 ± 0.3 cm to 4.8 ± 0.3 
cm (p<0.05) (Figure 1). In addition, at 3 months follow-up LAESV and LAEDV had decreased 
signifi cantly in the SR-group in comparison to baseline measurements (Table 2). In contrast, in 
the AF-group, LAESV and LAEDV showed a tendency to increase, although the diff erences were 
not signifi cantly diff erent (Table 2). As a consequence, at 3 months follow-up all LA dimensions 
and volumes were signifi cantly larger in the AF-group as compared to the SR-group (Table 2). 
DISCUSSION
The fi ndings in current study demonstrate that reverse remodeling of the LA occurs after suc-
cessful radiofrequency catheter ablation for AF. In patients who maintained sinus rhythm, LA 
dimensions showed a signifi cant decrease at 3 months follow-up. In contrast, in patients with 
recurrence of AF during follow-up, an increase in LA dimensions was observed. Furthermore, 
LA volumes decreased signifi cantly in the SR-group, whereas a tendency towards a further 
increase in LA volumes was observed in the AF-group. 
Figure 1. Left atrial anteroposterior diameter at baseline and 3 months follow-up in the SR-group and the AF-group. * p <0.05 SR-group vs. 
AF-group; † p<0.01 baseline vs. 3 months follow-up; ‡ p<0.05 baseline vs. 3 months follow-up.
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In the current study, LA dimensions and volumes were measured using standard 2-dimen-
sional echocardiography to determine LA size at baseline and 3 months follow-up. A signifi cant 
decrease in LA anteroposterior diameter was observed in the SR-group. Although M-mode 
is used commonly in clinical practice to measure LA dimension, it may not be suffi  cient to 
determine true LA size (6). Since M-mode represents only 1 dimension of the LA, it may under-
estimate LA size. Therefore, short- and long-axis of the LA were also evaluated on the apical 
4- and 2-chamber images. The short- and long-axis measurements confi rmed the fi ndings 
observed on M-mode echocardiography (LA anteroposterior diameter). A signifi cant decrease 
was observed in patients who maintained sinus rhythm, and an increase in LA dimensions was 
observed in patients with recurrence of AF. 
LA enlargement may result in an asymmetrical geometry of the LA. Therefore, optimal 
assessment of LA size should include LA volume measurements (6). In the current study 
the biplane Simpson’s rule (4,5) was used to assess LAEDV and LAESV. Several reports have 
demonstrated that this method is an accurate technique for assessment of LA volumes using 
echocardiography (6,7). Furthermore, this method has been validated against CT (4) and MRI 
techniques (8) in previous studies. Using the biplane Simpson’s rule, a signifi cant decrease in 
LA volumes was demonstrated in the SR-group at 3 months follow-up, whereas a tendency 
towards an increase in LA volumes was noted in the AF-group. 
CONCLUSIONS
In conclusion, LA cavity size decreases in patients who maintain sinus rhythm after radiofre-
quency catheter ablation, whereas LA size increases in patients with recurrence of AF. 
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ABSTRACT 
Real-time 3-dimensional echocardiography (RT3DE) can provide a unique combination of accu-
rate left atrium (LA) volume quantifi cation and rapid, automatic assessment of LA function. The 
aim of the study was to evaluate the changes in LA volumes and function in patients with atrial 
fi brillation (AF) undergoing radiofrequency catheter ablation (RFCA), using RT3DE. 
Fifty-seven consecutive patients referred for RFCA were studied. Paroxysmal AF was present 
in 43 patients (75%), and persistent AF in 14 (25%). After a mean follow-up of 7.9 ± 2.7 months, 
patients were divided into 2 groups: successful RFCA (SR group) and recurrence of AF (AF 
group). RT3DE was performed before, within 3 days and 3 months after RFCA to assess LA vol-
umes (maximum, minimum and preA) and LA functions (passive, active and reservoir). A total 
of 38 patients (67%) had successful RFCA (SR group). Immediately after RFCA, no signifi cant 
changes in LA volumes and function were observed. After 3 months, a signifi cant reduction in 
LA volumes (maximum: from 26 ± 8 to 23 ± 7 mL/m2, p <0.01) was noted only in the SR group, 
together with a signifi cant improvement in LA active (from 22 ± 8 to 33 ± 9%, p<0.01) and reser-
voir functions (from 116 ± 45 to 152 ± 54%, p <0.01). Conversely, the AF group showed a trend 
towards a deterioration of LA volumes and function. In conclusion, in patients who maintain 
sinus rhythm after RFCA, a signifi cant reverse remodeling and functional improvement of the 
LA is observed using RT3DE. 
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Recently, real-time 3-dimensional echocardiography (RT3DE) has been validated against 
magnetic resonance imaging and has been shown to be more accurate and reproducible than 
2-dimensional (2D) echocardiography for the quantifi cation of left atrial (LA) volumes (1,2). 
Furthermore, RT3DE may be a novel, reliable technique for the assessment of LA function, 
providing unique information about phasic changes of LA volumes during the cardiac cycle 
(3,4). In the present study, RT3DE was used to evaluate the changes in LA volumes and function 
in atrial fi brillation (AF) patients treated with radiofrequency catheter ablation (RFCA).
METHODS
In a 10 months period, 57 consecutive patients (44 men; age 56 ± 9 years) with symptomatic 
drug-refractory AF, referred to our institution for RFCA in accordance to the current guidelines 
criteria, were included in this study. According to the ACC/AHA/ESC Guidelines defi nition (5), 
paroxysmal AF was present in 43 patients (75%), while persistent AF was present in the remain-
ing 14 patients (25%); none of the patients had permanent AF. Mean AF duration (calculated 
from the time of the fi rst episode) was 4.6 ± 4.1 years and the patients had an unsuccessful 
treatment with 3 ± 1 anti-arrhythmic drugs (mainly fl ecainide, propafenone, sotalol and amio-
darone). 
After RFCA, the patients were evaluated at the out-patient clinic on a regular basis. During 
follow-up, all medication, including anti-arrhythmic drugs, were continued in all patients for 
3 months after the RFCA procedure. Afterwards, anti-arrhythmic drugs were discontinued at 
discretion of the physician. At the latest follow-up, successful RFCA was defi ned as the absence 
of symptomatic recurrences lasting more than 3 minutes (6) and/or the absence of AF episodes 
lasting more than 30 seconds (detected with 24-hours Holter ECG recording and surface ECG) 
during follow-up, after a blanking period of 1 month (5,7). Accordingly, the study population 
was divided into 2 groups: patients with successful RFCA (SR group) and patients who had 
recurrence of AF (AF group).Before and within 3 days after the ablation procedure, RT3DE was 
performed to assess LA and left ventricular (LV) size and function. In addition, conventional 2D 
color-Doppler echocardiography was performed to assess mitral regurgitation (MR) and LV fi ll-
ing pattern. After 3 months follow-up, the echocardiograms were repeated to assess the eff ect 
of the RFCA on LA volumes and function. 
Real-time 3-dimensional echocardiography
Patients were imaged with a commercially available system (iE33, Philips Medical Systems, 
Bothell, Washington) equipped with X3, fully sampled matrix transducer. Apical full-volume 
data sets were obtained in all patients, combining 7 small real-time sub-volumes to provide a 
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larger pyramidal volume. The acquisition was performed during end-expiratory apnea within 
1 breath hold. Frame rate ranged from 20 to 35 frames/sec. The RT3DE data sets were stored 
digitally and quantitative analyses were performed off -line using a semi-automated contour 
tracing algorithm (Q-Lab, version 5.0, Philips Medical Systems) based on 5 reference points. In 
all patients the image quality was suffi  cient for quantitative analysis and the post-processing 
of the images was performed within 10 minutes. Left ventricular volumes and function were 
assessed as previously described in detail (8). 
Quantifi cation of LA volumes was performed using the semi-automated contour tracing 
algorithm developed for the LV, but marking 5 atrial reference points: 4 at the anterior, inferior, 
lateral and septal part of atrial dome and 1 at the level of the mitral annulus (Figure 1). The 
position of the reference points was chosen to avoid changes in the view orientation that the 
software automatically generates, since the position of the dome of the LA is opposite of the 
apex of the LV. Manual corrections of the automatic trace were made to exclude the LA append-
age and the pulmonary vein ostia. Left atrial volumes were measured at 3 time points during 
the cardiac cycle: 1) maximum volume (LAmax) at end-systole, just before mitral valve opening; 
2) minimum volume (LAmin) at end-diastole, just before mitral valve closure; 3) volume before 
atrial active contraction (LApreA) obtained from the last frame before mitral valve reopening or 
Figure 1. Assessment of LA volumes using RT3DE. An automatic border detection is obtained marking 5 reference points in the apical 2- and 
4-chamber views (upper panel) and the LA 3D model is provided by the software. The changes of LA volumes during the heart cycle are plotted 
as a curve (lower panel).
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at time of the P wave on the surface ECG. All LA volumes were indexed to the body surface area, 
as recommended (9). 
Twenty patients were randomly identifi ed for inter- and intra-observer agreement. Accord-
ing to the Bland-Altman analysis, intra-observer variability was excellent with a mean diff er-
ences of 1.2 ± 2.9 mL for LAmax, 0.1 ± 1.1 mL for LAmin and 0.8 ± 2.3 mL for LApreA (p = NS). 
Inter-observer variability was also good with a mean diff erence for LAmax, LAmin and LApreA of 3.6 
± 5.6 mL, 0.7 ± 5.4 mL and 1.9 ± 3.4 mL, respectively (p = NS). 
The LA function was derived from the LA volumes and expressed with the following param-
eters (10,11): 1) Total atrial emptying fraction: LAEF = ([LAmax – LAmin]/LAmax) x100; 2) Active 
atrial emptying fraction: LAactive = ([LApreA – LAmin]/LApreA) x100, which is considered an index 
of LA active contraction; 3) Passive atrial emptying fraction: LApassive = ([LAmax – LApreA]/LAmax) 
x100, which is considered an index of LA conduit function; 4) Atrial expansion index: LAreservoir = 
([LAmax – LAmin]/LAmin) x100, which is considered an index of LA reservoir function. 
The severity of MR was graded semi-quantitatively from color-Doppler images in the con-
ventional parasternal long-axis and apical 4-chamber view and characterized as follows: absent, 
mild (ratio jet area/LA area <20%), moderate (jet area/LA area 20% to 40%) and severe (jet area/
LA area >40%) (12). Left ventricular diastolic function was evaluated according to the Canadian 
Consensus recommendations (13) through the following Doppler measurements: ratio of early 
(E) to late (A) diastolic fi lling velocities (E/A) and deceleration time (DT) of the E wave. 
Radiofrequency catheter ablation procedure
The RFCA procedure was aimed at electrical isolation of all pulmonary veins from the LA. Endo-
cardial mapping was performed with a 4-mm quadripolar mapping/ablation catheter (7Fr Ther-
mocool, Biosense Webster, Diamond Bar, California, USA), using a 3D electroanatomic mapping 
system (CARTO, BiosenseWebster). A 6Fr diagnostic catheter placed in the right atrium served 
as a temporal reference. Radiofrequency current was applied outside the ostia of all pulmonary 
veins, using the ablation catheter with a 4-mm open loop irrigated tip. The following power and 
temperature settings were used: irrigation rate 20 ml/min, maximum temperature 50º C, and 
maximum radiofrequency energy 30W. At each point, the radiofrequency current was applied 
until a voltage of <0.1 mV was achieved, with a maximum of 60 s/point. The procedure was con-
sidered successful when pulmonary vein isolation was confi rmed by the recording of entrance 
block during SR or pacing in the coronary sinus. All patients received heparin intravenously 
(activated clotting time >300 sec) to avoid thrombo-embolic complications during the catheter 
ablation procedure. After RFCA, the rhythm was continuously monitored until discharge. 
Statistical analysis
Continuous data are presented as mean ± standard deviation. Categorical data are presented 
as absolute numbers or percentages. Independent-samples T test and Wilcoxon rank-test 
were used to compare continuous variables, as appropriate, and χ2 test was used to compare 
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categorical variables. Sequential data measurements were analyzed by the general linear 
model (GLM) procedure for repeated measures. For all tests, a p value <0.05 was considered 
signifi cant. A statistical software program SPSS 15.0 (SPSS Inc, Chicago, II, USA) was used for 
statistical analysis. 
RESULTS
Baseline clinical characteristics of the study population are summarized in Table 1. At baseline, 
RT3DE revealed a mild enlargement of LA volume and a moderate reduction in LAEF, LAactive and 
LAreservoir (Table 2), as compared to the reference values for a normal LA (9,14). Left ventricular 
systolic and diastolic functions were normal and in 27 patients MR was present (mild n = 24; 
moderate n = 3) (Table 3). Six patients were in AF at the baseline evaluation and all had a recur-
rence of AF during follow-up. In these patients, LApreA, LAactive, LApassive and LV diastolic function 
could therefore not be assessed. 
After a mean follow-up of 7.9 ± 2.7 months, 38 patients (67%) had successful RFCA (SR 
group), whereas 19 patients (33%) had recurrence of AF (AF group). Of note, these patients were 
classifi ed in the same group also at 3 months follow-up evaluation. No signifi cant diff erences 
were found in the baseline clinical characteristics between the AF and SR groups, except for the 
percentage of patients with persistent AF (Table 1). At baseline, RT3DE showed larger LAmax in 
the AF group than in the SR group (31 ± 8 vs. 26 ± 8 mL/m2, p <0.05), but no signifi cant diff er-
ences in LA and LV function (Table 2 and 3). Conventional 2D color-Doppler echocardiography 
revealed a comparable LV diastolic function and prevalence of MR (mild/ moderate) between 
Table 1. Baseline clinical characteristics of the total study population and of patients with and without recurrence of AF after radiofrequency 
catheter ablation






Atrial fi brillation 
group
n = 19
Age (years) 56 ± 9 57 ± 9 53 ± 9
Male/Female 44/13 28/10 16/3
Body surface area (m2) 2.1 ± 0.2 2.1 ± 0.3 2.1 ± 0.1
Atrial fi brillation: Paroxysmal/Persistent 45 (79%) / 12 (21%) 34 (89%) / 4 (11%) 11 (58%) / 8 (42%)*
Duration atrial fi brillation (years) 4.6 ± 4.1 4.5 ± 4.1 4.6 ± 4.1
Number of anti-arrhythmic drugs per patient 3 ± 1 3 ± 1 3 ± 1
ACE-inhibitor and/or Angiotensin receptor 
blocker
26 (46%) 17 (45%) 9 (47%)
Heart rate (beats/minute) 62 ± 20 60 ± 13 66 ± 36
Hypertension 25 (44%) 13 (34%) 11 (58%)
Diabetes mellitus 6 (11%) 6 (15%) 0 (0%)
Coronary artery disease 3 (5%) 2 (5%) 1 (5%)
*p <0.05 SR group versus AF group.
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the 2 groups (Table 3). Immediately after the RFCA procedure, no signifi cant changes in LA vol-
umes were observed (Table 2). However, after 3 months of follow-up, a signifi cant decrease in 
LA volumes was noted in the SR group, involving LAmax, LAmin and LApreA volumes. Conversely, 
the AF group showed a trend towards an increase in LA volumes during follow-up (Table 2). An 
example of a patient in the SR group with a signifi cant reduction of LAmax and LAmin is shown 
in Figure 2. In both groups, no signifi cant changes in LA function were noted immediately after 
the RFCA procedure. However, after 3 months of follow-up, a signifi cant improvement of LAactive 
and LAreservoir was noted in the SR group, whereas in the AF group these parameters showed 
a signifi cant deterioration (Figure 3). In contrast, LApassive function did not change signifi cantly 
in both groups. In concordance with the changes in LAactive, a signifi cant improvement in LAEF 
was observed in the SR group, while a signifi cant deterioration in LAEF was observed in the AF 
group (Table 2). 
Table 2. Left atrium (LA) volumes and function at baseline, immediately after and 3 months after the ablation procedure in the total study 













LA maximum volume (mL/m
2)
   Baseline
   After ablation
   3 months follow-up
28 ± 9 26 ± 8
26 ± 8








LA minimum volume (mL/m
2)
   Baseline
   After ablation
   3 months follow-up
14 ± 6 13 ± 5
12 ± 5








LA volume preA (mL/m
2)
   Baseline
   After ablation
   3 months follow-up
16 ± 5 16 ± 5
16 ± 5
 14 ± 5*
18 ± 6
18 ± 4






LA total emptying fraction (%)
   Baseline
   After ablation
   3 months follow-up
50 ± 11 52 ± 10
52 ± 10
 58 ± 10*
47 ± 13
44 ± 12





LA passive emptying fraction (%)
   Baseline
   After ablation
   3 months follow-up










LA active emptying fraction (%)
   Baseline
   After ablation
   3 months follow-up
22 ± 8 22 ± 8
21 ± 6
 33 ± 9*
24 ± 7
17 ± 7





LA expansion index (%)
   Baseline
   After ablation
   3 months follow-up
110 ± 48 116 ± 45
117 ± 43
 152 ± 54*
101 ± 55
92 ± 49





*p <0.01 (GLM for repeated measures within subjects); § p value derived from GLM for repeated measures between subjects (sinus rhythm vs. 
atrial fi brillation).
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Mean LV ejection fraction was 58 ± 9% in the SR group and 57 ± 11% in the AF group (p = 
NS) and no signifi cant changes were observed during follow-up. Similarly, LV diastolic function 
was normal in both groups before the RFCA procedure and did not change during follow-up 
(Table 3). However, 12 patients in the SR group and 3 patients in the AF group had an abnormal 
Table 3. Left ventricular function at baseline and 3 months after the ablation procedure in the total study population and in patients with or 
without recurrence of atrial fi brillation






Atrial fi brillation 
group
n = 19
Left ventricular ejection fraction (%)
   Baseline
   3 months follow-up





   Baseline
   3 months follow-up





   Baseline
   3 months follow-up






   Baseline







* p <0.01 baseline vs. follow-up.




, 3 months after the RFCA (panel B vs. panel A). LA
max
 decreased 
from 83 to 66 mL/m2 and LA
min
 decreased from 44 to 33mL/m2.
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LV relaxation based on E/A <1. For these patients an improvement in LV fi lling pattern was 
noted in the SR group only (E/A ratio from 0.7 ± 0.2 to 1.6 ± 0.5, p <0.01). Only 3 patients had 
clinically relevant MR (moderate or severe) and a signifi cant improvement in the degree of MR 
after RFCA was only observed in the SR group (Table 3). 
DISCUSSION
The main fi ndings of the current study can be summarized as follows: 1) three months after 
RFCA, a signifi cant reduction in LA volumes and a clear improvement of LA active contrac-
tion and LA reservoir function was observed in patients with a successful RFCA procedure; 2) 
patients with recurrence of AF after RFCA showed a trend towards a worsening of LA volumes 
and function
Real-time 3-dimensional echocardiography
In the present study, RT3DE was used to assess LA volumes and function in patients treated 
with RFCA for AF. The assessment of LA size is fundamental in the management of patients with 
AF, since it has important prognostic value and is used as a surrogate marker of therapy success 
(15-18). The most recent recommendations for cardiac chamber quantifi cation indicate LA vol-
ume as the preferred measurement of LA size (9). However, the majority of the previous studies 
only evaluated LA diameter and LA area, using conventional 2D echocardiography (16,18,19). 
Although most frequently used, 2D echocardiography is limited for the assessment of LA vol-
ume by signifi cant geometric assumptions and low reproducibility due to diverging position 
and orientation of imaging planes. RT3DE has been demonstrated to be more accurate for LA 
volumes quantifi cation, with the most favorable test-retest variation (1,2,4). In addition to LA 
volumes, assessment of LA function is of particular signifi cance in patients treated with RFCA 
for AF. However, accurate non-invasive measurements for LA function are still lacking. Recently, 
initial studies have proposed tissue Doppler imaging (TDI) and 2D strain as new modalities to 
assess LA myocardial function (20,21). However, these techniques need to be further validated 
for this purpose and have some limitations related to the angle dependency of TDI (21) and the 
 
Figure 3. Left atrium active emptying fraction (LA
active
; panel A) and expansion index (LA
reservoir
; panel B) at baseline, immediately after 
catheter ablation and at 3 months follow-up (FU) in SR and AF groups.
130
diffi  cult analysis of LA systole with 2D strain (20). In contrast, RT3DE is well validated (3,4,22) 
and provides a unique combination of an accurate measurement of LA volumes together with a 
rapid and automatic detection of phasic changes of LA volumes that provides detailed informa-
tion of the diff erent LA functions. 
Eff ect of RFCA on LA volumes and function
The relationship between LA enlargement and AF is complex: structural changes of the LA 
may be related several factors including 1) pressure or volume overload due to underlying 
structural heart disease; 2) the increased LV fi lling pressure induced by the tachyarrhythmia; 3) 
AF itself (23,24). Supporting the latter hypothesis, abnormal atrial histology (fi brosis, necrosis 
and infl ammation) has been found uniformly in patients with lone AF (25). Furthermore, LA 
dilatation has been directly correlated with the duration of AF, as a result of LA electrical and 
structural remodeling (18). In the present study, mild dilatation of the LA was noted at baseline 
using RT3DE. This may be explained by the relatively low prevalence of patients with persistent 
AF and with structural heart disease (Table 1). Of note, the AF group, compared to the SR 
group, demonstrated larger baseline LA volumes, probably related to the higher percentage 
of persistent AF. Furthermore, after 3 months a signifi cant decrease in LA volumes was noted 
in patients with successful RFCA. These results are in agreement with previous studies that 
showed a signifi cant reduction in LA volumes after conversion of AF to SR, either by electrical 
cardioversion or RFCA (6,14,26). The reduction in LAmin as observed in the present study is most 
probably the direct result of the improvement of LA active contraction; whereas the reduction 
in LAmax is refl ecting a true reverse remodeling that is related with the long-lasting restoration 
of SR. Although LA reverse remodeling may also be ascribed to atrial scarring caused by RFCA, 
this is very unlikely since LA volumes tended to worsen in patients with recurrence of AF during 
follow-up. 
In addition, an improvement in LA function was observed in patients who maintained SR 
after RFCA. The LA serves multiple functions. During LV systole and isovolumic relaxation, it 
operates as a “reservoir” that receives blood from pulmonary veins and stores energy in the 
form of pressure; during the early diastole, it operates as a “conduit” for transfer blood into the 
LV after mitral valve opening; during the late diastole the “active” contraction of LA contributes 
to LV stroke volume by 20-30% (22,23). To interpret the baseline and follow-up fi ndings of the 
present study, it is important to consider that the major determinants of LAactive are the heart 
rhythm, the atrial contractility and the LApreA (Frank-Starling eff ect) (3,11). The LAreservoir is rather 
infl uenced by LV systolic function (mitral annulus displacement) and by LA wall stiff ness (11,27). 
On the contrary, LApassive is mainly related to LV diastolic function (11,28). 
In the present study, a moderate reduction of LAactive and LAreservoir was noted at baseline 
evaluation. Conversely, no signifi cant impairment of LApassive was observed. Since LV systolic 
and diastolic functions were normal on average and LApreA was even decreased compared to 
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the normal values, the reduction in LAactive and LAreservoir is most probably related to the eff ect 
of AF itself on the contractility and the stiff ness of atrial walls. 
Immediately after RFCA, no signifi cant changes in LA functions were found, but LAactive 
tended to worsen. This fi nding occurred in both the SR and AF groups and can be related to the 
phenomenon of atrial “stunning” (29). After 3 months of follow-up, a signifi cant improvement 
in LAactive and LAreservoir was noted in the SR group, whereas in the AF group these parameters 
showed a signifi cant deterioration. Since LV systolic and diastolic functions did not change 
after RFCA and LApreA was even decreased, the functional improvement in the SR group is 
most probably related to a favorable eff ect of the long-lasting restoration of SR on the intrinsic 
characteristics of the atrial myocardium (24). These fi ndings are in line with previous studies 
(6,14) and carry important clinical implications, since they may translate into a reduced risk 
of AF recurrences and thrombo-embolic complications at long-term follow-up (24). However, 
the exact impact of LA reverse remodeling and improvement of LA function on cardiovascular 
outcomes remains to be determined. 
The results of the present study need to be confi rmed in a larger population with longer 
clinical and echocardiographic follow-up. In addition, in patients with paroxysmal AF, asymp-
tomatic recurrences cannot be excluded and may have infl uenced the success rate in the 
present study. 
CONCLUSIONS
In conclusion, the eff ect of RFCA on LA size and function can be accurately evaluated with 
RT3DE. In the present study, a signifi cant reverse remodeling and functional improvement of 
the LA was noted in patients who maintain sinus rhythm after RFCA. In contrast, a deterioration 
of LA volumes and function was observed in patients with recurrence of AF.
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Background: The association between LA reverse remodeling and improvement in LA strain 
after catheter ablation has not been investigated thus far. 
Objectives: The purpose of this study was to assess left atrial (LA) strain during long-term 
follow-up after catheter ablation for atrial fi brillation (AF), and fi nd predictors for LA reverse 
remodeling. 
Methods: In 148 patients undergoing catheter ablation for AF, LA volumes and LA strain were 
assessed with echocardiography at baseline and after a mean of 13.2 ± 6.7 months follow-up. 
The study population was divided according to LA reverse remodeling at follow-up: ‘Respond-
ers’ were defi ned as patients who exhibited ≥15% reduction in maximum LA volume at long-
term follow-up. LA systolic (LAs) strain was assessed with tissue Doppler imaging. 
Results: At follow-up, 93 patients (63%) were classifi ed as a responder, whereas 55 patients 
(37%) were non-responders. At baseline, LAs strain was signifi cantly higher in the responders 
as compared with the non-responders (19 ± 8% vs. 14 ± 6%, p=0.001). In the responders, a 
signifi cant increase in LAs strain was noted from baseline to follow-up (from 19 ± 8% to 22 ± 9%, 
p<0.05), whereas no change was noted in the non-responders. LAs strain at baseline was the 
strongest predictor of LA reverse remodeling (Odds ratio 1.089; 95% CI 1.014-1.169, p=0.019). 
Conclusions: In the present study, 63% of the patients exhibited LA reverse remodeling after 
catheter ablation for AF, with a concomitant improvement in LA strain. Left atrial strain at base-
line was the strongest predictor of LA reverse remodeling. 
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Left atrial (LA) enlargement is associated with cardiac morbidity and is a robust predictor of 
cardiovascular outcome (1,2). The relation between LA enlargement and atrial fi brillation (AF) 
has been well recognized. However, it still remains controversial whether LA enlargement 
causes AF (3), or vice versa (4). 
Reversal of LA enlargement, or ‘reverse remodeling’, has been demonstrated with drug 
therapy and after restoration of sinus rhythm with cardioversion (5). In addition, it has been 
shown that LA reverse remodeling may occur after successful catheter ablation for AF (6). 
At the same time, LA function may improve after restoration of sinus rhythm with cath-
eter ablation (7). Using tissue Doppler imaging, it has been demonstrated that LA strain may 
improve at three months after successful catheter ablation for AF (8). However, it is unclear 
whether these changes in LA strain remain during long-term follow-up. More importantly, the 
association between LA reverse remodeling and the improvement in LA strain has not been 
investigated thus far. Accordingly, the purpose of the present study was to evaluate reverse 
remodeling and LA strain during long-term follow-up after catheter ablation for AF. In addition, 
predictors for LA reverse remodeling were studied. 
METHODS
Study population and study protocol
The study population comprised 148 patients from an ongoing clinical registry (6) with symp-
tomatic drug-refractory AF, who were referred for radiofrequency catheter ablation. Before the 
ablation procedure and after 12 months follow-up, an extensive echocardiographic evaluation 
was performed to assess LA strain. In a subgroup of patients with an available echocardiogram 
during sinus rhythm both at baseline and at follow-up (n=122), LA late diastolic strain (repre-
senting LA active contraction) and LV systolic strain was assessed. At long-term follow-up, the 
study population was divided according to reverse remodeling of the LA after the catheter 
ablation procedure.
Catheter ablation procedure
The protocol of the catheter ablation procedure has been described in more detail elsewhere 
(9). In brief, electrical isolation of all pulmonary veins from the LA was attempted using an elec-
troanatomic mapping system with an image integration module (CARTOTM and CartoMergeTM, 
Biosense Webster, Diamond Bar, California). Endocardial mapping and ablation was performed 
with a 4 mm quadripolar mapping/ablation catheter, with an open loop irrigated tip (7F 
Thermocool, Biosense Webster). A 6F diagnostic catheter placed in the right atrium served as 
a temporal reference. Radiofrequency current was applied outside the ostia of all pulmonary 
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veins using the following settings: irrigation rate 20 mL/min, maximum temperature 50°C, 
maximum radiofrequency energy 30 W. At each point, radiofrequency current was applied until 
a voltage <0.1 mV was achieved, with a maximum of 60 seconds per point. The procedure was 
considered successful when pulmonary vein isolation was confi rmed by recording entrance 
block during sinus rhythm or pacing in the coronary sinus. All patients received heparin intra-
venously (activated clotting time > 300 sec) to avoid thrombo-embolic complications. 
After the catheter ablation procedure, all patients were evaluated at the out-patient clinic 
on a regular basis. All medication, including anti-arrhythmic drugs, was continued in all patients 
during the fi rst 3 months of follow-up. Afterwards, anti-arrhythmic drugs were discontinued 
at the discretion of the physician. A surface ECG was acquired at every follow-up visit, and 
24-hours Holter monitoring was performed at 3 to 6 months intervals. Maintenance of sinus 
rhythm during follow-up was defi ned as the absence of symptomatic recurrences lasting more 
than 3 minutes and/or the absence of AF episodes lasting more than 30 seconds detected with 
24-hour Holter monitoring or surface ECG, after a blanking period of 1 month (10). 
Echocardiography
Two-dimensional echocardiography was performed within 2 days before the ablation proce-
dure, and at 12 months follow-up. Two-dimensional images were recorded with the patient 
in the left lateral decubitus position using a commercially available system (Vivid 7, General 
Electric-Vingmed, Milwaukee, Wisconsin, USA). Images were acquired using a 3.5-MHz trans-
ducer at a depth of 16 cm in the parasternal and apical views (standard long-axis and 2- and 
4-chamber images). Standard 2-dimensional images and color Doppler data were saved in cine 
loop format. All analyses were performed off -line using commercial software (Echopac 7.0.0, 
General Electric-Vingmed). 
Left ventricular end-diastolic and end-systolic volumes were assessed from the apical 2- and 
4-chamber images, and indexed to body surface area; LV ejection fraction (LVEF) was calculated 
using the biplane Simpson’s rule (11). Left ventricular diastolic function was evaluated using the 
following Doppler measurements: ratio of early (E) to late (A) diastolic fi lling velocities (E/A) and 
deceleration time of the E wave (12). In addition, LV systolic strain and strain rate was assessed 
using color-coded tissue Doppler imaging in a subgroup of patients, as previously described (13). 
Left atrial volumes and ejection fraction The LA anteroposterior diameter was measured at 
end-systole on the M-mode image obtained from the parasternal long-axis view. Furthermore, 
LA volumes were measured on apical 2- and 4-chamber views. Maximum LA volume (LAmax) 
was defi ned as the largest LA volume just prior to mitral valve opening; minimum LA volume 
(LAmin) was defi ned as the smallest possible LA volume in ventricular diastole. All LA volumes 
were indexed to body surface area, as recommended (14). Left atrial total emptying (LAEF) was 
calculated using the biplane Simpson’s rule (14). 
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Defi nition of LA reverse remodeling To study the determinants of reverse remodeling of the 
LA after catheter ablation, the study population was divided into 2 groups according to the 
extent of decrease in LAmax during follow-up (15). ‘Responders’ were defi ned as patients who 
exhibited ≥15% reduction in LAmax at long-term follow-up. The ‘non-responders’ were patients 
who demonstrated a decrease in LAmax<15%, or an increase in LAmax during follow-up. 
Left atrial strain analysis Left atrial deformation properties were studied using color-coded 
tissue Doppler imaging, by offl  ine analysis of standard apical 2- and 4-chamber images of 
3 consecutive heart beats. Frame rates were at least 115 frames/s, and the sector width was 
adjusted to allow the highest possible frame rate. 
A sample volume (6 x 4 mm) was placed at the basal to mid parts of the LA septum and 
lateral wall (4-chamber view), and the LA anterior and inferior wall (2-chamber view). If neces-
sary, Gaussian smoothing was applied to create clear strain curves. From the reconstructed strain 
curves, myocardial LA longitudinal lengthening or LAs strain (representing LA expansion func-
tion) was identifi ed as the peak positive strain value during LV systole. In a subgroup of patients 
with an available echocardiogram during sinus rhythm both at baseline and at follow-up (n=122), 
myocardial LA shortening, or LAa strain (representing LA active contraction) was identifi ed as the 
peak negative strain value during LV diastole occurring after the P-wave on the ECG. 
Peak LAs strain and LAa strain was assessed for the 4 regions (septal, lateral, anterior, infe-
rior), and averaged to acquire global LAs strain and LAa strain values. Similar, LAs strain rate and 
LAa strain rate, representing the speed at which LA deformation occurs, was assessed in the 4 
regions and averaged (Figure 1). 
Statistical analysis
All continuous variables had normal distribution (as evaluated by Kolmogorov-Smirnov tests). 
Summary statistics for these variables are therefore presented as mean ± standard deviation 
(SD). Categorical data are summarized as frequencies and percentages. 
Diff erences in clinical and echocardiographic variables between the responders and the 
non-responders were evaluated using unpaired Student t-tests (continuous variables), Chi-
square tests or Fisher’s exact tests (dichotomous variables), as appropriate. Diff erences in con-
tinuous variables between baseline and follow-up were evaluated using paired Student t-test. 
Intra- and inter-observer reproducibility for the assessment of LA strain and LA strain rate 
was determined by intraclass correlation coeffi  cient and Bland-Altman analysis. Intra-observer 
reproducibility was determined by repeating the strain and strain rate measurements at 2 
diff erent time points by one experienced reader in 15 randomly selected patients. A second 
experienced reader performed the strain analysis in the same 15 patients, providing the inter-
observer reproducibility data. Intra-class correlation coeffi  cient and the mean bias with limits 
of agreement (2 SD) from Bland-Altman analysis are reported. 
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To explore potential predictors of response, univariate analysis of baseline clinical and 
echocardiographic characteristics was performed fi rst. Odds ratios were calculated with 95% 
confi dence intervals as an estimate of the risk associated with each variable. Independent 
predictors of LA reverse remodeling were obtained by performing a multivariate logistic regres-
sion analysis based on enter model. Those variables with p<0.1 at the univariate analysis were 
included. Statistical analyses were performed using SPSS software (version 15.0, SPSS Inc. Chi-
cago, Illinois). All statistical tests were two-sided, and a p-value <0.05 was considered signifi cant. 
RESULTS
Study population
A total of 148 patients were treated with radiofrequency catheter ablation. Baseline characteris-
tics of the total study population are summarized in Table 1. Atrial fi brillation was paroxysmal in 
112 patients (76%) and persistent in 36 patients (24%). Mean duration of follow-up was 13.2 ± 
Figure 1. Strain rate imaging in the apical 2-chamber view in a patient at baseline. Samples are placed in the basal-mid atrial inferior 
(yellow) and anterior (green) atrial walls. With the use of the vertical green lines indicating aortic valve opening (AVO) and aortic valve closure 
(AVC), peak strain rate values of the diff erent segments can be obtained (white arrows). LAa indicates peak LA strain rate during late ventricular 
diastole, representing the speed at which LA deformation during active contraction occurs. LAs indicates peak LA strain rate during ventricular 
systole, representing the speed at which LA deformation during LA expansion occurs.
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6.7 months. During follow-up, 99 patients (67%) remained in sinus rhythm, whereas 49 patients 
(33%) had recurrence of AF. None of the patients underwent a repeat procedure during follow-up.
Left atrial volumes and strain analysis
In the overall study population, LA diameter decreased from 43 ± 5 mm to 42 ± 5 mm (p=0.003) 
during follow-up. In addition, LAmax decreased signifi cantly from baseline to follow-up (from 30 
± 7 ml/m2 to 25 ± 7 ml/m2, p<0.001). In parallel, LAmin decreased from 18 ± 6 ml/m
2 to 15 ± 7 ml/
m2 (p<0.001). Finally, there was a modest but statistically signifi cant improvement in LAEF from 
baseline to follow-up in the overall study population (from 41 ± 13% to 45 ± 14%, p=0.002). 
Left atrial strain and strain rate measurements were feasible in 2078 of 2160 attempted 
segments (96%). In 15 randomly selected patients, reproducibility data for LA strain and LA 
strain rate measurements was assessed. Intra-observer agreement for the assessment of LA 
strain and LA strain rate was good. Intra-class correlation coeffi  cients were: 0.8 for LA strain 
and 0.6 for LA strain rate. For LA strain, mean bias was 0.98 (limits of agreement: -4.39 – 6.34) 
without signifi cant trend. For LA strain rate, mean bias was -0.02 (limits of agreement: -0.34 – 
0.31) without signifi cant trend. Similar, inter-observer agreement for LA strain and LA strain rate 
was good. Intra-class correlation coeffi  cients were: 0.7 for LA strain and 0.8 for LA strain rate. For 
LA strain, mean bias was -0.14 (limits of agreement: -5.91 – 5.64). For LA strain rate, mean bias 
was -0.10 (limits of agreement: -0.21 – 0.42). 
In the overall study population, LA deformation properties showed a signifi cant improve-
ment during follow-up. LAs strain increased from 17 ± 7% to 19 ± 9% (p=0.001), and LAs strain 
rate increased from 1.1 ± 0.4 1/s to 1.2 ± 0.5 1/s (p=0.001). Similar, LAa strain improved from 









   Age, years 54 ± 9 55 ± 8 54 ± 10 0.5
   Gender, M / F 117 / 31 75 / 18 42 / 13 0.5
   Body surface area, m2 2.1 ± 0.2 2.1 ± 0.2 2.1 ± 0.2 0.4
   Type of AF
      Paroxysmal, n (%) 112 (76) 76 (82) 36 (65) 0.03
      Persistent, n (%) 36 (24) 17 (18) 19 (35) 0.03
   Duration of AF, years 5.3 ± 4.5 5.4 ± 4.2 5.2 ± 4.9 0.9
   Previous anti-arrhythmic drugs, n 3.2 ± 1.5 3.3 ± 1.6 3.1 ± 1.3 0.4
   ACE inhibitor / ATII, n (%) 72 (49) 46 (49) 26 (47) 0.9
   Hypertension, n (%) 62 (42) 42 (30) 20 (36) 0.3
   Coronary artery disease, n (%) 9 (6) 6 (6) 3 (5) 1.0
Echocardiographic characteristics
   LVEDV, ml/m2 54 ± 12 54 ± 12 53 ± 12 0.4
   LVESV, ml/m2 23 ± 7 23 ± 7 23 ± 6 0.9
   LVEF, % 57 ± 7 57 ± 8 56 ± 7 0.4
   E/A 1.3 ± 0.4 1.3 ± 0.4 1.3 ± 0.4 0.8
   Deceleration time (ms) 243 ± 70 247 ± 67 237 ± 77 0.5
* Responders vs. non-responders. ACE = angiotensin converting enzyme; AF = atrial fi brillation; ATII = angiotensin II receptor blocker; LVEDV = 
left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume.
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-4 ± 3% to -6 ± 6% (p=0.03), and LAa strain rate improved from -1.4 ± 0.7 1/s to -1.6 ± 0.7 1/s 
(p=0.03).
Left atrial reverse remodeling
Based on the cut-off  value (≥15% decrease in LAmax), 93 patients (63%) were classifi ed as a 
responder, whereas 55 patients (37%) were non-responders. Baseline characteristics of the two 
groups are listed in Table 1. The proportion of patients with paroxysmal AF was signifi cantly 
higher among the responders compared with the non-responders (82% vs. 65%, p=0.03). 
Responders vs. non-responders Mean follow-up duration was comparable in the 2 groups 
(responders 12.7 ± 5.2 months vs. non-responders 13.8 ± 8.6 months, p=0.3). Importantly, 69% 
(n=38) of the non-responders experienced recurrence of AF, as compared to 12% (n=11) of the 
responders (p<0.001). At follow-up, 34 responders (37%) and 17 non-responders (31%) were 
off  anti-arrhythmic drugs (p=0.6). The majority of the patients were on either beta-blockers or 
class IC anti-arrhythmic drugs. There were no diff erences between the 2 groups regarding the 
use of beta-blockers (27% vs. 22%, respectively, p=0.6) and class IC anti-arrhythmic drugs (32% 
vs. 31%, p=1.0) at follow-up. 
Left ventricular systolic strain signifi cantly improved in the responders during follow-up 
(from -20 ± 5% to -22 ± 4%, p<0.05), whereas it decreased in the non-responders (from -20 
± 5% to -18 ± 5%, p<0.05). Similar, an improvement in LV systolic strain rate was noted in the 
responders, and an impairment was noted in the non-responders (Table 2). 
Left atrial volume and strain analysis By defi nition, LAmax decreased signifi cantly in the 
responders (from 31 ± 7 ml/m2 to 22 ± 6 ml/m2, p<0.001), whereas a small increase was 
observed in the non-responders (from 29 ± 5 ml/m2 to 31 ± 6 ml/m2, p=0.002). Left atrial diam-
eter and LAmin were comparable in the 2 groups at baseline. However, a signifi cant decrease 
was observed in the responders during follow-up, resulting in signifi cant diff erences between 
the two groups at follow-up (Table 2). Finally, LAEF increased signifi cantly in the responders, 
whereas no change was noted in the non-responders (Table 2). 
Left atrial deformation properties demonstrated diff erent trends during follow-up accord-
ing to the presence of LA reverse remodeling. LAs strain was signifi cantly higher at baseline 
in the responders, as compared to the non-responders (Table 2). In addition, a signifi cant 
increase in LAs strain was noted in the responders, whereas no change was observed in the 
non-responders (Figure 2). Similarly, LAs strain rate at baseline was signifi cantly higher in 
the responders, as compared with the non-responders (Table 2). During follow-up, LAs strain 
rate increased signifi cantly in the responders, whereas no change was observed in the non-
responders (Table 2). Similar trends were noted for LAa strain and LAa strain rate. Whereas LAa 
strain and strain rate improved signifi cantly in the responders, LAa strain remained similar and 
LAa strain rate decreased in the non-responders (Table 2 and Figure 2). 
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Prediction of LA reverse remodeling
Univariate and multivariate logistic regression analysis was performed to determine the predic-
tors of LA reverse remodeling. The results of the logistic regression analysis are shown in Table 
3. At multivariate analysis, the strongest predictors of LA reverse remodeling after catheter 
ablation were LAs strain at baseline (Odds ration 1.089; 95% CI 1.014-1.169, p=0.019) and LAmax 
(Odds ration 1.086; 95% CI 1.018-1.159, p=0.012). 
DISCUSSION 
In the present study, LA reverse remodeling and LA strain were studied in 148 patients undergo-
ing catheter ablation for AF. In 93 patients (63%), LA reverse remodeling was noted at long-term 
follow-up. In these patients, LA systolic and late diastolic strain and strain rate increased sig-
nifi cantly from baseline to follow-up. In patients without LA reverse remodeling, no signifi cant 
Table 2. Echocardiographic results of the study population at baseline and follow-up
Responders Non-responders P-value *
LA diameter, mm
   Baseline 43 ± 4 43 ± 5 0.6
   Follow-up 40 ± 4 † 45 ± 6 † <0.001
LAmax, ml/m
2
   Baseline 31 ± 7 29 ± 5 0.04
   Follow-up 22 ± 6 †‡ 31 ± 6 † <0.001
LAmin,ml/m
2
   Baseline 19 ± 6 17 ± 5 0.2
   Follow-up 12 ± 5 † 19 ± 8 <0.001
LAEF, %
   Baseline 41 ± 14 41 ± 12 0.9
   Follow-up 46 ± 11 † 42 ± 18 0.1
LAs strain, %
   Baseline 19 ± 8 14 ± 6 0.001
   Follow-up 22 ± 9 † 15 ± 8 <0.001
LAs strain rate, 1/s
   Baseline 1.2 ± 0.4 1.0 ± 0.4 0.02
   Follow-up 1.4 ± 0.4 † 1.0 ± 0.4 <0.001
LAa strain, % §
   Baseline -4 ± 3 -4 ± 3 0.4
   Follow-up -6 ± 6 † -4 ± 3 0.03
LAa strain rate, 1/s §
   Baseline -1.4 ± 0.7 -1.3 ± 0.9 0.3
   Follow-up -1.7 ± 0.7 † -1.1 ± 0.7 <0.001
LV strain, % §
   Baseline -20 ± 5 -20 ± 5 0.6
   Follow-up -22 ± 4 † -18 ± 5 † <0.001
LV strain rate, 1/s §
   Baseline -1.2 ± 0.4 -1.1 ± 0.3 0.1
   Follow-up -1.4 ± 0.5 † -1.0 ± 0.3 <0.001
* Responders vs. non-responders; † p<0.05 baseline vs. follow-up; ‡ by defi nition; § data available in 76 responders and 46 non-responders. 
LA = left atrial; LA
EF
 = left atrial total emptying fraction; LA
max
 = maximum left atrial volume; LA
min
 = minimum left atrial volume; LV = left 
ventricular.
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changes in LA strain and strain rate were noted. Importantly, LAs strain at baseline was the 
strongest predictor of LA reverse remodeling. 
Left atrial reverse remodeling
Left atrial remodeling includes structural, electrical, metabolic and neurohumoral changes, and 
may occur in response to several pathologic processes. Atrial dilatation is an important aspect 
of LA structural remodeling (1). Recently, it has been suggested that the extent of LA structural 
remodeling may play an important role in the success of AF ablation (16). Interestingly, several 
studies have demonstrated that this atrial enlargement is, at least partially, reversible. Reverse 
LA remodeling has been demonstrated with drug therapy (17), after mitral valve surgery (15), 
Figure 2. Changes in LAs strain and LAa strain according to LA reverse remodeling. From baseline (black bars) to follow-up (white bars), 
diff erent changes in LAs strain (upper panel) and LAa strain (lower panel) were observed in the 2 groups. In the responders, a signifi cant 
improvement in LAs strain and LAa strain was observed. In contrast, the non-responders did not show an improvement in LAs strain or LAa 
strain from baseline to follow-up.
Chapter 9
A




and with cardiac resynchronization therapy (18). In addition, successful catheter ablation for AF 
may result in reversal of LA dilatation (6). 
Although the exact underlying pathophysiology of LA reverse remodeling remains unclear, 
it has been suggested that reversal of LA dilatation may have prognostic implications and may 
reduce the risk of AF (5). Therefore, LA reverse remodeling may become a surrogate marker of suc-
cess after AF ablation. Typically, maintenance of sinus rhythm during follow-up is used to defi ne 
successful catheter ablation (10). However, asymptomatic AF recurrence may result in overes-
timation of success. Importantly, in the present study, there is an overlap between responders 
and patients who maintained sinus rhythm (82 out of 93 responders), and non-responders and 
patients with recurrence of AF (38 out of 55 non-responders). Therefore, LA reverse remodeling 
may be a more robust marker for successful AF ablation that can easily be quantifi ed. 
Interestingly, in the patients that exhibited LA reverse remodeling, an improvement in LA 
function was observed in the present study. The concordance of LA reverse remodeling and 
improvement in LA function has previously been demonstrated (7). In addition, predictors 
for LA reverse remodeling were studied in the present study. Although the proportion of 
patients with paroxysmal and persistent AF was diff erent among the responders and the non-
responders, the type of AF was not predictive for LA reverse remodeling at multivariate analysis. 
This indicates that the type of AF is not an independent determinant of LA structural changes 
that deteriorate LA myocardial deformation and reduce the ability of the LA to reverse remodel. 
Interestingly, at multivariate analysis, LA systolic strain (as a novel marker of LA reservoir func-
tion) was the strongest predictor of LA reverse remodeling during follow-up. 
Left atrial strain analysis
Recent studies have demonstrated the feasibility of strain analysis to assess segmental LA func-
tion (19). In LA function, three diff erent phases can be distinguished: 1) LA reservoir function, 
during ventricular systole; 2) LA conduit function, during early ventricular diastole; 3) LA booster 
pump function, during late ventricular diastole. In the present study, tissue Doppler imaging 
was used to assess LA peak systolic and late diastolic strain, which represent LA reservoir 
function and LA booster pump function, respectively (20). At baseline, LA strain was impaired 
Table 3. Univariate and multivariate logistic regression analysis for prediction of reverse remodeling after catheter ablation
Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) P-value
Age 1.015 (0.977-1.054) 0.457 … …
Hypertension 1.441 (0.727-2.858) 0.295 … …
Type of AF 2.359 (1.098-5.071) 0.028 1.937 (0.846-4.438) 0.118
LVEF 1.022 (0.976-1.071) 0.349 … …
LAmax 1.058 (1.003-1.117) 0.040 1.086 (1.018-1.159) 0.012
LAs strain 1.102 (1.039-1.168) 0.001 1.089 (1.014-1.169) 0.019
LAs strain rate 2.996 (1.163-7.716) 0.023 1.422 (0.502-4.027) 0.508
C-statistic: 0.712; OR = Odds ratio, other abbrevations as in Tables 1 and 2.
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as compared with previously reported values for healthy controls (21,22). Left atrial reservoir 
function is mainly determined by LV systolic function and LA wall stiff ness (23). In patients 
with AF and preserved LVEF, subtle changes in LV and LA myocardium may already be present 
(24,25). Indeed, myocardial deformation imaging techniques may reveal these subtle changes. 
Impaired LAs strain and strain rate indicate reduced compliance of the LA, and may indirectly 
refl ect high fi brosis content. These functional changes may therefore refl ect structural changes 
that may determine the ability of the LA to reverse remodel after catheter ablation for AF. 
Interestingly, an improvement in LA strain was observed in patients with LA reverse remod-
eling during follow-up. Several other studies have demonstrated improvements in LA strain in 
response to therapy. In a cohort of 107 heart failure patients undergoing cardiac resynchro-
nization therapy, LA strain was assessed at baseline and after 3 months follow-up. In patients 
who exhibited LV reverse remodeling after cardiac resynchronization therapy, LA systolic strain 
improved from 16.8 ± 9.8% to 21.8 ± 9.4% (p=0.002), in parallel with LA reverse remodeling (26). 
Thomas et al. (27) noted improvements in LA strain and strain rate in 37 patients with AF who 
maintained sinus rhythm during 6 months after cardioversion. Similarly, it has been demon-
strated that LA strain and strain rate may improve after catheter ablation for AF (8). Schneider 
et al. demonstrated a signifi cant increase in LA systolic strain in patients who maintained sinus 
rhythm after catheter ablation, whereas it remained unchanged in patients with recurrence 
of AF. In addition, it was demonstrated that LA systolic strain and strain rate may predict the 
maintenance of sinus rhythm during 3 months follow-up (8). 
In the present study, similar improvements in LA strain and strain rate were observed 
in 148 patients after long-term follow-up. In addition, it was demonstrated that LA strain at 
baseline was the strongest predictor for LA reverse remodeling during follow-up. Previously, 
it has been demonstrated that LA systolic strain may predict the maintenance of sinus rhythm 
after cardioversion (24). Although the exact mechanism remains to be elucidated, it may well 
be that the degree of impairment in atrial compliance (represented by LA systolic strain) plays 
an important role in the ability to reverse LA enlargement and maintain sinus rhythm during 
follow-up. 
Interestingly, the improvements in LA strain and strain rate in the responders were accom-
panied by improvements in LV systolic strain. These fi ndings suggest that LA and LV myocardial 
deformations are closely related. Restoration of sinus rhythm with catheter ablation results in an 
improved LA function and subsequent more effi  cient LV fi lling pattern and LV mechanics (7,28). 
At the same time, the improvement in LV systolic function and diastolic fi lling pattern due to 
heart rhythm normalization may result in an improved LA function, and may therefore be a 
determinant of LA reverse remodeling. Additional studies are warranted to elucidate whether 
the improvement in LV mechanics precedes the improvement in LA function or vice versa. 
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In the present study, 63% of the patients exhibited LA reverse remodeling after catheter abla-
tion for AF. In these responders, LA strain and strain rate increased signifi cantly from baseline to 
follow-up. In contrast, no changes in LA strain and strain rate were noted in the non-responders. 
Left atrial systolic strain at baseline was the strongest predictor of LA reverse remodeling. 
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ABSTRACT
Background: The eff ect of successful catheter ablation on left ventricular (LV) strain in patients 
with preserved LV systolic function is unknown. The aim of the present study was to assess the 
long-term eff ects of catheter ablation for atrial fi brillation (AF) on LV strain and strain rate in 
patients with preserved LV ejection fraction. 
Methods and Results: In 78 patients undergoing catheter ablation for AF, speckle tracking 
strain imaging was performed to assess LV strain in 3 directions (radial, circumferential and lon-
gitudinal) at baseline and after 12 months follow-up. The study population was divided into 2 
groups, according to the maintenance of sinus rhythm during follow-up. After 13.8 ± 4.7 months 
follow-up, 54 patients (69%) were in sinus rhythm (SR-group), whereas 24 patients (31%) had 
recurrence of AF (AF-group). No signifi cant changes in LV ejection fraction from baseline to 
follow-up were noted (60 ± 7% vs. 59 ± 7%, p=NS). Circumferential strain improved signifi cantly 
in the SR-group (-18.3 ± 3.2% vs. -20.4 ± 3.8%, p<0.001), whereas it remained unchanged in the 
AF-group (-18.9 ± 3.5% vs. -17.9 ± 3.1%, p=NS). In the SR-group, signifi cant improvements in LV 
longitudinal strain and strain rate were noted, whereas in the AF-group, LV longitudinal strain 
and strain rate deteriorated signifi cantly at long-term follow-up. 
Conclusion: After successful catheter ablation, LV circumferential and longitudinal strain and 
strain rate improve signifi cantly in patients who maintain sinus rhythm. In contrast, a decrease 
in LV longitudinal strain and strain rate is observed in patients with recurrence of AF. 
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Radiofrequency catheter ablation procedures are considered a reasonable option in the treat-
ment of patients with highly symptomatic, drug-refractory atrial fi brillation (AF). It has been 
demonstrated that these procedures can eff ectively restore sinus rhythm and provide long-
term relief of symptoms (1). Furthermore, reverse remodeling and functional improvement of 
the left atrium (LA) has been reported after successful catheter ablation for AF (2,3). 
In addition, the restoration of sinus rhythm may result in an improvement in left ventricular 
(LV) systolic function. It has been demonstrated that LV ejection fraction improves following 
successful catheter ablation in patients with systolic heart failure (4-6). In patients with pre-
served systolic function however, studies have failed to demonstrate a change in LV ejection 
fraction after catheter ablation (7). It is likely however, that LV ejection fraction does not refl ect 
subtle changes in systolic LV function, and therefore the eff ect of catheter ablation on LV systolic 
function cannot be detected by measuring LV ejection fraction. Recently, two-dimensional (2D) 
speckle tracking strain imaging has been introduced (8,9). This novel technique may detect 
more subtle abnormalities in LV systolic function, as compared with conventional parameters 
such as LV ejection fraction (10). In addition, it allows angle-independent evaluation of LV 
systolic strain in 3 directions: radial, circumferential, and longitudinal (11). 
Accordingly, the purpose of the present study was to assess the long-term eff ects of 
catheter ablation for AF on LV function and deformation properties. Two-dimensional speckle 
tracking strain imaging was used to study LV strain and strain rate in patients with maintenance 
of sinus rhythm and patients with recurrence of AF after radiofrequency catheter ablation. 
METHODS
Study population and study protocol
The study population comprised selected patients with symptomatic drug-refractory AF, who 
were referred for radiofrequency catheter ablation. Before the ablation procedure and after 12 
months follow-up, an extensive echocardiographic evaluation was performed. To minimize the 
confounding eff ect of variations in heart rhythm on LV deformation properties, only patients 
with an available echocardiogram during sinus rhythm at baseline and at follow-up were stud-
ied. In addition, patients with moderate or severe valvular disease, or patients with a history of 
heart failure or coronary artery bypass graft were excluded from the study. Out of 98 patients 
who underwent radiofrequency catheter ablation, 20 patients were excluded because of the 
presence of AF during the baseline or follow-up echocardiogram. The remaining 78 patients 
formed the study population of the present study. 
To study the eff ect of successful catheter ablation on LV function and deformation proper-
ties, the study population was divided into 2 groups, according to the maintenance of sinus 
154
rhythm during the 12 months follow-up. In addition, LV function and deformation properties 
were assessed in a group of 20 healthy controls matched for age, gender, body surface area 
who were selected from an echocardiographic database. 
Radiofrequency catheter ablation
The catheter ablation procedure was aimed at electrical isolation of all pulmonary veins from 
the LA, and has been described in more detail elsewhere (12). In brief, endocardial mapping 
and ablation was performed with a 4 mm quadripolar mapping/ablation catheter (7F Thermo-
cool, Biosense Webster, Diamond Bar, California), using an electroanatomical mapping system 
(CARTOTM, Biosense Webster). A 6F diagnostic catheter placed in the right atrium served as a 
temporal reference. Radiofrequency current was applied outside the ostia of all pulmonary 
veins, using the ablation catheter with a 4 mm open loop irrigated tip (maximum fl ow 20 mL/
min, maximum temperature 50°C, maximum radiofrequency energy 30 W). At each ablation 
point, radiofrequency current was applied until a voltage <0.1 mV was achieved, with a maxi-
mum of 60 seconds per point. Pulmonary vein isolation was confi rmed by recording entrance 
block during sinus rhythm or pacing in the coronary sinus (1). All patients received heparin 
intravenously (activated clotting time 300-400 sec) to avoid thrombo-embolic complications. 
Follow-up
After the catheter ablation procedure, patients were evaluated at the out-patient clinic on a 
regular basis. All medication, including anti-arrhythmic drugs, was continued in all patients 
during the fi rst 3 months after the ablation procedure. Thereafter, anti-arrhythmic drugs were 
discontinued at the discretion of the physician. A surface ECG was acquired at every follow-up 
visit, and 24-hours Holter monitoring was performed at 3 to 6 months intervals. A successful 
catheter ablation was defi ned as the absence of symptomatic recurrences lasting more than 
3 minutes and/or the absence of AF episodes lasting more than 30 seconds detected with 
24-hours Holter monitoring or surface ECG, after a blanking period of 1 month (1). 
Subsequently, the study population was divided into 2 groups according to the absence 
or presence of AF during follow-up. The ‘SR-group’ comprised patients with maintenance of 
sinus rhythm during follow-up, whereas patients in the ‘AF-group’ had recurrence of AF during 
follow-up. Clinical and echocardiographic variables at baseline and at 12 months follow-up 
were compared between the 2 groups.  
Echocardiography
Two-dimensional echocardiography was performed within 2 days before the ablation pro-
cedure, and after 12 months follow-up. Images were recorded with patients in the left lateral 
decubitus position using a commercially available system (Vivid 7, General Electric Vingmed, 
Milwaukee, Wisconsin). 
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Images acquisition was performed using a 3.5-MHz transducer at a depth of 16 cm in the 
standard parasternal and apical views (standard long-axis and 2- and 4-chamber images). 
Standard M-mode and 2D images including color Doppler data from 3 consecutive heart beats 
were saved in cine loop format. All analyses were performed off -line using commercial software 
(Echopac 6.1, General Electric Vingmed). 
The anteroposterior diameter of the LA was measured at end-systole on the M-mode image 
obtained from the parasternal long-axis view (13). Left atrial volume was calculated using the 
biplane area-length method (13). In addition, LV end-diastolic and end-systolic diameters 
were acquired from the parasternal long-axis view (13). Left ventricular end-diastolic and 
end-systolic volumes were assessed from the apical 2- and 4-chamber images, and LV ejection 
fraction was calculated using the biplane Simpson’s rule (14). Finally, LV diastolic function was 
assessed using the mitral infl ow pattern from the pulsed-wave Doppler images (15), and tissue 
Doppler imaging. The ratio of early (E) to late (A) diastolic fi lling velocities (E/A), deceleration 
time of the E wave, the septal early diastolic mitral annular motion velocity (E’), and the E/E’ 
ratio were assessed. Subsequently, LV diastolic function was classifi ed as being normal, abnor-
mal relaxation (mild diastolic dysfunction, grade 1), pseudonormal fi lling (moderate diastolic 
dysfunction, grade 2) or restrictive fi lling pattern (severe diastolic dysfunction, grade 3) (16,17). 
Left ventricular strain analysis 
On standard gray-scale images (frame rate 75 ± 11 frames/s), 2D speckle tracking strain imaging 
was used to study LV deformation. Novel speckle-tracking software was used, as previously 
described (8,9,18). Briefl y, this technique permits angle-independent measurement of myo-
cardial strain in 3 diff erent directions (radial, circumferential, and longitudinal). It tracks the 
characteristic pattern of natural acoustic markers present in the myocardial wall (‘speckles’) 
from frame-to-frame throughout the cardiac cycle. Myocardial strain is then calculated by the 
change in position of the speckle pattern with respect to the initial position (8,9). 
Three distinct patterns of LV deformation were assessed: 1) radial strain; representing 
myocardial thickening/thinning in the short-axis plane; 2) circumferential strain; representing 
myocardial shortening/lengthening in the short-axis plane; and 3) longitudinal strain; repre-
senting myocardial shortening/lengthening in the long-axis plane. Peak systolic radial and 
circumferential strain/strain rate were calculated by averaging the peak systolic values of the 
6 segments from the LV mid ventricular short-axis view. Peak systolic longitudinal strain/strain 
rate was calculated by averaging the peak systolic values of the 18 segments, derived from 
the 6 segments of the 3 apical views (2-, 4-chamber and apical long axis views) (Figure 1). For 
myocardial strain, regional thickening or lengthening is expressed as a positive value, and thin-
ning or shortening as a negative value (19). Finally, strain rate (expressed in 1/s) was calculated 
in all 3 directions, representing the speed at which myocardial deformation occurs (19).
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Statistical analysis
All continuous variables had normal distribution (as evaluated by Kolmogorov-Smirnov tests). 
Summary statistics for these variables are therefore presented as mean values ± one standard 
deviation (SD). Categorical data are summarized as frequencies and percentages. Diff erences in 
clinical and echocardiographic variables between the SR-group and the AF-group were evalu-
ated using unpaired Student t-tests (continuous variables), Chi-square tests or Fisher’s exact 
tests (dichotomous variables), as appropriate. Changes in echocardiographic variables from 
baseline to follow-up were evaluated using paired Student t-tests. 
Intra- and inter-observer reproducibility of strain and strain rate measurements by 
2-dimensional speckle tracking strain analysis was determined by linear regression (Pearson’s 
correlation coeffi  cient) and Bland-Altman analysis. Intra-observer reproducibility was deter-
mined by repeating the strain and strain rate measurements at two diff erent time points by one 
experienced reader in 20 randomly selected patients. A second experienced reader performed 
the strain analysis in the same 20 patients, providing the inter-observer reproducibility data. 
Multivariate logistic regression analysis based on enter model was performed for the 
prediction of the maintenance of sinus rhythm at follow-up. The dependent variable was the 






Figure 1. Assessment of left ventricular strain. Left ventricular strain was assessed in 3 directions: radial strain (upper panel) and circumferential 
strain (middle panel) were assessed on short-axis images. Longitudinal strain (lower panel) was assessed on standard apical images.
Chapter 10
LV strain after A
F ablation
157
maintenance of sinus rhythm. As independent variables, the number of antiarrhythmic drugs, 
LA remodeling (represented by the change in LA volume), change in mean arterial pressure and 
LV mass index, change in longitudinal strain and change in circumferential strain after catheter 
ablation were entered in the model. Model discrimination was assessed using c-statistic. All 
analyses were performed using SPSS software (version 12.0, SPSS Inc. Chicago, Illinois, USA). All 
statistical tests were two-sided, and a p-value <0.05 was considered signifi cant.
RESULTS
Study population
The baseline characteristics of the study population are summarized in Table 1. The majority of 
the patients had paroxysmal AF (67 patients, 86%), in 11 patients (14%) persistent AF was pres-
ent. Mean time from the fi rst documented AF episode to the radiofrequency catheter ablation 
procedure was 5.9 ± 3.9 years. A mean of 3.4 ± 1.4 diff erent anti-arrhythmic drugs per patient 
had been used previously. 








Age, yrs 54 ± 9 54 ± 9 54 ± 8 NS
Gender, M/F 63 / 15 43 / 11 20 / 4 NS
Body surface area, m2 2.1 ± 0.2 2.1 ± 0.2 2.1 ± 0.1 NS
Heart rate, bpm 62 ± 11 61 ± 9 63 ± 15 NS
Blood pressure 
   Systolic, mmHg 133 ± 16 133 ± 16 135 ± 16 NS
   Diastolic, mmHg 81 ± 12 81 ± 12 82 ± 11 NS
LV mass index, g/m2 111 ± 24 109 ± 26 117 ± 20 NS
Type of AF 
   Paroxysmal, n (%) 67 (86) 49 (91) 18 (75) NS
   Persistent, n (%) 11 (14) 5 (9) 6 (25) NS
Duration of AF, yrs 5.9 ± 3.9 6.0 ± 4.2 4.2 ± 3.0 NS
Anti-arrhythmic drugs used per patient 3.4 ± 1.4 3.6 ± 1.4 3.1 ± 1.3 NS
   Beta-blocker, n (%) 36 (46) 23 (43) 13 (54) NS
   Calcium channel blocker, n (%) 7 (9) 4 (7) 3 (13) NS
   Class IC anti-arrythmic drug, n (%) 27 (35) 19 (35) 8 (33) NS
   Amiodarone, n (%) 25 (32) 19 (35) 6 (25) NS
ACE inhibitor / ATII, n (%) 40 (51) 27 (50) 13 (54) NS
Statin, n (%) 20 (26) 14 (26) 6 (25) NS
Hypertension, n (%) 36 (46) 22 (41) 14 (58) NS
Diabetes Mellitus, n (%) 4 (5) 3 (6) 1 (4) NS
Coronary artery disease, n (%) 5 (6) 4 (7) 1 (4) NS
* SR-group vs. AF-group; ACE =  Angiotensin converting enzyme; AF = atrial fi brillation; ATII = Angiotensin II receptor blocker.
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After a mean of 13.8 ± 4.7 months follow-up, 54 patients (69%) were in sinus rhythm (SR-
group), whereas 24 patients (31%) had recurrence of AF (AF-group). The study population was 
subsequently divided into 2 groups, according to the success of the catheter ablation proce-
dure. No signifi cant diff erences in baseline characteristics were noted between the 2 groups 
(Table 1). 
In the total study population, no signifi cant diff erences in heart rate between the baseline 
and follow-up echocardiogram were noted (baseline 62 ± 11 bpm vs. follow-up 63 ± 20 bpm, 
p=NS). In addition, no diff erences between the 2 groups at the follow-up echocardiogram were 
noted (SR-group 64 ± 9 bpm vs. AF-group 62 ± 10 bpm, p=NS). In the overall study population, 
no diff erences in mean systolic (from 133 ± 16 mmHg to 131 ± 16 mmHg, p=NS) or diastolic 
(from 81 ± 12 mmHg to 80 ± 9 mmHg, p=NS) blood pressure was noted during follow-up. 
In addition, there were no diff erences between the SR-group and the AF-group with regard 
to the use of anti-arrhythmic drugs at baseline (Table 1). At follow-up, 27 patients (35%) used 
beta-blockers (including Sotalol), 1 patient (1%) used a calcium channel blocker, 17 patients 
(22%) used a class IC anti-arrhythmic drug, and 6 patients (8%) used Amiodarone. At follow-up, 
there were no signifi cant diff erences in the use of anti-arrhythmic drugs between the SR-group 
and the AF-group, except for the use of beta-blockers (SR-group n=12 [35%] vs. AF-group n=15 
[63%], p<0.01). By defi nition of the study protocol, all patients were in sinus rhythm during both 
echocardiographic evaluations.
Echocardiographic changes during follow-up
In the overall study population, a decrease in LA diameter and LA volume was noted from baseline 
to follow-up (Table 2). Interestingly, this decrease in LA diameter was more pronounced in the 
SR-group (baseline 43 ± 5 mm vs. follow-up 40 ± 5 mm, p<0.01), as compared with the AF-group 
(baseline 45 ± 5 mm vs. follow-up 45 ± 5 mm, p=NS). Similar, LA volumes decreased signifi cantly 
in the SR-group from baseline to follow-up (from 58 ± 18 ml to 51 ± 14 ml, p<0.01), whereas no 
changes in LA volumes were noted in the AF-group (from 65 ± 17 ml to 64 ± 21 ml, p=NS). 
Table 2. Echocardiographic parameters at baseline and at long-term follow-up in the total study population
Baseline (n=78) Follow-up (n=78) P value
LA diameter, mm 44 ± 5 42 ± 5 <0.05
LA volume, ml 60 ± 18 55 ± 17 <0.01
E/A ratio 1.3 ± 0.5 1.4 ± 0.5 <0.05
Deceleration time, ms 236 ± 48 234 ± 56 NS
E/E’ ratio 8.8 ± 3.4 8.8 ± 4.2 NS
LV end-diastolic diameter, mm 54 ± 5 54 ± 5 NS
LV end-systolic diameter, mm 32 ± 6 32 ± 6 NS
LV end-diastolic volume, ml 124 ± 29 124 ± 28 NS
LV end-systolic volume, ml 49 ± 17 50 ± 15 NS
LV ejection fraction, % 60 ± 7 59 ± 7 NS
LA = left atrial; LV = left ventricular.
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In addition, an improvement in diastolic function was observed in the overall study popula-
tion (Table 2). Mean E/A ratio increased from 1.3 ± 0.5 to 1.4 ± 0.5 (p<0.05). At baseline, 48 
patients (62%) had normal diastolic function, whereas 21 patients (27%) had mild diastolic 
dysfunction and 9 patients (11%) had moderate diastolic dysfunction. At long-term follow-up, 
16 patients improved in diastolic function: 59 patients (76%) had normal diastolic function, and 
12 patients (15%) had mild, and 7 patients (9%) had moderate diastolic dysfunction. 
Finally, LV dimensions and volumes were similar at baseline and at follow-up in the overall 
study population (Table 2). In addition, there was no signifi cant change in LV ejection fraction 
(from 60 ± 7% to 59 ± 7%, p=NS). Both in the SR-group and in the AF-group, no signifi cant 
changes were noted in LV volumes and LV ejection fraction from baseline to follow-up (Table 3). 
Table 3. Left ventricular systolic function and strain/ strain rate at baseline and follow-up in the SR-group and the AF-group 
SR-group (n=54) AF-group (n=24) P value
LV end-diastolic diameter, mm
   Baseline 53 ± 6 55 ± 4 NS
   Follow-up 53 ± 6 55 ± 5 NS
LV end-systolic diameter, mm
   Baseline 32 ± 6 33 ± 5 NS
   Follow-up 32 ± 5 34 ± 7 NS
LV end-diastolic volume, ml
   Baseline 123 ± 30 127 ± 26 NS
   Follow-up 124 ± 30 123 ± 23 NS
LV end-systolic volume, ml
   Baseline 49 ± 17 49 ± 17 NS
   Follow-up 51 ± 15 49 ± 13 NS
LV ejection fraction, %
   Baseline 60 ± 7 62 ± 7 NS
   Follow-up 59 ± 7 61 ± 6 NS
GRS, %
   Baseline 40.1 ± 17.0 39.1 ± 13.1 NS
   Follow-up 37.2 ± 15.2 38.3 ± 15.3 NS
GRSr, 1/s
   Baseline 1.9 ± 0.6 1.7 ± 0.5 NS
   Follow-up 1.9 ± 0.6 1.7 ± 0.4 NS
GCS, %
   Baseline -18.3 ± 3.2 -18.9 ± 3.5 NS
   Follow-up -20.4 ± 3.8 ‡ -17.9 ± 3.1 <0.05
GCSr, 1/s
   Baseline -1.1 ± 0.3 -1.1 ± 0.2 NS
   Follow-up -1.2 ± 0.3 † -1.1 ± 0.2 <0.05
GLS, %
   Baseline -18.8 ± 2.7 -19.1 ± 1.5 NS
   Follow-up -19.6 ± 2.6 ‡ -17.9 ± 1.8 † <0.05
GLSr, 1/s
   Baseline -0.9 ± 0.1 -1.0 ± 0.1 NS
   Follow-up -1.0 ± 0.1 † -0.9 ± 0.1 * <0.001
* p<0.05 vs. baseline; † p<0.01 vs. baseline; ‡ p<0.001 vs. baseline; GCS = Global circumferential strain; GCSr = Global circumferential strain 
rate; GLS = Global longitudinal strain; GLSr = Global longitudinal strain rate; GRS = Global radial strain; GRSr = Global radial strain rate; LV = 
left ventricular.
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Left ventricular strain and strain rate
Linear regression analysis demonstrated good intra- and inter-observer agreement for the 
radial, circumferential and longitudinal strain and strain rate measurements (Table 4). In addi-
tion, Bland-Altman analysis showed a small bias for all strain and strain rate measurements 
performed by the same observer (intra-observer variability) and the two diff erent observers 
(inter-observer variability) (Table 4). 
Strain and strain rate values for the overall study population at baseline were compared 
with a group of 20 healthy controls (mean LV ejection fraction 60 ± 7%). Radial strain and 
radial strain rate were not signifi cantly diff erent between the overall study population and 
the healthy controls (40.1 ± 15.6% vs. 40.8 ± 11.7%, p=NS; and 1.8 ± 0.6 1/s vs. 1.9 ± 0.6 1/s, 
p=NS, respectively). In contrast, both circumferential strain and circumferential strain rate were 
signifi cantly reduced in the study population, as compared to the controls (-18.4 ± 3.1% vs. 
-20.1 ± 3.3%, p<0.05; and -1.1 ± 0.2 1/s vs. -1.3 ± 0.3 1/s, p<0.05). Similar, both longitudinal 
strain and longitudinal strain rate were signifi cantly lower in the overall study population, as 
compared to the healthy controls (-18.9 ± 2.4% vs. -20.4 ± 2.1%, p<0.05; and -0.9 ± 0.1 1/s vs. 
-1.1 ± 0.2 1/s, p<0.01). 
In the overall study population, radial strain did not change signifi cantly from baseline to 
follow-up (from 40.6 ± 15.1% to 37.5 ± 15.1%, p=NS). In addition, radial strain rate was similar at 
baseline and follow-up (1.8 ± 0.6 1/s and 1.8 ± 0.6 1/s, respectively; p=NS). Within the 2 groups, 
no diff erences were noted for radial strain and radial strain rate at baseline and at long-term 
follow-up (Table 3). Radial strain at long-term follow-up was comparable in the SR-group and 
the AF-group (Figure 2). 
In contrast, circumferential strain improved signifi cantly from baseline to follow-up in the 
total study population (from -18.6 ± 3.2% to -19.7 ± 3.6%, p<0.01). Similar, circumferential 
strain rate improved signifi cantly from baseline to follow-up (from -1.1 ± 0.2 1/s to -1.2 ± 0.3 1/s, 
p<0.05). Baseline values for circumferential strain and strain rate were comparable for the SR-
group and the AF-group (Table 3). Importantly, circumferential strain and strain rate improved 
only in the SR-group from baseline to follow-up (from -18.3 ± 3.2 % to -20.4 ± 3.8%, p<0.001; 
and from -1.1 ± 0.3 1/s to -1.2 ± 0.3 1/s, p<0.01, respectively), whereas no signifi cant changes 
Table 4. Intra- and inter-observer reproducibility of myocardial strain and strain rate
Intra-observer Inter-observer 
Mean diff erence ± 2SD * r † Mean diff erence ± 2SD * r †
Radial strain (%) 1.40 ± 11.52 0.94 -4.83 ± 12.80 0.89
Radial strain rate (1/s) 0.14 ± 0.36 0.94 -0.14 ± 0.64 0.88
Circumferential strain (%) -0.35 ± 3.96 0.85 -1.21 ± 4.51 0.88
Circumferential strain rate (1/s) -0.02 ± 0.26 0.87 -0.01 ± 0.30 0.86
Longitudinal strain (%) -0.51 ± 2.66 0.91 0.57 ± 3.40 0.87
Longitudinal strain rate (1/s) -0.06 ± 0.12 0.91 0.01 ± 0.24 0.86
* As assessed with Bland-Altman analysis; † as assessed with linear regression analysis.
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Figure 2. The strain values at follow-up are demonstrated for both the SR-group (black bars) and the AF-group (white bars). After long-
term follow-up, radial strain (upper panel) was comparable in the SR-group (37.2 ± 15.2%) and the AF-group (38.3 ± 15.3%). However, 
circumferential strain (middle panel) and longitudinal strain (lower panel) were signifi cantly lower in the AF-group (-17.9 ± 3.1% and -17.9 ± 
1.8%, respectively), as compared with the SR-group (-20.4 ± 3.8% and -19.6 ± 2.6%, respectively). * p<0.05
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were noted in the AF-group (Table 3). As a result, circumferential strain at long-term follow-up 
was signifi cantly higher in the SR-group, as compared with the AF-group (Figure 2). 
Longitudinal strain was not signifi cantly diff erent at baseline and follow-up in the total 
study population (-18.9 ± 2.4% and -19.1 ± 2.5% respectively, p=NS). In addition, longitudinal 
strain rate was similar at baseline -1.0 ± 0.1 1/s) and follow-up (-1.0 ± 0.1 1/s, p=NS). However, 
the changes in longitudinal strain and strain rate from baseline to follow-up were diff erent in 
the 2 groups: Whereas longitudinal strain improved signifi cantly in the SR-group (from -18.8 ± 
2.7% to -19.6 ± 2.6%, p<0.001), it deteriorated signifi cantly in the AF-group (from -19.1 ± 1.5% 
to -17.9 ± 1.8%, p<0.01). At long-term follow-up longitudinal strain was signifi cantly diff erent 
between the 2 groups (Figure 2). In the SR-group, 37 of the 54 patients (69%) demonstrated 
an improvement in longitudinal strain (from -18.5 ± 2.8% to -20.0 ± 2.6%, p<0.001), whereas 
17 of the 37 patients (31%) in the SR-group showed no improvement (from -19.6 ± 2.4% to 
-18.9 ± 2.4%, p<0.01). In the AF-group, 18 of the 24 patients (75%) exhibited deterioration in 
longitudinal strain (from -19.7 ± 1.6% to -17.6 ± 1.7%, p<0.001), whereas 6 of the 24 patients 
(25%) did not exhibit deterioration in longitudinal strain (from -18.3 ± 1.7% to -18.8 ± 1.8%, 
p=NS). Similarly, longitudinal strain rate improved signifi cantly in the SR-group, whereas it 
deteriorated in the AF-group (Table 3). An example of a patient from the SR-group demonstrat-
ing improvements in LV circumferential and longitudinal strain is shown in Figure 3. 
A multivariate logistic regression analysis was performed to study the predictors of the 
maintenance of sinus rhythm after catheter ablation. The results of the multivariate logistic 
regression analysis are shown in Table 5. Interestingly, the change in longitudinal strain and 











Figure 3. In this patient, global radial strain did not improve from baseline (38.1%, panel A) to 12 months follow-up (37.3%, panel B). 
In contrast, a signifi cant improvement in global circumferential strain (baseline -19.4%, panel C; follow-up -26.5%, panel D) and global 
longitudinal strain (baseline-17.3%, panel E; follow-up -22.5%, panel F) was observed.
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sinus rhythm: Change in circumferential strain: Odds ratio 0.537, 95% confi dence interval 0.339 
to 0.849, p = 0.008; change in longitudinal strain: Odds ratio 0.338, 95% confi dence interval 
0.155 to 0.737, p = 0.006. 
DISCUSSION
In the present study, 78 patients with preserved LV systolic function, undergoing radiofre-
quency catheter ablation for AF, were studied. At long-term follow-up, a signifi cant improve-
ment in circumferential and longitudinal strain and strain rate was observed. Importantly, these 
improvements were only present in patients who maintained sinus rhythm during follow-up, 
whereas patients who had recurrence of AF did not exhibit improvements in circumferential 
and longitudinal strain.
Left ventricular function after catheter ablation
Signifi cant improvements in LV strain were observed after successful catheter ablation in the 
current study in patients with preserved LV systolic function. The benefi cial eff ect of catheter 
ablation on LV function has been demonstrated previously in patients with impaired LV systolic 
function (4-6). Interestingly, in patients with preserved LV systolic function, the favorable eff ects 
of catheter ablation on LV function are less clear. In 52 patients with an LV ejection fraction 
>50% undergoing catheter ablation, Lutomsky et al. noted that LV ejection fraction remained 
unchanged after 6 months follow-up (from 60 ± 6% to 59 ± 9%, p=0.22) (7). It was concluded 
that successful catheter ablation may be less benefi cial in patients with normal LV ejection 
fraction (7). 
However, it may well be that the positive eff ects of the restoration of sinus rhythm on LV 
systolic function are present, but cannot be detected by conventional parameters such as LV 
ejection fraction. The evaluation of LV strain may detect more subtle abnormalities in LV systolic 
function (20), which can improve after AF ablation. Indeed, preliminary data in 25 patients with 
normal LV ejection fraction suggest that LV deformation may improve after catheter abla-
tion for AF (21). In the present study, 2D speckle tracking strain imaging was used to assess 
LV function after catheter ablation for AF in 78 patients. Similar to previous data (7), mean LV 
Table 5. Logistic regression analysis for predictors of maintenance of sinus rhythm after catheter ablation
Odds ratio 95% confi dence interval p-value
Number of anti-arrhythmic drugs 2.267 0.508 – 10.121 0.284
Change in LV mass index 0.996 0.952 – 1.043 0.878
Change in mean arterial pressure 1.011 0.926 – 1.104 0.808
Change in maximum LA volume 1.015 0.965 – 1.067 0.566
Change in circumferential strain 0.537 0.339 – 0.849 0.008
Change in longitudinal strain 0.338 0.155 – 0.737 0.006
C-statistic: 0.934.
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ejection fraction did not improve after long-term follow-up. However, signifi cant changes in LV 
circumferential and longitudinal strain and strain rate were noted, in particular in the patients 
who maintained sinus rhythm during follow-up. 
The improvement in LV function (according to strain and strain rate) after successful cath-
eter ablation can be attributed to the normalization of the heart rate, or to the restoration of 
sinus rhythm and subsequent more effi  cient LV fi lling. However, at present it remains unclear 
what mechanism contributes most (1,22). In the current study, the mean heart rate did not 
change signifi cantly from baseline to follow-up. Per study protocol, both echocardiograms 
were acquired during sinus rhythm, and therefore the diff erences in LV strain cannot be attrib-
uted to changes in heart rhythm during image acquisition. Furthermore, signifi cant changes 
in circumferential and longitudinal strain and strain rate were only noted in the patients who 
maintained sinus rhythm during follow-up. Therefore, the current results suggest that the 
improvement in LV function after catheter ablation may be more related to restoration and 
long-term maintenance of sinus rhythm than to normalization of heart rate. 
At the same time, it may also be that an improvement in LV function ultimately results in 
favorable reverse remodeling of the left atrium and subsequently in a reduced risk of recurrent AF 
(23). Interestingly, in the present study, improvements in circumferential and longitudinal strain 
were the only predictors for maintenance of sinus rhythm during follow-up (Table 5). Although 
the restoration of sinus rhythm and the improvement in LV function after catheter ablation are 
clearly related, it remains unclear which factor is the exact cause and which is the consequence. 
Left ventricular strain
In the present study, 3 distinct patterns of LV deformation were studied: radial, circumferential 
and longitudinal strain. Interestingly, diff erent responses during long-term follow-up were 
noted among the various strain patterns. Previously, several studies have demonstrated the 
eff ects of diff erent clinical settings on these strain patterns (24-27). In an animal model of 
myocardial ischemia, it was noted that circumferential and longitudinal strain, as assessed 
with speckle tracking echocardiography, were most sensitive to reduced coronary fl ow (24). In 
addition, in 53 patients with diabetes, Fang et al. demonstrated a signifi cant impairment of lon-
gitudinal strain as compared with controls, while radial strain was compensatory increased (25). 
Finally, in patients with hypertrophic cardiomyopathy but normal LV systolic function, marked 
reductions in longitudinal strain have been demonstrated (26,27). From anatomical studies, it 
is known that there is a diff erence in orientation of the endocardial and epicardial myocardial 
fi bers. It has been suggested that the LV myocardial architecture is a transmural continuum 
of two helical fi ber geometries, with a right-handed helical geometry in the subendocardial 
region gradually changing into a left-handed geometry in the subepicardial region (28). The 
discrepancy among the various strain patterns as found in the abovementioned studies may be 
explained by the fact that the longitudinal fi bers located in the subendocardium, mediating the 
long axis deformation, may be more susceptible to pathologic changes (29). 
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In the present study, baseline values for LV strain were comparable in the SR-group and 
the AF-group, and modestly reduced as compared with previously reported values for healthy 
controls (25,26). Interestingly, circumferential and longitudinal strain improved signifi cantly 
in patients who maintained sinus rhythm after catheter ablation. In contrast, in patients with 
recurrence of AF, circumferential strain remained unchanged and longitudinal strain even 
deteriorated. No signifi cant changes in radial strain were noted in both groups. It may be that, 
similar to detrimental eff ects of various pathologic changes, the longitudinal fi bers may be 
more prone to the benefi cial eff ect of restoration of normal sinus rhythm and subsequent more 
effi  cient LV fi lling and contraction. 
Limitations
Some limitations of the present study need to be addressed. First, the study population was 
divided into two groups, based on recurrence of symptomatic AF episodes and/or detection 
of AF with surface ECG and 24-hours Holter monitoring on a regular basis. Asymptomatic AF 
recurrence during follow-up may therefore have been missed. Second, no data on the exact 
AF burden before the ablation procedure and during follow-up are available in the present 
study. Although potential asymptomatic AF recurrences may aff ect the results, and exact AF 
burden assessment may provide more information on the relation between improvement in LV 
function and AF recurrence, the defi nition of AF recurrence in the present study is according to 
the recommendations from the Heart Rhythm Society Expert Consensus Statement (1). 
In addition, only a small number of patients with persistent AF was included in the study. 
Therefore, no comparisons between patients with paroxysmal and persistent AF could be 
performed. However, to minimize the confounding eff ect of variations in heart rhythm on LV 
deformation properties, only patients with an available echocardiogram during sinus rhythm 
at baseline and at follow-up were included in the present study. A larger population in future 
studies may allow comparison between paroxysmal and persistent AF patients. 
Finally, in the present study, LV dyssynchrony was not routinely assessed. Future studies 
may investigate if LV dyssynchrony is present in patients undergoing catheter ablation, and 
if the improvement in LV function as demonstrated in the present study is associated with an 
improvement in LV dyssynchrony.
CONCLUSIONS
In patients with preserved LV systolic function undergoing catheter ablation for AF, improve-
ments in LV strain were noted, without signifi cant changes in LV ejection fraction. Longitudinal 
and circumferential strain and strain rate improved in patients who maintained sinus rhythm 
during follow-up. In contrast, patients who had recurrence of AF exhibited no improvements in 
circumferential or longitudinal strain. 
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ABSTRACT 
Cardiac pacing is the only eff ective treatment for patients with sick sinus syndrome and 
atrioventricular conduction disorders. In cardiac pacing, the endocardial pacing lead is typi-
cally positioned at the right ventricular (RV) apex. At the same time, there is increasing indirect 
evidence, derived from large pacing mode selection trials and observational studies, that 
conventional RV apical pacing may have detrimental eff ects on cardiac structure and left ven-
tricular (LV) function, which is associated with development of heart failure. These detrimental 
eff ects may be related to the abnormal electrical and mechanical activation pattern of the 
ventricles (or ventricular dyssynchrony) caused by RV apical pacing. Still, it remains uncertain if 
the deterioration of LV function as noted in a proportion of patients receiving RV apical pacing 
is directly related to acutely induced LV dyssynchrony. The upgrade from RV pacing to cardiac 
resynchronization therapy (CRT) may partially reverse the deleterious eff ects of RV pacing. It 
has even been suggested that selected patients with a conventional pacemaker indication 
should receive CRT to avoid the deleterious eff ects. This review will provide a contemporary 
overview of the available evidence on the detrimental eff ects of RV apical pacing. Furthermore, 
the available alternatives for patients with a standard pacemaker indication will be discussed. 
In particular, the role of CRT and alternative RV pacing sites in these patients will be reviewed. 
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INTRODUCTION
For decades, cardiac pacing has been an eff ective treatment in the management of patients 
with brady- and tachy-arrhythmias (1). New indications for pacing such as drug-refractory 
heart failure have been introduced (2). However, sick sinus syndrome and atrioventricular (AV) 
conduction disorders still remain the most important indications for cardiac pacing (3). The 
endocardial pacing lead is typically positioned at the right ventricular (RV) apex. In general RV 
apical pacing is very well tolerated and eff ective. However, it has been suggested that RV api-
cal pacing may have detrimental eff ects on cardiac structure and left ventricular (LV) function 
(4). This may be related to the abnormal electrical and mechanical activation pattern of the 
ventricles (or ventricular dyssynchrony) caused by RV apical pacing. In recent years, the asso-
ciation between RV apical pacing and mechanical dyssynchrony, and their eff ects on cardiac 
function have been studied by electrophysiologists, cardiac imaging experts and physiologists. 
Although the approach to this complex problem may diff er among them, the overlapping 
perspectives have provided important pathophysiologic information. 
In this manuscript, the potential detrimental eff ects of RV apical pacing, and the underlying 
pathophysiology will be reviewed. In particular, the role of ventricular dyssynchrony will be 
discussed. Furthermore, the therapeutic options in patients with a pacemaker indication will 
be reviewed; including the role of CRT and alternative RV pacing sites.
THE EFFECTS OF RV APICAL PACING
Cardiac pacing is the only eff ective treatment for symptomatic sinus node disease, and can 
improve symptomatic chronotropic incompetence (1). In addition, numerous studies have 
demonstrated symptomatic and functional improvement by cardiac pacing in patients with 
AV block (5). Furthermore, conventional dual-chamber pacing can improve cardiac function 
in selected patients with LV dysfunction (6). Finally, cardiac pacing is an eff ective treatment in 
controlling symptoms of chronic, drug-refractory atrial fi brillation (7). In the last decades, there 
have been signifi cant increases in the incidence of pacemaker implantations (8). 
A number of large randomized clinical trials have provided important information for 
selection of the optimal pacing mode (9-11). But more importantly, these trials have suggested 
an association between RV apical pacing and cardiac morbidity and mortality. In addition, a 
number of clinical (12,13)  and pre-clinical (14,15) studies have investigated the exact eff ects of 
RV apical pacing on cardiac function. Furthermore, it has been suggested that pacing-induced 
mechanical dyssynchrony is associated with a deterioration of LV function and clinical status in 
patients with permanent RV apical pacing (16). 
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Evidence from pacing mode trials
Several large, randomized clinical trials on pacing mode selection have suggested an association 
between a high percentage of RV apical pacing and a worse clinical outcome (17). A substudy 
of the MOde Selection Trial (MOST) demonstrated a strong association between RV pacing 
and the risk of heart failure hospitalization and atrial fi brillation in both ‘physiologic pacing’ 
(DDDR: n=707) and ventricular pacing (VVIR: n=632) (10). It was noted that >40% of ventricular 
pacing in the DDDR group was associated with an increased risk of heart failure hospitalization 
(hazard ratio 2.60; 95% CI 1.05 - 6.47; p<0.05) and that >80% of ventricular pacing in the VVIR 
group was associated with an increased risk of heart failure hospitalization (hazard ratio 2.50; 
95% CI 1.44 - 4.36; p<0.05). In the Dual Chamber and VVI Implantable Defi brillator (DAVID) trial 
patients with a standard indication for a defi brillator implantation, but without an indication for 
anti-bradycardia pacing, were randomized between ‘physiologic pacing’ (DDDR mode, lower 
rate of 70 bpm) or ventricular back-up pacing (VVIR mode, lower rate of 40 bpm) (11). After 
a median follow-up of 8.4 months, the primary outcome measure (freedom from death and 
absence of hospitalization for new or worsened heart failure) was lower in the VVIR-40 group 
than in the DDDR-70 group (relative hazard 1.61; 95% CI 1.06 – 2.44; p=0.03). Interrogation of 
the defi brillator device revealed a signifi cantly higher percentage of ventricular paced beats in 
the DDDR-70 group at 3 months follow-up. Importantly, a trend towards a worse survival at 12 
months was noted in patients with a high percentage of pacing at 3 months follow-up (11). It 
should be noted however that not only RV apical pacing itself may have resulted in this worse 
outcome, but also the higher mean heart rate, and the changes in AV coupling in the DDDR 
group may have detrimental eff ects. 
These trials suggest that there is no clinical benefi t of ‘physiologic’ DDDR pacing over VVIR. 
This may be explained by the higher percentage of ventricular pacing in the DDDR groups, 
as a result of the short programmed AV interval. Thus, the benefi cial eff ect of maintaining AV 
synchrony by ‘physiologic’ DDDR pacing may be reduced by the deleterious eff ects of RV apical 
pacing itself. 
Unfortunately, the exact amount of RV apical pacing that negatively aff ects cardiac function 
remains unclear from these trials. A certain amount of ventricular pacing may actually be ben-
efi cial since it maintains physiologic AV conduction (6). At the same time, the negative eff ects 
of RV apical pacing may be more pronounced in certain patient populations. In particular, 
patients with underlying conduction disease (18) and patients with ischemic heart disease (19) 
may be at risk. Furthermore, it has been suggested that in patients who require pacing for a 
longer period of time, and patients with depressed LV function at baseline are more susceptible 
for the deleterious eff ects of RV apical pacing (4). More studies are therefore needed to fully 
understand the benefi cial and deleterious eff ects of RV apical pacing, and to better identify the 
patients who are at risk for the detrimental eff ects of RV pacing. The available studies in which 
the underlying pathophysiology is studied will be reviewed in the following paragraphs. 
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Pathophysiology of detrimental eff ects
In general, the negative eff ects of RV apical pacing have been attributed to the abnormal 
electrical and mechanical activation pattern of the ventricles (14). During RV apical pacing, 
the conduction of the electrical wave front propagates through the myocardium, rather than 
through the His-Purkinje conduction system. As a result, the electrical wave front propagates 
more slowly and induces heterogeneity in electrical activation of the myocardium, comparable 
to left bundle branch block. This is characterized by a single breakthrough at the interventricu-
lar septum, and the latest activation at the inferoposterior base of the LV (20-22). 
Similar to the changes in electrical activation of the ventricles, the mechanical activa-
tion pattern of the LV is changed during RV apical pacing. Importantly, not only the onset of 
mechanical contraction is changed, but also the pattern of mechanical contraction (14). In sev-
eral animal studies, it has been demonstrated that the early-activated regions near the pacing 
site exhibit rapid early systolic shortening, resulting in pre-stretch of the late activated regions 
(15,23). As a result, these regions exhibit an increase in (delayed) systolic shortening, imposing 
systolic stretch to the early activated regions exhibiting pre-mature relaxation. This abnormal 
contraction pattern of the various regions of the LV may result in a redistribution of myocardial 
strain and work and subsequent less eff ective contraction (15). 
Both the abnormal electrical and mechanical activation pattern of the ventricles can result 
in changes in cardiac metabolism and perfusion, remodeling, hemodynamics and mechanical 
function. An overview of the potential harmful eff ects of RV apical pacing on cardiac function is 
provided in Table 1. The eff ects on cardiac metabolism and perfusion have been demonstrated 
in both clinical and pre-clinical studies (24). Even in the absence of coronary artery disease, 
myocardial perfusion defects may be present in up to 65% of the patients after long-term RV 
apical pacing, and are mainly located near the pacing site (12,25). 
Table 1. Acute and long-term eff ects of RV apical pacing
Changes in electrical activation and mechanical activation
Metabolism / perfusion
   Changes in regional perfusion
   Changes in oxygen demand
Remodeling
   Asymmetric hypertrophy
   Histopathological changes
   Ventricular dilation
   Functional mitral regurgitation
Hemodynamics
   Decreased cardiac output
   Increased LV fi lling pressures
Mechanical function
   Changes in myocardial strain
   Interventricular mechanical dyssynchrony
   Intraventricular mechanical dyssynchrony
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Long-term RV pacing may also result in structural changes, and LV remodeling. Endomyo-
cardial biopsies in 14 patients with congenital complete AV block revealed cellular and intracel-
lular alterations, including mitochondrial variations and degenerative fi brosis, after long-term 
permanent RV pacing (26). In addition, changes in LV wall thickness (27), and LV remodeling 
(28) may occur after long-term RV pacing. In addition, functional mitral regurgitation and left 
atrial remodeling may occur during RV apical pacing (29,30). 
Moreover, hemodynamic properties and global mechanical function may be aff ected by 
the abnormal electrical and mechanical activation of the LV. Pacing at the RV apex may result 
in a decrease in cardiac output and may alter LV fi lling properties (13). Changes in myocardial 
strain and timing of regional strain may occur during RV apical pacing. Using magnetic reso-
nance imaging in an animal model of cardiac pacing, Prinzen et al. noted a signifi cant decrease 
in strain in the regions close to the pacing site, whereas an increase in myocardial strain was 
noted in remote regions (15). Importantly, timing of peak regional strain is also changed during 
pacing. This is often referred to as ‘mechanical dyssynchrony’ (31). 
Mechanical dyssynchrony during RV apical pacing
Right ventricular apical pacing can induce both interventricular dyssynchrony (between the RV 
and the LV), as well as intraventricular dyssynchrony (within the LV) (16). It has been demon-
strated that the presence of ventricular dyssynchrony is associated with an increased risk of car-
diac morbidity (32) and mortality (33) in heart failure patients. In addition, it has been suggested 
that the presence of mechanical dyssynchrony after long-term RV apical pacing is associated 
with reduced LV systolic function and deterioration in functional capacity (16). However, there 
are only a few studies that have demonstrated a direct relation between (pacing-induced) ven-
tricular dyssynchrony and clinical heart failure. At the same time, it has been shown that restora-
tion of normal conduction and ‘cardiac synchrony’ by cardiac resynchronization therapy (CRT) 
results in normalization of LV systolic function (34,35). This suggests that an abnormal activation 
pattern (left bundle branch block during RV apical pacing) or ventricular dyssynchrony may 
be directly related to a deterioration of LV function. Therefore, the assessment of ventricular 
dyssynchrony may provide important information in patients with permanent RV apical pacing. 
Several echocardiographic techniques are available for the assessment of cardiac mechani-
cal dyssynchrony. These include conventional Doppler techniques, tissue Doppler imaging, 
strain analysis and novel three-dimensional echocardiography. The majority of the techniques 
have been used to quantify inter- and intraventricular dyssynchrony in heart failure patients 
referred for CRT (36). Likewise, these techniques can be used to detect the presence of ventricu-
lar mechanical dyssynchrony during acute and long-term RV apical pacing. 
For the quantifi cation of interventricular dyssynchrony, conventional Doppler techniques 
are typically used (Figure 1). For both ventricles, the electromechanical delay is calculated as 
the time from onset of the QRS complex to the onset of pulmonary systolic fl ow (RV electro-
mechanical delay) or aortic systolic fl ow (LV electromechanical delay). The time diff erence 
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between the RV and LV electromechanical delay represents interventricular dyssynchrony 
(37). From previous studies, it has become clear that RV apical pacing can induce signifi cant 
interventricular dyssynchrony (16,38). 
For the assessment of intraventricular (or LV) dyssynchrony, several echocardiographic 
techniques are available, including tissue Doppler imaging, two-dimensional speckle-tracking 
strain analysis, and real-time three-dimensional echocardiography (39). In general, LV dys-
synchrony is represented by the delay in mechanical activation between the interventricular 
septum and the posterior or lateral wall (Figure 2). Already in 1977, Gomes et al. demonstrated 
the eff ect of RV apical pacing on the mechanical delay between the septum and the posterior 
wall (40). During the acute onset of cardiac pacing in 12 patients, it was noted that there was 
an early rapid pre-ejection posterior motion of the interventricular septum. In addition, the 
posterior wall of the LV exhibited a delayed contraction, resulting in a signifi cant delay between 
Figure 1. Schematic representation of interventricular dyssynchrony during RV apical pacing. For assessment of interventricular 
dyssynchrony, the ECG and systolic fl ow through the pulmonary artery and aorta (assessed with Doppler echocardiography) are typically used. 
Both the RV and LV electromechanical delay are measured from the onset of QRS (dashed black line). The RV electromechanical delay is the time 
from the onset of QRS to the onset of pulmonary systolic fl ow (blue arrow). The LV electromechanical delay is the time from the onset of QRS to 
the onset of aortic systolic fl ow (red arrow). Subsequently, the interventricular dyssynchrony can be calculated as the diff erence between the RV 
and the LV electromechanical delays (black arrow).
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the activation of the septum (61 ± 5 ms) and the posterior wall (116 ± 18 ms) (40). More recently, 
these fi ndings have been confi rmed with dedicated echocardiographic techniques (41-44). 
From these studies, it has become apparent that RV apical pacing can induce signifi cant intra-
ventricular mechanical dyssynchrony, which has been related to reduced LV function. 
CLINICAL IMPLICATIONS
From the large pacing-mode selection trials and observational studies, it has become apparent 
that conventional RV apical pacing is associated with an increased risk of adverse events (e.g. 
development of LV dilatation and heart failure). However, in daily clinical practice not all patients 
who receive RV apical pacing will experience these adverse events (19). In a retrospective study 
including 286 patients with permanent pacing after AV junction ablation, it was noted that LV 
Figure 2. Schematic representation of intraventricular dyssynchrony during RV apical pacing. Intraventricular dyssynchrony is represented 
by the delay in mechanical activation between diff erent segments within the LV. In this example, longitudinal strain curves of the septum and 
the posterior or lateral wall are demonstrated. The time from onset of QRS to peak systolic strain for the septum (green arrow) and the posterior 
or lateral wall (red arrow) is indicated. The diff erence in time-to-peak strain for the various segments is the delay in mechanical activation, or LV 
intraventricular dyssynchrony (indicated by the black arrow).
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ejection fraction (LVEF) decreased signifi cantly in only 9% of the patients during follow-up (45). 
In another retrospective study of 304 patients with pacemaker implantation for high degree AV 
block, the clinical outcome after at least one year of RV apical pacing was studied (46). A total of 
79 patients (26%) developed new-onset heart failure after a mean of 6.5 ± 5.7 years of pacing. It 
appears that some patients are more susceptible to the detrimental eff ects of RV apical pacing 
than others, possibly related to mechanical ventricular dyssynchrony. 
Ventricular dyssynchrony may be present in up to 50% of the patients after long-term RV 
apical pacing (38,41,47). Importantly, it has been demonstrated that the presence of mechani-
cal dyssynchrony after long-term RV apical pacing is associated with LV dilatation, and a dete-
rioration of LV systolic function and functional capacity (16). However, it remains unclear if LV 
dyssynchrony is an acute phenomenon, which may then induce deterioration of LV function at 
longer follow-up and subsequent development of heart failure. 
A recent study in patients with structurally normal hearts, undergoing electrophysiologic 
testing revealed that signifi cant LV dyssynchrony may be induced acutely in up to 36% of indi-
viduals (Figure 3) (48). A concomitant impairment in LV systolic function was observed, refl ected 
by a reduction in LVEF (from 56 ± 8% to 48 ± 9%, p=0.001) and LV longitudinal strain (from -18.3 
± 3.5% to -11.8 ± 3.6%, p<0.001) (48). In 153 patients undergoing pacemaker implantation for 
standard indications, Pastore et al. assessed LV dyssynchrony using tissue Doppler echocar-
diography at baseline and after at least 24 hours (mean 1.7 ± 0.3 days) of continuous RV apical 
pacing (49). A total of 101 patients (66%) exhibited signifi cant LV dyssynchrony. Interestingly, 
the amount of pacing-induced LV dyssynchrony was related to the presence of LV dysfunction 
at baseline (Figure 4). It has been demonstrated previously that the conduction abnormali-
ties induced by RV apical pacing may be enhanced by accompanying conduction disease at 
Figure 3. Right ventricular apical pacing acutely induces LV dyssynchrony. Echocardiographic analysis of LV dyssynchrony during intrinsic 
rhythm (panel A) and immediately after onset of RV apical pacing (panel B). Speckle-tracking strain analysis enables the evaluation of the 
timing of systolic strain. The color-coded curves represent the time-strain curves of 6 mid-ventricular segments of the LV. During intrinsic 
rhythm (panel A), a synchronous contraction of all LV segments is present. In contrast, during RV apical pacing, signifi cant LV dyssynchrony 
is present: there is a signifi cant delay (130 ms) between the time-to-peak strain of the antero-septum (yellow arrow) and the posterolateral 
segment (purple arrow).
180
baseline (18). Unfortunately, the abovementioned studies only assessed LV dyssynchrony and 
LV function in the acute phase. Although it has been demonstrated that the negative eff ects of 
the abnormal LV activation sequence may sustain even after termination of RV apical pacing 
(50), it still remains unclear whether the acutely induced LV dyssynchrony is the basis for the 
development of LV dysfunction and heart failure after long-term RV apical pacing. In addition, 
it is still unclear why some patients acutely develop ventricular dyssynchrony, and others do 
not. This may be due to subtle diff erences in the location of the pacing lead within the RV 
apex, and thus the proximity of the Purkinje system. At the same time, some echocardiographic 
techniques used to assess ventricular dyssynchrony may not be sensitive enough to detect 
small changes in electromechanical activation (51). Therefore, more studies are needed on 
acutely induced ventricular dyssynchrony, and its long-term eff ects. 
When future studies show that the acutely induced LV dyssynchrony is associated with 
deterioration of LV function during follow-up, ventricular dyssynchrony assessment during 
pacemaker implantation may have important clinical implications. If LV dyssynchrony is present 
immediately after onset of RV apical pacing, a CRT device may be preferred over conventional 
RV apical pacing. In contrast, if no LV dyssynchrony is present, conventional RV apical pacing 
alone may be accepted. Monitoring of LV dyssynchrony and LV function is then warranted. 
At the same time, with the increasing evidence of the detrimental eff ects of RV apical 
pacing, it has been suggested that the percentage of ventricular pacing should be kept to a 
Figure 4. Left ventricular dyssynchrony during RV pacing according to baseline LVEF. In 153 patients undergoing pacemaker implantation, 
LV dyssynchrony was assessed during RV apical pacing. Patients were classifi ed according to baseline LVEF: normal (LVEF >55%), moderately 
depressed (LVEF 35-55%), or severely depressed (LVEF <35%). The extent of LV dyssynchrony was strongly related with baseline LVEF. In 
patients with normal LVEF, 45% of the patients developed LV dyssynchrony (40 out of 89), whereas 39 of the 42 patients (93%) with moderately 
depressed LVEF developed LV dyssynchrony. In patients with severely depressed LVEF (n=22), all patients exhibited LV dyssynchrony during RV 
apical pacing (49). LV = left ventricular; LVEF = left ventricular ejection fraction; RV = right ventricular
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minimum (4). However, in a large proportion of patients, RV pacing is inevitable (1). For these 
patients, a number of alternative strategies to minimize the induction of mechanical dyssyn-
chrony and other deleterious eff ects have been proposed. These therapeutic options, including 
the upgrade from RV pacing to CRT, ‘de novo’ CRT, and alternative pacing sites, will be discussed 
in the following paragraphs. 
THERAPEUTIC OPTIONS IN PATIENTS WITH RV APICAL PACING 
The detrimental eff ects of RV apical pacing related to cardiac metabolism, remodeling, hemo-
dynamics and mechanical function may be prevented or partially reversed by CRT or alterna-
tive RV pacing sites. In the subset of patients who experience detrimental eff ects of RV apical 
pacing, CRT may restore the synchronous contraction of the LV and subsequently improve LV 
function. Alternatively, a number of strategies, including alternative RV pacing sites, have been 
suggested to avoid the deleterious eff ects of RV apical pacing. All these therapeutic options will 
be discussed in the following paragraphs.
Upgrade of RV apical pacing to CRT
Several studies have demonstrated benefi cial eff ects of the upgrade from RV apical pacing to CRT 
(Table 2). Reverse remodeling of the LV (defi ned as a reduction in LV end-diastolic or end-systolic 
volume) after upgrade from RV apical to CRT has been demonstrated in several studies (47,52,53). 
In addition, the severity of mitral regurgitation may improve after upgrade to CRT (54-57). 
Furthermore, LV hemodynamics and mechanical function may improve after upgrade to 
CRT. In an invasive hemodynamic study in 18 patients with congenital complete AV block who 
had received RV apical pacing for a mean of 81 ± 10 months, CRT resulted in a signifi cant increase 
in LV dP/dtmax (58). In parallel, a signifi cant decrease in LV end-diastolic pressure and isovolumic 
pressure half-time was observed (58). Improvements in global LVEF have been demonstrated in 
various studies, including four prospective studies with more than 110 patients with previous 
AV junction ablation and pacemaker implantation (52,54,59,60) (Table 2). 
Finally, it has been demonstrated that the upgrade from RV apical pacing to CRT may 
result in a signifi cant improvement in exercise capacity and NYHA functional class (57) (Figure 
5). Unfortunately, at present it remains uncertain if the upgrade to CRT in previously paced 
patients results in an improved prognosis. 
Eff ect on ventricular dyssynchrony In parallel with the improvements in LV function, LV dys-
synchrony may improve after upgrade from RV apical to CRT. An acute reduction in the LV 
pre-ejection interval after onset of CRT in previously paced patients has been demonstrated in 
several studies (61,62). Importantly, this eff ect is maintained during mid- and long-term follow-
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pacing, tissue Doppler imaging was used to assess LV dyssynchrony. After a mean of 144 ± 17 
days, a signifi cant decrease in the mean septal-to-lateral delay was noted from 101 ± 12 ms to 
10 ± 9 ms (p<0.001) (53). Likewise, with the use of novel speckle-tracking echocardiography it 
has been demonstrated that the diff erence in time-to-peak strain of various LV segments (as a 
measure of LV dyssynchrony) decreases signifi cantly after upgrade to CRT (47). 
RV apical pacing versus CRT
With the promising results of upgrading patients from RV apical pacing to CRT, it has been 
suggested that patients with moderate to severe LV dysfunction and a standard pacemaker 
indication may actually benefi t from CRT instead of RV apical pacing alone. A number of obser-
vational studies and randomized trials have performed a head-to-head comparison between 
the two pacing modes. 
The eff ects of the two pacing modes on LV remodeling have been studied in the Homburg 
Biventricular Pacing Evaluation (HOBIPACE) trial (63). In this trial, 30 patients with standard 
indications for permanent pacing and a LVEF ≤40%, were randomized between RV pacing and 
CRT. After 3 months of pacing, cross-over to the other pacing modality was performed. The LV 
end-systolic volume was 177.3 ± 68.7 ml at baseline, and decreased modestly with RV pacing 
(160.2 ± 73.4 ml, p<0.05). When compared with RV pacing, CRT signifi cantly reduced LV end-
systolic volume by 17% (133.1 ± 66.5 ml, p<0.001) (63). 
In addition to LV remodeling, improvements in LV hemodynamics (64,65) and LV mechani-
cal function (66) during CRT have been demonstrated. In the Post AV Nodal Ablation Evaluation 
(PAVE) trial, 184 patients were randomized after AV junction ablation in two parallel arms 
(conventional RV pacing or CRT) (66). Mean LVEF at follow-up was signifi cantly lower in the 
81 patients who underwent RV pacing as compared with the 103 patients with CRT (41 ± 13% 
vs. 46 ± 13%, p<0.05) (66). However, it should be noted that other trials, including the Optimal 
Pacing SITE (OPSITE) trial (67), demonstrated only modest improvement in LVEF during CRT 
compared to RV pacing. 
Figure 5. Changes in NYHA functional class and 6 minute walking-test after upgrade from RV pacing to CRT. In 44 patients with conventional 
pacemaker indications, an upgrade to CRT was performed after a mean of 49 ± 34 months of RV apical pacing. After 6 months of CRT, NYHA 
class improved from 2.5 ± 0.7 to 2.1 ± 0.4 (left panel), and the distance walked during the 6 minute walking-test increased from 324 ± 20 m to 
386 ± 99 m (right panel) (57). CRT = cardiac resynchronization therapy; NYHA = New York Heart Association; RV = right ventricular pacing.
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A number of randomized trials have compared conventional RV apical pacing and CRT 
(Table 3). Although some trials have demonstrated clear long-term benefi t of CRT over RV pac-
ing with regard to peak VO2 or the distance walked during the 6 minute walking-test (63,66), 
others have demonstrated only modest (67,68) or no benefi t at all (69). The ongoing Biventricu-
lar Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace) trial will 
demonstrate if CRT actually provides benefi t in morbidity and mortality over conventional RV 
apical pacing (70). 
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Eff ect on ventricular dyssynchrony For mechanical dyssynchrony, only a few studies have 
systematically compared RV apical pacing and CRT. In 6 heart failure patients referred for CRT, 
Matsushita et al. assessed dyssynchrony during RV apical pacing and during CRT (71). During 
CRT, a decrease in both LV intraventricular dyssynchrony (RV pacing 322 ± 101 ms vs. CRT 209 
± 88 ms, p<0.05) and interventricular dyssynchrony (RV pacing 37.2 ± 44.7 ms vs. CRT 16.2 ± 
47.4 ms, p<0.05) was noted (71). In a randomized study comparing DDDR pacing and CRT in 50 
patients with high degree AV block, Albertsen et al. assessed ventricular dyssynchrony using 
tissue Doppler imaging (69). After 12 months follow-up, the number of LV segments displaying 
delayed longitudinal contraction (representing LV dyssynchrony) was signifi cantly lower in the 
patients with CRT, as compared with the patients with DDDR pacing (69). These studies suggest 
that CRT may be superior over RV apical pacing with regard to the induction of LV dyssynchrony. 
Together with the promising results on LV remodeling and LV function, it may well be that CRT 
is a good therapeutic option in patients with moderate to severe LV dysfunction and a conven-
tional indication for cardiac pacing. However, it should be noted that although CRT reduces the 
amount of ventricular dyssynchrony, normal electromechanical activation is not completely 
restored (72,73). In addition, it remains uncertain if there is a signifi cant improvement in long-
term outcome with CRT, as compared with conventional RV apical pacing. Therefore, more 
studies are needed to fully appreciate the role of CRT in these patients (1). 
Pacing strategies and alternative pacing sites
Alternatives for RV apical pacing may be important in patients who have a depressed LV func-
tion at baseline or patients who are expected to be paced frequently (complete AV block) or 
for a longer period of time (young patients, congenital AV block). Various pacing strategies 
have been suggested to minimize the amount of RV apical pacing. In addition, strategies to 
minimize de-synchronization of ventricular contraction using alternative pacing sites have 
been proposed. 
Atrial-based pacing Atrial-based pacing may be preferred over RV apical pacing in selected 
patient groups, since it prevents cardiac de-synchronization by maintaining normal ventricular 
electrical activation. Nielsen et al. randomized 177 patients with sinus node disease between 
AAIR pacing or DDDR pacing with a short AV delay or DDDR pacing with a fi xed long AV delay 
(74). During a mean follow-up of 2.9 ± 1.1 years, left atrial and LV diameters increased and LV 
fractional shortening decreased in the DDDR groups, whereas no changes occurred in the 
AAIR group. In addition, atrial fi brillation was less common in the AAIR group as compared to 
the two DDDR groups (7.4% vs. 23.3% and 17.5%, respectively; p=0.03)(74). However, other 
large randomized trials have not been able to consistently demonstrate an improved outcome 
of atrial-based pacing. In a recent meta-analysis from 5 randomized clinical trials comparing 
atrial-based and ventricular pacing, no signifi cant reduction in mortality with atrial-based pac-
ing could be demonstrated (hazard ration 0.95; 95% CI 0.87 – 1.03; p=0.19). In addition, no 
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diff erences were found in the composite end-point of stroke, cardiovascular death, and heart 
failure hospitalization between the diff erent pacing modes (Figure 6). However, a signifi cant 
reduction in atrial fi brillation was noted with atrial-based pacing (hazard ratio 0.80; 95% CI 
0.72 – 0.89; p<0.001) (75). 
Atrial-based pacing to prevent cardiac de-synchronization may only be feasible in selected 
patients. There is still concern about atrial-based pacing in patients with sinus node disease, 
because of the development of AV block in these patients (76). In the abovementioned trial, 
the incidence of progression to symptomatic AV block was 1.9% per year (74). Therefore, atrial-
based pacing for the maintenance of ventricular synchrony is only recommended in patients 
with sinus node disease without AV conduction abnormalities (1). 
Minimal ventricular pacing algorithms In addition, specifi c pacing algorithms have been 
introduced to minimize unnecessary RV pacing. These algorithms promote normal AV conduc-
tion and target maintenance of intrinsic ventricular conduction (77,78). Thereby, the algorithms 
avoid the induction of LV dyssynchrony. In the Inhibition of unnecessary RV pacing with AVSH in 
ICDs Study (INTRINSIC RV), the eff ects of the use of an AV search hysteresis algorithm was stud-
ied (77). A total of 988 patients with an indication for an Implantable Cardioverter Defi brillator 
were randomized between VVI-40 back-up pacing or DDDR pacing with the AV search hysteresis 
Figure 6. Meta-analysis on atrial-based pacing versus ventricular pacing. A meta-analysis of 5 randomized clinical trials including more 
than 7000 patients compared atrial-based pacing with ventricular based pacing. This fi gure demonstrates the eff ect of the pacing modes on the 
diff erent outcome parameters (mortality, stroke or cardiovascular death, stroke, heart failure hospitalization, atrial fi brillation), expressed as the 
hazard ratio and 95% confi dence interval (CI). A signifi cant reduction in the incidence of stroke and atrial fi brillation was observed, in favor of 
atrial-based pacing. The remaining outcome parameters did not show a signifi cant diff erence between the two pacing modes (75).
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algorithm. In the DDDR group, 32 patients (6.4%) met the composite primary end-point of all-
cause mortality and heart failure hospitalization, as compared with 46 patients (9.5%) in the 
VVI group (p<0.001). It was concluded that the use of the AV search hysteresis algorithm was 
associated with similar clinical outcomes compared with VVIR backup pacing (77). 
Similar, in the Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-
ventricular Conduction (SAVE PACe) trial, 1065 patients with sinus node disease and intact AV 
conduction were randomized between conventional dual-chamber pacing and dual-chamber 
minimal ventricular pacing (78). With the use of the minimal RV pacing algorithm, the percent-
age of paced ventricular beats was signifi cantly reduced, as compared with conventional 
dual-chamber ventricular pacing (9.1 vs. 99.0%, p<0.001). After a mean of 1.7 ± 1.0 years, the 
development of persistent atrial fi brillation was signifi cantly reduced with minimal ventricular 
pacing (7.9% in minimal RV pacing vs. 12.7% in conventional dual-chamber pacing, p=0.004). 
Although these results suggest that this reduction is directly related to the decrease in RV apical 
pacing, a better AV coupling may have contributed as well. Unfortunately, no signifi cant diff er-
ence in mortality or heart failure hospitalizations between the two groups was observed (78). 
These studies suggest a favorable eff ect of minimizing ventricular pacing algorithms. However, 
more studies are needed to fully appreciate the exact clinical benefi ts in daily practice (1). 
Alternative RV pacing sites Pacing at the RV outfl ow tract, septal pacing and direct His bundle 
pacing have been suggested as alternatives to the RV apex when pacing is inevitable (79). 
Because of the closer proximity to the normal conduction system, these sites may result in 
less electrical activation delay (represented by a shorter QRS duration) and less mechanical 
dyssynchrony. 
From all alternative RV pacing sites, the RV outfl ow tract has been studied the most 
extensively. A meta-analysis of 9 studies with 217 patients comparing RV outfl ow tract and RV 
apical pacing demonstrated a favorable eff ect of RV outfl ow tract pacing on hemodynamics 
(80). Unfortunately, the majority of the studies involved short-term follow-up studies. A recent 
retrospective study demonstrated a better survival in patients with RV outfl ow tract pacing as 
compared with RV apical pacing (81). The favorable eff ect of RV outfl ow tract pacing may be 
related to the more physiologic activation pattern, resulting in less LV dyssynchrony. However, a 
small study with 14 patients could not demonstrate a benefi t of RV outfl ow tract pacing over RV 
apical pacing with regard to LV dyssynchrony (82). More studies with dyssynchrony analysis and 
long-term follow-up comparing RV outfl ow pacing and RV apical pacing are therefore needed. 
Septal pacing may be another good alternative for RV apical pacing. Short-term studies 
have suggested good results compared with RV apical pacing (83), with good pacing thresholds 
and lead stability (84). In addition, less ventricular dyssynchrony may be present during septal 
pacing as compared with RV apical pacing (85). However, at long-term follow-up, septal pacing 
may not be superior over RV apical pacing. In a randomized study including 98 patients with AV 
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block (53 septal pacing vs. 45 apical pacing), no diff erences in LVEF and exercise capacity were 
found after 18 months follow-up (86). 
Direct His bundle pacing or para-Hisian pacing has also been suggested as an alternative 
for RV apical pacing. In one of the fi rst clinical studies with permanent direct His bundle pacing, 
Deshmukh et al. demonstrated the feasibility of this strategy (87). Implantation was successful 
in 12 of 14 patients (86%), with maintenance of His bundle capture at long-term follow-up in 
11 patients (92%). After a mean of 23.4 ± 8.3 months, LV end-diastolic diameter had decreased 
from 51 ± 10 mm to 43 ± 8 mm (p<0.01) and LVEF had increased from 18.2 ± 9.8% to 28.6 ± 
11.2% (p<0.05) (87). Importantly, it has been demonstrated that His bundle pacing may result 
in less inter- and intraventricular dyssynchrony (88,89). In a randomized study comparing RV 
apical pacing and para-Hisian pacing in 16 patients, Occhetta et al. noted a signifi cant reduc-
tion in interventricular dyssynchrony during para-Hisian pacing as compared with RV apical 
pacing (34 ± 18 ms vs. 47 ± 19 ms, p<0.05) (89). 
Although the various studies have demonstrated benefi cial eff ects of the alternative pac-
ing sites, at present septal and direct His bundle pacing are still not recommended in patients 
requiring permanent cardiac pacing because of diffi  culties with lead positioning, and concerns 
about lead stability and threshold (1). In addition, it should be remembered that any electrical 
stimulation outside the normal conduction system may ultimately result in electromechani-
cal changes with deleterious eff ects on LV function. Furthermore, the majority of the studies 
on alternative pacing sites were non-randomized studies with small study populations and 
short-term follow-up. Nonetheless, there is increasing evidence that these alternative sites may 
provide benefi t over conventional RV apical pacing. 
CONCLUSIONS
From large pacing mode selection trials and observational studies, it has become apparent that 
a high amount of RV apical pacing may be associated with a worse clinical outcome (deteriora-
tion of LV systolic function, development of heart failure and atrial fi brillation). Unfortunately, 
it remains unclear if there is an ‘optimal amount’ of RV pacing, and which patients at most 
susceptible for the deleterious eff ects of RV pacing. The negative eff ects may be related to 
the induction of ventricular dyssynchrony by RV apical pacing. Future studies are needed to 
address these remaining questions. 
Various therapeutic options have been suggested in patients with a conventional pace-
maker indication. The upgrade to CRT may partially reverse the deleterious eff ects of RV apical 
pacing. New pacing strategies and alternative RV pacing sites may prevent the induction of 
ventricular dyssynchrony and the deterioration of LV function.
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ABSTRACT
Background: Atrioventricular (AV) node ablation and subsequent long-term RV pacing is a 
well-established treatment option in patients with atrial fi brillation (AF). 
Objectives: To assess the eff ects of long-term right ventricular (RV) pacing on left ventricular 
(LV) dyssynchrony, LV function and heart failure symptoms.
Methods: In 55 patients with drug-refractory AF, AV node ablation and implantation of a 
pacemaker was performed. At baseline and after a mean of 3.8 ± 1.7 years, LV dyssynchrony 
(by M-mode echocardiography and tissue Doppler imaging), LV function and volumes and 
functional status were assessed.
Results: After long-term RV pacing, 27 patients (49%) had developed LV dyssynchrony. Con-
comitantly, these patients worsened in heart failure symptoms (NYHA class increased from 1.8 
± 0.6 to 2.2 ± 0.7, p<0.05), with a decrease in LV ejection fraction (from 48 ± 7% to 43 ± 7%, 
p<0.05) and an increase in LV end-diastolic volume (from 116 ± 39 ml to 130 ± 52 ml, p<0.05). 
Conversely, patients without LV dyssynchrony did not deteriorate in heart failure symptoms, LV 
function or LV volumes.
Conclusions: Long-term RV pacing can induce LV dyssynchrony in almost 50% of patients 
treated with AV node ablation for chronic AF. The development of LV dyssynchrony was associ-
ated with deterioration in heart failure symptoms, systolic LV function and LV dilatation.
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INTRODUCTION
Chronic atrial fi brillation (AF) represents the most commonly encountered cardiac arrhythmia, 
and contributes substantially to cardiac morbidity and mortality (1). Although pharmacological 
therapy still is considered fi rst-line therapy (2), anti-arrhythmic drugs are frequently ineff ective 
and may have serious side-eff ects. Therefore, several non-pharmacological therapies have 
been introduced (3). 
Atrioventricular (AV) node ablation and subsequent permanent pacing is a well-established 
treatment option in patients with chronic, drug-refractory AF (4). AV node ablation and per-
manent pacing may improve quality of life and exercise capacity (5), and may be superior to 
pharmacological therapy in controlling symptoms of AF (4,6). 
However, recent studies have shown detrimental eff ects of long-term right ventricular (RV) 
pacing (7,8). Left ventricular (LV) dilatation (remodeling) (7) with a decrease in LV ejection frac-
tion (8) after long-term RV pacing have been reported. 
The underlying cause of these adverse eff ects is unknown but may be related to induction 
of LV dyssynchrony after long-term RV pacing, with subsequent deterioration of LV function. To 
evaluate this hypothesis, the eff ects of long-term RV pacing on LV function and dyssynchrony 
were evaluated in patients with chronic AF with normal LV function and without valvular dis-
ease undergoing AV node ablation and RV pacing. 
METHODS
Study population
We retrospectively studied 55 patients who suff ered from permanent AF, despite optimal 
pharmacological therapy. Accordingly, all patients were scheduled for AV node ablation and 
pacemaker implantation. All patients had preserved LV systolic function without signifi cant 
valvular disease. At baseline and after a minimum period of one year RV pacing, New York Heart 
Association (NYHA) functional class was assessed and echocardiography was performed. 
Ablation and pacemaker implantation
Atrioventricular node ablation was performed with a 4 mm quadripolar mapping / ablation 
catheter (EPT, Boston Scientifi c, Natick, Massachusetts, USA), accessed through the femoral 
vein. A temporary pacing electrode was placed in the RV apex for back-up pacing. Radiofre-
quency energy was applied at the AV node until complete AV-block was achieved. Thereafter 
the pacemaker was implanted. Pacemaker leads were inserted through the subclavian vein 
using standard implantation techniques. The RV leads were positioned in the RV apex in all 
patients. After implantation, pacemakers were routinely programmed to VVIR mode.
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Echocardiography
All patients underwent echocardiography before the ablation procedure and after long-term 
RV pacing. Images were recorded with patients in the left lateral decubitus position using a 
commercially available system (Vingmed Vivid Seven, General Electric-Vingmed, Milwaukee, 
Wisconsin, USA). Images were obtained using a 3.5-MHz transducer at a depth of 16 cm in the 
parasternal (long- and short-axis) and apical (two-chamber and four-chamber) views. Standard 
two-dimensional images and color Doppler data triggered to the QRS complex were saved in 
cine-loop format. 
LV end-diastolic and end-systolic volumes and LV ejection fraction were calculated from 
apical two- and four-chamber images using the biplane Simpson’s rule (9). Furthermore, LV 
end-diastolic diameter was measured from the parasternal long-axis images. 
The severity of mitral regurgitation was graded semi-quantitatively using color-fl ow Dop-
pler in the conventional parasternal long-axis and apical four-chamber images (10). Mitral 
regurgitation was characterized as: minimal = 1+ (jet area/left atrial area<10%), moderate = 
2+ (jet area/left atrial area 10-20%), moderate-severe = 3+ (jet area/left atrial area 20-45%), or 
severe = 4+ (jet area/left atrial area >45%) (10).
Ventricular dyssynchrony
At baseline and after long-term RV pacing, LV dyssynchrony was assessed. Septal-to-posterior 
wall motion delay (SPWMD) was assessed using an M-mode recording from the parasternal 
short-axis view at the papillary muscle level. The interval between the maximal posterior dis-
placement of the septum and the maximal displacement of the LV posterior wall was calculated 
(11). As reported by Pitzalis et al, SPWMD ≥130 ms was used as the cut-off  value for LV dys-
synchrony (11,12). 
Furthermore, interventricular dyssynchrony was calculated as the diff erence between LV 
electromechanical delay (time from QRS onset to aortic systolic fl ow onset) and RV electrome-
chanical delay (time from QRS onset to pulmonary systolic fl ow onset) (13). An interventricular 
delay ≥40 ms was used as a cut-off  value for interventricular dyssynchrony, as previously 
described (13,14). 
In addition, LV dyssynchrony was assessed using color-coded tissue Doppler imaging (TDI) 
after long-term RV pacing in 52 patients. The frame rates ranged from 80 to 115 frames/s, 
depending on the sector width of the range of interest; pulse repetition frequencies ranged 
from 0.5 to 1 kHz, resulting in aliasing velocities ranging from 16 to 32 cm/s. TDI parameters 
were measured from color-coded images of three consecutive heart beats by off -line analysis. 
Data were analyzed using commercially available software (Echopac 6.1, General Electric-
Vingmed). To assess LV dyssynchrony, the sample volume was placed in the basal portions of 
the septum and lateral wall; the time to peak systolic velocity was obtained in the septum and 
lateral wall, and the septal-to-lateral delay in peak velocity was calculated as an indicator of LV 
dyssynchrony. A septal-to-lateral delay ≥65 ms was used as a cut-off  value for LV dyssynchrony 
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assessed with TDI, as previously reported (15). The interventricular dyssynchrony and TDI 
images were evaluated by two independent observers, blinded to the results of the SPWMD.
Statistical analysis
Results are presented as mean values ± SD, or number (%). Continuous data were compared using 
paired or unpaired Student t test when appropriate. Correlation between SPWMD and TDI was 
assessed using Pearson’s linear correlation. Agreement between SPWMD and TDI was expressed 
in a 2X2 table using κ statistics. A κ value of <0.4 represents poor agreement, a κ between 0.4 and 
0.75 represents fair to good agreement, and a κ value of >0.75 is considered an excellent agree-
ment based on the Fleiss classifi cation (16). A p value <0.05 was considered statistically signifi cant. 
RESULTS
Study population
Fifty-fi ve patients were studied. Baseline characteristics of the patients are listed in Table 1. All 
patients had preserved LV systolic function at baseline. None of the patients had signifi cant 
mitral regurgitation or LV dysfunction. In all patients AV node ablation with subsequent 
pacemaker implantation was performed successfully. No complications related to the ablation 
procedure or pacemaker implantation were observed. Mean follow-up was 3.8 ± 1.7 years 
(range 1.2 to 8.7 years). 







Age (yrs) 61 ± 11 60 ± 11 62 ± 12
Gender (M/F) 27/28 15/13 12/15
Duration AF (yrs) 7 ± 5 8 ± 5 7 ± 5
Anti-arrhythmic drugs used per patient 3.3 ± 1.3 3.4 ± 1.5 3.2 ± 1.2
Hypertension 27 (49%) 14 (50%) 13 (48%)
Coronary artery disease 5 (9%) 2 (7%) 3 (11%)
Clinically relevant MR (grade ≥ 2+) 0 0 0
Previous myocardial infarction 3 (6%) 1 (4%) 2 (7%)
NYHA functional class
   I 22 (40%) 13 (46%) 9 (33%)
   II 26 (47%) 11 (39%) 15 (56%)
   III 7 (13%) 4 (14%) 3 (11%)
   IV 0 0 0
QRS duration (ms) 99 ± 12 100 ± 13 98 ± 10
SPWMD (ms) 63 ± 31 60 ± 36 67 ± 22
IVD (ms) 25 ± 13 24 ± 14 25 ± 12
AF = atrial fi brillation; IVD = interventricular delay; MR = mitral regurgitation; NYHA = New York Heart Association; SPWMD = septal-to-
posterior wall motion delay.
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At baseline, mean interventricular delay was 25 ± 13 ms. None of the patients had an inter-
ventricular delay ≥40 ms, representing interventricular dyssynchrony. Mean SPWMD before AV 
node ablation and pacemaker implantation was 63 ± 31 ms (range 4 to 122 ms). In none of the 
patients, a SPWMD ≥130 ms was present at baseline, indicating absence of LV dyssynchrony in 
all patients. 
After long-term RV pacing, mean SPWMD was 121 ± 64 ms (range 11 to 240 ms). In 27 
patients (49%) a SPWMD ≥130 ms was present, indicating LV dyssynchrony. Accordingly, the 
study population was divided into two groups: with or without LV dyssynchrony at follow-up, 
based on a SPWMD delay ≥130 ms after long-term RV pacing. Baseline characteristics of the 
two groups are listed in Table 1. There were no diff erences in baseline characteristics between 
the two groups (Table 1). 
Intraventricular dyssynchrony
Intraventricular dyssynchrony as assessed with TDI was available in 52 patients after long-term 
RV pacing. The patients who did not develop LV dyssynchrony on M-mode echocardiography 
after long-term RV pacing, did also not exhibit LV dyssynchrony on TDI (mean septal-to-lateral 
delay 37 ± 45 ms). In contrast, the patients who had developed LV dyssynchrony as assessed 
by M-mode echocardiography also displayed LV dyssynchrony on TDI (mean septal-to-lateral 
delay 109 ± 26 ms, p<0.05 vs. patients without LV dyssynchrony). Of note, all patients with 
SPWMD ≥130 ms on M-mode had a septal-to-lateral delay ≥65 ms assessed with TDI (Table 
2). In contrast, there were 4 patients without dyssynchrony on M-mode, that had a septal-
to-lateral delay ≥65 ms assessed with TDI. A linear relation was found between SPWMD and 
septal-to-lateral delay (R = 0.66, p<0.01) (Figure 1). When applying the cut-off  values (SPWMD 
≥130 ms, septal-to-lateral delay ≥65 ms) for LV dyssynchrony, an excellent agreement (κ = 0.85) 
between SPWMD and TDI to detect LV dyssynchrony was observed (Figure 2). Disagreement 
between SPWMD and TDI was based on 4 (8%) patients, in which LV dyssynchrony could only 
be detected with TDI (Table 2).
Table 2. Agreement between SPWMD and septal-to-lateral delay




present 25 0 25
absent 4 23 27
Total 29 23 52
There is an excellent agreement (92%) between the two methods to assess LV dyssynchrony (κ = 0.85, p<0.01). The disagreement is related to 
4 (8%) patients, in which LV dyssynchrony could only be detected with TDI. LV = left ventricle; TDI = tissue Doppler imaging; SPWMD = septal-
to-posterior wall motion delay.
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Figure 1. A linear relation was found between SPWMD and septal-to-lateral delay after chronic RV pacing. RV = right ventricle; SPWMD = 
septal-to-posterior wall motion delay.
Figure 2. SPWMD and septal-to-lateral delay after chronic RV pacing. For LV dyssynchrony, a cut-off  value of SPWMD >130 ms (dashed line), 
and septal-to-lateral delay >65 ms (solid line) was used. There is a good agreement between SPWMD and septal-to-lateral delay. In only 4 
patients, there was a disagreement between SPWMD and septal-to-lateral delay.
LV = left ventricle; RV = right ventricle; SPWMD = septal-to-posterior wall motion delay.
202
Interventricular dyssynchrony
At baseline, none of the patients exhibited interventricular dyssynchrony (mean interventricular 
delay 25 ± 13 ms). After long-term RV pacing, mean interventricular delay did not increase sig-
nifi cantly in the patients without LV dyssynchrony (24 ± 14 ms vs. 35 ± 25 ms, p=NS). In contrast, 
interventricular delay revealed a signifi cant increase in the patients with LV dyssynchrony after 
long-term RV pacing (25 ± 12 ms vs. 49 ± 19 ms, p<0.05). In 19 patients (70%) with LV dyssynchrony, 
an interventricular delay ≥40 ms was present after long-term RV pacing, indicating the presence 
of interventricular dyssynchrony. In contrast, in only 5 patients (17%) without LV dyssynchrony, 
an interventricular delay ≥40 ms was present (p<0.01 vs. patients with LV dyssynchrony).
Clinical and echocardiographic eff ects of long-term RV pacing
After long-term RV pacing, functional status and LV parameters were re-assessed in all patients. 
In patients without LV dyssynchrony, NYHA class improved from 1.7 ± 0.7 to 1.4 ± 0.5 (p<0.01), 
whereas NYHA class deteriorated in patients who had developed LV dyssynchrony (from 1.8 
± 0.6 to 2.2 ± 0.7, p<0.05) (Figure 3). Furthermore, LV ejection fraction decreased signifi cantly 
in patients with LV dyssynchrony (48 ± 7% vs. 43 ± 7%, p<0.05), whereas LV ejection fraction 
remained unchanged in patients without LV dyssynchrony (Figure 3). 
Also, in patients with LV dyssynchrony, an increase in LV end-diastolic volume (116 ± 39 
ml vs. 130 ± 52 ml, p<0.05) and LV end-systolic volume (62 ± 26 ml vs. 75 ± 35 ml, p<0.05) was 
observed after long-term RV pacing (Table 3). In addition, LV end-diastolic diameter increased 
signifi cantly in patients with LV dyssynchrony (5.3 ± 0.8 cm vs. 5.6 ± 0.7 cm, p<0.05), whereas 
no diff erence in LV diameter was observed in patients without LV dyssynchrony after long-term 
RV pacing (Table 3). 
Figure 3. Eff ects of chronic RV pacing on clinical status and LV ejection fraction. Panel A: In patients with LV dyssynchrony, NYHA functional class 
deteriorated signifi cantly, whereas NYHA functional class improved signifi cantly in patients without LV dyssynchrony. Panel B: LV ejection fraction 
decreased signifi cantly in patients with LV dyssynchrony after chronic RV pacing. * p < 0.05 baseline vs follow-up; † p < 0.05 with dyssynchrony vs 
without dyssynchrony. LV = left ventricle; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; RV = right ventricle.
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DISCUSSION
The current observations demonstrate the adverse eff ects of long-term RV pacing on LV syn-
chrony and LV function. In 49% of the patients treated with AV node ablation and pacemaker 
implantation, LV dyssynchrony was induced after long-term RV pacing associated with an 
increase in heart failure symptoms, a decrease in global LV function and LV dilatation.
Eff ects of long-term RV pacing
In patients with drug-refractory AF, ablation of the AV node and permanent pacing has proven 
to be eff ective (4). However, the benefi cial eff ect of the therapy may (partially) be reversed by 
the non-physiological activation pattern of the interventricular septum. Several studies (7,17-
20) have reported negative eff ects of permanent RV pacing. Regional perfusion defects (17,18), 
asymmetrical hypertrophy of the ventricular wall (19) and an impairment of LV ejection fraction 
(20) have been reported after permanent RV pacing.
Furthermore, Thambo et al (7) recently demonstrated the induction of LV dyssynchrony after 
long-term RV pacing in 23 patients with congenital complete AV-block. Following long-term 
RV pacing, the mean SPWMD, as a measure of LV dyssynchrony, had signifi cantly increased as 
compared to baseline (41 ± 16 ms vs. 84 ± 26 ms, p<0.05). In addition, the septal-to-lateral delay 
as measured by TDI was signifi cantly larger in patients with permanent pacing as compared to 
controls (59 ± 18 ms vs. 19 ± 9 ms, p<0.01). Similar results were demonstrated in the current 
study, showing an increase in SPWMD from 63 ± 31 ms to 121 ± 64 ms (p<0.05) after long-term 
RV pacing, and in 27 (49%) patients the SPWMD exceeded 130 ms, indicating substantial LV 
dyssynchrony. 






   Baseline 49 ± 6 48 ± 7
   Follow-up 49 ± 8 43 ± 7 * †
LVEDV (ml)
   Baseline 119 ± 46 116 ± 39
   Follow-up 121 ± 31 130 ± 52 *
LVESV (ml)
   Baseline 61 ± 25 62 ± 26
   Follow-up 62 ± 19 75 ± 35 *
LVEDD (cm)
   Baseline 5.2 ± 0.6 5.3 ± 0.8
   Follow-up 5.3 ± 0.4 5.6 ± 0.7 * †
Clinically relevant MR (grade ≥ 2+)
   Baseline 0 0
   Follow-up 2 (7%) 5 (18%)
* p < 0.05 baseline vs. follow-up; † p < 0.05 with dyssynchrony vs. without dyssynchrony. LV = left ventricle; LVEDD = left ventricular end-
diastolic diameter, LVEDV = left ventricular end-diastolic volume, LVEF = left ventricular ejection fraction, LVESV = left ventricular end-systolic 
volume, MR = mitral regurgitation, RV = right ventricle.
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The presence of LV dyssynchrony may result in systolic LV dysfunction (21,22). Thambo et 
al (7) reported a signifi cantly lower cardiac output in patients with LV dyssynchrony after long-
term RV pacing, as compared to healthy controls. In addition, LV end-diastolic diameter had 
signifi cantly increased in these patients as compared to controls (5.5 ± 0.7 cm vs. 4.6 ± 0.6 cm, 
p<0.05). The observations in the present study are in line with these previous results: patients 
with LV dyssynchrony after long-term RV pacing showed a decrease in LV ejection fraction, 
with an increase in LV volumes and LV end-diastolic diameter (Table 3) indicating LV dilatation.
Assessment of LV dyssynchrony
In the current study, LV dyssynchrony was measured by M-mode echocardiography. With 
M-mode echocardiography the SPWMD can be measured as recently introduced by Pitzalis et 
al (11). The SPWMD indicates the delay between the maximal systolic motion of the septum and 
the LV free wall, refl ecting intraventricular dyssynchrony (11). At baseline, none of the patients 
in the current study had SPWMD exceeding 130 ms, which is used as the upper limit of normal 
LV synchrony. After long-term RV pacing however, 27 (49%) patients had developed LV dys-
synchrony, as illustrated by a SPWMD ≥130 ms. 
In addition to SPWMD, TDI was used to assess the septal-to-lateral delay. TDI is a sophisti-
cated echocardiographic technique that permits measurement and timing of myocardial sys-
tolic (and diastolic) velocities. By comparing the diff erences in time to peak systolic velocities of 
diff erent LV regions, TDI can identify LV dyssynchrony (23). 
Both M-mode using SPWMD and TDI using the septal-to-lateral delay have proven to be 
eff ective in the detection of LV dyssynchrony (11,15). In the current study, a good agreement 
was detected between the SPWMD and septal-to-lateral delay (Figure 2). In particular, all 
patients with LV dyssynchrony on M-mode also exhibited LV dyssynchrony on TDI, and only 
4 patients (8%) without LV dyssynchrony on M-mode had LV dyssynchrony on TDI, indicating 
minimal underestimation of LV dyssynchrony by SPWMD. Marcus et al (24) have recently dem-
onstrated substantial underestimation of LV dyssynchrony by M-mode echocardiography as 
compared to TDI in patients with severe LV dysfunction. In particular, in patients with ischemic 
LV dysfunction and akinesia of the (antero-)septum, assessment of SPWMD may not be feasible 
and TDI may be preferred for accurate detection of LV dyssynchrony (25). In the current study 
however, all patients had preserved LV function without signifi cant valvular disease, explaining 
the better agreement between the two techniques.
Clinical implications
The observations in the current study demonstrate that RV pacing may induce LV dyssynchrony 
in a substantial percentage of patients with preserved LV function who undergo AV node 
ablation. In addition, the induction of LV dyssynchrony was associated with a deterioration 
of LV function and clinical status. Therefore, it needs to be considered whether these patients 
should have undergone biventricular pacing rather than RV pacing. Recently, several studies 
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have compared diff erent pacing strategies for patients with AF treated with AV node ablation 
and permanent pacing. In the PAVE trial (8), 184 patients treated with AV node ablation and 
pacemaker implantation were randomly assigned to RV pacing or biventricular pacing. After 
6 months follow-up, the LV ejection fraction was signifi cantly lower in 81 patients who under-
went RV pacing as compared to 103 patients with biventricular pacing (41 ± 13% vs. 46 ± 13%, 
p<0.05). Unfortunately, LV dyssynchrony was not assessed in the PAVE study. 
The OPSITE-study (26) compared RV pacing and biventricular pacing in patients with 
permanent AF undergoing AV node ablation. After 6 months, patients with RV pacing had 
a signifi cant lower LV ejection fraction as compared to biventricular pacing (43 ± 11% vs. 45 
± 13%, p<0.05). In addition, NYHA functional class was signifi cantly lower with RV pacing as 
compared to biventricular pacing (1.6 ± 0.7 vs. 1.8 ± 0.7, p<0.05). 
In addition, a positive eff ect of upgrading long-term RV pacing to biventricular pacing has 
recently been demonstrated. Leon et al (27) reported an improvement in NYHA functional class 
and LV function after upgrading to biventricular pacing in 20 heart failure patients with chronic 
AF, previous AV node ablation and RV pacing. 
The aforementioned studies provide evidence for the benefi t of biventricular pacing, as 
compared to RV pacing in patients with chronic AF and AV node ablation (8,26,27). The obser-
vations in the present study illustrate that in a substantial part of the patients with preserved 
LV function who undergo AV node ablation, long-term RV pacing can induce LV dyssynchrony, 
which appears associated with adverse eff ects, including an increase in heart failure symptoms, 
and a decrease in LV function with LV dilatation. Whether LV dyssynchrony results in LV dilata-
tion or vice versa, remains unclear. The abnormal electrical activation pattern induced by RV 
pacing may result in LV dyssynchrony, with subsequent LV dilatation and regional contraction 
abnormalities (20,22). Conversely, Yu et al demonstrated that a large LV end-systolic diameter 
predicted the severity of LV dyssynchrony in patients with heart failure (28). However, in the 
present study, no diff erences in baseline LV dimensions or volumes were found between the 
patients with and without LV dyssynchrony after long-term RV pacing. Therefore, no predictors 
for the induction of LV dyssynchrony could be identifi ed. It may well be that the patients who 
develop LV dyssynchrony may benefi t from biventricular pacing, whereas the patients who do 
not develop LV dyssynchrony may not need biventricular pacing. Accordingly, patients should 
be evaluated after RV pacing for development of LV dyssynchrony, and if LV dyssynchrony 
is induced, biventricular pacing should be considered. Ideally, patients who are at risk for 
development of LV dyssynchrony should be identifi ed at baseline (before AV node ablation and 
pacemaker implantation), but the results of the current study could not demonstrate any diff er-
ence in baseline variables (Table 1). Clearly, additional studies in large populations are needed 
to confi rm the current fi ndings, and to develop selection criteria for patients with normal LV 




Some limitations of the present study need to be addressed. First, it is a retrospective study, 
and it has a relatively small study population. Larger, prospective studies on the development 
(and prediction) of LV dyssynchrony after AV node ablation are needed. Furthermore, relatively 
soft end-points (NYHA functional class and ventricular remodeling) were used to assess clinical 
effi  cacy. However, these parameters are often used as markers for clinical effi  cacy (8,26,27). 
Finally, the changes in LV ejection fraction and LV end-diastolic volume in the patients with LV 
dyssynchrony in the present study are relatively small, but statistically signifi cant. 
CONCLUSIONS
In patients treated with AV node ablation, long-term RV pacing induced LV dyssynchrony in 
49% of patients. These patients appear to develop heart failure symptoms with a reduction 
in LV systolic function and LV dilatation. These patients may benefi t from biventricular pacing 
rather than RV pacing. 
Chapter 12
D
yssynchrony induced by RV pacing
207
REFERENCES
 1. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fi brillation on 
the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
 2. Fuster V, Ryden LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with 
atrial fi brillation: executive summary. J Am Coll Cardiol 2001;38:1231-66.
 3. Scheinman MM, Morady F. Nonpharmacological approaches to atrial fi brillation. Circulation 
2001;103:2120-5.
 4. Brignole M, Gianfranchi L, Menozzi C et al. Assessment of atrioventricular junction ablation and DDDR 
mode-switching pacemaker versus pharmacological treatment in patients with severely symptom-
atic paroxysmal atrial fi brillation: a randomized controlled study. Circulation 1997;96:2617-24.
 5. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing 
therapy for atrial fi brillation : a meta-analysis. Circulation 2000;101:1138-44.
 6. Marshall HJ, Harris ZI, Griffi  th MJ, Holder RL, Gammage MD. Prospective randomized study of abla-
tion and pacing versus medical therapy for paroxysmal atrial fi brillation: eff ects of pacing mode and 
mode-switch algorithm. Circulation 1999;99:1587-92.
 7. Thambo JB, Bordachar P, Garrigue S et al. Detrimental ventricular remodeling in patients with congeni-
tal complete heart block and chronic right ventricular apical pacing. Circulation 2004;110:3766-72.
 8. Doshi RN, Daoud EG, Fellows C et al. Left ventricular-based cardiac stimulation post AV nodal ablation 
evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-5.
 9. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by 
two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
 10. Thomas JD. How leaky is that mitral valve? Simplifi ed Doppler methods to measure regurgitant orifi ce 
area. Circulation 1997;95:548-50.
 11. Pitzalis MV, Iacoviello M, Romito R et al. Cardiac resynchronization therapy tailored by echocardio-
graphic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22.
 12. Pitzalis MV, Iacoviello M, Romito R et al. Ventricular asynchrony predicts a better outcome in patients 
with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol 2005;45:65-9.
 13. Porciani MC, Puglisi A, Colella A et al. Echocardiographic evaluation of the eff ect of biventricular pac-
ing: The InSync Italian Registry. European Heart Journal, Supplement 2000;2:J23-J30.
 14. Rouleau F, Merheb M, Geff roy S et al. Echocardiographic assessment of the interventricular delay of 
activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 
2001;24:1500-6.
 15. Bax JJ, Bleeker GB, Marwick TH et al. Left ventricular dyssynchrony predicts response and prognosis 
after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-40.
 16. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. New York: Wiley, 2003.
 17. Tse HF, Lau CP. Long-term eff ect of right ventricular pacing on myocardial perfusion and function. J 
Am Coll Cardiol 1997;29:744-9.
 18. Skalidis EI, Kochiadakis GE, Koukouraki SI et al. Myocardial perfusion in patients with permanent 
ventricular pacing and normal coronary arteries. J Am Coll Cardiol 2001;37:124-9.
 19. van Oosterhout MF, Prinzen FW, Arts T et al. Asynchronous electrical activation induces asymmetrical 
hypertrophy of the left ventricular wall. Circulation 1998;98:588-95.
 20. Tse HF, Yu C, Wong KK et al. Functional abnormalities in patients with permanent right ventricular 
pacing: the eff ect of sites of electrical stimulation. J Am Coll Cardiol 2002;40:1451-8.
 21. Burkhoff  D, Oikawa RY, Sagawa K. Infl uence of pacing site on canine left ventricular contraction. Am J 
Physiol 1986;251:H428-H435.
 22. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work 
during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll 
Cardiol 1999;33:1735-42.
208
 23. Yu CM, Bax JJ, Monaghan M, Nihoyannopoulos P. Echocardiographic evaluation of cardiac dyssyn-
chrony for predicting a favourable response to cardiac resynchronisation therapy. Heart 2004;90 
Suppl 6:vi17-vi22.
 24. Marcus GM, Rose E, Viloria EM et al. Septal to Posterior Wall Motion Delay Fails to Predict Reverse 
Remodeling or Clinical Improvement in Patients Undergoing Cardiac Resynchronization Therapy. J 
Am Coll Cardiol 2005;46:2208-14.
 25. Bax JJ, Ansalone G, Breithardt OA et al. Echocardiographic evaluation of cardiac resynchronization 
therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004;44:1-9.
 26. Brignole M, Gammage M, Puggioni E et al. Comparative assessment of right, left, and biventricular 
pacing in patients with permanent atrial fi brillation. Eur Heart J 2005;26:712-22.
 27. Leon AR, Greenberg JM, Kanuru N et al. Cardiac resynchronization in patients with congestive heart 
failure and chronic atrial fi brillation: eff ect of upgrading to biventricular pacing after chronic right 
ventricular pacing. J Am Coll Cardiol 2002;39:1258-63.
 28. Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asyn-
chrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54-60.
1 3
Acute eff ects of right ventricular 
apical pacing on left ventricular 










Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Circ Arrhythmia Electrophysiol 2009;2:135-45 




Background: Long-term right ventricular (RV) apical pacing has a detrimental eff ect on left 
ventricular (LV) function. However, the acute eff ects of RV apical pacing on LV mechanics 
remain unclear. The purpose of this study was to assess the acute impact of RV apical pacing 
on global LV function, evaluating LV contraction synchrony and LV shortening and twist, using 
2-dimensional (2D) speckle-tracking strain imaging.
Methods and Results: A group of 25 patients with structural normal hearts referred for elec-
trophysiological (EP) study were studied. Two-dimensional echocardiography was performed 
at baseline and during RV apical pacing at the time of the EP study. Changes in LV synchrony 
and mechanics (longitudinal shortening and twist) were assessed using speckle-tracking 
strain imaging. In addition, 25 controls matched by age, gender and LV function were studied 
during sinus rhythm. The group of patients (44±12 years, 10 men) and the group of controls 
(48 ± 3 years, 8 men) showed comparable LV synchrony, LV longitudinal shortening and LV 
twist at baseline. However, during RV apical pacing, a more dyssynchronous LV contraction was 
observed in the patients (from 21 ms [Q1:10, Q3:53] to 91 ms [Q1:40, Q3:204], p<0.001) together 
with an impairment in LV longitudinal shortening (from -18.3 ± 3.5% to -11.8 ± 3.6%, p<0.001) 
and in LV twist (from 12.4 ± 3.7º to 9.7 ± 2.6º, p=0.001).
Conclusions: During RV apical pacing, an acute induction of LV dyssynchrony is observed. In 
addition, LV longitudinal shortening and LV twist are acutely impaired. 
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Several animal and human studies have demonstrated detrimental eff ects of right ventricular 
(RV) apical pacing on cardiac function (1-4). The direct electrical stimulation of the RV apex 
induces an abnormal activation sequence and asynchronous ventricular contraction (3-5). 
Subsequently, left ventricular (LV) performance is impaired with a decrease in stroke volume 
and an abnormal LV relaxation (2). In patients with severe LV dysfunction, these eff ects are 
more pronounced and permanent RV apical pacing may result in a higher risk of morbidity and 
mortality at long-term follow-up (6,7). Recently, it has been shown that patients with long-term 
RV pacing and LV dysfunction also had LV dyssynchrony (8,9). The question that arises from this 
observation is whether RV pacing induced LV dyssynchrony resulted in LV dysfunction with 
heart failure, or whether RV pacing resulted in LV dysfunction and heart failure with subsequent 
development of LV dyssynchrony. 
Importantly, in the majority of the studies that thus far have evaluated the long-term eff ects 
of RV apical pacing, the study population comprised patients with structural heart disease, 
which is a confounding factor that may amplify the detrimental eff ects of RV pacing on LV 
function (6,10,11). The exact eff ects of RV apical pacing on LV function in patients without struc-
tural heart disease have not been studied extensively (12). In addition, primarily the long-term 
eff ects of RV apical pacing have been studied, and not much information is available on the 
acute eff ects of RV pacing on LV function and LV dyssynchrony. 
The recently introduced echocardiographic speckle-tracking analysis enables comprehen-
sive evaluation of LV mechanics (LV synchrony, LV systolic function and LV twist) by studying LV 
deformation in 3 directions (radial, longitudinal and circumferential) (13-16). Importantly, this 
technique may reveal more subtle changes in LV systolic function, as compared to conventional 
measures such as LV ejection fraction. 
Accordingly, the purpose of the present study was to assess the acute impact of RV apical 
pacing on global LV function in a group of patients without structural heart disease, evaluating 
LV contraction synchrony and LV global longitudinal shortening and twist, using 2-dimensional 
(2D) speckle-tracking strain imaging. 
METHODS
Study population
Twenty-fi ve patients, who were referred for an electrophysiological (EP) study for evaluation 
of supraventricular arrhythmias, were included in the present study. Inclusion criteria were: 
age>18 years old, no evidence of structural heart disease by 2D echocardiography, QRS dura-
tion on surface electrocardiogram <120 ms and New York Heart Association functional class I. 
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Study protocol
In the patient group, echocardiography was performed during sinus rhythm before the EP 
study, and during RV apical pacing at the end of the EP study. During the EP study, a standard 
diagnostic catheter (6F, Quadripolar catheter, Biosense-Webster, Diamond Bar, CA, USA) allow-
ing temporary pacing was positioned in the RV apex. Constant RV apical overdrive pacing 
was performed for 5 minutes. To ensure continuous capture, RV apical pacing was performed 
with a cycle length of at least 100 ms shorter than the baseline cycle length. After 5 minutes, 
the echocardiogram was acquired during RV apical pacing. Surface electrocardiograms were 
recorded during sinus rhythm and RV pacing. 
In addition, 25 controls frequency-matched for age, gender, body surface area and LV sys-
tolic function were selected from an echocardiographic database. The control group comprised 
patients referred for echocardiography with atypical chest pain, palpitations or syncope with-
out murmur. In particular, only patients with normal LV systolic function without LV dilatation 
were selected. Furthermore, subjects who were referred for echocardiographic evaluation of 
known valvular disease, murmur, or heart failure were excluded. 
Therefore, all subjects (both patients and controls), had normal echocardiograms, without 
structural heart disease. Patients underwent 2D echocardiography during sinus rhythm and 
during RV apical pacing (at the EP laboratory) whereas controls were imaged at the echocar-
diography laboratory during sinus rhythm only. Informed consent to participate was obtained 
from all subjects.
Echocardiography
A commercially available system was used (Vingmed Vivid 7 or Vivid-I, General Electric-Ving-
med, Milwaukee, Wisconsin) and data were obtained using a 3.5-MHz transducer at a depth of 
16 cm in the parasternal (long- and short-axis) and apical (2-, 3- and 4-chamber) views. Data 
acquisition was performed by an experienced sonographer during sinus rhythm and RV apical 
pacing with the patients in the supine position. Special care was taken to avoid either oblique 
parasternal short-axis views of the LV or foreshortened LV apical views. 
Acquired data were transferred to an off -line workstation for further analysis (EchoPac 
version 6.0.1, General Electric-Vingmed). Left ventricular dimensions (end-diastolic and end-
systolic diameter, septum and posterior wall thickness) were measured from the M-mode 
recordings derived from parasternal long-axis views. Furthermore, LV volumes and LV ejection 
fraction were measured from the 2- and 4-chamber apical views using the biplane Simpson’s 
rule (17). 
Speckle-tracking strain analysis 
From standard gray-scale images, 2D speckle-tracking strain analysis was performed to study 
several aspects of LV mechanics: LV synchrony, global longitudinal shortening and LV twist. 
For this purpose, novel speckle-tracking software was used, as previously described (16). In 
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brief, this technique allows angle-independent measurement of myocardial strain in 3 diff erent 
directions: circumferential shortening and radial thickening in the short-axis views and longitu-
dinal shortening in the apical views. Natural acoustic markers (or speckles), equally distributed 
in the myocardial wall, form a characteristic pattern that is tracked from frame-to-frame along 
the cardiac cycle. The change in the position of the speckle pattern with respect to the initial 
position is used to calculate myocardial strain (16). In the selected views, the endocardial 
border is traced manually at an end-systolic frame. Next, a region of interest, that includes the 
myocardial wall, is displayed automatically. The software allows for further adjustment of the 
region of interest in order to fi t the entire myocardial wall within the boundaries. Then, the 
tracking quality can be evaluated and validated. Finally, the region of interest is divided in 6 
segments and the time-strain curves along the cardiac cycle for each segment are displayed. 
LV synchrony To evaluate LV synchrony, mid ventricular short-axis images at the level of the 
papillary muscles were selected and 2D speckle-tracking radial strain analysis was performed, 
as previously described (15). The time from the onset of QRS to the peak strain value was 
measured for each segment (anteroseptal, anterior, lateral, posterior, inferior and septal). 
Subsequently, the diff erence between the earliest and the latest segments was calculated. LV 
dyssynchrony was defi ned as a time diff erence ≥130 ms between the earliest and the latest 
segments, as previously described (5,15). To compare diff erences between sinus rhythm and 
RV apical pacing, LV dyssynchrony was normalized to RR interval, as previously described (18). 
LV longitudinal shortening In addition to conventional measurements of LV systolic function 
based on 2D echocardiography, LV longitudinal shortening was evaluated. For this purpose, 
automated function imaging, a method based on 2D speckle-tracking strain imaging, was used 
(16). The selected views were the apical 2-, 3- and 4-chamber views. In brief, from an end-systolic 
frame of each view, 2 basal points at the mitral annulus, and 1 point at the apex, were used as 
reference points to trace the region of interest spanning the entire myocardial wall. Using a 
17-segment model, the peak systolic longitudinal strain for each LV segment was calculated 
and presented as a “polar map”, with the average value of peak systolic longitudinal strain for 
each view and the averaged global longitudinal peak systolic strain for the complete LV (Figure 
1). Conventionally, longitudinal shortening is presented in negative values. 
LV twist The helical disposition of the myocardial fi bers determines the characteristic wringing 
motion of the LV. As previously described, viewed from the LV apex, the apical segments of 
the LV show a systolic counter-clockwise rotation whereas the basal segments of the LV show 
a clockwise rotation (19). The assessment of LV rotation by 2D speckle-tracking strain imaging 
requires the acquisition of the LV short-axis at the apical level (the most distal level from the 
papillary muscles) and at the basal level (the level where the leafl ets of the mitral valve are visu-
alized) (14). In each short-axis image, the region of interest including the entire myocardial wall 
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is traced at an end-systolic frame and divided into 6 segments. Subsequently, the time-rotation 
curves are displayed along the cardiac cycle. The counter-clockwise rotation is conventionally 
presented as positive values and the clockwise rotation as negative values. The diff erence 
between the systolic apical and basal rotation results in LV twist (Figure 2)(14). 
Reproducibility of the assessment of LV rotation was analyzed with repeated measurements 
by an experienced observer at two diff erent time points and by a second experienced observer. 
Intra- and inter-observer agreements for these measurements were evaluated by Bland-Altman 
analysis. Intra-observer variability was good, with an excellent agreement (mean ± 2SD was -0.1 
± 2.2º) between two repeated measurements. Similarly, inter-observer variability showed an 
excellent agreement (mean ± 2SD was 0.14 ± 3.4º).
Statistical analysis
All variables were normally distributed (as assessed by Kolmogorv-Smirnov test), except LV 
dyssynchrony indexed to RR interval. Continuous variables are presented as mean ± SD, when 
normally distributed, and as median (25th and 75th percentiles: Q1, Q3) when non-normally 
distributed. Comparisons between the patients and the matched controls were performed 
Figure 1. The automated function imaging algorithm enables the measurement of global LV longitudinal strain from 3 standard apical views 
of the LV. The apical long-axis view of the LV (panel A) should be measured fi rst, defi ning the aortic valve closure. The time interval between the 
R wave and the aortic valve closure is used as a reference for the measurement of LV shortening at 4- and 2-chamber view loops (panels B and 
C respectively). Finally, the algorithm provides the peak systolic longitudinal strain for each LV segment in a “bull‘s eye” plot, with the average 
value of peak systolic longitudinal strain for each view and the averaged global longitudinal peak systolic strain for the complete LV (panel D).
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using the unpaired Student t-test (for normally distributed variables) and Mann-Whitney U-test 
(for non-normally distributed variables). Comparisons within the group of patients during sinus 
rhythm and RV apical pacing were performed using the paired Student t-test (for normally 
distributed variables) and Wilcoxon Signed Ranks test (for non-normally distributed variables). 
All statistical analyses were performed with SPSS software (version 16.0, SPSS Inc., Chicago, 
Illinois). All statistical tests were two-sided, and a p-value <0.05 was considered statistically 
signifi cant.
RESULTS
The study protocol could be completed in all 25 patients (mean age 44 ± 12 years, 10 men/15 
women). In 15 (60%) patients, atrioventricular nodal reentry tachycardia was demonstrated 
Figure 2. Assessment of LV twist by 2D speckle-tracking strain imaging. LV twist was calculated using 2D speckle-tracking strain imaging 
applied to LV apical (panel A) and basal (panel B) short-axis view. The LV apex demonstrates a counter clockwise systolic peak rotation, whereas 
the LV base shows a clockwise systolic peak rotation. The diff erence between the apical and the basal systolic peak rotation results in LV twist.
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during the EP study, whereas in the remaining 10 patients, no tachyarrhythmia was documented. 
In all individuals, echocardiographic image quality was suffi  cient for quantitative analysis. Echo-
cardiographic data acquisition was performed at a mean frame rate of 84 ± 13 frames/sec. By 
defi nition, at baseline all the patients and matched controls showed structural normal hearts with 
synchronous LV systolic contraction as evaluated by 2D speckle-tracking radial strain imaging. 
To acquire the echocardiographic data during RV apical pacing, continuous capture was 
ensured by pacing with a cycle length of at least 100 ms shorter than the baseline cycle length. 
Mean heart rate was 69 ± 14 bpm at baseline and 106 ± 11 bpm during RV apical pacing 
(p<0.001). During RV apical pacing, the QRS duration on the surface electrocardiogram was 
signifi cantly longer as compared to baseline (131 ± 18 ms vs. 92 ± 7 ms; p=0.001). 
Eff ects of RV apical pacing on LV dimensions and volumes
Baseline LV dimensions and volumes were comparable between the patients and the matched 
controls (Table 1). During RV apical pacing, a signifi cant decrease in LV end-diastolic diameter 
and volume were observed in the patients, whereas LV end-systolic diameter and volume did 
not change (Table 2). Consequently, LV ejection fraction decreased signifi cantly from 56 ± 8% 
to 48 ± 9% (p=0.001). 
Eff ect of RV apical pacing on LV mechanics 
LV synchrony With the use of 2D speckle-tracking radial strain, LV synchrony was assessed in the 
study population. Median time diff erence between the earliest and latest segments (corrected 
by RR interval) was similar in the patient group and the matched controls at baseline (Table 






Age, yrs 44 ± 12 48 ± 3 0.100
Gender, M/F 10/15 8/17 0.556
Heart rate, bpm 69 ± 14 72 ± 12 0.469
LV dimensions and volumes
   LV end-diastolic diameter (mm) 49 ± 5 49 ± 4 0.567
   LV end-systolic diameter (mm) 30 ± 5 27 ± 4 0.126 
   Interventricular septum thickness (mm) 10 ± 2 10 ± 2 0.816
   Posterior wall thickness (mm) 10 ± 2 10 ± 2 0.787
   LV end-diastolic volume (ml) 99 ± 26 95 ± 22 0.538
   LV end-systolic volume (ml) 44 ± 16 38 ± 11 0.183
   LV ejection fraction (%) 56 ± 8 60 ± 6 0.069
LV mechanics
   LV synchrony (RR-indexed) (ms) * 21 (10, 53) 20 (0, 68) 0.953
   LV longitudinal shortening (%) -18.3 ± 3.5 -18.5 ± 4.1 0.947
   LV apical rotation (º) 7.1 ± 3.5 6.4 ± 3.5 0.507
   LV basal rotation (º) -5.4 ± 2.7 -6.6 ± 2.4 0.084
   LV twist (º) 12.4 ± 3.7 13.0 ± 3.2 0.538
*expressed as median (25th, 75th percentiles); LV = left ventricular.
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1). In contrast, during RV apical pacing, the time diff erence between the earliest and the latest 
segments increased signifi cantly from 21 ms (Q1: 10, Q3: 53) to 91 ms (Q1: 40, Q3: 204) (p<0.001). 
In 9 (36%) patients, a time diff erence >130 ms between the earliest and the latest activated 
segments was present during RV apical pacing, indicating the presence of LV dyssynchrony. An 
example of a patient with LV dyssynchrony during RV pacing is shown in Figure 3. 
LV longitudinal shortening At baseline, the LV longitudinal shortening assessed by automated 
function imaging was comparable between patients and matched controls. Mean peak systolic 
global longitudinal strain was -18.3 ± 3.5% in the patients and -18.5 ± 4.1% in the matched 
controls (p=0.9). However, the LV global longitudinal strain value decreased signifi cantly during 
RV apical pacing from -18.3 ± 3.5% to -11.8 ± 3.6% (p<0.001). Representative examples of LV 
longitudinal shortening during sinus rhythm and RV pacing are shown in Figure 4. 
LV twist At baseline, no signifi cant diff erences in LV rotation and twist between the patients 
and matched controls were observed (Table 1). However, during RV apical pacing, LV rotation 
showed signifi cant changes. While the LV apex showed a slight decrease in rotation (from 7.1 
± 3.5º to 6.7 ± 2.6º, p=0.6), the base of the LV showed a signifi cant decrease in rotation (from 
-5.4 ± 2.7º to -3.0 ± 2.1º, p<0.001). Consequently, LV twist was signifi cantly impaired during RV 
apical pacing (from 12.4 ± 3.7º to 9.7 ± 2.6º, p=0.001). An example of a patient with a signifi cant 
decrease in LV twist during RV pacing is shown in Figure 5. 
Table 2. Changes in LV dimensions, volumes and mechanics during RV apical pacing in the 25 patients undergoing electrophysiological testing




LV dimensions and function
   LV end-diastolic diameter (mm) 49 ± 5 45 ± 6 -4.0 ± 5.2 <0.001
   LV end-systolic diameter (mm) 30 ± 5 29 ± 6 -0.2 ± 4.5 0.827
   LV end-diastolic volume (ml) 99 ± 26 88 ± 25 -11.0 ± 12.2 <0.001
   LV end-systolic volume (ml) 44 ± 16 45 ± 16 1.0 ± 11.4 0.615
   LV ejection fraction (%) 56 ± 8 48 ± 9 -8.0 ± 10.2 0.001
LV mechanics
   LV synchrony (RR-indexed) (ms)* 21 (10, 53) 91 (40, 204) 50 (12,174) <0.001
   LV longitudinal shortening (%) -18.3 ± 3.5 -11.8 ± 3.6 7.0 ± 4.0 <0.001
   LV apical rotation (º) 7.1 ± 3.5 6.7 ± 2.6 -0.4 ± 3.2 0.573
   LV basal rotation (º) -5.4 ± 2.7 -3.0 ± 2.1 2.4 ± 2.8 <0.001
   LV twist (º) 12.4 ± 3.7 9.7 ± 2.6 -2.7 ± 3.6 0.001
*expressed as median (25th, 75th percentiles); LV= left ventricular; RV= right ventricular; SR= sinus rhythm.
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DISCUSSION 
The present study provides more insight into the acute eff ects of RV apical pacing on cardiac 
mechanics in patients with structural normal hearts. Right ventricular apical pacing acutely 
induced dyssynchronous LV contraction associated with impairment in LV longitudinal systolic 
function. Furthermore, a deleterious eff ect on the characteristic torsional deformation of the LV 
during systole was noted. 
Changes in LV dimensions induced by RV apical pacing
The baseline LV dimensions observed in the present study were comparable in patients and 
controls. However, during RV apical pacing a decrease in LV end-diastolic diameter and volume 
Figure 3. Changes in LV synchrony during RV apical pacing. LV dyssynchrony was measured using 2D speckle-tracking radial strain applied 
to midventricular short-axis images. A synchronous contraction was observed in sinus rhythm (panel A). During RV apical pacing, the time delay 
between the earliest and latest segments increased signifi cantly, showing a more dyssynchronous LV contraction (panel B).
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was observed, whereas the LV end-systolic dimensions remained unchanged. Consequently, LV 
ejection fraction showed a signifi cant impairment during RV pacing. 
In general, information on the acute eff ects of RV apical pacing on LV dimensions and 
volumes in patients with preserved LV function is scarce (2,10). Recently, Liu et al. studied the 
acute eff ects of RV apical pacing on LV function in a group of 35 patients with sick sinus syn-
drome using real-time 3-dimensional echocardiography (10). During RV apical pacing, patients 
showed a decrease in LV end-diastolic volume (from 79 ± 22 ml to 76 ± 20 ml, p=0.07) and in LV 
ejection fraction (from 57 ± 8% to 54 ± 8%, p=0.01) (10). In addition, in a group of patients with 
preserved LV ejection fraction studied by Lieberman et al. RV apical pacing induced a moderate 
decrease in LV ejection fraction (from 51 ± 12% to 48 ± 14%, p=NS) whereas the LV dimensions 
remained unchanged (2). 
Figure 4. This fi gure shows the changes in global longitudinal peak systolic strain (GLPSS) in the same patient as in Figure 2. The LV 
longitudinal shortening was assessed on standard apical views using automated function imaging. Panel A shows the polar map with a normal 
and homogeneous GLPSS during sinus rhythm. However, during RV apical pacing, a signifi cant decrease in GLPSS was observed (panel B).
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Several factors may contribute to the decrease in LV end-diastolic dimension and volume 
and LV ejection fraction during RV apical pacing. Normal LV diastolic fi lling may be impaired by 
the loss of normal atrioventricular conduction and subsequent decrease in left atrial contribu-
tion to diastolic fi lling (20,21). In addition, the earlier activation of the RV may hamper LV fi lling 
that is accomplished by the shared interventricular septum (20-22). Both mechanisms may 
result in a decrease in LV pre-load during RV apical pacing and, according to the Frank-Starling 
law, result in a lower LV stroke volume.
Figure 5. Changes in left ventricular (LV) rotation during RV apical pacing. LV rotation was assessed by applying 2D speckle-tracking 
strain imaging at the LV apex and base. Subsequently, LV twist is derived from the diff erence between the apical and basal rotations. This 
fi gure demonstrates LV rotation and twist in the same patient as in Figure 3 and 4. Panel A shows both apical and basal LV rotations during 
sinus rhythm. During RV apical pacing (panel B), a decrease in both apical and basal LV rotations was observed, with a subsequent signifi cant 
decrease in LV twist.
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Changes in LV synchrony during RV apical pacing 
In the present study, the synchronicity of the LV was evaluated by 2D speckle-tracking radial 
strain imaging, measuring the time diff erence between the earliest and the latest activated 
segments. Using this technique, synchronous contraction of the LV was observed in both the 
controls and the patients at baseline. During RV apical pacing, the time diff erence between the 
earliest and the latest activated segments increased signifi cantly, refl ecting a more dyssynchro-
nous contraction pattern of the LV. In particular, 9 (36%) patients exhibited signifi cant LV dys-
synchrony (>130 ms between the earliest and the latest activated segments) during RV pacing. 
Several animal and human studies have reported the acute eff ects of RV apical pacing on 
LV synchrony (10,12,23). Wymann et al. demonstrated the changes in LV mechanical activation 
synchrony during RV apical pacing using tagged-magnetic resonance imaging in an experi-
mental study (23). During RV apical pacing, the breakthrough of the mechanical activation was 
located at the interventricular septum and spread along the LV walls ending at the lateral wall 
(23). As a result, the mechanical activation delay was signifi cantly higher during RV apical pac-
ing (77.6 ± 16.4 ms) as compared to right atrial pacing (43.6 ± 17.1 ms). 
Similarly, clinical studies have observed an acute induction of LV systolic dyssynchrony by 
RV apical pacing (10,12). Fornwalt et al. assessed the eff ects of RV apical pacing on systolic dys-
synchrony using tissue Doppler imaging in 14 pediatric patients with normal cardiac structure 
and function (12). After 1 minute of RV apical pacing signifi cant LV systolic dyssynchrony was 
noted, compared with sinus rhythm (from 49 ± 28 ms to 94 ± 47 ms, p<0.05). In addition, Liu et 
al. demonstrated an acute increase of LV systolic dyssynchrony index assessed with real-time 
3-dimensional echocardiography during RV apical pacing in a group of patients with sick sinus 
syndrome (from 5.3 ± 2.1% to 7.0 ± 2.5%) (10). 
The induction of LV dyssynchrony by RV apical pacing, as observed in the present and previ-
ous studies may be explained by changes in the electro-mechanical activation pattern during 
pacing. During ectopic activation of the LV by RV apical pacing, the depolarization impulse 
spreads through the slower-conducting myocardium rather than through the His-Purkinje sys-
tem, resulting in a heterogeneous electrical and mechanical activation of the LV (24). However, 
it remains undetermined why some patients develop LV dyssynchrony during RV pacing while 
other patients do not.
Changes in LV shortening and twist induced by RV apical pacing
In the present study, changes in LV systolic mechanics were evaluated, focusing on LV longi-
tudinal shortening and LV twist. In sinus rhythm, patients and controls showed comparable 
values of LV shortening and LV twist. However, during RV apical pacing, a signifi cant decrease in 
both parameters was observed. The complex architecture of the LV determines a characteristic 
deformation pattern consisting of systolic shortening in the longitudinal and circumferential 
directions together with thickening in the radial direction (25). When viewed from the LV apex, 
this deformation pattern results in a typical wringing movement with a net counter-clockwise 
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rotation of the apex relative to the base of the heart (14). Any abnormality in this complex 
pattern of deformation and twist could signifi cantly aff ect cardiac performance. 
Several experimental studies have demonstrated changes in LV strain during RV pacing 
(3,23,25,26). Prinzen et al. described the non-uniformity of myocardial fi ber strain during RV 
pacing as compared to the uniformity observed during right atrial pacing using sonomicro-
metry technique in a dog-model (3). Interestingly, in the early-activated LV areas the amount 
of shortening was lower than in the remote areas, resulting in a decrease in the net LV strain 
pattern during RV pacing (3). In addition, Liakopoulos et al. evaluated the eff ects of RV apical 
pacing on LV segmental shortening in a swine-model with sonomicrometry technique as well 
(25). The authors observed a pronounced decrease in LV segmental shortening during RV apical 
pacing at the posterior wall (from 18.8 ± 6.1% in sinus rhythm to 13.6 ± 9.6% during RV apical 
pacing, p<0.05) (25). 
In the present study, the novel automated function imaging algorithm was used to assess 
global LV systolic shortening. Similar to the aforementioned studies, a signifi cant decrease 
in LV longitudinal shortening was observed acutely during RV apical pacing. In addition, the 
resultant torsional movement of the LV showed a signifi cant decrease during RV apical pacing. 
A decrease in both apical and basal rotation was observed during RV pacing in the present 
study. However, this decrease was more pronounced in the LV basal level. 
A reduction in LV strain and LV twist has been previously reported in several clinical 
situations (hypertrophic cardiomyopathy, aortic stenosis and myocardial infarction) (27-29). 
However, the eff ect of RV apical pacing on LV twist has only been studied in animal experi-
ments (30,31). Buchalter et al. demonstrated that the LV torsional movement depends on the 
sequence of LV depolarization, showing signifi cant reduction in the LV twist during RV apical 
pacing (30). Furthermore, Sorger et al., in a tagged magnetic resonance study, observed a dra-
matic decrease in LV twist during RV apical pacing as compared to atrial pacing (6.1 ± 1.7º vs. 
11.1 ± 3.5º, p<0.001) (31). The results of the current study are in agreement with these previous 
studies. Moreover, the present fi ndings illustrate that the decrease in LV twist is simultaneous 
to the impairment in LV longitudinal shortening. The long-term eff ects of RV apical pacing on 
LV strain and twist however are still unclear and need further study. 
Clinical implications 
Previous studies demonstrated that long-term RV apical pacing may increase the risk of LV dys-
function and heart failure associated with the presence of LV dyssynchrony by 25-30% (9,32). 
The precise time course of development of these phenomena (LV dysfunction, heart failure 
and LV dyssynchrony) after RV pacing is currently unclear. In the present study, 36% of the 
patients developed signifi cant LV dyssynchrony acutely during RV apical pacing, as assessed 
by 2-dimensional speckle-tracking strain imaging. In addition, signifi cant impairment in LV sys-
tolic function was observed refl ected by reduced LV ejection fraction, but also an impaired LV 
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longitudinal shortening and reduced LV twist. Whether this acutely induced LV dyssynchrony 
is the basis for the development of heart failure after long-term RV pacing needs further study.
Study Limitations
Some limitations need to be addressed. First, short-term eff ects of RV apical pacing on LV 
mechanics were assessed in the present study and, to avoid intrinsic ventricular conduction, 
pacing rate was set to 25% over the normal sinus rhythm, resulting in a high heart rate. These 
non-physiological conditions may preclude us to draw conclusions about the long-term 
eff ects of chronic RV pacing on LV performance. Second, all patients were considered to have 
structural normal hearts according to the clinical history, physical examination and the results 
of the complementary diagnostic exams performed. Unfortunately, endomyocardial biopsies 
were not available to confi rm the absence of structural heart disease. Finally, additional studies 
evaluating diff erent pacing sites and longer follow-up are needed to better understand the 
long-term eff ects of the acutely induced changes in LV mechanics by RV pacing. 
CONCLUSIONS
In the present study, speckle-tracking analysis applied to conventional 2D echocardiography 
was used to study the acute eff ects of RV apical pacing on LV mechanics. Right ventricular 
apical pacing acutely induced a dyssynchronous LV contraction together with a decrease LV 
longitudinal function. In addition, the characteristic torsional deformation of the LV during 
systole was impaired acutely by RV apical pacing. 
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ABSTRACT 
Background: Recent studies have shown detrimental eff ects of RV pacing, possibly related to 
the induction of LV dyssynchrony.
Objectives: Speckle-tracking strain analysis was used to assess the eff ects of permanent right 
ventricular (RV) pacing on the heterogeneity in timing of regional wall strain and left ventricular 
(LV) dyssynchrony. 
Methods: Fifty-eight patients treated with His bundle ablation and pacemaker implantation 
were studied. To assess the eff ect of RV pacing on time-to-peak radial strain of diff erent LV 
segments, speckle-tracking analysis was applied to standard LV short-axis images. In addition, 
NYHA functional class, LV volumes and systolic function were assessed at baseline and after 
long-term RV pacing. 
Results: At baseline, similar time-to-peak strain for the 6 segments was observed (mean 
371 ± 114 ms). In contrast, after a mean of 3.8 ± 2.0 years of RV pacing, there was a marked 
heterogeneity in time-to-peak strain of the 6 segments. In 33 patients (57%) LV dyssynchrony, 
represented by a time diff erence ≥130 ms between the time-to-peak strain of the (antero)septal 
and the posterolateral segments, was present. In these patients, a deterioration of LV systolic 
function and NYHA class was observed. In 11 patients ‘upgrade’ of the conventional pacemaker 
to a biventricular pacemaker resulted in partial reversal of the detrimental eff ects of RV pacing. 
Conclusions: Speckle-tracking analysis revealed that permanent RV pacing induced hetero-
geneity in time-to-peak strain, resulting in LV dyssynchrony in 57% of patients, associated with 
deterioration of LV systolic function and NYHA class. Biventricular pacing may reverse these 
adverse eff ects of RV pacing. 
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INTRODUCTION
Cardiac pacing is the only eff ective treatment in patients with symptomatic sinus node dysfunc-
tion or atrioventricular block. In order to maintain atrioventricular synchrony, dual-chamber 
pacing has been introduced. Surprisingly, large randomized trials have not been able to prove 
substantial benefi t of DDDR pacing over conventional VVIR pacing (1). More importantly, evi-
dence emerges that ventricular pacing should be kept to a minimum (2). Recently, several trials 
(3-5) have shown that conventional right ventricular (RV) pacing is associated with an increased 
risk for development of heart failure and death. Furthermore, left ventricular (LV) dilatation (6) 
and LV dysfunction (7) following RV apical pacing have been demonstrated. 
Currently, little data on the exact cause of the deleterious eff ects of RV pacing exist. Few ani-
mal studies have been performed on the eff ect of the abnormal ventricular activation pattern 
on regional wall strain (8-10). In a recent study, tissue Doppler imaging was used to demonstrate 
the possible relation between LV dyssynchrony and the detrimental eff ects of RV apical pacing 
(11). Tissue Doppler imaging however is not an ideal method, because with this technique myo-
cardial velocities are assessed, but no information on myocardial strain and active deformation 
is obtained. We hypothesized that the detrimental eff ects of RV pacing may be related to the 
induction of heterogeneity in time-to-peak radial strain of the LV walls, ultimately resulting 
in LV dyssynchrony. Strain imaging with MRI tagging may be the most accurate technique to 
assess radial strain and LV dyssynchrony (9); this technique however is technically demanding 
and is not feasible for patients with pacemakers. However, with the recently introduced speckle 
tracking analysis applied to standard echocardiograms (12,13), accurate strain imaging using 
echocardiography has become available. 
Therefore, in the current study speckle tracking radial strain was used to evaluate the eff ect 
of permanent RV pacing on the heterogeneity in timing of regional strain and LV dyssynchrony. 
For this purpose, we studied patients with permanent RV apical pacing after His bundle abla-
tion for drug-refractory atrial fi brillation. In addition, the eff ect of long-term RV pacing on 
LV systolic function, LV dilatation and functional class was evaluated. Finally, we evaluated 
whether upgrading RV pacing to biventricular reversed LV dyssynchrony, with an improvement 
in LV systolic function and functional class. 
METHODS
Study sample and study design
Sixty-three patients treated with His bundle ablation and pacemaker implantation were initially 
screened for the study. All patients had preserved LV systolic function and had no signifi cant 
valvular disease. Of the 63 patients, 5 patients (8%) were excluded because the echocardiogram 
image quality was unsuitable for quantitative speckle tracking strain analysis. Eventually, the 
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study sample comprised 58 patients with drug-refractory, permanent atrial fi brillation. Ten 
patients were included in a previous study on the eff ects of permanent RV pacing (11). In all 
patients a clinical decision to perform a His bundle ablation had been made. Before the His 
bundle ablation and pacemaker implantation procedure, and after a minimum of 1 year RV 
pacing, New York Heart Association (NYHA) functional class was assessed and an extensive 
echocardiographic evaluation was performed. Novel speckle tracking radial strain was used to 
evaluate the presence of LV dyssynchrony at baseline and after long-term RV pacing. LV systolic 
function, LV volumes and LV dimensions were assessed at baseline and after long-term RV api-
cal pacing to determine the eff ect of pacing on global LV function and LV size. Furthermore, 
the eff ect of biventricular pacing on LV dyssynchrony and LV function in previously RV paced 
patients was assessed in 11 patients who received an ‘upgrade’ of the conventional pacemaker 
to biventricular pacing because of the presence of LV dyssynchrony and heart failure symptoms. 
Ablation and pacemaker implantation
His bundle ablation was performed with a 4 mm quadripolar mapping / ablation catheter (EPT, 
Boston Scientifi c, Natick, Massachusetts, USA), accessed through the femoral vein. A temporary 
pacing electrode was placed in the RV apex for back-up pacing. After the detection of a clear 
His bundle signal, radiofrequency energy was applied until complete AV-block was achieved. 
Thereafter the permanent pacemaker was implanted. Pacemaker leads were inserted through 
the subclavian vein using standard implantation techniques. The RV leads were positioned in 
the RV apex in all patients. After implantation, pacemakers were routinely programmed to VVIR 
mode. The day after the procedure an echocardiogram and a standard X-ray was performed to 
exclude pericardial eff usion and lead dislocation. 
Echocardiography
All patients underwent echocardiography before the ablation procedure and after long-term 
permanent RV pacing. Images were recorded with patients in the left lateral decubitus posi-
tion using a commercially available system (Vingmed Vivid 5 or 7, General Electric-Vingmed, 
Milwaukee, Wisconsin, USA). Images were obtained using a 3.5-MHz transducer at a depth of 
16 cm in the parasternal (long- and short-axis) and apical (2- and 4-chamber) views. Standard 
two-dimensional images and color Doppler data were digitally stored in cine-loop format. 
LV end-diastolic and end-systolic volumes were assessed from the apical 2- and 4-chamber 
images, and LV ejection fraction was calculated using the biplane Simpson’s rule (14). Further-
more, LV end-diastolic and end-systolic diameters were measured from the M-mode recordings 
derived from the parasternal long-axis images. The severity of mitral regurgitation was graded 
semi-quantitatively using color-fl ow Doppler in the conventional parasternal long-axis and 
apical 4-chamber images (15). Mitral regurgitation was characterized as: minimal = grade 1 
(jet area/left atrial area<10%), moderate = grade 2 (jet area/left atrial area 10-20%), moderate-
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severe = grade 3 (jet area/left atrial area 20-45%), or severe = grade 4 (jet area/left atrial area 
>45%) (15).
Strain analysis
Radial strain was assessed on LV short-axis images at the papillary muscle level, using speckle 
tracking analysis (12,13). Off -line analysis of radial strain was performed on digitally stored 
images (EchoPac version 6.0.1, General Electric-Vingmed) by 2 independent observers blinded 
to the clinical and other echocardiographic information. The novel speckle tracking software 
tracks frame-to-frame movement of natural acoustic markers, or speckles, on standard gray scale 
images of the myocardium (frame rate varied from 40 to 80 frames/s), as previously described 
(12,13). In brief, myocardial strain is assessed from temporal diff erences in the mutual distance 
of neighboring speckles. The change in length / initial length of the speckle pattern over the 
cardiac cycle can be used to calculate radial strain, with myocardial thickening represented as 
positive strain, and myocardial thinning as negative strain. Regional LV strain is assessed using a 
region of interest that spans the entire LV myocardium throughout the cardiac cycle. The traced 
endocardium is automatically divided into 6 standard segments: septal, anteroseptal, anterior, 
lateral, posterior, and inferior, respectively (16). 
Time-strain curves for all the 6 segments were constructed. Both peak radial strain values 
and time from QRS onset to peak radial strain were obtained. Consequently, the location of 
the earliest and latest activated segments and the heterogeneity in time-to-peak radial strain 
for the 6 segments were determined. LV dyssynchrony was defi ned as an interval ≥130 ms for 
the absolute diff erence in time-to-peak radial strain for the septal or anteroseptal wall versus 
the posterior or lateral wall (16). In addition, the time diff erence between the earliest and 
latest activated segments was calculated. Furthermore, intra- and interobserver variability for 
determining the time-to-peak radial strain were evaluated on short-axis images of 15 randomly 
selected patients. Intraobserver variability for determining the time-to-peak radial strain of all 6 
segments was 10 ± 11%, and interobserver variability was 8 ± 7%. The presence or absence of LV 
dyssynchrony after long-term RV apical pacing was confi rmed by tissue Doppler imaging (17). 
Upgrading permanent RV pacing to biventricular pacing
Biventricular pacing is able to resynchronize the asynchronous contracting heart. To test the 
hypothesis that LV dyssynchrony induced by RV apical pacing can be reversed by biventricular 
pacing, we studied 11 RV paced patients of the study sample who were ‘upgraded’ to biven-
tricular pacing. In these patients, an upgrade of the conventional pacemaker to a biventricular 
pacing device (Contak Renewal, Guidant Corporation, St. Paul, Minnesota, USA; or Insync Cen-
try, Medtronic Inc., Minneapolis, Minnesota, USA) was performed because of development of 
heart failure (NYHA class III or IV) and the presence of LV dyssynchrony. The LV pacing lead was 
inserted transvenously via the subclavian route. First, a coronary sinus venogram was obtained 
during occlusion of the coronary sinus using a balloon catheter. Next, the LV pacing lead was 
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inserted in the coronary sinus with the help of an 8Fr-guiding catheter, and positioned as far 
as possible in the venous system, preferably in the (postero)lateral vein. After a minimum of 
6 months of biventricular pacing, functional class of the patients was re-evaluated, and an 
extensive echocardiographic study was performed. 
Statistical analysis
All continuous variables had normal distribution (as evaluated by Kolmogorov-Smirnov tests). 
Summary statistics for these variables are therefore presented as mean values ± one standard 
deviation (SD). Categorical data are summarized as frequencies and percentages. Diff erences 
in baseline characteristics between patients with and without LV dyssynchrony are evaluated 
using unpaired Student t-tests (continuous variables), Chi-square tests or Fisher’s exact tests 
(dichotomous variables), as appropriate. 
One-way Analysis of variance (ANOVA) with repeated measures was applied to evaluate 
diff erences in time-to-peak radial strain between the 6 segments at baseline and at follow-
up within the separate cohorts of patients with and without LV dyssynchrony. Changes that 
occurred in the time-to-peak value between the baseline and follow-up visit were quantifi ed, 
and diff erences in changes according to the presence or absence of LV dyssynchrony were then 
analyzed by one-way ANOVA as well. Subsequently, two-way ANOVA (with repeated measures 
for segments) was applied to study diff erences in time-to-peak radial strain patterns between 
patients with and without LV dyssynchrony. Univariable and multivariable logistic regression 
analyses were performed to identify possible predictors of LV dyssynchrony. The following 
variables were investigated: age, duration of atrial fi brillation, coronary artery disease, QRS 
duration at baseline, LV ejection fraction and follow-up duration. All variables entered the 
multivariable stage, irrespective of the results of the univariable analyses. Subsequently, the 
backward deletion method was applied to build the fi nal regression model, and we intended 
to keep all variables with a p-value <0.15 in the model. We intended to report adjusted Odds 
Ratios (OR), however since no variable reached the pre-specifi ed p<0.15 we report only the 
crude unadjusted OR with their corresponding 95% confi dence intervals (CI). 
Changes in LV function and LV size between the baseline and follow-up visit were quanti-
fi ed, and diff erences in these changes between patients with and without LV dyssynchrony 
were studied by unpaired Student t-tests. Changes in LV ejection fraction over the 3 diff erent 
time points (baseline, RV pacing, biventricular pacing) for 11 patients who were upgraded to 
biventricular pacing, were analyzed with one-way ANOVA with Bonferroni post-hoc testing (3 
repeated tests; p<0.0167 was considered signifi cant for each test). 
Analyses were performed using SPSS software (version 12.0, SPSS Inc. Chicago, Illinois, 
USA). All statistical tests were two-sided, and a p-value <0.05 was considered signifi cant. 
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Fifty-eight patients treated with His bundle ablation and pacemaker implantation were studied. 
The baseline characteristics of the study sample are listed in Table 1. In all patients the ablation 
and pacemaker implantation procedures were performed successfully. No complications related 
to the procedures were observed. Mean follow-up was 3.8 ± 2.0 years (range 1.2 to 8.7 years).
Strain analysis: Heterogeneity in time-to-peak radial strain
Time-to-peak radial strain was assessed for the 6 standard segments: septal, anteroseptal, ante-
rior, lateral, posterior and inferior. A total of 762 segments were analyzed on the LV short-axis 
images. Of the 762 segments, 35 segments (5%) were excluded because of poor tracking scores. 
Subsequently, the site of earliest and latest mechanical activation throughout the cardiac 
cycle was determined. At baseline, there was a homogeneous distribution of the earliest and 
latest mechanical activated sites among the 6 segments (Figure 1, panel A). In contrast, after 
long-term permanent RV pacing, a marked heterogeneity in time-to-peak radial strain of the 
6 segments was observed (Figure 1, panel B). The septal and the anteroseptal segments were 
most frequently the earliest activated segments (34% and 30% of the total earliest activated 
segments, respectively); whereas the lateral and posterior segments were only seldom the 
earliest activated sites (7% and 6%, respectively). In contrast, the lateral and posterior segments 
were most frequently the latest activated segments (31% and 25%, respectively); whereas the 
septal (5%) and the anteroseptal (6%) were rarely the latest activated segments (Figure 1). 










Age, years 61 ± 11 59 ± 11 63 ± 12 0.1
Gender, M/F 33 / 25 15 / 10 18 / 15 0.8
Duration of AF, years 7 ± 5 7 ± 5 6 ± 5 0.3
Previous used anti-arrhythmic drugs, n 3.2 ± 1.3 3.2 ± 1.5 3.2 ± 1.1 0.9
Hypertension, n (%) 26 (45%) 12 (48%) 14 (42%) 0.8
Severe MR (grade 3-4), n (%) 0 (0%) 0 (0%) 0 (0%) 1.0
Coronary artery disease, n (%) 8 (14%) 3 (12%) 5 (15%) 1.0
Previous myocardial infarction, n (%) 4 (7%) 1 (4%) 3 (9%) 0.6
NYHA functional class 1.7 ± 0.6 1.7 ± 0.6 1.8 ± 0.7 0.5
QRS duration, ms 99 ± 10 100 ± 11 99 ± 11 0.8
* As assessed with unpaired Student t-tests (continuous variables), Chi-square or Fisher’s Exact tests (dichotomous variables), as appropriate. AF 
= atrial fi brillation; MR = mitral regurgitation; NYHA = New York Heart Association.
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LV dyssynchrony assessment with speckle tracking radial strain 
The diff erence in time-to-peak radial strain between the 6 segments can be used to assess LV 
dyssynchrony. A time diff erence ≥130 ms between the time-to-peak radial strain of the (antero)
septal and the posterolateral segments has been found to predict the response to cardiac 
resynchronization therapy (16). Therefore, we used this cut-off  value to determine the pres-
ence of LV dyssynchrony. In Table 2, the time-to-peak radial strain values at baseline and at 
follow-up are shown with the study sample divided according to the presence or absence of 
LV dyssynchrony. 
At baseline, strain curves revealed similar time-to-peak radial strain among the 6 segments 
(Table 2). Mean time-to-peak radial strain was 371 ± 114 ms for the 6 segments in all patients. 
There were no signifi cant diff erences in time-to-peak radial strain among the 6 segments at 
baseline (Table 2). Accordingly, there was no signifi cant delay between the (antero)septal 
and posterolateral segments (mean diff erence 26 ± 25 ms) Furthermore, the time diff erence 
between the earliest and the latest activated segments was 37 ± 31 ms. In none of the patients 
LV dyssynchrony, as represented by a time diff erence ≥130 ms between the (antero)septal and 
posterolateral segments, was present at baseline. 
Figure 1. Distribution of time-to-peak radial strain among the 6 segments. Panel A: Time-to-peak radial strain was similar among the 6 standard 
segments at baseline. Panel B: Distribution of the sites of earliest and latest mechanical activation after permanent right ventricular pacing. The 
septal and anteroseptal segments were most frequently the sites of earliest mechanical activation, whereas the lateral and posterior segments were 
most frequently the sites of latest mechanical activation. A= anterior; AS = anteroseptal; I = inferior; L= lateral; P = posterior; S = septal.
Chapter 14






















































































































































































































































































































































































































































In contrast, after a mean of 3.8 ± 2.0 years of permanent RV pacing, radial strain curves 
revealed signifi cant diff erences in time-to-peak radial strain among the 6 segments. In 33 (57%) 
patients there was a diff erence of ≥130 ms between the (antero)septal and posterolateral 
segments, indicating the presence of LV dyssynchrony. The study sample was subsequently 
divided in 2 groups: patients without LV dyssynchrony (n=25) and patients with LV dyssyn-
chrony (n=33) after permanent RV pacing. There were no signifi cant diff erences in baseline 
characteristics between the 2 groups (Table 1), and none of the variables that we considered 
were signifi cantly associated with the development of LV dyssynchrony (Table 3). Duration 
of follow-up was similar between the patients with and without LV dyssynchrony (4.0 ± 2.0 
years and 3.8 ± 2.0 years, respectively) and paced QRS duration at follow-up was not diff erent 
between the patients with and without LV dyssynchrony (169 ± 20 ms vs. 167 ± 21 ms, p=0.8). 
Radial strain after long-term permanent RV pacing 
In the patients with LV dyssynchrony, time-to-peak radial strain was signifi cantly shorter in the 
septal and anteroseptal segments, as compared to baseline values (septal 280 ± 120 ms vs. 366 
± 131 ms, p=0.014; anteroseptal 287 ± 100 ms vs. 369 ± 125 ms, p=0.019). In contrast, time-to-
peak radial strain in the lateral and posterior segments was signifi cantly longer, as compared 
to baseline values (lateral 453 ± 77 ms vs. 370 ± 129 ms, p=0.008; posterior 445 ± 93 ms vs. 371 
± 126 ms, p=0.007). 
Conversely, in the patients without LV dyssynchrony, no signifi cant diff erences in time-to-
peak radial strain among the 6 segments were observed. Time-to-peak radial strain was longer 
for all 6 segments as compared to baseline, but no signifi cant diff erences were detected (Table 2). 
In addition to time-to-peak strain, peak radial strain was assessed for the 6 standard seg-
ments. At baseline, no diff erences were noted in peak radial strain among the 6 segments 
(septal 31 ± 14%, anteroseptal 32 ± 13%, anterior 32 ± 15%, lateral 33 ± 16%, posterior 33 
± 17% and inferior 33 ± 14%). In contrast, after long-term RV pacing, peak radial strain was 
signifi cantly lower in the septal and the anteroseptal segments (21 ± 13%, p=0.007, and 24 ± 
16%, p=0.039 respectively) and signifi cantly higher in the lateral and posterior segments (43 ± 
20%, p=0.030, and 42 ± 20%, p=0.040 respectively), whereas peak radial strain remained similar 
in the anterior (32 ± 20%) and inferior (32 ± 18%) segments, as compared to baseline. Interest-
Table 3. Multivariable regression analysis for prediction of LV dyssynchrony 
OR (95% CI) P value
Age * 0.97 (0.92 – 1.01) 0.1
Duration of AF * 1.06 (0.94 – 1.19) 0.3
Coronary artery disease 0.61 (0.14 – 2.74) 0.5
QRS duration 1.01 (0.96 – 1.06) 0.8
LV ejection fraction 0.98 (0.88 – 1.09) 0.7
Follow-up duration * 0.92 (0.71 – 1.20) 0.5
* ratio per year.
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ingly, no signifi cant diff erences were noted between the patients with LV dyssynchrony and the 
patients without LV dyssynchrony. 
Thirty-eight patients underwent echocardiography within 1 day after the pacemaker 
implantation as part of the clinical evaluation. Of these patients, 14 (37%) showed LV dys-
synchrony immediately after pacemaker implantation. In addition, at follow-up tissue Doppler 
imaging was performed to confi rm the presence or absence of LV dyssynchrony. All patients 
with LV dyssynchrony on speckle tracking analysis also had LV dyssynchrony on tissue Doppler 
imaging (mean 103 ± 21 ms). All patients without LV dyssynchrony on speckle tracking analysis 
also had no LV dyssynchrony on tissue Doppler imaging (mean 29 ± 22 ms). 
At baseline and follow-up, NYHA functional class was assessed and echocardiographic 
evaluation was performed to assess LV volumes, diameters and LV systolic function. In the 
patients with LV dyssynchrony, NYHA functional class deteriorated from 1.8 ± 0.7 to 2.4 ± 0.7 
(p<0.001), whereas NYHA class improved in the patients without LV dyssynchrony (from 1.7 ± 
0.6 to 1.4 ± 0.6, p=0.008). The LV parameters as assessed with standard echocardiograms are 
listed in Table 4. 
Upgrading permanent RV pacing to biventricular pacing
In 11 patients, an upgrade of the conventional pacemaker to a biventricular pacing device was 
performed 4.1 ± 2.0 years after the His bundle ablation and pacemaker implantation procedure 
because of heart failure symptoms and the presence of LV dyssynchrony. The LV pacing lead 
was positioned in the mid lateral region in 3 patients (27%), and in the postero-lateral region in 
8 patients (73%). After a mean of 11 ± 8 months, an extensive echocardiogram was performed 
to assess LV function and LV dyssynchrony. 
In all patients, radial strain curves revealed disappearance of the LV dyssynchrony after 
upgrade to biventricular pacing. Time-to-peak radial strain for the diff erent segments were: 
septal 373 ± 56 ms, anteroseptal 362 ± 53 ms, anterior 369 ± 53 ms, lateral 367 ± 54 ms, pos-
terior 386 ± 43 ms, inferior 374 ± 48 ms. In none of the patients, a diff erence in time-to-peak 
radial strain ≥130 ms between the (antero)septal and posterolateral segments was present. A 
Table 4. Echocardiographic parameters of LV function and LV size at baseline and after RV pacing 
LV dyssynchrony absent (n=25) LV dyssynchrony present (n=33)
Baseline Follow-up Δ Baseline Follow-up Δ P value *
LV ejection fraction, % 48 ± 5 51 ± 7 + 4 ± 8 48 ± 5 39 ± 10 - 10 ± 11 <0.001
LV end-diastolic volume, ml 115 ± 27 119 ± 29 + 3 ± 18 124 ± 38 158 ± 70 + 34 ± 50 0.004
LV end-systolic volume, ml 60 ± 17 58 ± 18 - 3 ± 14 65 ± 24 99 ± 59 + 37 ± 50 <0.001
LV end-diastolic diameter, cm 5.2 ± 0.7 5.4 ± 0.4 + 0.1 ± 0.7 5.5 ± 0.9 6.0 ± 1.0 + 0.4 ± 0.7 0.5
LV end-systolic diameter, cm 3.4 ± 0.6 3.5 ± 0.5 + 0.1 ± 0.7 3.8 ± 0.9 4.4 ± 1.3 + 0.5 ± 1.0 0.2
Fractional shortening, % 35 ± 9 35 ± 7 + 1 ± 9 32 ± 11 27 ± 12 - 4 ± 13 0.8
Clinically relevant mitral 
regurgitation (grade 3-4), n (%)
0 2 (8%) + 2 0 5 (15%) + 5 0.7
* Diff erence between Δ values of patients with LV dyssynchrony vs. patients without LV dyssynchrony, as assessed with unpaired t tests for 
continuous variables and Fisher’s Exact test for dichotomous variable.
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representative example of the speckle tracking strain curves of a patient at the diff erent time 
points is shown in Figure 2. 
Of interest, mean LV ejection fraction improved from 30 ± 8% to 39 ± 7% (p<0.001) after 
upgrade to biventricular pacing. In all patients, an increase in LV ejection fraction ≥5% was 
observed. LV ejection fractions for the diff erent time points in the 11 patients are demonstrated 
in Figure 3. In addition, the deleterious eff ects of RV apical pacing on LV volumes were partially 
reversed after upgrade to biventricular pacing. LV end-diastolic volume had decreased from 
224 ± 66 ml to 167 ± 47 ml (p=0.001), and LV end-systolic volume had decreased from 160 ± 
58 ml to 103 ± 34 ml (p<0.001) after upgrade to biventricular pacing. In all patients, a decrease 
in end-systolic volume ≥15% was observed. In addition, NYHA functional class improved after 
upgrade to biventricular pacing from 3.1 ± 0.3 to 2.1 ± 0.5 (p<0.001).
 
Figure 2. Radial strain curves assessed with speckle tracking analysis of a representative patient. The color-coded curves represent the 6 
segments (light blue = septal; yellow = anteroseptal; red = anterior; green = lateral; purple = posterior; dark blue = inferior). Panel A: Before 
His bundle ablation and pacemaker implantation, there was no signifi cant delay in time-to-peak radial strain among the 6 segments. Panel B: 
After 4 years of permanent RV pacing, a marked heterogeneity in time-to-peak strain for the 6 segments was observed. A time diff erence >130 
ms was present between the time-to-peak radial strain of the septal (arrow) and posterolateral (open arrow) segments. Panel C: In this patient, 
upgrade of the conventional pacemaker to a biventricular pacemaker was performed. More than 1 year after ‘upgrade’, the radial strain curves 
revealed restoration of synchronous LV activation, with no signifi cant delay between the time-to-peak radial strain of the diff erent segments.
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DISCUSSION
In the present study, speckle tracking revealed heterogeneity in time-to-peak radial strain and 
LV dyssynchrony in 57% of the patients with permanent RV pacing after His bundle ablation. 
The present study further extends our previous fi ndings (11). Whereas previously myocardial 
velocities were assessed with tissue Doppler imaging (11), in the present study timing of 
regional LV strain was assessed with the use of speckle tracking. Frequently, strain analysis 
allows for more accurate analysis of LV function/dyssynchrony since it may permit diff erentia-
tion between active contraction and passive motion. In addition, using this novel technique, 
accurate evaluation of LV dyssynchrony at baseline was possible, whereas in the previous study 
the M-mode derived septal-to-posterior wall motion delay was used (11). Most importantly, 
in the present study it was demonstrated that LV dyssynchrony induced by RV apical pacing 
could be reversed in patients receiving an ‘upgrade’ to biventricular pacing, with a concomitant 
improvement in LV function and functional class. 
Figure 3. Eff ect of upgrading to biventricular pacing on left ventricular ejection fraction. LV ejection fraction at diff erent time points for 11 
patients who were upgraded to biventricular (BiV) pacing after a mean of 4.1 ± 2.0 years of permanent RV pacing. After permanent RV pacing, 
LV ejection fraction had signifi cantly decreased. This was partly reversed after upgrade to biventricular pacing. * As assessed with repeated 
measures analysis of variance. Bonferroni post-hoc testing revealed signifi cant diff erences between baseline and RV pacing (p<0.001) and 
between RV pacing and BiV pacing (p<0.01).
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Strain analysis
In the present study, novel speckle tracking software applied to standard short-axis images was 
used to assess timing of regional wall strain, and identify regions of early and late activation in 
permanent RV paced patients. Speckle tracking radial strain is a novel technique that allows 
angle-independent measurement of regional strain and time-to-peak radial strain of diff erent 
segments among the LV wall (12,13). This new technique has recently been validated using 
sonomicrometry and magnetic resonance imaging (18,19). Furthermore, it has been demon-
strated that speckle tracking can quantify LV dyssynchrony, and accurately predict responders 
to cardiac resynchronization therapy (16). In addition, speckle tracking analysis allows for an 
accurate quantifi cation of regional wall strain and time-to-peak wall strain, with a high repro-
ducibility (20,21). In the current study, a good inter- and intra-observer agreement for this novel 
technique was noted. 
Using speckle tracking radial strain, induction of heterogeneity in strain after RV pacing 
was demonstrated, with a short time-to-peak radial strain of the anteroseptal segments and 
a long time-to-peak radial strain of the posterolateral segments. At present, no studies have 
been reported concerning the eff ects of permanent RV apical pacing on timing of regional wall 
strain in patients. In contrast, several animal studies have reported wall strain analysis during RV 
pacing (8-10). Wyman et al (8) used magnetic resonance imaging tagging to evaluate regional 
wall strain in 7 dogs during RV apical pacing. Similar to the present fi ndings, the authors dem-
onstrated an early activation of the septum with late activation of the lateral wall during RV 
apical pacing. Dohi et al (10) studied the eff ect of RV and biventricular pacing in 8 dogs using 
angle-corrected tissue Doppler strain imaging. The authors reported similar heterogeneity in 
activation with short time-to-peak strain in the septal segments (189 ± 55 ms) and long time-
to-peak strain in the free wall (487 ± 37 ms) during RV pacing. 
Furthermore, in the present study regional wall strain analysis revealed that the site of earli-
est mechanical activation was mainly located at the (antero)septum, whereas the site of latest 
activation was mainly located at the posterolateral wall. In a mapping study in 40 patients, 
Vassallo et al (22) demonstrated that the site of earliest activation in the left ventricle during 
RV pacing was consistently located in the septum. In addition, the authors demonstrated that 
the site of latest activation during RV apical pacing varied (22), but was predominantly located 
in the posterior wall. The current observations are in line with this study: 64% of the earliest 
activated segments were located in the (antero)septum, and 56% of the latest activated seg-
ments were located in the posterolateral wall (Figure 1). 
A signifi cant time diff erence between the earliest and latest time-to-peak radial strain rep-
resents intraventricular conduction delay or LV dyssynchrony. Previously, a time diff erence ≥130 
ms between the (early) septal and the (late) posterior wall, as assessed with speckle tracking 
radial strain, has been demonstrated to be a good predictor for response to cardiac resynchro-
nization therapy (16). Interestingly, in the present study not all patients exhibited a signifi cant 
delay between the earliest activated (antero)septum and the latest activated posterolateral 
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wall. In 53% of the patients, signifi cant LV dyssynchrony was present after long-term RV pacing. 
Furthermore, time-to-peak radial strain in the patients without LV dyssynchrony was later in all 
segments as compared to the non-paced baseline value. Thus, the exact eff ect of RV apical pac-
ing may diff er per patient. This may be related to the fact that the electrical impulses propagate 
more slowly through the myocardium during RV pacing than through the Purkinje system dur-
ing normal sinus rhythm. However, it remains unclear why some patients develop signifi cant LV 
dyssynchrony, and others do not. There were no diff erences in baseline characteristics between 
the two groups, and mean follow-up duration was similar in the two groups. Importantly, a 
multivariable logistic regression analysis including age, duration of atrial fi brillation, coronary 
artery disease, QRS duration at baseline, LV ejection fraction and follow-up duration was not 
able to identify any predictor for the development of LV dyssynchrony in the present study. 
Future studies are needed to identify the patients who are more vulnerable for the detrimental 
eff ects of permanent RV apical pacing. Furthermore, more studies are needed to determine 
whether LV dyssynchrony is induced acutely with RV apical pacing or develops over time.
Impact of RV pacing on LV function and heart failure symptoms
Recently, several trials have stressed the deleterious eff ects of RV apical pacing. In the DAVID 
trial (3), DDDR pacing increased the risk of death or heart failure hospitalization, as compared 
to VVIR back-up pacing in 506 patients with an indication for implantable cardioverter defi bril-
lator therapy. Similarly, the MOST trial (4) demonstrated that the cumulative percent ventricular 
pacing was a strong predictor of heart failure hospitalization in patients with DDDR and VVIR 
pacing. The aforementioned studies suggest that RV apical pacing should be avoided. However, 
the exact mechanism of the detrimental eff ect of RV apical pacing remains unclear in these 
studies. The present study shows that the decrease in LV systolic function and NYHA functional 
class is directly related to the presence of LV dyssynchrony. Previously, it has been suggested 
that the detrimental eff ects of RV apical pacing may be more pronounced in patients with LV 
dysfunction before pacemaker implantation (4). However, in the present study no diff erences 
in baseline characteristics between the patients with and the patients without LV dyssynchrony 
were found. 
Eff ects of upgrade to biventricular pacing 
To reverse the abnormal activation pattern (i.e. LV dyssynchrony) induced by RV pacing, 
biventricular pacing could be considered. In the present study, 11 patients received ‘upgrade’ 
of the conventional pacemaker to biventricular pacing. LV dyssynchrony, induced by RV apical 
pacing, largely resolved with a concomitant improvement in LV function and NYHA functional 
class. Leon et al (23) reported similar results in 20 patients with severe heart failure and prior 
atrioventricular node ablation and permanent RV pacing. Following upgrade to biventricular 
pacing, LV ejection fraction improved from 22 ± 7% to 31 ± 12%, and NYHA class improved 
from 3.4 ± 0.5 to 2.4 ± 0.6. The HOBIPACE trial (24) recently demonstrated that in 30 patients 
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with standard pacemaker indication and LV dysfunction, biventricular pacing was superior to 
conventional RV pacing regarding LV systolic function (ejection fraction biventricular 34.8 ± 
8.9% vs. RV pacing 28.5 ± 11.2%, p<0.001), NYHA functional class (biventricular 1.9 ± 0.6 vs. RV 
pacing 2.5 ± 0.7, p<0.05) and exercise capacity (peak oxygen consumption biventricular 14.0 ± 
3.0 ml/min/kg vs. RV pacing 12.5 ± 2.9 ml/min/kg, p<0.001). 
In addition, alternate pacing sites (such as RV outfl ow tract, paraHisian or direct His bundle 
pacing) have been proposed to replace RV apical pacing (2). Several short-term studies have 
reported a modest benefi t of RV outfl ow tract, as compared to RV apical pacing (25). Further-
more, paraHisian (26) and direct His bundle pacing (27) have been proven to be feasible. How-
ever, concerns about long-term lead stability at the various sites exist, and no large randomized 
trials on long-term benefi t over RV apical pacing have been reported. Still, alternate pacing sites 
may prevent the occurrence of LV dyssynchrony as induced by RV apical pacing, and therefore 
could be considered in patients who need permanent pacing. 
Limitations
In the present study only 6 segments at the mid-ventricular level were analyzed using radial 
strain analysis. Analysis at more basal and apical levels and analysis of circumferential or longi-
tudinal strain may provide additional information on the eff ects of RV apical pacing on LV func-
tion. Nonetheless, it has been demonstrated that radial strain analysis at the mid-ventricular 
level is of great value for the detection of LV dyssynchrony and the prediction of response to 
cardiac resynchronization therapy (16). Additional head-to-head comparisons are needed to 
determine which type of strain analysis (radial, longitudinal or circumferential) provides opti-
mal information. 
CONCLUSIONS
Speckle tracking radial strain revealed that permanent RV pacing induced heterogeneity in 
time-to-peak strain among the LV walls (with early activation in the (antero)septal and late 
activation in the posterolateral segments). In 57% of patients, this resulted in the presence of 
LV dyssynchrony. In these patients a deterioration of LV systolic function and NYHA functional 
class was observed. Upgrade to biventricular pacing resulted in (partial) reversal of these detri-
mental eff ects of RV pacing. 
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ABSTRACT
Purpose: Right ventricular (RV) apical pacing induces dyssynchrony by left bundle branch block 
type electrical activation sequence in the heart, and may impair left ventricular (LV) function. 
Whether these functional changes are accompanied with changes in myocardial perfusion, 
oxidative metabolism and effi  ciency, and the relation with the induction of LV dyssynchrony are 
unknown. Our study was designed to study the acute eff ects of RV pacing on these parameters. 
Methods: Ten patients with normal LV ejection fraction and VVI/DDD pacemaker were studied 
during AAI-pacing/sinus rhythm without RV pacing (pacing-OFF) and with RV pacing (pacing-
ON) at the same heart rate. Dynamic [15O]water and [11C]acetate positron emission tomography 
was used to measure perfusion and oxidative metabolism (kmono) of the LV. An echocardio-
graphic examination was used to assess LV stroke volume (SV) and LV dyssynchrony. Myocardial 
effi  ciency of forward work was calculated as systolic blood pressure x cardiac output/LV mass/ 
kmono. 
Results: RV pacing decreased SV in all subjects (mean decrease 13%, from 76 ± 7 to 66 ± 7 ml, 
p=0.004) but global perfusion and kmono were unchanged. The effi  ciency tended to be lower 
with pacing-ON (70 ± 20 vs. 81 ± 21 mmHg·L/g, p=0.066). In patients with dyssynchrony during 
pacing (n=6) effi  ciency decreased by 23% (from 78 ± 25 to 60 ± 14 mmHg·L/g, p=0.02) but in 
patients without dyssynchrony no change in effi  ciency was detected. Accordingly, heterogene-
ity in myocardial perfusion and oxidative metabolism was detected during pacing in patients 
with dyssynchrony but not in those without dyssynchrony. 
Conclusions: RV pacing resulted in a signifi cant decrease in SV. However, deleterious eff ects 
on LV oxidative metabolism and effi  ciency were observed only in patients with dyssynchrony 
during RV pacing. 
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INTRODUCTION
Right ventricular (RV) apical pacing induces a left bundle branch block (LBBB) type electrical 
activation sequence in the heart (1). This abnormal activation pattern of the ventricles may 
have detrimental eff ects on cardiac structure and function. Several clinical trials have demon-
strated an association between RV pacing and an increased risk of heart failure and death (2,3). 
In addition, RV pacing has been shown to impair left ventricular (LV) function both in normal 
and failing hearts (4-6). Importantly, it has been demonstrated that this deterioration in LV 
function is related to the presence of LV dyssynchrony during RV pacing (7). 
The exact eff ects of RV pacing on myocardial perfusion, oxidative metabolism and cardiac 
effi  ciency have not been fully elucidated. In experimental LBBB, signifi cant changes in regional 
myocardial perfusion and glucose metabolism have been observed (8). Similarly, RV pacing 
may result in regional alterations in glucose metabolism (9). Importantly, the relation between 
the presence of LV dyssynchrony during RV pacing and changes in myocardial perfusion, oxida-
tive metabolism and cardiac effi  ciency has not been studied. 
Therefore, the objective of the present study was to evaluate the eff ect of RV pacing on 
both global and regional oxidative metabolism and perfusion, and myocardial effi  ciency. In 
addition, the eff ect of RV pacing-induced LV dyssynchrony on myocardial oxidative metabolism 
and effi  ciency was studied. 
METHODS
Study population and study protocol
Ten patients (5 men, mean age 62 ± 17 years) with previously implanted RV or dual-chamber 
pacemaker and normal LV function were included in the study. None of the patients had ven-
tricular conduction abnormality during atrial rhythm. All the vasoactive medications were with-
held 24 hours prior the study. Patient characteristics are summarized in Table 1. [11C]acetate PET 
imaging was used to measure oxidative metabolism, [15O]H2O to measure myocardial perfusion 
and an echocardiographic examination to measure LV volumes, stroke work and dyssynchrony. 
Patients were studied both during AAI pacing or sinus rhythm without RV pacing (pacing-OFF) 
and during RV pacing (pacing-ON) at the same heart rate. During pacing-ON, AV delay was kept 
shorter (mean 129 ± 30 ms) than natural AV delay (mean 262 ± 79 ms) to ensure successful RV 
pacing (Table 1). 
The sequence was pacing-OFF – pacing-ON in seven patients and pacing-ON – pacing-OFF 
in three patients. The device was programmed to the desired setting at least 1 hour prior to 
the PET and echocardiographic studies. The PET and echocardiographic examinations were 
performed during the same day approximately 2 hours apart (Figure 1). A standard 12-lead 
ECG was recorded every 10 minutes during PET imaging to ensure the appropriate pacing 
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mode during the study. Maximal time interval between the initiation of atrial and ventricular 
activations (AV delay) and maximal QRS duration were measured both during pacing-ON and 
pacing-OFF. The protocol was approved by the institutional ethic review board of Turku Univer-
sity Hospital and was carried out in accordance with institutional guidelines. 
Echocardiography
Images were recorded with patients in the left lateral decubitus position using a commercially 
available system (Vingmed Vivid 7, General Electric-Vingmed, Milwaukee, Wisconsin, USA). 
Images were obtained using a 3.5-MHz transducer at a depth of 16 cm in the parasternal 
Table 1. Patient characteristics























1 F 87 septal yes 170 90 100 140
2 F 47 inferobasal no 350 120 100 170
3 M 54 septal no 190 160 110 100
4 M 66 basal no 270 150 100 160
5 F 62 septum yes 240 100 100 170
6 M 77 apical yes 380 180 90 170
7 M 62 septal no 270 140 110 180
8 M 68 basal yes 350 120 110 180
9 F 28 apical yes 250 140 80 180
10 F 73 apical yes 150 90 80 150
Mean ± SD 62 ± 17 262 ± 79 129 ±30* 98 ± 11 160 ± 25*
* p<0.001 vs. pacing-OFF; AV = atrioventricular; RV = right ventricular.
WA
1 2 3
PET 1 Echo 1




















PET 2 Echo 2
ACE
Figure 1. Study fl ow chart. The sequence was pacing-OFF – pacing-ON in 7 patients and pacing-ON – pacing-OFF in 3 patients. PM = 
pacemaker; WA = [15O]H
2
O PET; ACE = [11C] acetate; PET 1 = fi rst PET study; PET 2 = second PET study; Echo 1 = fi rst echocardiography study; 
Echo 2 = second echocardiography study.
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(long- and short-axis) and apical (2- and 4-chamber) views. Standard two-dimensional images 
and color Doppler data triggered to the QRS complex were digitally stored in cine-loop format. 
Cardiac output and LV work power  Cardiac output (CO) was derived from pulsed-wave Dop-
pler analysis. The LV outfl ow tract velocity-time integral was obtained from the LV long-axis 
apical view with the sample volume positioned approximately 5 mm proximal to the aortic 
valve. By measuring the diameter of the LV outfl ow tract and the heart rate, CO was derived 
(10). External, or forward, LV work power was calculated (LV work power = systolic blood pres-
sure (SBP) x CO); and subsequently forward LV work power per gram of tissue was calculated as: 
forward LV work power / LV mass (11). 
Left ventricular dyssynchrony  Left ventricular dyssynchrony was assessed with the use of 
speckle-tracking analysis and color-coded tissue Doppler imaging (TDI). Off -line analysis of LV 
dyssynchrony was performed on digitally stored images (EchoPac version 6.1, General Electric-
Vingmed) by an independent observer blinded to all other results; the echocardiographic 
studies during pacing-OFF and pacing-ON were evaluated in random order. 
The assessment of LV dyssynchrony with speckle-tracking analysis has been described 
in more detail previously (12,13). In brief, speckle-tracking analysis is a technique that tracks 
frame-to-frame movement of natural acoustic markers on standard gray scale images of the 
myocardium. With the use of dedicated algorithms, time-strain curves are constructed to assess 
myocardial strain throughout the cardiac cycle (14,15). Short-axis images of the LV at the level 
of the papillary muscles were used and automatically divided into 6 standard segments: septal, 
anteroseptal, anterior, lateral, posterior, and inferior, respectively. Time-strain curves for all the 
6 segments were then constructed. Subsequently, the time from QRS onset to peak radial strain 
of each segment was obtained. Left ventricular dyssynchrony was defi ned as an interval ≥130 
ms for the absolute diff erence in time-to-peak radial strain for the septal or anteroseptal wall 
versus the posterior or lateral wall (12,13). 
In addition, LV dyssynchrony was assessed using color-coded TDI by placing sample 
volumes in the basal portions of the septum, lateral, anterior and inferior wall (16). The time-
to-peak systolic velocity was obtained in these 4 regions and the maximum diff erence among 
the 4 regions was used as an indicator of LV dyssynchrony. A delay >65 ms was used as a cut-off  
value for LV dyssynchrony assessed with TDI, as previously reported (16). 
To study the eff ects of RV pacing and LV dyssynchrony on myocardial oxidative metabolism 
and effi  ciency, the PET data were fi rst analyzed based on RV pacing mode only, comparing 
the two pacing conditions (pacing-ON vs. pacing-OFF). Thereafter, the study population was 
divided into two groups, according to the presence of LV dyssynchrony during RV pacing. 
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Positron Emission Tomography
Patients were positioned in a whole body PET scanner (GE Advance Milwaukee, WI, USA) and 
[11C]acetate and [15O]H2O PET imaging was performed as previously described (11). The Carimas 
software package (17) for cardiac image analysis (Carimas, Turku PET Center, Turku, Finland) was 
used to sample the LV myocardium into polar maps. The resulting polar map represents the 
tracer uptake in the LV myocardium. Values of regional myocardial blood fl ow (MBF) expressed 
in millilitres per gram of tissue per minute and oxidative metabolism (clearance rate constant, 
kmono, 1/min) were automatically generated on a pixel-by-pixel basis, based on the previously 
published tracer kinetic models (18-22). Regional values of MBF and oxidative metabolism were 
then obtained using the conventional 17 segment model. The average values of the septal [2, 
3, 8, 9,14] and the lateral [5, 6, 11, 12 and 16] myocardial segments were used to calculate the 
septal-to-lateral wall ratios. In addition, myocardial effi  ciency (the relation between the forward 
work and oxygen consumption) was estimated as: forward LV work power per gram / LV kmono 
(SBP x CO/LV mass/LV kmono). 
Statistical Analysis
All continuous data are expressed as mean ± SD. Comparisons between pacing-OFF and pacing-
ON were performed using a two-sided paired t-test; comparisons between dyssynchrony vs. no 
dyssynchrony were performed using unpaired univariate repeated measurements ANOVA. A 
p-value < 0.05 was considered statistically signifi cant. 
RESULTS
Eff ects of RV pacing 
The patient characteristics, pacing lead positions and the presence of LV dyssynchrony as well 
as the ECG parameters during pacing-OFF and pacing-ON are presented in Table 1. By defi ni-
tion, AV delay was signifi cantly shorter during pacing-ON than pacing-OFF (129 ± 30 vs. 262 ± 
79 ms, p<0.001). RV pacing induced clear widening of QRS complex in all except one patient 
and QRS duration was signifi cantly longer during pacing-ON than pacing-OFF (160 ± 25 vs. 98 
± 11 ms, p<0.001). 
The hemodynamic, echocardiographic and PET results during pacing-OFF and pacing-ON 
are summarized in Table 2. There was no signifi cant diff erence in heart rate and blood pressures 
during pacing-OFF and pacing-ON (Table 2). In contrast, CO was 13% lower during pacing-ON 
as compared to pacing-OFF, and LV work power was 13% lower during pacing-ON (Table 2). 
For the total study population, the absolute global MBF was comparable during pacing-ON 
and pacing-OFF, but septal-to-lateral wall MBF ratio was 19% lower during pacing-ON than 
during pacing-OFF (p=0.017) (Table 2). Global myocardial oxidative metabolism (kmono) was 
comparable during pacing-ON and pacing-OFF. However, the septal-to-lateral wall kmono ratio 
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was 18% lower during pacing-ON than during pacing-OFF (p=0.009) (Table 2). These changes 
in LV function and oxidative metabolism resulted in a tendency for lower myocardial effi  ciency 
during pacing-ON than during pacing-OFF (p=0.066) (Table 2). 
Eff ects of RV pacing-induced LV dyssynchrony
For the total study population, mean LV dyssynchrony signifi cantly increased during pacing-
ON, both assessed with speckle-tracking imaging (pacing-OFF 18 ± 18 ms vs. pacing-ON 121 ± 
83 ms, p=0.003) and with TDI (pacing-OFF 12 ± 11 ms vs. pacing-ON 76 ± 39 ms, p=0.001). Using 
the previously reported cut-off  values (12,16), 6 of the 10 patients (60%) developed signifi cant 
LV dyssynchrony during RV pacing as assessed by echocardiography. The results in patients 
with dyssynchrony and without dyssynchrony are summarized in Table 3. The blood pressures 
and heart rates were comparable during pacing-ON and pacing-OFF. In patients with dys-
synchrony, CO decreased signifi cantly during pacing-ON as compared with pacing-OFF (from 
4.91 ± 0.55 to 4.20 ± 0.69 l/min, p=0.006). In contrast, in the patients without dyssynchrony a 
moderate decrease in CO was observed during pacing-ON (Table 3). A signifi cant decrease in 
LV work power was noted only in the patients with LV dyssynchrony during RV pacing (Table 3). 
In patients with dyssynchrony, global MBF was not diff erent between the pacing conditions 
but septal-to-lateral wall MBF ratio was 24% lower during pacing-ON (p=0.016). In patients 
without dyssynchrony, no diff erence in global MBF as well as in septal-to-lateral wall MBF ratio 
was detected between pacing-OFF and pacing-ON (Table 3). Similar to the changes in MBF, in 
patients with dyssynchrony global kmono was comparable during pacing-ON and pacing-OFF, but 
the septal-to-lateral wall kmono ratio was 22% lower during pacing-ON than during pacing-OFF 
(p=0.038). In patients without dyssynchrony, both global kmono, as well as the septal-to-lateral wall 
kmono ratio were not diff erent between pacing-OFF and pacing-ON (Table 3). 
Finally, in patients with dyssynchrony myocardial effi  ciency was 23% lower during pacing-
ON than during pacing-OFF (p=0.023). In contrast, in patients without dyssynchrony myocardial 
effi  ciency was comparable during pacing-ON and pacing-OFF (p=0.70)(Figure 2). 
Table 2. The eff ects of RV pacing on hemodynamics, LV function and PET-derived parameters
Measure Pacing-OFF Pacing-ON p-value
Heart rate, bpm 63 ± 8 67 ± 10 0.053
Systolic BP, mmHg 129 ± 25 130 ± 24 0.42
Diastolic BP, mmHg 69 ± 11 72 ± 9 0.27
CO, l/min 4.87 ± 0.69 4.24 ± 0.80 0.0003
LV work power, mmHg·l/min/g 5.17 ± 1.80 4.56 ± 1.78 0.013
MBF, ml/min/g 1.04 ± 0.21 1.05 ± 0.15 0.52
MBF septal/lateral ratio 0.81 ± 0.13 0.66 ± 0.07 0.017
kmono, min
-1 0.069 ± 0.016 0.069 ± 0.016 0.94
kmono septal/lateral ratio 1.10 ± 0.19 0.90 ± 0.13 0.009
Effi  ciency, mmHg·l/g 80.67 ± 20.54 69.93 ± 20.34 0.066
CO = cardiac output; LV = left ventricular; MBF = myocardial blood fl ow.
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DISCUSSION
RV pacing, myocardial oxidative metabolism and effi  ciency
To our knowledge, this is the fi rst study to investigate the eff ect of RV pacing on myocardial 
oxidative metabolism and effi  ciency of work. We found that the global LV perfusion and oxida-
tive metabolism remained unchanged despite reduction in LV function during RV pacing. This 
tended to impair effi  ciency of cardiac work. Concordantly with the previous study on glucose 
metabolism, we found an altered distribution of perfusion and oxidative metabolism as septal-
to-lateral wall ratios were reduced during RV pacing (9). 
In agreement with earlier fi ndings, RV pacing in the present study resulted in a reduction in 
cardiac output and LV work power and this occurred without changes in hemodynamics and 
heart rate. Right ventricular pacing causes an activation pattern similar to LBBB, and it reduces 
the septal-to-lateral wall ratio of mechanical work in the healthy canine heart (23). In a study 
by Preumont et al. with eight candidates for permanent pacemaker implantation, RV pacing 









   Pacing-OFF 1.04 ± 0.21 1.03 ± 0.16 1.07± 0.31
   Pacing-ON 1.05 ± 0.15 1.03 ± 0.16 1.07 ± 0.15
   p-value* 0.5 0.9 0.5
MBF septal-to-lateral ratio
   Pacing-OFF 0.81 ± 0.13 0.85 ± 0.15 0.75 ± 0.08
   Pacing-ON 0.66 ± 0.07 0.65 ± 0.07 0.71 ± 0.04 †
   p-value* 0.02 0.02 0.8
kmono, min
-1
   Pacing-OFF 0.069 ± 0.017 0.071 ± 0.022 0.068 ± 0.003
   Pacing-ON 0.069 ± 0.016 0.074 ± 0.029 0.061 ± 0.006
   p-value* 0.9 0.7 0.2
kmono septal-to-lateral ratio
   Pacing-OFF 1.10 ± 0.19 1.11 ± 0.22 1.09 ± 0.17
   Pacing-ON 0.90 ± 0.13 0.87 ± 0.05 0.95 ± 0.20
   p-value* 0.009 0.04 0.19
CO, l/min
   Pacing-OFF 4.87 ± 0.69 4.91 ± 0.55 4.82 ± 0.95
   Pacing-ON 4.24 ± 0.80 4.20 ± 0.68 4.30 ± 1.06
   p-value* <0.001 0.006 0.05
LV work power, mmHg·l/min/g
   Pacing-OFF 5.17 ± 1.80 5.32 ± 2.06 4.95 ± 1.61
   Pacing-ON 4.56 ± 1.78 4.52 ± 1.83 4.61 ± 1.97
   p-value* 0.013 0.04 0.2
Effi  ciency, mmHg·l/g
   Pacing-OFF 76.29 ± 23.82 78.11 ± 25.35 73.55 ± 24.78
   Pacing-ON 66.37 ± 22.24 60.40 ± 13.93 75.32 ± 31.33 †
   p-value* 0.07 0.02 0.7
* Pacing-OFF vs. Pacing-ON; † p<0.05 with dyssynchrony vs. without dyssynchrony; CO = cardiac output; MBF = myocardial blood fl ow; LV = 
left ventricular
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induced heterogeneity in regional glucose metabolism (9). The defects in glucose uptake were 
found in the left ventricle near the stimulation site, primarily in the inferior, apical and septal 
wall. However, the results in the distribution of myocardial perfusion have been more variable 
either showing no abnormalities (9) or corresponding decrease in septal-to-lateral perfusion 
(24,25). On the other hand, it was found that regional myocardial perfusion defects may be 
present in up to 65% of the patients after long-term RV pacing (24,25). 
LV dyssynchrony, myocardial oxidative metabolism and effi  ciency
In the present study, 60% of the patients exhibited signifi cant LV dyssynchrony during RV 
pacing. Previously, it has been demonstrated that RV pacing may result in signifi cant LV dys-
synchrony in a substantial proportion of patients (13). In the present study, speckle-tracking 
strain analysis was used to assess if patients developed LV dyssynchrony during RV pacing, 
and cardiac metabolism and effi  ciency data were analyzed accordingly. Interestingly, during RV 
pacing QRS duration increased signifi cantly in nine out of ten patients, but signifi cant LV dys-
synchrony was noted only in 60% of the patients. This is in agreement with earlier notion that 
approximately one third of the heart failure patients with prolonged QRS do not demonstrate 
ventricular dyssynchrony (26). 
Importantly, in the patients with LV dyssynchrony during RV pacing, signifi cant changes 
in septal-to-lateral ratio of MBF and kmono were observed. In contrast, in patients without LV 
dyssynchrony during RV pacing, no signifi cant changes were noted. These fi ndings emphasize 
that the perfusion, metabolic and work effi  ciency abnormalities are paralleling with induced 
mechanical changes (or LV dyssynchrony). The magnitude of the deterioration of myocardial 


















































Figure 2. Myocardial effi  ciency with pacing-OFF and pacing-ON in patients developing dyssynchrony with RV pacing (panel A) and in 
patients not developing dyssynchrony with RV pacing (panel B). ● = individual values, ♦ = group mean
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large eff ect was detected in patients with preserved systolic function. In patients with a failing 
heart, similar degree of eff ect would likely be clinically signifi cant. 
Previous studies in patients with LBBB have demonstrated that LV dyssynchrony is linked 
with adverse eff ects on MBF, metabolism and effi  ciency (27-29). Signifi cant heterogeneity 
(decreased septal-to-lateral wall ratio) was reported for both MBF (28,29) and oxidative 
metabolism (11,27,29). Restoration of the normal contraction sequence of the LV by cardiac 
resynchronization therapy abolishes the heterogeneity and improves myocardial effi  ciency 
(11,27). The present study suggests that altered myocardial metabolism and cardiac effi  ciency 
may be the underlying mechanism for the deterioration in LV function in patients with LV dys-
synchrony during RV pacing. 
Study limitations 
In the present study a shortened AV delay was used during pacing-ON. This was necessary 
to enable successful pacing without increasing heart rate. Liebold and coworkers (30) inves-
tigated the eff ect of PR interval during pacing on cardiac function and found that when this 
interval is shorter LV performance was deteriorated. However, this happened only with very 
short PR intervals (40 ms) and the optimal interval was 80 ms or higher. In the present study, all 
PR intervals were 90 ms or higher and, therefore, it is unlikely that a slightly shorter PR interval 
during RV pacing would contribute to the reduced LV function. In the present study quite a 
small number of patients was studied. This is especially true for prespecifi ed subgroup analysis. 
However, each patient was studied twice to allow direct measurement of the eff ects of RV pac-
ing. Relatively many measurements were performed in a relatively small number of patients. 
Advanced and very accurate but laborious techniques were applied and we believe that this 
patients group was large enough to obtain reliable fi ndings.  
CONCLUSIONS
RV pacing may result in a signifi cant decrease in LV performance. However, LV oxidative metab-
olism and effi  ciency become abnormal only in patients who exhibit LV dyssynchrony during 
RV pacing. This study emphasizes the importance of synchronous LV contraction also in the 
non-failing heart. Further studies are needed to assess whether altered myocardial effi  ciency 
contributes to the previously suggested unfavorable eff ects of RV pacing in patients with a 
failing heart. 
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ABSTRACT
Background: ARVD/C is characterized by fi brofatty replacement of RV myocardium and RV 
dilatation. These pathologic changes may result in electromechanical dyssynchrony. 
Objectives: To study the prevalence and mechanisms underlying right ventricular (RV) dyssyn-
chrony in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) using tissue 
Doppler echocardiography (TDE).
Methods: Electrocardiography, conventional and TDE was performed in 52 ARVD/C patients 
fulfi lling Task Force criteria and 25 controls. RV end-diastolic and end-systolic areas, RV frac-
tional area change (RVFAC), and left ventricular (LV) volumes and function were assessed. 
Mechanical synchrony was assessed by measuring diff erences in time-to-peak systolic velocity 
(TSV) between the RV free wall, ventricular septum and LV lateral wall. RV dyssynchrony was 
defi ned as the diff erence in TSV between the RV free wall and the ventricular septum, >2 SD 
above the mean value for controls. 
Results: Mean diff erence in RV TSV was higher in ARVD/C compared to controls (55 ± 34 ms vs. 
26 ± 15 ms, p<0.001). Signifi cant RV dyssynchrony was not noted in any of the controls. Based 
on a cut-off  value of 56 ms, signifi cant RV dyssynchrony was present in 26 ARVD/C patients 
(50%). Patients with RV dyssynchrony had larger RV end-diastolic area (22 ± 5 vs. 19 ± 4 cm2, 
p=0.02), and lower RVFAC (29 ± 8 vs. 34 ± 8%, p=0.03) compared to ARVD/C patients without RV 
dyssynchrony. No diff erences in QRS duration, LV volumes and function were present between 
the two groups. 
Conclusions: RV dyssynchrony may occur in up to 50% of ARVD/C patients, and is associated 
with RV remodeling. This fi nding may have therapeutic and prognostic implications in ARVD/C. 
Chapter 16





Arrhythmogenic right ventricular dysplasia cardiomyopathy (ARVD/C) is an inherited disease 
characterized by fi brofatty replacement of right ventricular (RV) myocardium (1). The diagnosis 
is established based on the presence of a conglomeration of factors (2,3). Other than ventricu-
lar arrhythmias, ARVD/C results in progressive RV dilatation and systolic dysfunction leading to 
heart failure (4,5). 
Ventricular electro-mechanical delay (or mechanical dyssynchrony) has been well described 
in left ventricular (LV) failure and has formed the basis of cardiac resynchronization therapy 
leading to signifi cant improvements in symptoms, functional capacity and survival in heart 
failure patients (6). Although RV mechanical dyssynchrony has been described in pulmonary 
hypertension (7), there are no data on whether a primary RV cardiomyopathy such as ARVD/C 
is associated with mechanical dyssynchrony. Tissue Doppler (TDE) and strain (SE) echocardiog-
raphy have emerged as the predominant means of evaluating ventricular mechanics (8,9). 
Several components of the ARVD/C disease process could potentially lead to the develop-
ment of RV mechanical dyssynchrony. Fibrofatty infi ltration could involve the RV conduction 
system resulting in electrical and electro-mechanical delays. Similar to LV failure, RV dilatation 
and dysfunction may cause dyssynchrony. Lastly, other factors such as pulmonary pressures 
and LV involvement may infl uence RV mechanical properties. Importantly, ventricular electro-
mechanical dyssynchrony has prognostic and therapeutic implications (10,11). 
Accordingly, the aims of this study were to determine the prevalence of mechanical dys-
synchrony in a large cohort of ARVD/C patients and to better elucidate the factors infl uencing 
RV mechanics in ARVD/C. 
METHODS
Study population and protocol
This study was approved by the institutional review board with written informed consent 
obtained in all subjects. The study population comprised 52 ARVD/C patients with diagnosis 
confi rmed by Task Force criteria (2) and 25 control subjects. All control subjects were healthy 
volunteers, recruited on campus, with no history of medical illness, not on any cardioactive 
medications, who had a normal echo Doppler examination (18 men, 7 women; mean age 32 ± 
6 years). All patients underwent a detailed history and physical examination, 12 lead electrocar-
diogram (ECG), signal averaged ECG, conventional echocardiography and TDE/SE. 
Echocardiography
Conventional and TDE/SE images were acquired from at least 3 consecutive heart beats 
and digitally stored for off -line analysis using a Vivid 7 ultrasound machine (GE Healthcare, 
260
Waukesha, WI). Offl  ine analysis was performed using EchoPAC PC version 6.1 (GE Healthcare). 
During image acquisition, special care was taken to acquire accurate images of the RV free wall. 
Off -plane images of the RV were acquired to maximize visualization of RV morphology. 
The RV outfl ow tract dimension was measured in the parasternal short-axis view at the level 
of the aortic valve plane (12). In addition, RV end-diastolic area (RVEDA) and RV end-systolic 
area (RVESA) were measured by tracing the RV endocardial border on the apical 4-chamber 
view and RV fractional area change (RVFAC) was calculated as a measure of RV systolic function 
using the following equation: RVFAC = (RVEDA - RVESA)/ RVEDA x 100% (12). Biplane LV end-
diastolic and -systolic volumes were assessed from the apical 2- and 4-chamber images, and LV 
ejection fraction was calculated using the biplane Simpson’s formula (13). 
Tissue Doppler/strain echocardiography
Standard apical 4-chamber images and narrow-angle-sector images were acquired for tissue 
Doppler and strain analysis. Adjustments to the sector width were made to visualize one myo-
cardial wall at a time (RV free wall, interventricular septum, LV lateral wall), in order to obtain 
an optimal alignment between the wall and the ultrasound beam, and to maximize frame rates 
(mean frame rate 253 ± 46 frames/s). The gain settings, fi lters and pulse repetition frequency 
were adjusted to optimize color saturation and to avoid aliasing. 
Off -line analysis was performed by placing the Doppler sample at the basal segment of 
the RV free wall, interventricular septum and LV lateral wall, as previously described (14). Semi-
automated tissue tracking was used to maintain the sample area within the region of interest 
throughout the cardiac cycle. Peak systolic tissue velocity of each segment was obtained and 
averaged from 3 cardiac cycles. For peak systolic strain analysis, an off set (strain) distance of 12 
mm was used; for all segments the time-to-peak systolic strain was similarly assessed. Off -line 
analyses were performed by two observers, blinded to the results of the echocardiographic RV 
function analysis. 
Ventricular dyssynchrony
For the assessment of ventricular dyssynchrony, the time from the onset of the QRS complex 
to the peak systolic tissue velocity of diff erent segments was measured (TSV). The diff erence 
between the TSV of the septum and the TSV of the RV free wall was calculated as an indicator of 
RV dyssynchrony. Signifi cant RV dyssynchrony was defi ned as a septal to RV free wall TSV delay 
exceeding 2 standard deviation (SD) above the mean value for the control group. 
Similarly, for LV dyssynchrony the diff erence in TSV between the septum and the LV lateral 
wall was calculated. A value > 2 SD above the mean value derived from the control group, was 
used as a cut-off  value for the presence of signifi cant LV dyssynchrony. Finally, interventricular 
dyssynchrony was calculated as the diff erence in TSV between the RV free wall and the LV lateral 
wall. The cut-off  value for signifi cant interventricular dyssynchrony was defi ned similar to RV 
and LV dyssynchrony. 
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Continuous data are presented as mean ± SD; categorical data are presented as frequencies 
and percentages. Diff erences between the ARVD/C patients and the controls, and between the 
ARVD/C patients with and without ventricular dyssynchrony, were evaluated using unpaired 
student t test (continuous variables), or Chi-square tests (dichotomous variables). Diff erences 
in continuous variables between controls and ARVD/C patients with and without ventricular 
dyssynchrony were evaluated with one-way ANOVA. Correlations between echocardiographic 
variables and the extent of RV dyssynchrony were assessed with Pearson’s correlation test. 
Inter- and intra-observer variability for the assessment of TSV of the RV free wall and the 
interventricular septum and RV dyssynchrony were assessed using Bland-Altman analysis, in 
10 random ARVD/C patients that were analyzed by two independent observers (inter-observer 
variability) and by a single observer at two diff erent time points (intra-observer variability); 
mean diff erences ± SD and 95% confi dence intervals are reported. In addition, kappa statistic 
was used to assess the inter- and intra-observer variability for the classifi cation of the presence 
or absence of RV dyssynchrony. 
All statistical analyses were performed using SPSS software (version 12.0, SPSS Inc. Chicago, 
Illinois). All statistical tests were two-sided, and a p-value <0.05 was considered statistically 
signifi cant. 
RESULTS
Baseline characteristics of the 52 ARVD/C patients are summarized in Table 1. In none of the 
patients, symptoms of right-sided heart failure were present. Right ventricular areas (RVEDA 
and RVESA) were higher and RVFAC signifi cantly lower in ARVD/C compared to the controls 
(Table 2). There were no signifi cant inter-group diff erences in LV volumes and function. Peak 
systolic velocities and strain values in the interventricular septum and the LV lateral wall were 
comparable between the ARVD/C patients and controls (Table 2). In contrast, RV free wall peak 
systolic velocity (7.4 ± 2.1 cm/s vs. 9.9 ± 1.2 cm/s, p<0.001) and RV free wall peak systolic strain 
(-19 ± 7% vs. -25 ± 9%, p=0.002) were signifi cantly lower in ARVD/C patients compared to 
controls, respectively. 
Ventricular dyssynchrony
In all subjects, echocardiographic images were of suffi  cient quality to assess time-to-peak 
systolic velocity. Mean TSV of the septum and the RV free wall in the ARVD/C patients was 159 
± 40 ms and 210 ± 42 ms, respectively. In the controls, mean TSV of the septum and the RV free 
wall was 135 ± 39 ms and 160 ± 33 ms, respectively. Mean time-to-peak strain of the septum 
and RV free wall was 387 ± 67 ms and 434 ± 73 ms in the ARVD/C patients and 345 ± 88 ms and 
368 ± 75 ms in the controls. 
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The mean diff erence in TSV between the septum and the RV free wall, representing RV dys-
synchrony, was 55 ± 34 ms in the ARVD/C patients, and 26 ± 15 ms in the controls (p<0.001). 
Based on a cut-off  value of ≥56 ms, signifi cant RV dyssynchrony was present in 26 ARVD/C 
patients (50%). In these patients, mean RV dyssynchrony was 84 ± 20 ms, whereas it was 26 
± 16 ms in the remaining patients (p<0.001). An example of a patient with signifi cant RV dys-
synchrony is shown in Figure 1. 
Table 1. Baseline characteristics 
ARVD/C patients (n=52)
Age, yrs 41 ± 12
Gender, M/F 22 / 30
Symptomatic, n (%) 45 (87)
   Syncope, n (%) 13 (25)
   Palpitations, n (%) 18 (35)
   Ventricular tachycardia, n (%) 14 (27)
   Other symptoms, n (%) 9 (17)
Implantable cardioverter-defi brillator, n (%) 45 (87)
Filtered QRS duration, ms 131 ± 36
Right bundle branch block, n (%) 10 (19)
Epsilon waves, n (%) 0 (0)
T wave inversion in right precordial leads, n (%) 39 (75)
RV systolic pressure, mmHg 29 ± 6
RV = right ventricular.






RVOT diameter (cm) 2.6 ± 0.2 2.9 ± 0.4 0.001
RVEDA (cm2) 17 ± 3 20 ± 5 <0.001
RVESA (cm2) 9 ± 2 14 ± 4 <0.001
RVFAC (%) 44 ± 7 32 ± 8 <0.001
LVEDV (ml) 108 ± 31 104 ± 27 0.5
LVESV (ml) 45 ± 14 45 ± 14 0.9
LVEF (%) 59 ± 5 57 ± 5 0.1
Septum
   Peak systolic velocity (cm/s) 5.9 ± 1.1 5.4 ± 1.1 0.1
   Peak systolic strain (%) -24 ± 6 -21 ± 7 0.1
RV free wall
   Peak systolic velocity (cm/s) 9.9 ± 1.2 7.4 ± 2.1 <0.001
   Peak systolic strain (%) -25 ± 9 -19 ± 7 0.002
LV lateral wall
   Peak systolic velocity (cm/s) 7.0 ± 2.1 6.5 ± 1.4 0.2
   Peak systolic strain (%) -18 ± 8 -18 ± 6 0.2
LV = left ventricular; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-
systolic volume; RV = right ventricular; RVEDA = right ventricular end-diastolic area; LVESA = right ventricular end-systolic area; RVFAC = right 
ventricular fractional area change; RVOT = right ventricular outfl ow tract.
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Mean TSV for the LV lateral wall in the ARVD/C patients and the controls was 171 ± 47 ms 
and 155 ± 47 ms, respectively. Mean time-to-peak strain of the LV lateral wall was 398 ± 70 ms 
in the ARVD/C patients and 370 ± 86 ms in the controls. There was no signifi cant diff erence in LV 
dyssynchrony between the ARVD/C patients and the controls (21 ± 18 ms vs. 22 ± 19 ms, p=0.7). 
Using a cut-off  value of ≥60 ms (>2 SD of the controls), 2 ARVD/C patients (4%) demonstrated 
signifi cant LV dyssynchrony. 
Interventricular dyssynchrony, calculated as the diff erence in TSV between the RV free wall 
and the LV lateral wall, was 53 ± 36 ms in the ARVD/C patients and 21 ± 15 ms in the controls 
(p<0.001). Based on a cut-off  value of ≥51 ms (>2 SD of the controls), signifi cant interventricular 
dyssynchrony was present in 22 patients (42%) with ARVD/C. In these patients, mean inter-
ventricular dyssynchrony was 88 ± 17 ms, whereas it was 27 ± 21 ms in the remaining patients 
(p<0.001). In 19 of the 26 patients with RV dyssynchrony (73%), signifi cant interventricular 
dyssynchrony was present. Conversely, in 23 of the 26 patients without RV dyssynchrony (88%), 
no signifi cant interventricular dyssynchrony was present.  
Factors infl uencing RV dyssynchrony
We examined several morphologic and functional factors that could potentially impact RV 
mechanical synchrony. These included 1) Electrocardiographic: presence of RV conduction 
abnormalities as typifi ed by QRS duration and presence of right bundle branch block; 2) Mor-
phologic: RV volumes and LV volumes; 3) Functional: RV function and LV function. To study 
Figure 1. Example of an ARVD/C patient with signifi cant RV dyssynchrony. Samples are placed at the basal parts of the septum (yellow 
curve), RV free wall (red curve) and LV lateral wall (green curve). In this patient, a signifi cant delay between the septum and the RV free wall 
was present (110 ms), indicated by the yellow and red arrows.
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these factors, ARVD/C patients were divided into those with RV dyssynchrony (n=26) and those 
without RV dyssynchrony (n= 26). 
No diff erences in RV conduction abnormalities, evaluated by signal averaged and surface 
ECG, were noted between the two groups: fi ltered QRS duration on signal averaged ECG was 
similar in ARVD/C patients with versus those without RV dyssynchrony (134 ± 41 ms vs. 128 
± 32 ms, respectively; p=0.6). No diff erence in the prevalence of T wave inversion in right 
precordial leads was noted between the two groups (with RV dyssynchrony n=18; without 
RV dyssynchrony n=21, p=0.5). Similarly, there were no diff erences in the prevalence of right 
bundle branch block noted in 5 patients (19%) with RV dyssynchrony and in 5 patients (19%) 
without RV dyssynchrony (p=1.0). In addition, there was no diff erence in the number of patients 
with documented ventricular tachycardia at baseline between the group with and the group 
without RV dyssynchrony (10 patients vs. 4 patients, p=0.1). 
Compared to patients without RV dyssynchrony, the patients with RV dyssynchrony had 
larger RVEDA (Table 3), and a lower RVFAC (Figure 2). No signifi cant diff erences in LV volumes, 
function, and peak systolic velocities and peak systolic strain were noted between patients 
with and without RV dyssynchrony. In contrast, peak systolic strain of the RV free wall was 
signifi cantly decreased in patients with RV dyssynchrony, compared with patients without RV 
dyssynchrony (Figure 2). 
A modest, but signifi cant correlation was found between FAC and RV dyssynchrony (r=-0.38, 
p=0.001), and between RVEDA and RV dyssynchrony (r=0.38, p=0.001). In addition, a modest, 
but signifi cant correlation was found between peak systolic strain of the RV free wall and RV 
dyssynchrony (r=0.40, p<0.001).  
Table 3. Echocardiographic data in ARVD/C patients with and without right ventricular dyssynchrony





RVOT diameter (cm) 2.9 ± 0.4 2.9 ± 0.4 0.9
RVEDA (cm2) 19 ± 4 22 ± 5 0.02
RVESA (cm2) 12 ± 3 16 ± 5 0.005
RVFAC (%) 34 ± 8 29 ± 8 0.03
LVEDV (ml) 104 ± 28 103 ± 26 1.0
LVESV (ml) 45 ± 13 45 ± 15 1.0
LVEF (%) 57 ± 4 57 ± 6 0.8
Septum
   Peak systolic velocity (cm/s) 5.4 ± 1.3 5.4 ± 1.0 1.0
   Peak systolic strain (%) -21 ± 7 -22 ± 7 0.8
RV free wall
   Peak systolic velocity (cm/s) 7.4 ± 2.5 7.3 ± 1.7 0.9
   Peak systolic strain (%) -22 ± 7 -16 ± 6 0.001
LV lateral wall
   Peak systolic velocity (cm/s) 6.4 ± 1.5 6.6 ± 1.4 0.5
   Peak systolic strain (%) -19 ± 7 -16 ± 5 0.1
Abbreviations as in Table 2.
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Reproducibility of RV dyssynchrony
The intra-observer and inter-observer variability for time-to-peak systolic velocity for the RV 
free wall were 1.0 ± 16.6 ms (95% CI -31.6 to 33.6), and 0 ± 26.7 ms (95% CI -52.3 to 52.3), respec-
tively. The intra-observer and inter-observer variability for RV dyssynchrony were 0 ± 18.9 ms 
(95% CI -36.9 to 36.9) and -5.0 ± 29.5 ms (95% CI -62.9 to 52.9), respectively. For the classifi cation 
of the presence or absence of RV dyssynchrony, an excellent agreement was noted between 
the two observers (κ=0.80) and within the same observer (κ=1.0). 
DISCUSSION
We present a previously unreported fi nding of signifi cant ventricular mechanical dyssynchrony 
in patients with a primary RV cardiomyopathy, ARVD/C. In a relatively large cohort of ARVD/C 
patients we demonstrate RV dyssynchrony in 50% and interventricular dyssynchrony in 42% 
of the patients. Patients with RV dyssynchrony had larger RV volumes and lower RV function 
compared to controls. 
Figure 2. Right ventricular fractional area change (upper panel) and RV peak systolic strain (lower panel) in the 25 controls, 26 ARVD/C 
patients without RV dyssynchrony and 26 ARVD/C patients with RV dyssynchrony. Both RV fractional area change and RV peak systolic strain 
were signifi cantly decreased in the ARVD/C patients with RV dyssynchrony.
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Right ventricular dyssynchrony
The presence of LV and interventricular dyssynchrony has been studied in a broad spectrum 
of clinical settings (9). In contrast, RV dyssynchrony has not been studied extensively. The 
presence of RV dyssynchrony was fi rst reported by Lopez-Candales et al. in 20 patients with 
pulmonary hypertension (7). Using time-to-peak strain between the septum and RV free wall, 
RV dyssynchrony was found to be more pronounced in patients with pulmonary hypertension 
as compared to controls (92 ± 78 ms vs. 11 ± 23 ms, p<0.001). In contrast, there were no dif-
ferences in LV dyssynchrony between the two groups (7). Similarly, intra- and inter-ventricular 
dyssynchrony was examined in 34 patients with LV systolic heart failure, mean LV ejection 
fraction 22 ± 7% (56% with non-ischemic cardiomyopathy) (15). Mean RV dyssynchrony was 59 
± 45 ms and mean LV dyssynchrony was 80 ± 62 ms. 
In a larger unselected cohort of patients with a primary RV cardiomyopathy (ARVD/C), we 
report for the fi rst time the occurrence of signifi cant RV and interventricular mechanical dys-
synchrony. As opposed to previous studies, dyssynchrony in this population occurred in the 
absence of confounding factors such as pulmonary hypertension and LV failure. Our data also 
established a cutoff  value for mechanical dyssynchrony in the RV using 25 healthy controls. 
Interestingly, our cutoff  value of 56 ms is close to the previously reported cut-off  values for LV 
dyssynchrony (16). 
Factors infl uencing RV dyssynchrony in ARVD/C 
The presence of RV dyssynchrony is not surprising given previous and recent knowledge about 
the pathophysiology of ARVD/C. Recent data on potential causal genes suggest that most 
mutations involve genes that encode desmosomal proteins and include but are not limited to 
desmoplakin, plakophilin 2 and desmoglein (17-19). Thus ARVD/C is considered a desmopathy 
that is likely associated with abnormal cell to cell coupling, both electrically and mechanically, 
providing the substrate for the RV dyssynchrony. 
Akin to LV dysfunction, electrical conduction abnormalities in the RV could be associated 
with mechanical delays. However, in our cohort we found no diff erences in QRS duration and/or 
the presence of right bundle branch block between patients with and without RV dyssynchrony. 
Although in general the presence of mechanical dyssynchrony is related to intra-ventricular 
conduction abnormalities, substantial LV ventricular dyssynchrony has been previously dem-
onstrated in the absence of QRS prolongation (20,21). Thus ARVD/C may be another example 
of dyssynchrony with a narrow QRS. Another potential explanation may be that in ARVD/C, 
ventricular dyssynchrony is more related to regional and heterogeneous abnormalities in 
conduction and contractility, not evident on a surface ECG (22).  
In contrast to the lack of association between electrocardiographic abnormalities and dys-
synchrony, RV morphology and function appeared to be related to RV dyssynchrony. Larger 
RVEDA and RVESA were noted in the patients with RV dyssynchrony. However, this relationship 
was not as strong as previously reported in patients with pulmonary hypertension (r=0.70, 
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p<0.001 between RVEDA and RV dyssynchrony) (23). One potential reason for a weaker 
relationship could be the diff erence in pathology. ARVD/C is a patchy infi ltrative process with 
regional dilatation while pulmonary hypertension (pressure overload) aff ects the RV globally 
and is more likely to cause uniform chamber dilatation in the load-sensitive RV (24). 
Similar to dyssynchrony associated with LV failure (20,25), our data indicate a relationship 
between RV function, as determined by RVFAC and RV peak systolic strain, and RV dyssynchrony 
in ARVD/C. These fi ndings are also in line with previous studies in patients with pulmonary 
hypertension (7,23) and systolic heart failure (15). Finally, fi brofatty infi ltration in ARVD/C could 
involve the conduction system and thereby introduce electro-mechanical delays resulting in 
dyssynchrony. Similar relationships have been examined in ischemic cardiomyopathy where 
signifi cant amounts of fi brosis result in the presence of mechanical dyssynchrony (22). 
Our fi ndings present several incremental points of knowledge concerning ARVD/C that 
could be potentially used for prognostic and therapeutic purposes. In patients with LV failure, 
the presence of signifi cant ventricular dyssynchrony is associated with a worse prognosis (10). 
Dyssynchrony in ARVD/C may similarly predict worse clinical outcomes. Serial monitoring of RV 
dyssynchrony may identify patients at higher risk and deserving of aggressive therapy. Cardiac 
resynchronization therapy has improved symptoms and survival in dyssynchronous left heart 
failure (8,26). The presence of signifi cant RV or interventricular dyssynchrony may introduce 
the possibility of resynchronization therapy for right sided failure in patients with ARVD/C who 
would otherwise be transplant candidates. However, more prospective studies are needed to 
further elucidate the clinical implications of the presence of RV dyssynchrony in ARVD/C. 
Limitations
The mean age of the control group was lower than the ARVD/C patients. This may aff ect the 
defi nition of RV dyssynchrony for the ARVD/C patients. However, it has been demonstrated 
that ventricular dyssynchrony does not depend on age (27). In addition, LV dyssynchrony was 
comparable between the controls and the ARVD/C patients in the present study. Lastly, we 
strictly selected healthy normal controls since a previous defi nition for RV dyssynchrony was 
not available. Older controls tended to have medical conditions such as hypertension and 
diabetes, whose eff ects on RV dyssynchrony are unclear and were therefore excluded from the 
normal group. Larger studies with the power to assess the infl uence of other co-morbidities 
should ideally include an age-matched control group. 
Furthermore, in the present study only TDE was used to defi ne interventricular dyssyn-
chrony. Interventricular dyssynchrony, calculated as the time diff erence between RV and LV 
pre-ejection intervals may have also provided additional information. However, RV outfl ow 
Doppler was not consistently performed in a fair number of subjects and we are unable to 
assess this parameter in our population. 
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Duration of disease is likely an important factor in the development of RV dyssynchrony in 
ARVD/C. However, determining the onset and duration of disease in this relatively asymptom-
atic group is challenging. We are therefore unable to evaluate its infl uence on RV dyssynchrony. 
Similarly, the extent of fi brofatty infi ltration may be an important factor in the pathogenesis 
of RV dyssynchrony in ARVD/C patients. In a small subset of patients enrolled in the present 
study, who also had clinical magnetic resonance imaging, we found no correlation between the 
extent of fi brofatty infi ltration (as assessed by gadolinium enhancement) and RV dyssynchrony. 
These data were not presented due to the small sample size and lack of statistical power to off er 
reliable conclusions. 
Finally, although the present study is the fi rst observational study that demonstrates the 
presence of RV dyssynchrony in ARVD/C patients, unfortunately, this cross-sectional analysis 
does not provide insights into the clinical signifi cance of the presence of RV dyssynchrony, and 
its exact role in ARVD/C management remains unclear. However, our fi ndings prompt larger 
longitudinal studies to evaluate the infl uence of dyssynchrony on diagnosis, treatment and 
prognostication of ARVD/C patients including prediction of clinical outcomes such as heart 
failure, potential for arrhythmias and response to treatment. In particular, future studies may 
allow a more systematic assessment of several important factors including but not limited to 
duration of disease and genotype. 
CONCLUSIONS
Signifi cant RV dyssynchrony may occur in up to 50% of ARVD/C patients and is associated with 
RV remodeling and dysfunction rather than electrocardiographic abnormalities. This fi nding 
may have therapeutic and prognostic implications in ARVD/C.  
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ABSTRACT
Valvular heart disease is an important cause of morbidity and mortality. Aortic stenosis and 
mitral regurgitation account for the majority of patients with native valve disease. Although sur-
gical treatment provides satisfactory outcome, a large proportion of patients do not undergo a 
surgical intervention, because of the high estimated operative risk and multiple co-morbidities. 
Recently, new techniques that enable percutaneous treatment of valvular heart disease 
have been developed and their feasibility has been reported in several studies. All techniques 
target a minimal invasive procedure with a low risk of procedure related complications. In this 
manuscript, an overview of the various percutaneous procedures for mitral and aortic valve 
disease will be provided. In addition, an update on the ongoing trials in percutaneous valve 
procedures will be presented. Finally, the role of imaging in performing percutaneous valve 





Valvular heart disease is an important cause of morbidity and mortality. Aortic stenosis (AS) and 
mitral regurgitation (MR) account for the majority of native valve disease (1,2). Although surgi-
cal treatment has good outcome in most patients, operative risk may be high due to age and 
co-morbidity. Importantly, a large proportion of patients (in particular with AS) are not referred 
for surgery. Data from the recent Euro Heart Survey on valvuluar heart disease, revealed that up 
to 30% of the patients with severe valvular disease did not undergo surgery, although an indi-
cation existed (3). The high estimated operative risk, multiple co-morbidities and patient’s age 
are the main reasons for denial of surgery. Therefore, there is a need for alternative procedures, 
particularly in the elderly. 
Over the past few years, techniques for percutaneous valve repair and replacement have 
been developed and feasibility has been reported in numerous studies, both in animal models 
and randomized trials in patients (4). All techniques target a minimal invasive procedure with 
a low risk of complications. This review provides an overview of the various percutaneous 
procedures for mitral and aortic valve disease and a summary of the ongoing trials. Moreover, 
the role of imaging in these percutaneous valve procedures is also discussed.
PERCUTANEOUS MITRAL PROCEDURES
Several percutaneous approaches for the treatment of mitral valve (MV) stenosis and MR are 
available. The fi eld of percutaneous MV repair has many important diff erences compared to per-
cutaneous aortic valve (AV) replacement. The anatomy or mechanism of MR may involve one or 
more elements of the MV apparatus. The patient population, depending on the mechanism of 
regurgitation, can vary in age, co-morbidities and symptomatology. The timing of intervention 
and the goals (or endpoints) of treatment are also less well defi ned. The surgical “gold standard” 
is not as readily identifi able when diff erent mechanisms of MR are critically analyzed. Therefore, 
the development and evaluation of MV technologies pose unique challenges compared to the 
percutaneous AV replacement. The diff erent percutaneous MV procedures are summarized in 
Table 1, and will be discussed in the following paragraphs. 
Percutaneous mitral commissurotomy 
Balloon commissurotomy is now an accepted therapy for selected patients with rheumatic 
mitral stenosis (1,2). It has been shown that percutaneous mitral commissurotomy provides 
excellent early hemodynamic eff ects, and a lower rate of residual stenosis and restenosis as 
compared with surgical mitral commissurotomy (5). Currently, percutaneous mitral commis-
surotomy is typically performed utilizing the Inoue technique with transseptal access to the 
left atrium and antegrade access to the MV and the use of a self-seating balloon (6). The goal 
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is to produce a controlled tear of the fused MV commisures. Since this is a well-established 
procedure, and has been studied extensively, percutaneous balloon mitral commissurotomy 
will not be reviewed in detail here.
Paravalvular leak closure 
Paravalvular leaks may occur following surgical valve replacement due to suture dehiscence, 
endocarditis or technical errors. When regurgitation is hemodynamically signifi cant or results in 
clinically important hemolysis, percutaneous closure may off er an alternative to re-operation in 
high risk patients and patients with contraindications for surgery (7). Only selected defects are 
suitable for percutaneous closure. In general, multiple defects, defects that measure above 8 
mm in diameter, or extend over a broad circumference of the valve, cannot be eff ectively dealt 
with. A variety of implantable devices have been utilized. At present, coils are favored for very 
small defects, patent ductus devices for medium defects and atrial septal occluders for larger 
defects. However, more experience is needed to fully understand the best strategy and optimal 
approach for patients with paravalvular leakage (7). 
Leafl et repair (Edge-to-edge) 
The most advanced percutaneous mitral repair procedure is the edge-to-edge repair proce-
dure with the Evalve Percutaneous Mitral Repair System or MitraClip® device (Evalve Inc., Menlo 
Table 1. Percutaneous mitral valve procedures reported to date
Approach
Device Feature Company Status
Leafl et repair
MitraClip Edge-to-edge clip Evalve Pivotal
Mobius Edge-to-edge suture Edwards Lifesciences On hold
Coronary sinus annuloplasty
MONARC Delayed eff ect Edwards Lifesciences Clinical data
PTMA Late adjustment Viacor Clinical data
Carillon Adjustable Cardiac Dimensions Clinical data
Direct remodeling
Coapsys Transmyocardial cord 
(minimal invasive)
Myocor Clinical data 
iCoapsys Transmyocardial cord Myocor Clinical data
PS3 Transatrial cord Ample Medical Clinical data
Annular plication
Mitralign Left ventricular procedure Mitralign Preclinical
Accucinch Left ventricular procedure Guided Delivery Systems Preclinical
Annular shrinking
QuantumCor Radiofrequency QuantumCor Preclinical
Valve replacement




Park, CA) modeled after a surgical procedure which has been shown to be eff ective in selected 
patients (8). Alfi eri surgical repair involves suturing a small segment of the anterior mitral leafl et 
to the posterior leafl et. The result is a double-orifi ce MV with improved leafl et coaptation. The 
percutaneous procedure using the MitraClip device (Figure 1) involves transseptal cannulation 
of the left atrium, and positioning of the delivery catheter perpendicular to the MV. During 
echocardiographic guidance, a clip is placed to appose the anterior and posterior MV leafl ets, 
creating a double-orifi ce valve (9). An example of the percutaneous edge-to-edge repair with 
the use of the MitraClip is shown in Figure 2. 
A similar procedure utilizing percutaneously placed sutures (MobiusTM, Edwards Life-
sciences Inc., Irvine, CA) has been reported (10). However clinical trials have been put on hold 
due to the technical diffi  culty of suture placement and poor durability. 
 
Figure 1. The MitraClip device is a 2-armed, polyester-covered, soft tissue–fi xation device (left panel). The outside dimension when closed is 
4 mm; in the grasping position, the 2 “arms” span about 20 mm. In the open position, it is used to grasp and immobilize the central mitral leafl et 
scallops by retraction of the delivery catheter. Each arm has an opposing “gripper” that aids in securing the leafl ets in the clip by means of small, 
multipronged friction elements. All these elements are clearly visible on fl uoroscopy (right panel).
Figure 2. Outline of the percutaneous MV repair procedure (MitraClip) using fl uoroscopic and echo guidance. Severe MR is seen by 
transthoracic and transesophageal echocardiography (panel A). The device sheath is placed in the left atrium after transseptal puncture (panel 
B). The clip is advanced just above the MV in the closed confi guration (panel C). The MitraClip is then opened in the left atrium (panel D) and 
advanced into the left ventricle (panel E). Subsequently, the clip is pulled back in systole to stabilize the MV leafl ets (panel F), the grippers are 
quickly lowered and the clip is closed (panel G). After confi rming that the leafl ets are adequately captured between an arm on the ventricular 
side and a gripper on the atrial side, the clip is closed in a locked position. Once a functioning double-orifi ce mitral valve is confi rmed with 
echocardiography, the clip is detached (panel H). There is minimal MR after the procedure with excellent procedural outcome.
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Coronary sinus annuloplasty 
This approach is based on the close anatomical relation of the mitral annulus with the coronary 
sinus. Several devices for this approach exist. The MONARCTM device (Edwards Lifesciences Inc.) 
consists of a nickel titanium alloy (nitinol) implant (11). The implant itself is comprised of three 
sections; a distal self-expanding anchor, a spring-like ‘bridge’, and a proximal self-expanding 
anchor (Figure 3). The distal anchor is deployed in the great cardiac vein and the proximal anchor 
is deployed in the proximal coronary sinus. The bridge has shape memory properties that result 
in shortening forces at body temperature. Biodegradable suture is interwoven in the spring like 
bridge section, initially preventing shortening. Following implantation the suture degrades 
allowing the bridge section to shorten. The anchors draw the proximal coronary sinus and distal 
great cardiac vein together while the bridge section tenses and straightens indirectly displacing 
the posterior annulus anteriorly and reducing mitral annulus diameter and septal-lateral distance. 
The Percutaneous Transvenous Mitral Annuloplasty system (PTMATM, Viacor Inc., Wilming-
ton, MA) utilizes an indwelling catheter placed within the coronary sinus (12). Wire-like implants 
can be placed into the coronary sinus via the catheter system. A potential advantage of the 
system is the ability to add or remove rods to vary the eff ect of the device. Late adjustment is 
possible by surgically accessing the closed system from a subclavicular pocket. 
Figure 3. The MONARC device consists of two self-expanding stent-like anchors which are implanted in the coronary sinus (upper panel). 
The anchors are joined by a longer bridge segment which is designed to gradually shorten after implantation. As this occurs the anchors are 
drawn together shortening the coronary sinus and the adjacent posterior mitral annulus. The lower panel demonstrates the position of the 




The CARILLON™ Mitral Contour System (Cardiac Dimensions Inc., Kirkland, WA) consists of 
a steel wire shaped with distal and proximal stent like anchors (13). The length of the central 
connector segment can be varied at the time of implantation to adapt the degree of shortening 
of the coronary sinus. Advantages of the device include the ability to adjust or remove the 
device at the time of implantation. 
Direct remodeling 
Several percutaneous techniques for direct remodeling of the left ventricle and the MV for 
the treatment of MR are in early testing stages. The Coapsys® and iCoapsysTM devices (Myocor® 
Inc., Maple Grove, MN) target remodeling of the left ventricle as well as the mitral annulus and 
subvalvular apparatus by implantation of a transventricular cord. The Coapsys device (Figure 4) 
consists of three epicardial pads implanted on the exterior surface of the heart at the level of the 
mitral annulus using a surgical approach (14,15). A tether connecting the three anchors can be 
shortened to cause a conformational change in the left ventricle and mitral annulus. Recently, a 
truly percutaneous implanted version of the device entitled iCoapsys has been introduced (16). 
For implantation of the iCoapsys device, a specifi cally designed needle, guidewire and sheath 
are used to obtain controlled access in to the pericardial space. The posterior target zone is 
between the papillary muscle and the P2 segment of the mitral annulus, about two centimeters 
apical to the atrioventricular groove. Once proper alignment is achieved, a needle is passed 
from each catheter into the ventricle. A fl exible wire introduced through the posterior catheter 
is captured by a snare from the anterior catheter. The fl exible wire is used to place the transven-
tricular cord, which is exteriorized through the delivery sheath. Then, the permanent implant 
device is placed over the cord, posterior pad fi rst. Finally, the cord is tightened to achieve the 
desired eff ect, trimmed and the catheters are removed. 
The Percutaneous Septal Shortening System PS3 (Ample Medical Inc., Foster City, CA) 
delivers an implant into the posterior annulus with a tether attached to an atrial septal closure 
device. Both produce anterior movement of the posterior annulus, thereby restoring the line of 
coaptation (17,18). The PS3 system diff ers from the Coapsys system in that it creates a transatrial 
Figure 4. The Coapsys device consists of three epicardial pads and a fl exible chord connecting them (left panel). The right panel 
schematically shows the implantation of the Coapsys device and the fi nal position of the epicardial pads.
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bridge as opposed to a transventricular bridge. The advantages of the PS3 system when 
compared to the transventricular cinching devices include the relative ease of placement and 
avoidance of left circumfl ex coronary artery impingement. However, this transatrial approach 
may not result in additional advantages, such as left ventricular remodeling, as compared with 
the transventricular devices. 
Other percutaneous mitral procedures 
Several other percutaneous procedures in the treatment of MR are being evaluated in pre-
clinical studies (Table 1). Percutaneous procedures that replicate surgical suture plication of 
the posterior mitral annulus have been developed. The Mitralign Direct Annuloplasty SystemTM 
(Mitralign Inc., Salem, NH) and the Accucinch Annuloplasty SystemTM (Guided Delivery Systems 
Inc., Santa Clara, CA) involve catheter access through the AV in order to place various types 
of anchors into the left ventricular aspect of the posterior mitral annulus. These anchors are 
attached by sutures which can then be pulled tight drawing the anchors together and plicating 
the mitral annulus. 
The QuantumCor catheter device (QuantumCor Inc., Lake Forest, CA) targets remodeling of 
the MV annulus by delivery of radiofrequency energy directly to the tissue. 
The Endovalve Mitral Valve Replacement System (Endovalve Inc., Princeton, NJ) is a pros-
thetic valve folded in into a catheter and delivered antegrade through transseptal access. The 
fi rst animal study has shown the feasibility of the device, and more results are eagerly awaited. 
PERCUTANEOUS AORTIC PROCEDURES 
The diff erent percutaneous AV procedures will be discussed in the following paragraphs and 
are summarized in Table 2.
Aortic valvuloplasty 
Current guidelines indicate that aortic valvuloplasty might be useful as a bridge to surgery 
or as palliation in non-surgical candidates (1,2). The procedure is generally performed utiliz-
ing retrograde access from the femoral artery, although some operators prefer an antegrade, 
transseptal approach. Since the fi rst reports of this procedure more than 20 years ago (19), vari-
ous procedural enhancements such as lower profi le balloons and sheaths, more appropriate 
Table 2. Percutaneous aortic valve procedures reported to date 
Approach Device Feature Company Status
Valve implantation
Cribier-Edwards valve Balloon expandable Edwards Lifesciences Clinical data
SAPIEN valve Balloon expandable Edwards Lifesciences Clinical data




balloon sizing in relation to annulus diameter, and burst pacing to reduce balloon and cardiac 
movement during balloon infl ation, may have improved outcome beyond that encountered in 
the early reported experience (6). Nonetheless, no survival benefi t after balloon valvuloplasty 
has been shown (20). Therefore, at present AV balloon valvuloplasty plays a limited role in the 
management of degenerative AS.
Aortic valve implantation 
The balloon expandable percutaneous AV was fi rst tested in 1992 by Andersen et al. in an 
animal model (21). The subsequent initial human implantation was performed by Cribier et al. 
in 2002, via an antegrade approach, in a 57-year old man with calcifi c AS and cardiogenic shock 
(22). Immediately after valve implantation, the patient’s hemodynamic conditions improved 
markedly with good valve function. The valve performed well over the next four months, 
although the patient died from complications unrelated to the procedure or the prosthetic 
valve. At present, two types of catheter delivered aortic prosthetic valves are available and have 
seen extensive clinical use. 
The fi rst is the balloon-expandable Edwards SAPIEN valve (Edwards Lifesciences Inc.), suc-
cessor of the initially used Cribier-Edwards valve (Figure 5). It incorporates a balloon-expandable 
stainless steel stent, fabric sealing cuff  and bovine pericardial leafl ets. Current prosthesis sizes 
include 23 and 26 mm expanded size for aortic annulus diameters between 18 to 22 mm and 21 
to 25 mm, respectively. Typically, a balloon valvuloplasty is performed fi rst, and subsequently 
the prosthesis is deployed; both processes are performed during rapid right ventricular pacing 
(23). Initial procedures were performed utilizing femoral venous puncture, transseptal access 
to the left atrium and passage through the MV to reach the AV (22,24). However, the antegrade 
delivery of the AV has a potential drawback of damaging the anterior mitral leafl et as the valve 
traverses through the left atrium to the aorta. Currently, a retrograde approach from the femo-
ral artery is preferred (25,26). Recently an alternative, transapical approach has been proposed 
Figure 5. The Edwards balloon expandable prosthetic valve is constructed of a stainless steel stent, bovine pericardial leafl ets and a fabric 
sealing cuff .
284
in patients with extensive femoral artery disease. After an intercostal incision, direct puncture 
of the apical portion of the left ventricular free wall is performed to gain catheter access to the 
left ventricle and AV (27). 
The other type of catheter delivered aortic prosthetic valve is the CoreValve ReValving 
systemTM (CoreValve Inc, Irvine, CA), consisting of a self-expanding nitinol alloy stent with a 
pericardial sealing cuff  and leafl ets (Figure 6). The device is constrained within a delivery 
sheath, expanding to its predetermined shape when the sheath is withdrawn (28). The Core-
Valve total length is 50 mm, and it has a specifi c design features with a waist in the middle 
part. The lower part of the valve is designed to expand using high radial forces; the middle 
part includes the pericardial tissue valve and is constrained to avoid coronary occlusion. The 
upper part of the prosthesis enables fi xation in the ascending aorta. While the fi rst-generation 
device used bovine pericardial tissue and was constrained within a 24F delivery sheath, the 
second-generation device incorporated a porcine pericardial tissue valve within a 21F sheath. 
The fi rst generation CoreValve was limited to an ascending aorta diameter of 30 mm, whereas 
the broader upper section of the second-generation device allowed for its deployment in an 
ascending aorta up to 45 mm diameter. Currently, third-generation (18F) prostheses are avail-
able with an inner valve diameter of 21 mm. The CoreValve is typically implanted retrograde 
from the femoral artery under fl uoroscopic guidance, and a cardiac assist device, extracorporal 
membrane oxygenation or a full-bypass support was used in the fi rst series (29). However, at 
present, the CoreValve is implanted without cardiac assist or full-bypass support. In May 2007, 
the CoreValve became the fi rst percutaneous valve to receive CE mark approval in Europe. 
Finally, many new percutaneous valves such as Lotus™ Valve System (Sadra Medical Inc., 
Campbell, CA), and the percutaneous AV from Direct Flow Inc. (Santa Rosa, CA), AorTx Inc. (Palo 




Alto, CA) and Heart Leafl et Inc. (Maple Grove, MN) are also entering early human studies. The 
hope is that these newer valve technologies will improve on fi rst-generation devices by using 
collapsible, infl atable valve frames for repositioning before fi nal deployment and hopefully a 
smaller size for easy deliverability. 
(PRE)CLINICAL STUDIES AND TRIALS ON PERCUTANEOUS VALVE 
PROCEDURES 
The introduction of new technology typically involves preclinical developmental studies, phase 
I and phase II clinical trials. In general, it should be noted that only limited numbers of patients 
have been treated with percutaneous valve procedures, and that a clear learning curve for 
performing these procedures is present. In the following paragraphs, the reported studies and 
ongoing clinical trials for both percutaneous MV and AV procedures will be discussed.
Percutaneous mitral valve procedures
Leafl et repair (Edge-to-edge) For this percutaneous MV repair approach, the MitraClip is 
the most commonly used device. Preclinical data from a porcine model was fi rst published 
in 2003 (9). Complete endothelialization and encapsulation of the clip was seen with no clip 
embolization or thromboembolism. The phase I prospective, multi-center safety and feasibility 
trial entitled EVEREST (Endovascular Valve Edge-to-Edge Repair Study) has been reported in 
2005, with short-term and six-month results in the fi rst 27 patients (30). All patients enrolled 
were candidates for MV surgery and had MR that was centered between A2 and P2, meeting 
prespecifi ed parameters for fl ail dimensions or leafl et tethering to ensure device capture of 
the leafl ets. Most patients had degenerative MV disease (n = 25, 93%). Successful deployment 
of the clips was achieved in 24 of the 27 patients (89%). Partial clip detachment (n = 3), severe 
residual MR (n = 2) and device malfunction (n = 1), required MV surgery after initial successful 
percutaneous clip implantation. Now that the capability to place two clips has been introduced, 
residual MR may become less common. Of the 27 initial patients in the EVEREST trial, 13 patients 
(48%) remained with MR grade 2+ or less at six months follow-up. One year follow-up on these 
patients shows a durable reduction in MR if initial procedural success is achieved (Figure 7) 
(31). The primary safety endpoint of EVEREST I was freedom from death, myocardial infarction, 
cardiac tamponade, cardiac surgery for failed clip, clip detachment, stroke or septicemia. A 
prespecifi ed event rate of 34.4% was expected based on comparison to surgical event rates, 
however only 15% of patients had a major adverse event (clip detachment n = 3; stroke n = 
1). The pivotal phase II trial has been initiated (EVEREST II) comparing percutaneous MV repair 
approach to standard cardiac surgery. The study design is a prospective, multicenter, random-
ized, controlled trial with a 2:1 randomization to study and control arms, respectively (Table 3). 
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Coronary sinus annuloplasty As discussed in previous paragraphs, several devices are avail-
able, each with specifi c features. The MONARC system has recently been implanted in patients 
with chronic ischemic MR. Initial results in humans showed successful implantation in four of 
fi ve patients, with one failure leading to coronary sinus perforation. However, separation of the 
nitinol bridge segment was observed in three of four patients, and no signifi cant changes in MR 
grade or mitral annulus diameter were found at follow-up (11). With additional animal experi-
ence showing improved results with the new device design, a trial using the MONARC device 
has started enrolling functional MR patients. The EVOLUTION trial, a multi-center feasibility and 
safety study in Europe and Canada, has begun with a primary safety objective of procedural 
success and 30-day safety, and a 90-day effi  cacy endpoint of reduction in MR by one grade 
(Table 3). Preliminary results were recently presented, showing successful implantation in 32 of 
36 patients (89%). Preliminary effi  cacy data indicate the effi  cacy endpoint (MR reduction by 1 
grade at 90 days) was met in 9 of 17 patients analyzed (53%) (32). 
The PTMA system has also been reported to eff ectively reduce severe MR. In a sheep model 
of ischemic MR a single rod resulted in immediate reduction of MR from grade 3+ or 4+ to 
grade 0 or 1+ in all animals. A reduction of the mitral annulus diameter was observed (pre-
insertion 30 ± 2 mm vs. post-insertion 24 ± 2 mm, p<0.03), without any sign of mitral stenosis 
(12). Human implantation has been performed in patients undergoing open heart surgery for 
ischemic MR (33). In four patients who had attempted implantation of the multi-lumen device, 
there was successful delivery in only three patients. The mitral annulus anterior-posterior 
diameter decreased from 41 ± 4 mm to 35 ± 2 mm, resulting in a reduction in MR from grade 2 
or 3+ to 1+. Unfortunately, the PTMA device could not be implanted permanently (33). Further 
short- and long-term human data, including the PTOLEMY trial (Table 3), are pending. 
Figure 7. After 12 months follow-up, a signifi cant improvement in MR grade (panel A) and left ventricular (LV) end-diastolic volume (panel 
B) was observed in 46 patients with severe MR treated with percutaneous edge-to-edge repair (MitraClip). Mitral regurgitation grade decreased 
from 3.2 ± 0.7 to 1.8 ± 0.9 (p<0.001), and LV end-diastolic volume decreased from 172 ± 43 to 146 ± 36 (p<0.001) indicating a sustained 




Table 3. Ongoing trials on percutaneous valve procedures
Name Device Type Design Sample 
Size
Primary Endpoint Comment
Percutaneous mitral valve procedures






MV repair / 
replacement
390 Safety: Freedom 
from MAE (30 days) 
Effi  cacy: Freedom 
from surgery for 
valve dysfunction, 
death, and 3+ or 
4+ MR













70 Safety: Freedom 
from MAE (30 days) 
Effi  cacy: Freedom 
from surgery for 
valve dysfunction, 











120 Clinical Endpoints 
and quality of life 
indicators

































250 Safety: Freedom 
from MAE (12 
months) 
Effi  cacy: Mean 
change in MR grade 
Concomitant 
coronary artery 











Enrollment not yet 
started













AVR vs. no 
AVR
250 1-year mortality Group B: Inoperable 
patients
AMADEUS = cArillon Mitral Annuloplasty Device European Union Study; AVR = aortic valve replacement; EVEREST = Endovascular Valve 
Edge-to-Edge REpair STudy; MAE = major adverse events; MR = mitral regurgitation; PARTNER = Placement of AoRTic TraNscathetER Valve 
trial; RESTOR-MV = Randomized Evaluation of a Surgical Treatment for Off -pump Repair of the Mitral Valve; VIVID = Valvular and Ventricular 
Improvement Via iCoapsys Delivery.
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The initial preclinical testing of the CARILLON system indicated that there were anatomical, 
design and safety issues with this coronary sinus device, as three of twelve dogs had left circum-
fl ex coronary artery ischemia, causing fatality in two dogs (13). Nonetheless, in the seven dogs 
with successful implantation, a reduction in mitral annular size at four weeks follow-up was 
observed compared to those with unsuccessful implantation (33.7 ± 2.3 mm vs. 37.3 ± 1.1 mm, 
p<0.05) (13). Subsequent experiments were done in an ovine model, demonstrating favorable 
acute hemodynamic eff ects and no mortality (34). A multi-center human safety and feasibility 
study is currently underway in Europe entitled AMADEUS (cArillon Mitral Annuloplasty Device 
European Union Study), enrolling patients with grade 2+ to 4+ functional MR and NYHA class 
II to IV. A Phase I investigational device exemption study entitled COMPETENT targets a similar 
patient population in the United States and is designed to assess hemodynamics, quality of life, 
and exercise tolerance (Table 3). 
Direct remodeling There are several other approaches to percutaneous treatment of MR that 
are being evaluated (Table 1). The Coapsys, iCoapsys and PS3 system have both proven feasible 
in animal and human studies and therefore are discussed at some length in the following 
paragraphs. 
The Coapsys system involves surgical placement of pericardial implants off -pump. These 
implants are placed on each side of the heart, with a tethering subvalvular cord that crosses 
the ventricle directly. This cord is then cinched up to decrease the septal-to-lateral diameter 
and eliminate MR. In initial animal studies using a canine tachycardia-model of functional MR 
(n = 10), this device reduced the mean MR grade from 2.9 ± 0.7 to 0.6 ± 0.7 (p<0.001), without 
adverse consequence on ventricular function (14). The safety and effi  cacy of the Coapsys device 
has also been demonstrated in humans. In 11 patients a sustained benefi t after 12 months 
follow-up on the severity of MR (from grade 2.9 ± 0.5 to 1.1 ± 0.6, p<0.05) and NYHA functional 
class (from 2.5 ± 0.5 to 1.2 ± 0.4, p<0.05) has been shown (15). The Randomized Evaluation 
of a Surgical Treatment for Off -pump Repair of the Mitral Valve trial (RESTOR-MV) is enrolling 
patients with coronary artery disease and ischemic MR, who undergo coronary artery bypass 
grafting combined with either traditional MV repair or Coapsys device placement (Table 3). 
Intra-operative results from this trial have been reported in the fi rst 19 patients receiving 
the implant, showing a reduction in MR after implantation from grade 2.7 ± 0.8 to 0.4 ± 0.7 
(p<0.001). All implants were performed successfully without cardiopulmonary bypass and no 
hemodynamic compromise or structural damage to the mitral apparatus was experienced (35). 
A similar system is currently under development for percutaneous use (iCoapsys). The device 
is implanted percutaneously through a pericardial access sheath, as previously described. 
The device was initially tested in a canine model (n = 8), achieving a reduction in MR grade 
from 3.2 to 0.7 (16). However, in the fi rst animal studies, device placement was complicated 
and it has been redesigned to more closely mimic the surgically-placed device. The iCoapsys 




percutaneous coronary intervention. This device theoretically provides a more comprehensive 
mechanism of action, preserving normal valve dynamics, and addressing the mitral annulus as 
well as the subvalvular space and abnormal left ventricular geometry. This geometric reshaping 
of the ventricle may be advantageous to ventricular function and remodeling and is unique to 
this device. The Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility 
Study will assess the safety and effi  cacy of the iCoapsys device in humans and is expected to be 
launched soon (Table 3). 
The PS3 system utilizes the coronary sinus and a septal closure device to place a cord 
across the atrium, create tension on the annulus, and subsequently reduce the septal-to-lateral 
dimension. This device has been applied to an ovine model of tachycardia-induced cardiomy-
opathy created by rapid right ventricular pacing (17). The degree of reduction in functional 
MR, and in the septal-lateral systolic distance, was the primary effi  cacy measure of this study. 
Sheep underwent short-term (n = 19) and long-term (n = 4) evaluation after implantation. 
The PS3 system was successfully implanted in all animals with no evidence of left circumfl ex 
coronary artery impingement and maintenance of coronary sinus patency. The short-term 
results indicated a signifi cant reduction in septal-lateral diameter from 32.5 ± 3.5 mm to 24.6 
± 2.4 mm post-procedure (p<0.001). This was maintained at 30-days in the long-term animals 
(septal-lateral diameter 25.3 ± 0.8 mm after 30 days). The results for reduction in MR in the 
short-term animals were similar, with an MR grade of 2.1 ± 0.6 pre-procedure versus 0.4 ± 0.4 
post-procedure (p<0.001). This result was maintained at 30-days follow-up (mean MR grade 0.2 
± 0.1). Additional hemodynamic and laboratory data were consistent with improved cardiac 
function (17). 
Recently, the results of the fi rst-in-human feasibility study of the PS3 system have been 
reported. In two patients with MR referred for surgical MV repair, the percutaneous PS3 system 
was implanted successfully before the conventional surgical procedure. Both MR severity and 
septal-to-lateral diameter decreased after device implantation. No coronary impingement was 
noted and surgery confi rmed good device position, without complications (18). Larger studies 
are needed to fully appreciate the strengths and limitations of the PS3 system. 
Percutaneous aortic valve procedures 
Balloon-expanding valve: Cribier-Edwards Valve After extensive testing in animal models (21) 
and a successful fi rst-in-man experience (22), a single center Phase 1 project was started in 
2003 for compassionate use of the Cribier-Edwards valve in patients with end-stage AS (24,36). 
These patients had been formally evaluated by two cardiothoracic surgeons and deemed to be 
unsuitable for surgical AV replacement. Thirty-six patients were enrolled in the Initial Registry 
of EndoVascular Implantation of Valves in Europe (I-REVIVE) trial which was followed by the 
Registry of Endovascular Critical Aortic Stenosis Treatment (RECAST) trial (36). Twenty seven 
of these patients underwent successful percutaneous AV implantation without coronary 
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occlusion or disruption of MV architecture. Of these, antegrade approach was successful in 
85% (23 of 26 patients) and retrograde approach in 57% (4 of 7 patients). The noteworthy 
procedural limitations were prosthesis migration/embolization, failure to cross the stenotic 
AV and para-valvular aortic regurgitation. Anatomic and functional success was obtained as 
evidenced by an improvement in aortic valve area (AVA) from 0.60 ± 0.11 cm2 to 1.70 ± 0.10 cm2 
(p<0.001), an increase in left ventricular ejection fraction (from 45 ± 18% to 53 ± 14%, p<0.05), 
and an improved NHYA functional class (from IV to I-II in over 90% of patients). Importantly, the 
improvement in AVA and mean aortic gradient was maintained at 24 months and the maxi-
mum improvement in left ventricular ejection fraction was observed in patients with depressed 
systolic function at baseline. The 30-day mortality was 22% (6 of 27 patients). Eleven patients 
were alive at nine months follow-up, and no device related deaths occurred up to 26 months 
after implantation (36). 
In their fi rst cohort, Webb et al. successfully implanted the Cribier-Edwards valve in 14 of 
18 patients who had previously been deemed unsuitable for surgical valve replacement (25). 
The AVA increased from 0.6 ± 0.2 to 1.6 ± 0.4 cm2 (p<0.001), and remained stable at one month 
follow-up. The early mortality was 11% (2 of 18) and short-term survival was 89% (16 of 18) 
at a mean of 75 days follow-up (25). The same group subsequently reported both short- and 
mid-term outcomes in an extended cohort of 50 patients who underwent percutaneous 
Cribier-Edwards valve implantation via a retrograde approach (26). Valve implantation was 
successful in 43 patients (86%) and the reasons for procedural failure were similar to those pre-
viously reported (36). The main diff erence was in the frequency of the vascular complications 
with the retrograde approach. In 43 patients who had successful implant, the 30-day mortality 
was 12% (5 of 43 patients) compared to expected mortality of 28% according to the logistic 
EuroScore. Of interest, there was a clear dichotomy in both procedural success and 30-day 
mortality, representing the learning curve. Procedural success increased from 76% in the fi rst 
25 patients to 96% in the second 25, and 30-day mortality fell from 16% to 8%. Importantly, no 
patients needed open heart surgery in the fi rst 30 days. There were no subsequent deaths and 
at median follow-up of 359 days, 81% of the patients who underwent successful transcatheter 
AV replacement were alive. Additionally, there was a signifi cant improvement in AVA and NYHA 
functional class (Figure 8) with durability of these parameters at one-year follow-up (26). 
In addition, the feasibility of transapical implantation of the Cribier-Edwards valve has been 
shown. Lichtenstein et al. successfully implanted the valve in seven patients unsuitable for 
open heart surgery and for percutaneous transfemoral AV implantation, secondary to severe 
aorto-iliac disease (27). This was a very high-risk elderly population (mean age 77 ± 9 years) 
with poor functional class (mean NYHA III) and high logistic EuroScore (mean 35 ± 26%). After 
implantation, the AVA increased from 0.7 ± 0.1 cm2 to 1.8 ± 0.8 cm2 and the mean AV gradient 
decreased from 31 ± 10 to 9 ± 6 mmHg. These parameters remained stable up to six months 




In another recent study, Walther et al. successfully used the transapical approach for 
implantation of the prosthesis in 55 of 59 (93.2%) elderly patients (mean age 81 ± 6 years) 
with a poor functional class (NYHA III-IV), high mean logistic EuroScore (27 ± 14%), and severe 
calcifi ed AS (mean AVA 0.5 ± 0.2 cm2) (37). After successful implantation, echocardiography 
revealed good valve function (mean AV gradient 9 ± 6 mmHg) with minor paravalvular leakage 
in 17 patients. At a mean follow-up of 110 ± 77 days (range 1 - 255 days) 78% of the patients 
were alive. It is evident from these series that device and technique related shortcomings can 
be readily addressed and to date over 500 Edwards percutaneous valves have been deployed 
worldwide, with high technical success. Importantly, use of the larger valve (26 mm) seems to 
be related to less para-valvular aortic regurgitation. 
Balloon-expanding valve: Edwards SAPIEN valve Initial results of the feasibility trial in the 
United States were presented at the 2007 TCT meeting (38). In this series, retrograde delivery 
was successful in 47 of 54 patients (87%). The intent-to-treat analysis of all 54 patients showed 
a 30-day mortality of 7.4% with a 30-day major adverse cardiac events rate of 16.7%. After this 
initial feasibility trial, a pivotal randomized multi-center trial, entitled PARTNER (Placement of 
AoRTic traNscathetER valves) has been started in North America and Europe and is projected 
to complete enrollment by the end of 2008 (Table 3). This prospective randomized clinical trial 
will enroll 600 patients in 2 separate treatment arms. The surgical arm of the trial is compar-
ing the SAPIEN valve to standard surgical AV replacement in 350 patients, with the objective 
of demonstrating non-inferiority. The medical management arm of the trial will compare the 
SAPIEN valve to appropriate medical therapy (including balloon valvuloplasty) in 250 patients 
who are considered too high risk for conventional open heart surgery, with the objective of 
demonstrating superiority of the SAPIEN valve. The primary endpoint in both arms of the trial is 
 
Figure 8. In 50 patients undergoing percutaneous AV replacement, a signifi cant improvement in NYHA functional class was observed after 
1 month (from 3.1 ± 0.6 to 1.7 ± 0.7, p<0.001). This improvement was maintained after 12 months follow-up (panel A). Similarly, aortic valve 
area signifi cantly improved after 1 month (from 0.6 ± 0.2 to 1.7 ± 0.4, p<0.001) and 12 months follow-up (panel B).
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mortality at one year with secondary endpoints that focus on long-term adverse cardiovascular 
events composite, valve performance and quality-of-life indicators. 
Self-expanding valve: CoreValve In 2005, the CoreValve aortic prosthesis was fi rst implanted 
in a patient. The subject was a 73-year old woman with severe calcifi ed AS, NYHA class IV heart 
failure and reduced left ventricular systolic function who was declined surgical AV replacement 
because of extensive co-morbidity (39). At two weeks follow-up her initial hemodynamic 
improvement persisted and she improved to NYHA class II. 
Subsequently, Grube et al. have reported signifi cant advancement in the CoreValve ReValv-
ing system from fi rst-generation to third-generation (28,29). In the pilot study, 25 patients 
underwent CoreValve implantation under general anesthesia with extracorporeal support 
(extracorporeal percutaneous femoro-femoral bypass) using the retrograde approach via a sur-
gical arterial cut-down (28). These patients had been deemed unsuitable for open heart surgery 
by a cardiologist and cardiovascular surgeon. Only fi rst- and second-generation devices were 
used in the pilot study. The patient cohort was elderly (mean age 80 ± 5 years) with NYHA class 
III-IV (96%), a mean AVA of 0.72 ± 0.13 cm2, and a median logistic EuroScore of 11%. Acute pro-
cedural success was achieved in 21 of 25 patients (84%) with a reduction in mean AV gradient, 
and a functional improvement in NYHA class at 30-days follow-up (Figure 9). Interestingly at 
30-days follow-up, 17 of 18 patients (94%) had none or only mild aortic regurgitation. Procedural 
limitations and complications were similar to the Cribier-Edwards valve. Major in-hospital car-
diovascular and cerebral events occurred in 8 patients (32%) whereas major bleeding occurred 
in 5 of 10 patients (50%) treated with the fi rst-generation device and in 1 of 15 patients (7%) 
treated with the second-generation prosthesis. Among 18  patients with device success (82%), 
no further adverse events occurred within 30 days after hospital discharge (28). 
Figure 9. After percutaneous implantation of the CoreValve prosthesis, a signifi cant improvement of mean AV pressure gradient (panel A) 
and NYHA class (panel B) was observed. Mean AV pressure gradient decreased from 44.2 ± 10.8 to 11.8 ± 3.4 mmHg (p<0.001) and NYHA class 




In the second series, the CoreValve was implanted in 50 and 36 patients using second- and 
third-generation devices, respectively (29). The study population included elderly patients 
(mean age 82 ± 6 years) with a poor functional class (83% NYHA class III-IV), high logistic Euro-
Score (22%), and severe calcifi ed AS. Acute device success, which was similar in both groups, 
was achieved in 76 of 86 (88%) patients. After implantation the mean AVA increased signifi -
cantly (from 0.60 ± 0.16 cm2 to 1.67 ± 0.41 cm2, p<0.05) along with an improvement in NYHA 
functional class (from 2.85 ± 0.73 to 1.85 ± 0.60, p<0.001). Peri-procedural rate of death, stroke, 
and myocardial infarction was 14%. Overall 30-day mortality rate was 12%, while the combined 
rate of death, stroke, and myocardial infarction was 22%. Impressively, in patients with device 
and procedural success, the mortality was 9% and 5%, respectively. 
Valve-in-valve concept While the experience with percutaneous AV procedures increases 
rapidly, a new concept has emerged also. Recently, the feasibility of a ‘valve-in-valve’ model 
has been reported for replacement of a aortic and mitral valve xenograft (40). Walther et al. 
implanted conventional aortic and mitral valve prostheses (23 or 25-mm Carpentier Edwards) 
in seven pigs. Subsequently, a transapical puncture was performed for positioning of the repeat 
23 mm transcatheter valve (Edwards SAPIEN). All transcatheter ‘valve-in-valve’ implantations 
were performed successfully and good valve function was demonstrated after the procedure. 
Recently, Grube and coworkers reported the fi rst use of the CoreValve to treat severe aortic 
regurgitation of a degenerated aortic bioprosthesis in an 80-year old man with extensive co-
morbidity and a logistic EuroScore of 36% (41). The insertion of the percutaneous AV using the 
CoreValve resulted in a complete resolution of severe, symptomatic aortic regurgitation of the 
seven-year old aortic bio-prosthesis placed by open heart surgery for severe calcifi ed AS. After 
one year follow-up, the patient is still free of symptoms with good ‘valve-in-valve’ prosthesis 
function (no aortic regurgitation, mean gradient 12 mmHg) (41). 
The ‘valve-in-valve’ concept is of particular interest since re-operation for degenerated 
xenografts may be challenging. The mortality risk for re-operation is signifi cantly higher than 
for fi rst isolated aortic valve replacement (42). Performing a percutaneous procedure when 
the initial AV xenograft has failed does not require re-sternotomy, cardiopulmonary bypass or 
cardioplegic arrest and thus has the potential for a lower morbidity and mortality rate. The 
initial results of the ‘valve-in-valve concept’ in animal models and in humans are promising. 
PERFORMING PERCUTANEOUS VALVE PROCEDURES
In percutaneous valve therapy, both careful selection of potential candidates and thorough 
follow-up after the procedure are of critical importance. In the following paragraphs, the selec-
tion of patients, procedural issues and strategies for follow-up are discussed. 
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Selection of patients 
The success of percutaneous valve procedures depends heavily upon appropriate selection of 
patients for a particular device. Both for percutaneous MV and AV procedures, a comprehensive 
assessment of valve pathology, vascular access and co-morbidity are critical for patient selection. 
Percutaneous mitral procedures Mitral regurgitation can result from many diff erent anatomi-
cal and functional aberrations of the MV, mainly related to annulus dilatation, leafl et prolapse 
or restricted leafl et motion. While percutaneous leafl et edge-to-edge repair is appropriate for 
patients with MR related to leafl et prolapse, the percutaneous coronary sinus mitral annulo-
plasty is more suitable for patients with mitral annulus dilatation (43). Therefore, anatomical 
selection of patients for percutaneous MV procedures is directly dependent on the echocardio-
graphic analysis including the mechanism of MR, leafl et size, coaptation height, annular dimen-
sion and severity of prolapse (44). In addition, for percutaneous coronary sinus annuloplasty, 
proper imaging to defi ne the proximity of the coronary sinus to the mitral annulus and the left 
circumfl ex coronary artery is mandatory (13).
Percutaneous aortic valve procedures In general, the selection of patients for percutaneous 
aortic valve procedures includes several issues. The severity and prognosis of the AS should be 
assessed fi rst. Afterwards, the presence of co-morbidity and surgical risk should be thoroughly 
investigated. If the patient is no surgical candidate, the feasibility of a percutaneous AV proce-
dure should be evaluated, including assessment of vascular access. 
A comprehensive assessment of the patient’s surgical risk with input from cardiologists, car-
diac surgeons and cardiac anesthesiologists is crucial in the selection of potential candidates. 
The initial feasibility experience of percutaneous AV replacement was appropriately restricted 
to patients that were deemed not to be candidates for surgical AV replacement (22,25). 
However, in the ongoing PARTNER trial (Table 3) patients with STS score >10 are randomized 
between surgical or percutaneous AV replacement (group A). Most of these patients have a 
high estimated surgical risk based on age, previous cardiac surgery, renal failure, cerebrovas-
cular disease and pulmonary disease. On the other hand, patients with estimated surgical 
mortality of more than 15% that are deemed inoperable by two surgeons with experience in 
performing high risk AV replacement are randomized between percutaneous AV replacement 
or no AV replacement in Group B (Table 3). Many of these patients have co-morbidities includ-
ing severe chronic obstructive pulmonary disease or anatomical challenges to surgery such 
as porcelain aorta, cardiac chambers or grafts adherent to the sternum. Careful selection and 
a thorough clinical evaluation for the assessment of the surgical risk are therefore essential in 
these patients. 
Extensive calcifi cations and tortuosity of the femoral artery and aorta may hamper position-




be considered (27). Careful screening of vascular access is therefore important in patients 
referred for percutaneous AV replacement. 
Procedure-related issues 
The majority of the technical issues are related to vascular access, transseptal puncture, device 
positioning and deployment. 
Vascular access The vascular access for percutaneous valve procedures may be challenging 
since catheters are often large: mitral balloon valvuloplasty or implantation of a coronary sinus 
device typically requires a 12F venous sheath (external diameter ~5 mm) (11). In contrast, 
percutaneous AV implantation may require a sheath as large as 24F (external diameter ~9 mm) 
(26). Insertion of such a large sheath is associated with a signifi cant potential for vascular injury 
including bleeding, dissection, occlusion and perforation. In 50 high-risk patients undergoing 
percutaneous AV replacement through the femoral artery, vascular injury occurred in 4 patients 
(8%) (26). However, vascular access techniques, equipment and pre-procedural screening may 
reduce this number. 
Transseptal puncture Many percutaneous valve procedures, including mitral valvuloplasty, 
paravalvular leak closure and antegrade aortic valvuloplasty or valve implantation, require a 
transseptal puncture to access the left atrium. Puncture of the interatrial septum is associated 
with a risk of pericardial bleeding and tamponade and may result in residual interatrial shunts. 
By visualizing the interatrial septum and the transseptal puncture needle, intracardiac echo-
cardiography is helpful in performing transseptal punctures safely and at precisely the desired 
locations (45). 
Device positioning and deployment In general, a clear learning curve for performing percu-
taneous valve procedures is present (26,30). During the procedure, various problems can be 
encountered while positioning and deploying the device. For all procedures, passage of bulky 
therapeutic catheters through the cardiac chambers, particularly in compromised patients can 
result in cardiac perforation or provoke arrhythmias, ranging from atrial to ventricular fi brillation. 
In percutaneous edge-to-edge leafl et repair, inappropriate device positioning may result in 
partial clip detachment (30) and should be monitored carefully. In case of unsuccessful percu-
taneous mitral edge-to-edge repair, surgical repair may be needed (30). During percutaneous 
mitral annuloplasty, acute ischemia due to left circumfl ex coronary artery impingement can 
be encountered (13). A paravalvular plug may interfere with mechanical valve leafl ets or may 
become dislodged and embolize requiring a complex percutaneous snaring procedure or even 
unplanned surgery (7). 
In percutaneous AV replacement, technical errors can result in a percutaneous AV being 
implanted within the ventricle or aorta (36). In addition, percutaneous aortic valvuloplasty or 
296
AV replacement may cause injury to adjacent conducting tissue and transient or sustained 
atrioventricular heart block requiring ventricular pacing. Finally, coronary occlusion may occur 
if a bulky native leafl et is displaced over a coronary ostium (25). 
Follow-up 
With the exception of valvuloplasty, little is known on late implications of percutaneous valve 
procedures. A careful follow-up of patients after percutaneous valve procedures is mandatory 
to assess prosthesis function and the presence of residual regurgitation or paravalvular leakage. 
Prosthesis function should be monitored since device fatigue may result in late stent frac-
ture, as has been common with fi rst-generation pulmonary valve implants (46). In the initial 
feasibility study using the coronary sinus annuloplasty for MR, separation of the nitinol bridge 
segment occurred without any adverse clinical events (11). Regular follow-up on prosthesis 
function is therefore mandatory. 
Furthermore, residual regurgitation, paravalvular leakage or failure of the bioprosthetic 
valve may require additional interventions. In a large cohort of 86 patients treated with the 
CoreValve for AS, two patients required an implantation of a second prosthesis (valve-in-valve) 
due to severe residual regurgitation (29). 
Finally, percutaneous implants may have unexpected implications, such as thromboem-
bolism and infection. In addition, the durability of percutaneous valves is currently unknown. 
Therefore, close follow-up of patients after a percutaneous valve procedure is warranted. In 
the reported and the ongoing trials on percutaneous valves, an extensive echocardiogram is 
typically performed for the assessment of prosthesis function and presence of residual regurgi-
tation or paravalvular leakage. 
THE ROLE OF IMAGING IN PERCUTANEOUS VALVE PROCEDURES 
Accurate visualization of the native valve, the prosthesis or device and their relationship is 
crucial before, during and after the percutaneous valve procedure. An overview on the role of 
various imaging modalities in percutaneous valve procedures is provided in Table 4. Several 
imaging modalities are available including echocardiography (transthoracic, transesophageal 
and intracardiac), multi-slice computed tomography (MSCT), magnetic resonance imaging 
(MRI) and fl uoroscopy. Whereas transthoracic echocardiography, MSCT and MRI are valuable 
imaging techniques before and after the procedure, transesophageal and intracardiac echocar-
diography are mainly used during the percutaneous valve procedure. 
Before percutaneous valve procedures 
Selection of potential candidates and procedural risk assessment are crucial issues before per-




of valve morphology, quantifi cation of the severity of valvular disease and assessment of 
vascular access and surrounding structures. 
For the assessment of both mitral and aortic valve morphology and the quantifi cation of 
the severity of valve disease, a routine transthoracic echocardiogram (Figure 10) is typically 
performed (1,2). However in case of suboptimal image quality of transthoracic echocardiog-
raphy, transesophageal echocardiography may be needed. In addition, recent studies have 
demonstrated that MSCT and MRI can also provide detailed information on valve morphology 
and function. Good correlations between MSCT and echocardiography for the assessment of 
Table 4. The role of imaging modalities in percutaneous valve procedures
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valve morphology and valve area have been reported (47). Finally, assessment of specifi c sur-
rounding structures, such as coronary arteries, is important before percutaneous MV and AV 
procedures. 
Percutaneous mitral valve procedures For coronary sinus annuloplasty in patients with MR, 
assessment of coronary sinus anatomy is of critical importance (Figure 11). Particularly, the rela-
tion with the MV annulus and the left circumfl ex coronary artery should be explored. The close 
relationship between the coronary sinus and the circumfl ex coronary artery (48) may explain 
the impingement of the coronary artery described in the fi rst animal studies (13). With the use 
of MSCT, this relation can be assessed non-invasively before the mitral annuloplasty procedure 
(49,50). In a recent study, the relation between the coronary sinus and the circumfl ex coronary 
artery was assessed in 105 patients, including 34 patients with heart failure and/or severe MR. It 
was noted that the circumfl ex artery coursed between the coronary sinus and the MV annulus 
in almost 70% of the patients, with a minimal distance of 1.3 ± 1.0 mm between the two struc-
tures (49). In addition, a broad variation in minimal distance between the coronary sinus and 
the mitral annulus was noted (Figure 12). Performing a percutaneous mitral annuloplasty may 
not be feasible if the coronary sinus courses along the left atrial posterior wall rather than along 
Figure 10. Transcatheter aortic valve implantation requires non-invasive estimation of the size of the annulus. One method is to estimate 
the diameter of the aortic annulus from a transthoracic long axis echocardiogram. Typically the measurement is made at the ventricular aspect 




the mitral annulus. By visualizing the coronary sinus and other relevant structures, MSCT may 
help in the selection of patients for percutaneous mitral annuloplasty. 
Percutaneous aortic valve procedures Before percutaneous AV procedures, vascular access 
should be screened. The calcifi cations and tortuosity of the aorta and femoral arteries should 
be evaluated, since this has important implications for the delivery of the prosthesis (transarte-
rial vs. transapical). Conventional angiography, MSCT and MRI are available for the assessment 
of vascular access. 
In addition, the extent and location of AV calcifi cations can be accurately assessed with 
MSCT. An example of a heavily calcifi ed AV is shown in Figure 13. In addition, MSCT enables 
accurate assessment of the diameter of the aortic annulus, necessary for correct prosthesis siz-
ing. Finally, the relation between the aortic annulus and the ostium of the left coronary leafl et 
can be visualized with MSCT (51). This may be important since occlusion of the coronary ostium 
has been reported as a serious complication of percutaneous AV replacement (25). 
Figure 11. Three-dimensional volume-rendered reconstruction of a 64-slice MSCT scan demonstrating the relationship between the 
coronary sinus (CS) and the mitral annulus (MA). In this patient, the CS coursed along the left atrial (LA) posterior wall, rather than along the 
MA, as indicated by the white arrow. Percutaneous mitral valve annuloplasty via the coronary sinus may not be feasible in these patients. GCV = 
great cardiac vein; LV = left ventricle.
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Figure 12. With the use of MSCT, the minimal distance between the coronary sinus (CS) and the mitral valve annulus (MVA) was assessed. 
In 90 patients without severe MR (black bars) and in 15 patients with severe MR (white bars), the distance was assessed at three diff erent levels 
(MVA level, proximal CS, distal CS). In the patients with severe MR, the distance between the CS and the MVA was signifi cantly greater compared 
to the patients without severe MR at all levels. The greater distance between the CS and MVA may hamper the use of percutaneous mitral 
annuloplasty. * = p<0.05.
Figure 13. Multi-slice computed tomography images demonstrating a heavily calcifi ed AV in a patient referred for percutaneous AV 
implantation. The left panel shows a short-axis reconstruction of the AV, indicating the calcifi cations on all leafl ets (white arrows). In the right 
panel, the reconstructed sagittal view (similar to a parasternal long-axis view on transthoracic echocardiography) clearly demonstrates the 





During percutaneous valve procedures, performing a transseptal puncture, positioning and 
deployment of the device are all critical processes and can be guided by various imaging 
modalities. Fluoroscopy remains the technique of choice, although it does not permit visualiza-
tion of cardiac soft-tissue structures and for patient and physician safety the radiation burden 
should be kept to a minimum. Therefore, both transesophageal and intracardiac echocardiog-
raphy have been used during AV (25,26,28,37) and MV (17,18,33,35) procedures in addition to 
fl uoroscopy. 
Transesophageal and intracardiac echocardiography are valuable techniques for perform-
ing transseptal procedures (45). Accurate real-time visualization of the interatrial septum and 
the transseptal puncture needle may greatly facilitate safe and accurate transseptal punctures. 
The positioning and deployment of the prosthesis are the most important processes during 
percutaneous valve procedures. Using fl uoroscopy (and contrast agents if needed) the relation-
ship between the native valve and the prosthesis can be well visualized. An example of coronary 
sinus assessment with the use of fl uoroscopy during a percutaneous MV procedure is shown in 
Figure 14. In addition to fl uoroscopy, transesophageal and intracardiac echocardiography can 
facilitate percutaneous valve procedures. In an animal model of percutaneous edge-to-edge 
repair, Naqvi et al. demonstrated that intracardiac echocardiography can accurately visualize 
Figure 14. Assessment of the coronary sinus prior to MV annuloplasty in a patient with severe MR. The coronary sinus has been cannulated 
from the femoral vein with a calibrated angiographic catheter. Contrast injection allows visualization of the coronary sinus and calibration using 
the radiopaque 1 cm markers on the catheter allow estimation of diameter and length of the coronary veins.
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the MV apparatus, guide the deployment of the leafl et suture and confi rm a double orifi ce 
mitral valve (52). 
Furthermore, transesophageal echocardiography is useful for the positioning of the percu-
taneous valve devices (Figure 2). In the EVEREST-I trial, a standardized protocol for transesopha-
geal echocardiography was implemented during the course of the trial (53). It was noted that 
the use of a standardized imaging protocol reduced the median ‘device time’ (defi ned as the 
time from the initial insertion of the guiding catheter to the fi nal removal of the clip delivery 
system) from 198 to 132 minutes. It was concluded that transesophageal echocardiography 
is essential for guiding percutaneous edge-to-edge repair (53). Recently, real-time three-
dimensional transesophageal echocardiography has been introduced. The three-dimensional 
aspect of this technique may further facilitate percutaneous valve procedures. However, experi-
ence is currently limited and more studies are needed to assess the relative merit of this new 
technique. 
Follow-up 
After a percutaneous valve procedure careful follow-up of the patient is essential. In particular, 
assessment of prosthesis function and position, and the presence of residual regurgitation or 
paravalvular leakage are important during follow-up. Transthoracic echocardiography is the 
primary imaging modality for all these issues. An example of transthoracic echocardiography 
in a patient with severe MR undergoing percutaneous edge-to-edge repair with the use of 
MitraClip is shown in Figure 15. Transthoracic echocardiography allows serial and quantitative 
assessment of prosthesis function and the presence of residual regurgitation or paravalvular 
leakage (54). In the EVEREST-I trial it has been demonstrated that it is feasible to use quantita-
tive parameters systematically for the follow-up of MR in patients undergoing percutaneous 
edge-to-edge repair using transthoracic echocardiography (55). 
For exact assessment of the position of the prosthesis, and its relation with surrounding 
structures, MSCT may be preferred over transthoracic echocardiography. Due to the high 
spatial resolution, MSCT enables a detailed evaluation of the prosthesis position in relation to 
the native valve and surrounding structures (11). An example of a patient with a percutaneous 
Figure 15. Transthoracic echocardiograms from a patient undergoing percutaneous edge-to-edge repair with the use of a MitraClip device. 
Severe MR is present at baseline (panel A). After placement of the MitraClip device there is immediate reduction in MR (panel B) with continued 




AV, assessed with MSCT is shown in Figure 16. Although the radiation exposure of MSCT is 
signifi cant and should always be considered, it may be the best imaging modality to visualize 
the exact prosthesis morphology and location.
CONCLUSIONS
Percutaneous aortic and mitral valve procedures are promising strategies in the treatment of 
patients with valvular heart disease. Both for AS and MR, diff erent procedures have demon-
strated their feasibility and safety in animal and human studies. Several clinical trials, including 
randomized trials between surgical and percutaneous treatment, are currently performed. The 
results of these trials will demonstrate the precise value of percutaneous valve procedures in 
patients with severe valvular heart disease, unsuitable for surgical treatment. Careful selection 
and screening of patients is crucial for percutaneous valve procedures. Diff erent imaging 
modalities are available for the selection of patients for percutaneous valve procedures. In addi-
tion, performing the actual procedure may be greatly facilitated by implementation of various 
imaging techniques. At present, only short-term results are available and therefore a careful 
follow-up of the patients after percutaneous valve procedures is mandatory.
Figure 16. Multi-slice computed tomography of the aortic valve (AV) in a patient referred for percutaneous AV replacement, in an axial (left 
panel), sagittal (middle panel) and coronal view (right panel). In the upper panel the extensive calcifi cations of the native AV are well visualized. 
The lower panel clearly demonstrates the location of the AV prosthesis (Edwards SAPIEN valve).
304
REFERENCES
 1. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease. Eur 
Heart J 2007;28:230-68.
 2. Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with 
valvular heart disease. Circulation 2006;114:e84-231.
 3. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in 
Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
 4. Vassiliades TA, Jr., Block PC, Cohn LH et al. The clinical development of percutaneous heart valve 
technology. J Am Coll Cardiol 2005;45:1554-60.
 5. Farhat MB, Ayari M, Maatouk F et al. Percutaneous balloon versus surgical closed and open mitral 
commissurotomy : seven-year follow-up results of a randomized trial. Circulation 1998;97:245-50.
 6. Feldman T. Core curriculum for interventional cardiology: percutaneous valvuloplasty. Catheter 
Cardiovasc Interv 2003;60:48-56.
 7. Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of 
prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 2006;68:528-33.
 8. Alfi eri O, De Bonis M, Lapenna E et al. “Edge-to-edge” repair for anterior mitral leafl et prolapse. Semin 
Thorac Cardiovasc Surg 2004;16:182-7.
 9. St Goar FG, Fann JI, Komtebedde J et al. Endovascular edge-to-edge mitral valve repair: short-term 
results in a porcine model. Circulation 2003;108:1990-3.
 10. Naqvi TZ, Buchbinder M, Zarbatany D et al. Beating-heart percutaneous mitral valve repair using 
a transcatheter endovascular suturing device in an animal model. Catheter Cardiovasc Interv 
2007;69:525-31.
 11. Webb JG, Harnek J, Munt BI et al. Percutaneous transvenous mitral annuloplasty: initial human experi-
ence with device implantation in the coronary sinus. Circulation 2006;113:851-5.
 12. Liddicoat JR, Mac Neill BD, Gillinov AM et al. Percutaneous mitral valve repair: a feasibility study in an 
ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 2003;60:410-6.
 13. Maniu CV, Patel JB, Reuter DG et al. Acute and chronic reduction of functional mitral regurgitation in 
experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 2004;44:1652-61.
 14. Fukamachi K, Inoue M, Popovic ZB et al. Off -pump mitral valve repair using the Coapsys device: a pilot 
study in a pacing-induced mitral regurgitation model. Ann Thorac Surg 2004;77:688-92.
 15. Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic 
mitral regurgitation: 1-year results. Ann Thorac Surg 2006;81:42-6.
 16. Pedersen WR, Block P, Feldman T. The iCoapsys Repair System for the percutaneous treatment of 
functional mitral insuffi  ciency. EuroIntervention 2007;1:A44-A48.
 17. Rogers JH, Macoviak JA, Rahdert DA, Takeda PA, Palacios IF, Low RI. Percutaneous septal sinus 
shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation 
2006;113:2329-34.
 18. Palacios IF, Condado JA, Brandi S et al. Safety and feasibility of acute percutaneous septal sinus 
shortening: fi rst-in-human experience. Catheter Cardiovasc Interv 2007;69:513-8.
 19. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of 
acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986;1:63-7.
 20. Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights 
into prognosis of valvular aortic stenosis. Circulation 1994;89:642-50.
 21. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artifi cial heart valves. Descrip-
tion of a new expandable aortic valve and initial results with implantation by catheter technique in 
closed chest pigs. Eur Heart J 1992;13:704-8.
 22. Cribier A, Eltchaninoff  H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve 




 23. Webb JG, Pasupati S, Achtem L, Thompson CR. Rapid pacing to facilitate transcatheter prosthetic 
heart valve implantation. Catheter Cardiovasc Interv 2006;68:199-204.
 24. Cribier A, Eltchaninoff  H, Tron C et al. Early experience with percutaneous transcatheter implanta-
tion of heart valve prosthesis for the treatment of end-stage inoperable patients with calcifi c aortic 
stenosis. J Am Coll Cardiol 2004;43:698-703.
 25. Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde 
from the femoral artery. Circulation 2006;113:842-50.
 26. Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in 
selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63.
 27. Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: 
initial clinical experience. Circulation 2006;114:591-6.
 28. Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding 
valve prosthesis in high-risk patients with aortic valve disease: the Siegburg fi rst-in-man study. Circu-
lation 2006;114:1616-24.
 29. Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic ste-
nosis in high-risk patients using the second- and current third-generation self-expanding CoreValve 
prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
 30. Feldman T, Wasserman HS, Herrmann HC et al. Percutaneous mitral valve repair using the edge-to-edge 
technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134-40.
 31. Rinaldi M, Kar S, Hermiller J, Smalling RW, Gray W, Carroll J et al. Signifi cant reverse remodeling of 
the left ventricle one year after percutaneous mitral repair with the MitraClip device. Am J Cardiol 
2007;100:S56-S59. 
 32. Webb JG, Kuck KH, Stone G et al. Percutaneous mitral annuloplasty with the MONARC system: Prelimi-
nary results from the EVOLUTION trial. American Journal of Cardiology 2006;98:49M.
 33. Dubreuil O, Basmadjian A, Ducharme A et al. Percutaneous mitral valve annuloplasty for ischemic 
mitral regurgitation: fi rst in man experience with a temporary implant. Catheter Cardiovasc Interv 
2007;69:1053-61.
 34. Kaye DM, Byrne M, Alferness C, Power J. Feasibility and short-term effi  cacy of percutaneous 
mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 
2003;108:1795-7.
 35. Grossi EA, Saunders PC, Woo YJ et al. Intraoperative eff ects of the coapsys annuloplasty system in a 
randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann Thorac Surg 
2005;80:1706-11.
 36. Cribier A, Eltchaninoff  H, Tron C et al. Treatment of calcifi c aortic stenosis with the percutaneous heart 
valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 
2006;47:1214-23.
 37. Walther T, Simon P, Dewey T et al. Transapical minimally invasive aortic valve implantation: multi-
center experience. Circulation 2007;116:I240-I245.
 38. Kodali S, O’Neill W, Moses J, Kapadia S, Williams M, Hanzel G et al. Six month to one year clinical 
outcomes following retrograde percutaneous aortic valve replacement in high risk patients: A report 
from the REVIVAL-II trial. Am J Cardiol 2007;100:S56-S59. 
 39. Grube E, Laborde JC, Zickmann B et al. First report on a human percutaneous transluminal implanta-
tion of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter 
Cardiovasc Interv 2005;66:465-9.
 40. Walther T, Falk V, Dewey T et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat 
xenograft implantation. J Am Coll Cardiol 2007;50:56-60.
 41. Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe 
aortic regurgitation in degenerated bioprosthesis: the fi rst valve in valve procedure using the Corev-
alve Revalving system. Catheter Cardiovasc Interv 2007;70:760-4.
306
 42. Astor BC, Kaczmarek RG, Heffl  in B, Daley WR. Mortality after aortic valve replacement: results from a 
nationally representative database. Ann Thorac Surg 2000;70:1939-45.
 43. Shemin RJ. Percutaneous valve intervention: a surgeon’s perspective. Circulation 2006;113:774-5.
 44. Casserly IP, Kapadia SR. Advances in percutaneous valvular intervention. Expert Rev Cardiovasc Ther 
2005;3:143-58.
 45. Jongbloed MR, Schalij MJ, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Bax JJ. Clinical applica-
tions of intracardiac echocardiography in interventional procedures. Heart 2005;91:981-90.
 46. Nordmeyer J, Khambadkone S, Coats L et al. Risk stratifi cation, systematic classifi cation, and anticipa-
tory management strategies for stent fracture after percutaneous pulmonary valve implantation. 
Circulation 2007;115:1392-7.
 47. Tops LF, Krishnan SC, Schuijf JD, Schalij MJ, Bax JJ. Noncoronary Applications of Cardiac Multidetector 
Row Computed Tomography. J Am Coll Cardiol Img 2008;1:94-106.
 48. Maselli D, Guarracino F, Chiaramonti F, Mangia F, Borelli G, Minzioni G. Percutaneous mitral annulo-
plasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and 
coronary arteries. Circulation 2006;114:377-80.
 49. Tops LF, Van de Veire NR, Schuijf JD et al. Noninvasive evaluation of coronary sinus anatomy and its 
relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation 
2007;115:1426-32.
 50. Choure AJ, Garcia MJ, Hesse B et al. In vivo analysis of the anatomical relationship of coronary 
sinus to mitral annulus and left circumfl ex coronary artery using cardiac multidetector computed 
tomography: implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol 
2006;48:1938-45.
 51. Tops LF, Wood DA, Delgado V et al. Noninvasive evaluation of the aortic root with multislice com-
puted tomography: Implications for transcatheter aortic valve replacement. J Am Coll Cardiol Img 
2008;1:321-30.
 52. Naqvi TZ, Zarbatany D, Molloy MD, Logan J, Buchbinder M. Intracardiac echocardiography for percu-
taneous mitral valve repair in a swine model. J Am Soc Echocardiogr 2006;19:147-53.
 53. Silvestry FE, Rodriguez LL, Herrmann HC et al. Echocardiographic guidance and assessment of percu-
taneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am 
Soc Echocardiogr 2007;20:1131-40.
 54. Gottdiener JS, Bednarz J, Devereux R et al. American Society of Echocardiography recommendations 
for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004;17:1086-119.
 55. Foster E, Wasserman HS, Gray W et al. Quantitative assessment of severity of mitral regurgitation by 
serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 
2007;100:1577-83.
1 8
Non-invasive evaluation of 
coronary sinus anatomy and its 
relation to the mitral valve annulus: 
implications for percutaneous 
mitral annuloplasty
Laurens F. Tops1
Nico R. Van de Veire1
Joanne D. Schuijf1
Albert de Roos2
Ernst E. van der Wall1
Martin J. Schalij1
Jeroen J. Bax1
1Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands




Background: Percutaneous mitral annuloplasty has been proposed as an alternative to surgi-
cal annuloplasty. In this respect, evaluation of the coronary sinus (CS) and its relation with the 
mitral valve annulus (MVA) and the coronary arteries is relevant. The feasibility of evaluating 
these issues non-invasively with Multi-slice Computed Tomography (MSCT) was determined.
Methods and Results: In 105 patients (72 men, age 59 ± 11 years), 64-slice MSCT was performed 
for non-invasive evaluation of coronary artery disease. Thirty-four patients with heart failure and/
or severe mitral regurgitation were included. Three-dimensional reconstructions and standard 
orthogonal planes were used to assess CS anatomy, and its relation with the MVA and circumfl ex 
artery. In 71 patients (68%) the circumfl ex artery coursed between the CS and the MVA, with a 
minimal distance between the CS and the circumfl ex artery of 1.3 ± 1.0 mm. The CS was located 
along the left atrial wall, rather than along the MVA, in the majority of the patients (ranging from 
90% at the level of the MVA to 14% at the level of the distal CS). The minimal distance between 
the CS and MVA was 5.1 ± 2.9 mm. In patients with severe mitral regurgitation, the minimal 
distance between the CS and the MVA was signifi cantly greater as compared to patients without 
severe mitral regurgitation (mean 7.3 ± 3.9 mm vs. 4.8 ± 2.5 mm, p<0.05).
Conclusion: In the majority of the patients, the CS courses superior to the MVA. In 68% of 
the patients, the circumfl ex artery courses between the CS and the mitral annulus. MSCT may 









Mitral annuloplasty is the most commonly performed surgical procedure for ischemic mitral 
regurgitation (MR) (1). Recently, a percutaneous approach to mitral annuloplasty has been 
proposed. Validation studies in animals have shown the feasibility of the percutaneous trans-
venous mitral annuloplasty (2-5). In addition, preliminary results of the fi rst human experience 
with percutaneous mitral annuloplasty have been described (6). 
However, anatomical studies have demonstrated the variable relationship between the 
coronary sinus (CS) and the mitral valve annulus (MVA) (7-9). It was noted that the CS may 
course adjacent to the posterior wall of the left atrium rather than along the MVA. Furthermore, 
a close relation between the CS and the left circumfl ex coronary artery (LCX) was detected, 
potentially limiting the use of percutaneous mitral annuloplasty. However, these anatomical 
studies were performed in structural normal hearts. 
Evaluation of the CS anatomy and its relation with the MVA and the coronary arteries 
may be of value in patients who are considered for percutaneous mitral annuloplasty. Multi-
slice computed tomography (MSCT) can provide an accurate non-invasive evaluation of the 
anatomy of the CS (10). Recent preliminary data suggest a potential use of MSCT scanning in 
patients considered for percutaneous mitral annuloplasty (11). 
Accordingly, the purpose of the present study was to evaluate the relation between the CS, 
the MVA and the coronary arteries using 64-slice MSCT in patients with structural normal hearts 
and in patients with severe MR.
METHODS
Study population
The study population comprised 105 consecutive patients referred for MSCT coronary angiog-
raphy. The total study population was divided into 3 groups: group I (controls, n=35) included 
patients without coronary artery disease and without structural heart disease; group II (CAD, 
n=36) comprised patients with either a history of myocardial infarction / percutaneous trans-
luminal coronary angioplasty / coronary artery bypass grafting, or a signifi cant stenosis in ≥1 
coronary artery on the MSCT scan; group III (heart failure, n=34) included patients with severe 
heart failure (left ventricular ejection fraction ≤ 35%).
Multi-slice Computed Tomography
MSCT was performed using a Toshiba Multi-slice Aquilion 64 system (Toshiba Medical Systems, 
Tokyo, Japan) with a collimation of 64 x 0.5 mm and a rotation time of 400 – 500 ms, depending 
on the heart rate. The tube current was 300 mA, at 120 kV. Non-ionic contrast material (Iomeron 
400, Bracco, Altana Pharma, Konstanz, Germany) was administered in the antecubital vein, with 
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an amount of 80 to 110 ml depending on the total scan time, and a fl ow rate of 5.0 ml/sec. 
Automated peak enhancement detection in the descending aorta was used for timing of the 
contrast bolus. After the threshold level of +100 Hounsfi eld units was reached, data acquisition 
was automatically initiated. Data acquisition was performed during an inspiratory breathhold 
of approximately 8 to 10 seconds, while the ECG was recorded simultaneously to allow retro-
spective gating of the data. The data set was reconstructed at 75% of the RR interval, with a slice 
thickness of 0.5 mm and a reconstruction interval of 0.3 mm. 
Data analysis
Data analysis was performed on a remote post-processing workstation (Vitrea 2, Vital Images, 
Plymouth, Minnesota). Three-dimensional volume rendered reconstructions and standard 
orthogonal planes were used to assess the anatomy and the course of the CS and its tributaries. 
Furthermore, the course of the coronary arteries and the coronary artery dominance (right, left, 
or balanced) was assessed. In particular, the course of the LCX in relation to the CS (inferior or 
superior) was determined (Figure 1). The axial slices were studied to assess the minimal distance 
between the LCX and the CS. 
With the use of reconstructed long-axis two- and four-chamber views and volume-rendered 
three-dimensional reconstructions, the relation between the CS and the MVA was assessed 
(Figure 2). The position of the CS in relation to the MVA (superior/inferior/same level), and the 
minimal distance between the CS and the MVA was determined (Figure 3). The anatomical and 
quantitative data were assessed at three diff erent levels: at the proximal CS, the distal CS, and 
at the level of the MVA. The proximal CS was defi ned as the site where the CS makes an angle 
with the right atrium. The distal CS was defi ned as the site where the CS makes a sharp angle 
Figure 1. Volume-rendered reconstructions showing the relation between the coronary sinus (CS) and the left circumfl ex coronary artery (Cx). 
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anteriorly and continues as the anterior interventricular vein (12). The level of the MVA was 
reconstructed using the long-axis two- and four-chamber views. 
Furthermore, the diameter of the MVA was derived from the long-axis two- and four-cham-
ber views (Figures 2A and 2B); the perimeter of the MVA was assessed on the reconstructed 
level of the MVA (Figure 2C). In addition, the anterior-posterior diameter and the superior-
inferior diameter of the proximal and distal CS were determined, as previously described (10). 
The analyses of the anatomical relations and the quantitative data were performed by two 
independent observers, blinded to the clinical data of the patients.
Echocardiography
Standard two-dimensional echocardiograms were obtained with patients in the left lateral 
decubitus position using a commercially available system (Vingmed Vivid 7, General Electric-
Vingmed, Milwaukee, Wisconsin, USA). Images were obtained using a 3.5-MHz transducer at 
a depth of 16 cm in the parasternal (long- and short-axis) and apical (two- and four-chamber) 
Figure 2. Long-axis 2-chamber (panel A) and 4-chamber (panel B) views were used to assess the course of the coronary sinus (CS)(white 
arrow) in relation to the mitral valve annulus (MVA), and the diameter of the MVA (black arrow). Furthermore, at the reconstructed level of the 
MVA (panel C), the CS location and the MVA perimeter were determined. Panel D shows a three-dimensional volume-rendered reconstruction 
demonstrating the course of the CS and its relation to the MVA and the left circumfl ex coronary artery.
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views. Standard two-dimensional images and color Doppler data triggered to the QRS complex 
were digitally stored in cine-loop format. Left ventricular ejection fraction was calculated from 
apical two- and four-chamber images using the biplane Simpson’s rule (13). The severity of MR 
was graded semi-quantitatively using color-fl ow Doppler in the conventional parasternal long-
axis and apical four-chamber images (14). MR was characterized as: minimal = 1+ (jet area/left 
atrial area<10%), moderate = 2+ (jet area/left atrial area 10-20%), moderate-severe = 3+ (jet 
area/left atrial area 20-45%), or severe = 4+ (jet area/left atrial area >45%) (14). 
Statistical analysis
Continuous data are presented as mean values ± standard deviation (SD); categorical data are 
presented as frequencies and percentages. Diff erences between the three groups were com-
pared using one-way Analysis of Variance (ANOVA) with Scheff é post-hoc testing for continu-
ous variables, and Chi-square tests for dichotomous variables. Diff erences between patients 
with and without severe MR were evaluated using Mann-Whitney U test (continuous variables), 
or Fisher’s Exact tests (dichotomous variables). All statistical analyses were performed using 
SPSS software (version 12.0, SPSS Inc. Chicago, Illinois, USA). All statistical tests were two-sided, 
whereas a p-value <0.05 was considered statistically signifi cant. 
Figure 3. Three-dimensional volume-rendered reconstructions were used to assess the position of the coronary sinus (CS)(white arrow) 
in relation to the mitral valve annulus. At the proximal CS (panel A) and at the distal CS (panel B), the relative position (super / same level / 









A total of 105 patients (age 59 ± 11 years, 72 men) were studied. The study population was 
divided in 3 groups: controls (n=35), patients with coronary artery disease (n=36), and patients 
with severe heart failure (n=34, 19 (56%) ischemic cardiomyopathy, 15 (44%) idiopathic cardio-
myopathy). The baseline characteristics of the patients are listed in Table 1. 
Anatomical observations
Coronary arteries and relation with coronary sinus Right coronary artery dominance was 
observed in 91 patients (87%), left coronary dominance in 13 (12%) and balanced in 1 patient 
(1%). In 71 patients (68%) the LCX coursed inferior to the CS; thus between the CS and the mitral 
annulus. In 34 patients (32%) the LCX coursed superior to the CS (Figure 1). The minimal dis-
tance between the CS and the LCX was 1.3 ± 1.0 mm. The mean number of marginal branches 
was 1.2 ± 0.6; there were no diff erences in number of marginal branches between the three 
groups, or between the patients with right or left coronary dominance. 
Anatomical relation between the coronary sinus and mitral valve annulus At the level of the 
MVA, the CS was located more superiorly in 95 patients (90%), more inferiorly in 1 patient (1%), 
and at the same level in 9 patients (9%). The minimal distance from the CS to the MVA was 5.1 
± 2.9 mm (range 1.4 to 16.8 mm). Also, the relation of the CS and the MVA was determined at 
the proximal and the distal CS. At the proximal CS, the CS was located more superior to the 
MVA in 57 patients (54%), more inferiorly in 7 patients (7%), and at the same level in 41 patients 
(39%). The minimal distance between the CS and the MVA at the proximal CS was 8.3 ± 2.3 mm 
(range 2.2 to 15.3 mm). At the distal CS, the CS was located more superiorly to the MVA in 15 
patients (14%), more inferiorly in 31 patients (30%), and at the same level in 59 patients (56%). 
Table 1. Baseline characteristics of the three patient groups
Controls (n=35) CAD (n=36) HF (n=34)
Age, years 54 ± 11 61 ± 10 * 63 ± 11 *
Gender, M/F 21 / 14 25 / 11 26 / 8
LVEF, % 62 ± 5 61 ± 9 27± 7 † ‡
Previous MI, n (%) 0 9 (25%) 19 (56%)
Risk factors, n (%)
   Diabetes mellitus 12 (34%) 14 (39%) 6 (18%)
   Hypertension 15 (43%) 17 (47%) 14 (41%)
   Hypercholesterolemia 14 (40%) 22 (61%) 17 (50%)
   Smoking 5 (14%) 15 (42%) 17 (50%)
   Positive family history 11 (31%) 10 (28%) 11 (32%)
* p<0.05 vs. controls, † p<0.001 vs. controls, ‡ p<0.001 vs. CAD; CAD = coronary artery disease; HF = heart failure; LVEF = left ventricular 
ejection fraction; MI = myocardial infarction
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The minimal distance between the CS and the MVA at the distal CS was 8.8 ± 3.4 mm (range 2.6 
to 18.6 mm). 
There were no statistical diff erences between the 3 groups, with regard to the location of 
the CS in relation to the MVA at any level. In contrast, the minimal distance between the CS 
and the MVA was signifi cantly greater in the heart failure patients, compared with the control 
patients and the patients with coronary artery disease (Table 2). 
Coronary sinus and mitral valve annulus: quantitative observations The mean diameter of 
the MVA at the two-chamber view was 40.8 ± 4.7 mm, the mean diameter at the four-chamber 
view was 36.4 ± 4.6 mm. The mean perimeter of the MVA was 119.4 ± 13.3 mm. 
The mean diameter of the CS at the proximal part was 10.0 ± 2.8 mm in the anterior-
posterior direction, and 14.4 ± 3.1 mm in the superior-inferior direction. The diameter of the 
CS at the distal part was 3.9 ± 0.7 mm in the anterior- posterior direction, and 4.0 ± 0.9 mm in 
the superior-inferior direction. No signifi cant diff erences in diameter of the CS were observed 
between the 3 groups (Table 2). With the use of multi-planar reformatted images, the total 
length of the CS was calculated. The mean length was 113 ± 18 mm (range 76 to 170 mm). The 
mean CS length was signifi cant larger in the heart failure patients, compared with the controls 
and the patients with coronary artery disease (Table 2).
Mitral regurgitation
In the total study population 50 patients (48%) had no MR, 30 (29%) patients had MR grade 
1+ and 10 patients (9%) had MR grade 2+; whereas MR was characterized as 3+ in 13 patients 
(12%), and 4+ in 2 patients (2%). To detect diff erences in the anatomical and quantitative data 
between patients with and without severe MR, the study population was divided in two groups: 
patients with MR grade ≤ 2+ (n=90) and patients with MR grade 3+ or 4+ (n=15). 
There were no diff erences between the two groups in the anatomical relation between the 
CS and MVA at any level. Furthermore, no signifi cant diff erences in diameters of the CS were 
Table 2. Quantitative analyses of the coronary sinus and the mitral valve annulus in the three patient groups
Controls (n=35) CAD (n=36) HF (n=34) p value * 
Minimal distance between CS and MVA
   at MVA level 4.4 ± 2.2 4.9 ± 2.7 6.2 ± 3.4 † 0.019
   at proximal CS 7.6 ± 1.6 7.9 ± 2.1 9.3 ± 2.8 † 0.006
   at distal CS 7.3 ± 3.3 8.5 ± 3.2 10.7 ± 3.0 ‡ § <0.001
CS diameter at proximal CS
   AP diameter 10.5 ± 2.7 9.7 ± 2.3 9.9 ± 3.3 0.5
   SI diameter 15.0 ± 3.2 14.0 ± 3.0 14.2 ± 3.0 0.3
CS diameter at distal CS
   AP diameter 3.9 ± 0.7 3.9 ± 0.6 4.0 ± 0.7 0.7
   SI diameter 4.1 ± 0.9 3.9 ± 0.7 4.0 ± 0.9 0.7
Total CS length 108 ± 12 106 ± 14 126 ± 19 ‡ || <0.001
* Assessed by analysis of variance with Scheff é post-hoc testing. † p<0.05 vs. controls; ‡ p<0.001 vs. controls; § p<0.05 vs. CAD; || p<0.001 
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noted. However, the minimal distance between the CS and the MVA at all levels was signifi cant 
greater in the patients with severe MR, compared to the patients without severe MR (Table 3). 
In addition, the diameters of the MVA and the total length of the CS were signifi cantly larger in 
the patients with severe MR (Table 3). 
DISCUSSION
In the present study, the relation between the CS, the MVA and the coronary arteries was evalu-
ated non-invasively using MSCT. The major fi ndings of the study are as follows: In 68% of the 
patients, the LCX courses between the CS and the MVA. In the majority of the patients, the CS 
courses superior to the MVA. In addition, the minimal distance between the CS and the MVA 
is greater in patients with heart failure and severe MR. The fi ndings of the present study have 
important implications for percutaneous mitral annuloplasty. 
Anatomical observations
Coronary sinus and coronary arteries A close relation between the CS and the LCX may 
limit the use of a percutaneous mitral annuloplasty. Circumfl ex artery compression has been 
reported as a serious complication in one of the fi rst animal studies on the percutaneous mitral 
annuloplasty (4). Previous anatomical studies have reported the relation between the CS, 
the coronary arteries and the MVA (8,9). Maselli et al (9) demonstrated that the LCX coursed 
between the CS and the MVA in 63.9% of the 61 studied human hearts. Of note, when the LCX 
coursed inferior to the CS, the number of marginal branches of the LCX was larger. However, no 
data on the minimal distance between the CS and the LCX were provided. 
These anatomical observations have previously been confi rmed with electron beam 
computed tomography (15,16). Mao et al (15) reported that in 80.8% of the studied patients, 
the LCX coursed inferiorly to the CS. Furthermore, it was demonstrated that the overlapping 
segment of the CS and the LCX was longer than 30 mm in 17.8% of the cases. However, again 
no data on the minimal distance between the CS and the LCX were provided. 
Table 3. Quantitative analyses of the coronary sinus and the mitral valve annulus in patients with and without severe mitral regurgitation
Patients without 
severe MR (n=90)
Patients with severe 
MR (n=15)
p value *
Minimal distance between CS and MVA
   at MVA level 4.8 ± 2.5 7.3 ± 3.9 0.005
   at proximal CS 8.1 ± 2.4 9.3 ± 1.9 0.019
   at distal CS 8.3 ± 3.1 12.1 ± 3.6 <0.001
MVA diameter (two-chamber view) 40.2 ± 4.7 44.3 ± 3.3 0.001
MVA diameter (four-chamber view) 35.8 ± 4.4 39.9 ± 4.4 0.002
MVA perimeter 118.1 ± 12.6 127.6 ± 14.7 0.020
Total CS length 110.1 ± 16.6 128.6 ± 14.6 <0.001
* As assessed with Mann-Whitney U test.
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In the present study, the LCX coursed inferiorly to the CS in 68% of the patients, with a 
minimal distance between the CS and the LCX of 1.3 ± 1.0 mm. The close relation between the 
CS and the LCX may limit the use of percutaneous mitral valve annuloplasty, in particular when 
the LCX courses inferior to the CS over a large distance (Figure 4).  
Figure 4. In this patient, the left circumfl ex coronary artery (Cx) courses between the coronary sinus (CS) and the mitral valve annulus (panel 
A, four-chamber view). The volume rendered reconstruction (panel B) and the reconstructed mitral valve annulus level (panel C) show that the 
Cx courses inferior to the CS over a large distance. Performing percutaneous mitral annuloplasty may result in compression of the Cx.
Figure 5. In this patient, the coronary sinus (CS) courses along the left atrial (LA) posterior wall, rather than along the mitral valve annulus. 
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Coronary sinus and mitral valve annulus Several anatomical studies have addressed the rela-
tion between the CS and the MVA (7-9). Shinbane et al (7) studied 10 normal adult cadaver 
hearts, and reported variable distances between the CS and the MVA along the course of the 
CS. Mean distances between the CS and the MVA were 14.1 ± 3.1 mm, 10.2 ± 4.9 mm and 10.7 ± 
3.5 mm, at 20, 40 and 60 mm distance from the ostium of the CS, respectively. El-Maasarany et 
al (8) studied the distances between the CS and the MVA in 32 normal cadaver hearts. Distances 
were assessed in 6 separate regions along the course of the CS. Mean distance was highly 
variable for the 6 regions; the shortest distance (5.8 mm) was observed at the anterolateral 
commissure of the MVA. Unfortunately, no data were provided regarding the position of the CS 
in relation to the MVA (superior/deeper/same level). In the largest anatomical study reported, 
Maselli et al (9) also noted variable distances between the CS and the MVA. At the level of the 
P2 and P3 scallops of the mitral valve, mean distances between the CS and the MVA of 5.7 ± 3.3 
mm and 9.7 ± 3.2 mm were reported. 
In the present study, the highly variable relation between the CS and the MVA was assessed 
non-invasively with MSCT. The CS was located more superior to the MVA in the majority of 
the patients (ranging from 90% at the level of the MVA to 14% at the level of the distal CS). 
Furthermore, minimal distances between the CS and the MVA were assessed at the proximal 
and the distal CS, and appeared to be highly variable (Table 2). Although this confi rms the 
previous anatomical studies, the use of diff erent reference points makes a direct comparison 
between the present study and previous in vitro studies diffi  cult. Importantly, in patients with 
severe MR, the minimal distance between the CS and the MVA may increase signifi cantly. In 
particular, in patients where the CS courses along the left atrial wall the use of percutaneous 
mitral annuloplasty may be not feasible (Figure 5). 
It should be noted however, that in the present study images were routinely reconstructed 
at 75% of the RR interval. However, the diameter and the distance between the CS and the 
MVA may vary during the cardiac cycle. Nevertheless, the present study shows that MSCT 
can accurately depict CS anatomy and its relation with the MVA, thereby providing important 
information in patients who are considered for percutaneous mitral annuloplasty.
Implications for percutaneous mitral annuloplasty
The present study shows the feasibility of the non-invasive evaluation of the CS anatomy and 
its relation with the MVA and the coronary arteries. In previous in vitro (7-9) and in vivo (15,16) 
studies, the relation between the CS, the MVA and the coronary arteries has been investigated. 
However, in none of these studies, patients with severe MR were studied. The present study 
emphasizes the variability in the relation between the CS and MVA. More importantly, it dem-
onstrates that in patients with severe MR, the minimal distance between the CS and the MVA is 
larger than in control patients (Table 3). 
The close relation between the CS and the LCX, and the variable distance between the CS 
and the MVA may hamper the clinical use of the percutaneous mitral annuloplasty in selected 
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patients (4). MSCT may identify the patients in whom percutaneous transvenous mitral annu-
loplasty may not be feasible. In 68% of the patients, the LCX courses between the CS and the 
MVA (Figure 4), with a potential risk of compression of the LCX when applying percutaneous 
mitral annuloplasty. Furthermore, in a large number of patients, the CS courses along the left 
atrial posterior wall, rather than along the MVA (Figure 5). In addition, in patients with severe 
calcifi cations of the MVA (Figure 6), a surgical approach may be preferred over a percutaneous 
approach. 
Our fi ndings are in good relation with recent data demonstrating the feasibility of non-
invasive evaluation of the CS anatomy in relation to the MVA using MSCT (11). Similar to the 
present study, a large variability in the distance between the CS and the MVA was noted (11). 
Novelties of the present study include the use of a 64-slice MSCT scanner, whereas in the previ-
ous study a 16-slice CT scanner (with a collimation of 4 x 1 mm) was used. In addition, in the 
present study patients with heart failure and patients with severe LV dilatation and subsequent 
functional MR were included. Therefore, a substantial part of the present study population 
consisted of potential candidates for percutaneous mitral annuloplasty. Both studies show 
that MSCT can accurately depict CS anatomy and its relation with the MVA, thereby providing 
important information in patients who are considered for percutaneous mitral annuloplasty. 
CONCLUSIONS
The relation between the CS, the MVA and the LCX can be evaluated non-invasively with MSCT. 
In 68% of the patients, the LCX coursed between the CS and the mitral annulus. Furthermore, at 
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the level of the MVA, the CS was located more superiorly in 90% of the patients. In the patients 
with severe MR, the minimal distance between the CS and the MVA was signifi cantly greater at 
all levels, compared to the patients without severe MR. MSCT may provide useful information in 
the selection of potential candidates for percutaneous mitral annuloplasty.
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ABSTRACT 
Background: By providing detailed anatomical information, MSCT may give more insight into 
the underlying mechanisms of functional mitral regurgitation (FMR).
Objectives: The purpose of the present study was to assess the anatomy and the geometry of 
the mitral valve by using 64-slice multi-slice computed tomography (MSCT). 
Methods: In 151 patients, including 67 patients with heart failure (HF) and 29 patients with 
moderate to severe FMR, 64-slice MSCT coronary angiography was performed. The anatomy of 
the subvalvular apparatus of the mitral valve was assessed, and mitral valve geometry, compris-
ing the mitral valve tenting height and leafl et tethering, was evaluated at the anterolateral, 
central and posteromedial levels. 
Results: In the majority of patients, the anatomy of the subvalvular apparatus was highly vari-
able due to multiple anatomic variations of the posterior papillary muscle: the anterior PM had 
a single insertion, whereas the posterior PM showed multiple heads and insertions (n=114, 
83%). The assessment of mitral valve geometry demonstrated that HF patients with moder-
ate to severe FMR had signifi cantly increased posterior leafl et angle and mitral valve tenting 
height at the central (44.4 ± 11.9º vs. 37.1 ± 9.0º, p=0.008; 6.6 ± 1.4 mm/m2 vs. 5.3 ± 1.3 mm/
m2, p<0.0001, respectively) and posteromedial levels (35.9 ± 10.6º vs. 26.8 ± 10.1º, p=0.04; 5.4 
± 1.6 mm/m2 vs. 4.1 ± 1.2 mm/m2, p<0.0001, respectively), as compared to HF patients without 
FMR. In addition, a more outward displacement of the PMs, refl ected by a higher mitral valve 
sphericity index, was observed in HF patients with FMR (1.4 ± 0.3 vs. 1.2 ± 0.3, p=0.004). Mitral 
valve tenting height at the central level and mitral valve sphericity index were the strongest 
determinants of FMR severity. 
Conclusions: MSCT provides anatomical and geometric information on the mitral valve appa-
ratus. In HF patients with moderate to severe FMR, a more pronounced tethering of the mitral 
leafl ets at the central and posteromedial levels was demonstrated using MSCT.
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Functional mitral regurgitation (FMR) is associated with poor outcome in patients with 
coronary artery disease and left ventricular (LV) dysfunction (1-3). One of the characteristics 
of FMR, diff erent from organic mitral regurgitation, is the preserved anatomy of the leafl ets 
and tendinous cords. Accordingly, mitral valve repair is a suitable surgical procedure to treat 
FMR. However, the results still remain controversial (4-7). The complex pathophysiology of FMR 
makes this entity a challenge for surgery. Several underlying mechanisms may contribute to 
FMR: LV remodeling, wall motion abnormalities, displacement of the papillary muscles (PMs) or 
mitral annulus deformation (8). All these mechanisms result in tethering of the mitral valve with 
failure of anteroposterior leafl et coaptation. 
Recent advances in 3-dimensional imaging techniques have allowed for a better under-
standing of the aforementioned changes in the mitral valve apparatus and LV geometry (9,10). 
Subsequently, new strategies for surgical mitral valve repair have been proposed (11,12). Multi-
slice computed tomography (MSCT) may be a valuable technique to study both LV geometry 
and mitral valve anatomy and geometry. Therefore, the purpose of the present study was to 
assess the anatomy and geometry of the mitral valve and the LV with the use of 64-slice MSCT 
in a large cohort of patients, including patients with FMR.
METHODS
Study population
A total of 151 consecutive patients referred to Leiden University Medical Center (Leiden, The 
Netherlands) for MSCT coronary angiography were studied. The study population was divided 
into 2 groups: group I (control patients, n = 84) comprised patients without coronary artery 
disease or structural heart disease and group II (heart failure-patients [HF], n = 67) comprised 
patients with heart failure and documented LV systolic dysfunction. The anatomy and geom-
etry of the mitral valve were examined, and diff erences among the two patient groups were 
assessed. In addition, diff erences in mitral valve geometry between HF patients with and 
without moderate to severe FMR were assessed.
Multi-slice computed tomography
All patients underwent scanning on a 64-slice MSCT scanner (Aquilion, Toshiba Medical Sys-
tems, Tokyo, Japan) using the following protocol: 120 kV, 300 mA, a rotation time of 400 to 
500 ms (depending on the heart rate), and collimation of 64 x 0.5 mm. A total of 80 to 110 ml 
of nonionic contrast medium (Iomeron 400, Bracco, Altana Pharma, Konstanz, Germany) was 
administered in the antecubital vein at 5 mL/s. Automated peak enhancement detection in the 
descending aorta was used to time the contrast bolus. Data acquisition started automatically 
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after the threshold level of +100 Hounsfi eld units was reached, and it was performed during 
an inspiratory breath-hold of 8 to 10 seconds. The ECG was recorded simultaneously to allow 
retrospective gating and reconstruction of the data at desired phases of the cardiac cycle. Data 
acquisition was performed at a rotation time of 400 ms resulting in a temporal resolution of 200 
ms in case of half reconstruction. In those patients with a heart rate > 70 beats/s, 3 cardiac beats 
were acquired resulting in segment reconstruction algorithm with slightly lower temporal 
reconstruction. All images were transferred to a dedicated workstation for data analysis (Vitrea 
2, Vitral Images, Plymouth, Minnesota).
Data analysis 
To study the anatomy and geometry of the mitral valve and the LV, the data set was reconstructed 
with a slice thickness of 0.5 mm and a reconstruction interval of 0.3 mm, at 30% and 75% of the 
RR interval for the systolic and diastolic phases, respectively. Standard orthogonal planes were 
used to assess the anatomy of the mitral valve apparatus. A reconstructed LV short-axis view was 
used to assess the mitral valve geometry. All parameters were corrected for body surface area. 
Anatomy of the subvalvular apparatus Reconstructed long-axis 2- and 4-chamber views and 
the reconstructed LV short-axis view in the diastolic phase were used to study the anatomy of 
the subvalvular apparatus. The anatomy of the PMs was assessed focusing on the number of 
heads (ranging from I to III) and the type of insertion to the ventricular wall (type A-C), accord-
ing to the classifi cation of morphological variants of the PMs, as described by Berdajs et al. (13) 
(Figure 1). Furthermore, the attachment of the basal part of the PMs to the LV wall was studied, 
with special attention to the type of attachment (solid or trabecularized attachment, Figure 1). 
Figure 1. Assessment of subvalvular apparatus of the mitral valve.Left panel: the anatomical variations of the papillary muscles (PMs) were 
classifi ed according to the number of heads and insertions (modifi ed after Berdajs et al, reference #13). The number of PM heads could range 
from 1 to 3 (type I, II and III, respectively), and the insertions could be common (subtype A) or divided (subtype B or C). Middle panel: Example 
of a type III/B posterior PM, demonstrating 3 PM heads, with 2 insertions. Right panel: The attachment of 2 type I PM showed thin trabeculae 
upholstering the surface of the LV wall.
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Left ventricular geometry To assess LV volumes and systolic function, the data set was recon-
structed with a slice thickness of 5.0 mm in the short-axis view, starting at early systole (0% of 
cardiac cycle) to end-diastole (95% of cardiac cycle) in steps of 5%. Endocardial borders were 
traced manually on the short-axis cine images and the PMs were regarded as being part of 
the LV cavity. Table 1 summarizes the LV parameters that were evaluated. The LV end-diastolic 
volume (LVEDV) and end-systolic volume (LVESV) were obtained and the LV ejection fraction 
(LVEF) was calculated by the diff erence between LVESV and LVEDV divided by the LVEDV (Table 
1). The sphericity index of the LV was calculated with the use of the following equation: LV 
sphericity index = EDV / [(LAD3 x 3.14)/ 6], where LAD is the long axis diameter of the LV (14).
Mitral valve geometry The mitral valve geometry was assessed in the reconstructed systolic 
phase. An overview of the measured variables is shown in Table 1. With the use of 2- and 
4-chamber views and the reconstructed LV short-axis view, a plane parallel to the mitral valve 
was reconstructed (Figure 2). At the level of the mitral valve annulus, the mitral annulus area 
was calculated by planimetry and the anteroposterior diameter (AP diameter) and the inter-
commissural diameter (CC diameter) were measured (Figure 2). 
Subsequently, a second plane parallel to the mitral valve was reconstructed, which clearly 
visualized both mitral commissures. Three anteroposterior planes perpendicular to this plane 
were defi ned to assess the geometry of the anterolateral, central and posteromedial parts of 
the mitral leafl ets (Figure 3). In all 3 planes, the degree of leafl et tethering was assessed by 
measuring the angle at which each leafl et met the mitral annulus plane (anterior leafl et, Aα; 
posterior leafl et, Pα; Figure 3). Mitral valve tenting height, defi ned as the distance between the 
leafl et coaptation and the mitral annulus plane, was also measured in all 3 planes (Figure 3) (9). 
Finally, in the systolic phase, the distance between the heads of PMs was measured (Figure 4). 
As an estimate of PMs displacement, the sphericity index of the mitral valve was calculated 
(9). The mitral valve sphericity index was defi ned as the ratio between the distance at the level of 
the basis of the PMs and the distance between this level and the mitral annulus plane (Figure 5).
Table 1. Summary of the left ventricular and mitral valve variables
Left ventricle
LV end-diastolic volume index




Mitral annulus area 
Intercommisural diameter (CC diameter)
Anteroposterior diameter (AP diameter)
Mitral valve sphericity index 
Distance between heads of papillary muscles
Anterior leafl et angle (Aα)
Posterior leafl et angle (Pα)
Tenting height (MVTHt)
LV = left ventricular.
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Echocardiography
Standard 2-dimensional echocardiograms were performed with patients in the left lateral 
decubitus position with a commercially available ultrasound system (Vingmed Vivid 7, General 
Electric-Vingmed, Milwaukee, Wisconsin). Images were obtained with a 3.5-MHz transducer 
at a depth of 16 cm in the parasternal (long- and short-axis) and apical (2- and 4-chamber) 
views. Standard 2-dimensional gray-scale images and color Doppler data were digitally stored 
in cine-loop format. LVEF was calculated from apical 2- and 4-chamber views with the biplane 
Simpson’s rule (15). The severity of mitral regurgitation was graded quantitatively from color-
fl ow Doppler in the conventional parasternal long-axis and apical 4-chamber views, using the 
proximal isovelocity surface area method. Eff ective regurgitant orifi ce area and regurgitant 
volume were calculated and mitral regurgitation was characterized according to the ACC/
AHA guidelines: mild (regurgitant orifi ce area <0.2 cm2 and regurgitant volume < 30 ml/beat); 
moderate (regurgitant orifi ce area 0.2-0.39 cm2 and regurgitant volume 30-59 ml/beat); severe 
(regurgitant orifi ce area ≥40 cm2 and regurgitant volume ≥60 ml/beat) (16). 
Figure 2. Assessment of the mitral valve annulus geometry. From the 2-and 4-chamber views (panel A and B), a short-axis view at 
the level of the mitral annulus was reconstructed (panel C).The area of the mitral annulus was quantifi ed by planimetry. In addition, the 
intercommissural diameter (CC diameter) and the anteroposterior diameter (AP diameter) of the mitral annulus were assessed (panel D). Ao = 
aorta; LA = left atrium; LV = left ventricle; MAA = mitral annulus area; RA = right atrium; RV = right ventricle.
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Figure 3. Assessment of the mitral valve geometry. Three anteroposterior planes perpendicular to the reconstructed LV short-axis view, 
at the level of the mitral commissures, were defi ned to assess the geometry of the anterolateral (A1-P1), central (A2-P2) and posteromedial 
(A3-P3) parts of the mitral leafl ets. The leafl et angles (Aα and Pα, as a refl ection of tenting of the leafl ets) and the mitral valve tenting height 
were measured in all 3 planes. AC = anterior commissure; Aα = anterior leafl et angle; MVTht = mitral valve tenting height; PC = posterior 
commissure; Pα = posterior leafl et angle; RA = right atrium; RVOT = right ventricular outfl ow tract.
Figure 4. Displacement of papillary muscles. At the reconstructed systolic phase, the distance between the heads of the papillary muscles 
was measured, as indicated by the black arrow.
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Statistical analysis
Continuous variables are presented as mean values ± SD; categorical variables are presented 
as frequencies and percentages. Diff erences between the two patient groups (controls vs. HF 
patients) were compared with the unpaired Student t-test for continuous variables and the 
chi-square tests for dichotomous variables. Diff erences between HF patients with moderate to 
severe FMR and HF patients without FMR were evaluated with the unpaired Student t-test. In 
addition, univariate linear regression analysis was performed to correlate various MSCT data on 
mitral valve geometry (mitral valve tenting height, anterior and posterior leafl et angles, mitral 
valve sphericity index) with the eff ective regurgitant orifi ce area obtained from echocardio-
graphy. Subsequently, major determinants of FMR severity were assessed among MSCT data on 
mitral valve geometry with a signifi cant correlation in the univariate analysis (p<0.05). For this 
purpose, multivariate linear regression analysis based on enter multiple regression analysis was 
performed. The dependent variable was the eff ective orifi ce regurgitant area and independent 
variables were anterior and posterior mitral leafl et angles and mitral tenting height at antero-
lateral, central and posteromedial levels and the mitral valve sphericity index. 
Figure 5. Sphericity index of the mitral valve. The sphericity index of the mitral valve was calculated as the ratio between the distance at the 
level of the papillary muscles basis (x) and the distance between this level and the mitral annulus plane (y).
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The reproducibility for the assessment of the tenting height, posterior and anterior leafl et 
angle at each level of the mitral valve was analyzed with repeated measurements by one expe-
rienced observer at two diff erent time points and by a second experienced observer. Intra- and 
inter-observer agreements for these measurements were evaluated by Bland-Altman analysis. 
Furthermore, intra-class correlation coeffi  cients were used as indicators of reproducibility. 
All statistical analyses were performed with SPSS software (version 12.0, SPSS Inc., Chicago, 




A total of 151 patients (mean age 60 ± 11, 87 men) were studied. The overall population was 
divided into two groups: controls (n = 84) and HF patients (n = 67; 36 [54%] with ischemic 
cardiomyopathy and 31 [46%] with idiopathic cardiomyopathy). Baseline characteristics of the 
two groups are shown in Table 2. 
Anatomic variations of subvalvular apparatus
In the majority of the patients, the anterior PM had a single insertion in the LV wall, either with 1 
PM head (type I, n = 75 [50%]) or 2 PM heads (type IIA n = 49 [33%]). Other anatomical variations 
of the anterior PM are listed in Table 3. In contrast, the anatomy of the posterior PM was more 
variable, showing multiple PM heads or multiple PM insertions in the majority of the patients 
(Table 3). 





Age (yrs) 57 ± 11 63 ± 11 *
Gender (M/F) 47/37 40/27
Body surface area (m2) 1.9 ± 0.2 1.9 ± 0.2
Hypertension, n (%) 37 (44) 29 (43)
Hypercholesterolemia, n (%) 32 (38) 27 (40)
Diabetes mellitus, n (%) 29 (35) 15 (22)
Smoking, n (%) 24 (29) 27 (40)
Positive family history, n (%) 25 (30) 24 (36)
Previous myocardial infarction, n (%)
   Anterior location, n(%)







MR severity, n (%)
   Non-MR
   Mild
   Moderate









*p-value = 0.002; HF = heart failure; MR = mitral regurgitation.
330
In addition, the type of attachment of the PMs to the LV wall was assessed. In all patients 
the solid body of the PM connected to the solid portion of the LV wall through a network of 
trabeculae covering the surface of the LV cavity. This type of attachment was seen for both the 
anterior PM and the posterior PM in all patients. 
Left ventricular and mitral valve geometry
The HF patients showed signifi cantly larger LV volumes and lower LVEF as compared to controls 
(Table 4). In addition, the LV sphericity index was signifi cantly increased in the HF patients (0.4 ± 
0.1 vs. 0.3 ± 0.1; p<0.001). The area of the mitral annulus was signifi cantly higher in HF patients 
compared to controls (Table 4), indicating annular dilatation. In addition, both the AP diameter 
and the CC diameter of the mitral annulus were increased in the HF patients. 
Table 3. Anatomic variations of the papillary muscles (n=151)
Type Anterior PM Posterior PM
I 75 (50%) 31 (21%)
IIA 49 (33%) 43 (29%)
IIB 15 (10%) 48 (32%)
IIIA 8 (5%) 6 (4%)
IIIB 4 (3%) 14 (9%)
IIIC 0 9 (6%)
PM = papillary muscle.






LVEDV index (ml/m2) 63 ± 15 95 ± 33 <0.0001
LVESV index (ml/m2) 23 ± 9 66 ± 31 <0.0001
LVEF (%) 62 ± 13 33 ± 12 <0.001
LV Sphericity index 0.3 ± 0.1 0.4 ± 0.1 <0.001
Mitral annulus area index (cm2/m2) 4.8 ± 0.9 5.8 ± 1.4 <0.0001
CC-D index (mm/m2) 21.6 ± 2.5 23.6 ± 2.9 <0.0001
AP-D index (mm/m2) 12.5 ± 2.1 15.0 ± 2.7 <0.0001
Mitral valve sphericity index 1.2 ± 0.2 1.3 ± 0.3 0.02
D-PM index (mm/m2) 11.3 ± 2.4 15.4 ± 2.8 <0.0001
Aα (°)
   Anterolateral
   Central











   Anterolateral
   Central










MVTHt index (mm/m2) 
   Anterolateral
   Central










AP-D = mitral valve anteroposterior diameter; Aα = anterior leafl et angle; CC-D = mitral valve intercommissural diameter; D-PM = distance 
between the heads of the papillary muscles; HF = heart failure; LVEDV = left ventricular end-diastolic volume index; LVEF = left ventricular 
ejection fraction; LVESV = left ventricular end-systolic volume index; MVTHt = mitral valve tenting height; Pα = posterior leafl et angle.
Chapter 19
M




The mitral valve sphericity index was defi ned as the ratio between the distance at the level of 
the basis of the PMs and the distance between this level and the mitral annulus plane (Figure 5). 
In the HF patients, a signifi cantly greater distance between the bases of the PMs was observed 
(15.4 ± 1.8 mm/m2 vs. 11.3 ± 2.4 mm/m2; p<0.001). In addition, the distance between the mitral 
annulus level and the PM line was signifi cantly diff erent (24.9 ± 4.3 mm/m2 vs. 22.3 ± 3.6 mm/
m2; p<0.0001). As a consequence, the mitral valve sphericity index was signifi cantly larger in HF 
patients (Table 4). In addition, the distance between the heads of the PMs was also signifi cantly 
larger in HF patients (Table 4). Finally, HF patients showed a signifi cant increase in the leafl et 
angles with a signifi cantly higher tenting height at all 3 levels of the mitral valve (Table 4).
Mitral valve geometry in patients with FMR
Among HF patients, 29 patients showed on echocardiography moderate to severe FMR 
(mean regurgitant volume 64.6 ± 21.8 ml/beat and mean eff ective regurgitant orifi ce area 0.4 
± 0.1cm2). To detect changes in mitral valve geometry in FMR, HF patients with moderate to 
severe FMR (n=29) were compared with HF patients without FMR (n=38). Previous history of 
inferior myocardial infarction was present in 2 (7%) HF patients with moderate to severe FMR 
and in 7 (18%) HF patients without (p = 0.11). The patients with moderate to severe FMR had 
comparable LV volumes and LVEF to patients without FMR (Table 5). The mitral annulus area 
was signifi cantly larger among patients with moderate to severe FMR, with also a signifi cantly 
larger CC diameter (Table 5). 
The distance between the basis of the PMs was larger in HF patients with moderate to 
severe FMR as compared to HF patients without FMR (16.5 ± 2.6 mm/m2 vs. 14.7 ± 2.7 mm/m2, 
respectively; p=0.006). There were no diff erences in the distance between the PM line and the 
mitral annulus plane between both groups of patients (25.1 ± 3.5 mm/m2 vs. 24.8 ± 4.9 mm/
m2; p=0.8). Consequently, the sphericity index of the mitral valve was signifi cantly higher in HF 
patients with moderate to severe FMR (Table 5). In addition, the distance between the heads 
of the PMs was signifi cantly larger among HF patients with moderate to severe FMR (Table 5). 
Compared to HF patients without FMR, HF patients with moderate to severe FMR showed 
an asymmetrical deformation of the mitral valve. Particularly, the angles of the posterior leafl et 
values at central and posteromedial levels were signifi cantly higher, whereas no signifi cant 
diff erences were observed either at the anterolateral level or the angles of the anterior leafl et 
(Table 5). As a consequence, the diff erences in mitral valve tenting height were more prominent 
at the central and the posteromedial levels (Table 5).
MSCT determinants of FMR severity
All MSCT derived parameters on mitral valve geometry (mitral valve tenting height, anterior 
and posterior leafl et angles and mitral valve sphericity index) showed a signifi cant correlation 
with the eff ective regurgitant orifi ce area assessed by echocardiography in all 3 levels of the 
mitral valve (anterolateral, central and posteromedial) (Table 6). However, on multivariate 
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analysis, the mitral valve tenting height at the central level (r = 0.58; p<0.0001) and the mitral 
valve sphericity index (r = 0.36; p<0.0001) were the strongest determinants of FMR severity. 
Table 5. Left ventricular and mitral valve geometry in HF patients with and without moderate to severe FMR 
HF patients with moderate 
to severe FMR
(n=29)




EROA (cm2) 0.4 ± 0.1 0.1 ± 0.02 <0.0001
Regurgitant volume (ml/beat) 64.6 ± 21.8 15.6 ± 12.3 <0.0001
LVEDV index (ml/m2) 101 ± 37 91 ± 30 0.2
LVESV index (ml/m2) 72 ± 37 62 ± 25 0.2
LVEF (%) 32 ± 14 33 ± 10 0.7
LV Sphericity index 0.4 ± 0.1 0.3 ± 0.1 0.1
Mitral annulus area index (cm2/m2) 6.3 ± 1.7 5.4 ± 0.9 0.02
CC-D index (mm/m2) 24.8 ± 2.5 22.8 ± 2.9 0.006
AP-D index (mm/m2) 15.6 ± 2.9 14.5 ± 2.4 0.1
Mitral valve sphericity index 1.4 ± 0.3 1.2 ± 0.3 0.004
D-PM index (mm/m2) 16.5 ± 2.5 14.7 ± 2.7 0.006
Aα (°)
   Anterolateral
   Central











   Anterolateral
   Central











   Anterolateral
   Central










EROA = eff ective regurgitant orifi ce area; FMR = functional mitral regurgitation; other abbreviations as in Table 4.




   Anterolateral
   Central











   Anterolateral
   Central











   Anterolateral
   Central










Mitral valve sphericity index 0.36 <0.0001 <0.0001
R2 of the model selected for multivariate analysis = 0.428. The anterior and posterior leafl et angle and the mitral valve tenting height at the 
posteromedial level were not included in the model because of the high inter-correlation of these variables (Pearson correlation coeffi  cient 
>0.70). Aα = anterior leafl et angle; MVTHt = mitral valve tenting height; Pα = posterior leafl et angle.
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In 15 randomly selected patients, reproducibility data was assessed. The intra-observer agree-
ment for the tenting height and leafl et angle measurements was good. The average diff erences 
were: 0.9 ± 1.4% for the tenting height, -3.3 ± 5.7% for the posterior leafl et angle, and -0.8 ± 
4.9% for the anterior leafl et angle. The intra-class correlation coeffi  cients for each intra-observer 
comparison were: 0.92 for the tenting height, 0.86 for the posterior leafl et angle and 0.85 for the 
anterior leafl et angle. 
Similarly, agreement of the measurements by two diff erent observers was good. The aver-
age diff erences were: 0.1 ± 1.2% for the tenting height, 0.9 ± 2.9% for the posterior leafl et angle 
and -0.4 ± 4.4% for the anterior leafl et angle. The intra-class correlation coeffi  cients for each 
inter-observer comparison were: 0.84 for the tenting height, 0.83 for the posterior leafl et angle 
and 0.84 for the anterior leafl et angle.
DISCUSSION
The present study demonstrates that MSCT enables a comprehensive assessment of the mitral 
valve apparatus, by providing an exact characterization of the anatomy of the subvalvular appa-
ratus and the geometry of the mitral valve. The main fi ndings can be summarized as follows: the 
anatomy of the subvalvular apparatus is highly variable, with variations in both the number of 
heads and insertions of the anterior and posterior PMs. Furthermore, the attachment of the PMs 
to the LV wall is not solid, but trabecularized in all patients. With the use of MSCT, an asymmetric 
deformation of the mitral valve was observed in HF patients with moderate to severe FMR. The 
posterior leafl et angles and the mitral valve tenting height were signifi cantly increased at the 
central and the posteromedial levels, as compared to HF patients without FMR. In addition, a 
more outward displacement of the PMs, refl ected by a higher mitral valve sphericity index, was 
observed in this subgroup of patients. The fi ndings of the present study may have important 
implications for surgical mitral valve repair in patients with severe FMR. 
Anatomic variations of subvalvular apparatus
A large variability in the anatomy of the subvalvular apparatus was observed in the present 
study (Figure 1 and Table 3). The characterization of the subvalvular apparatus may be of great 
importance for various surgical mitral valve repair approaches that include translocation or 
reconstruction and relocation of the PMs (11,17). Previous anatomical studies have also reported 
variations in PM anatomy (13,18). Berdajs et al. (13) studied 100 structural normal hearts and 
classifi ed the PMs according to the number of heads and insertions (Figure 1). The authors dem-
onstrated that the anatomy of the posterior PM was more heterogeneous compared with the 
anterior PM (13). The results of the present study are in line with previous anatomical studies: in 
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the majority of the patients, the posterior PM consisted of multiple heads or multiple insertions, 
whereas the anatomy of the anterior PM was more homogeneous (Table 3). 
In addition to PM anatomy, the characteristics of the PM attachments to the LV wall were 
assessed in the present study. Conventionally, the anchorage of the PM to the solid heart wall 
has been described as a direct connection with a broad base. However, recently, Axel noted 
that the attachment may rather be through a network of trabeculae (19). In the present study, 
similar attachments of the PMs were found. In all patients the bases of the PMs connected to 
the solid wall of the LV through a network of trabeculae instead of a solid attachment (Figure 1). 
The attachment of the PMs to the LV wall may have implications for surgical mitral valve repair. 
However, the exact clinical importance of this fi nding remains to be determined. Nonetheless, 
MSCT allows for a detailed analysis of the anatomy of the PMs and their attachment to the LV 
wall. 
Geometric changes in FMR
The geometry of the mitral valve was studied in 29 HF patients with moderate to severe FMR, 
and compared to HF patients without FMR (n = 38). In HF patients with moderate to severe FMR, 
remodeling of the LV and the mitral valve was observed. Importantly, mitral valve deformation 
aff ected predominantly the central and posteromedial parts of the valve, and the increase in 
mitral valve tenting height at the central level was the strongest determinant of FMR severity. 
In addition, the higher sphericity index of the mitral valve indicates that the displacement of 
the PMs plays a role in the development of FMR. These results are in agreement with previous 
in vitro and in vivo studies (9,20). Nielsen et al. (20) used an in vitro LV model to study the 
impact of PM misalignment on mitral leafl et coaptation and its relation with the severity of 
mitral regurgitation. The asymmetrical displacement of the PMs towards a more posterior level 
resulted in preserved or excessive anterior leafl et motion (prolapse-like) at the anterolateral 
level (close to the anterior commissure), whereas at the posteromedial level (close to the pos-
terior commissure), a failure of leafl et coaptation was observed (20). Kwan et al. (9), confi rmed 
these results using 3-dimensional echocardiography in patients with ischemic cardiomyopathy. 
An asymmetrical deformation of the mitral valve, with a “funnel-shaped” deformity on the level 
close to the posterior commissure and a “prolapse-like” deformity on the anterolateral side, 
was noted in patients with ischemic cardiomyopathy, in contrast to patients with idiopathic 
cardiomyopathy (9). The present study confi rms these results and demonstrates that MSCT may 
be of value for assessment of mitral valve remodeling in patients with FMR.
Determinants of FMR severity
The geometry parameters of the mitral valve assessed by 64-slice MSCT were related to the 
severity of FMR, particularly the mitral valve tenting height at the central level and the sphe-
ricity index of the mitral valve. These fi ndings are in agreement with previous data based on 
2- and 3-dimensional echocardiography (9). Kwan et al. demonstrated using 3-dimensional 
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echocardiography, that the medial mitral valve tenting area was the major determinant of the 
severity of mitral regurgitation in patients with dilated cardiomyopathy (9). In addition, the 
mitral valve sphericity index, as an indicator of the outward displacement of the PMs, suggests 
that FMR severity is also related to changes in LV cavity geometry, as previously described (21). 
Clinical implications
Accurate assessment of the interaction of the LV and the mitral valve apparatus is crucial in sur-
gical treatment of FMR (8). New surgical techniques that include restoration of LV geometry and 
relocation of the PMs have been proposed (11,17). For these procedures, an exact characteriza-
tion of the LV geometry and the subvalvular apparatus is mandatory. Furthermore, assessment 
of the deformation of the mitral annulus is important for surgical procedures that attempt to 
restore the geometry of the mitral valve (12). Finally, the assessment of leafl et tethering is of 
critical importance and may even predict the outcome of surgical mitral valve repair (22). 
Previously, it has been demonstrated that MSCT may be of value for assessment of mitral 
valve anatomy (23-25). However, in none of these studies, the geometry of the mitral valve and 
the interaction with the LV was studied. In the present study, 64-slice MSCT was used to assess 
mitral valve anatomy and geometry in a large cohort of patients, including patients with FMR. 
By providing detailed information on all components of the LV and mitral valve complex, MSCT 
may be of great value to guide surgical therapy for FMR. 
Study limitations
There is little evidence on the assessment of regurgitant mitral valve with MSCT (26). In the 
present study, the regurgitant orifi ce area was not quantifi ed with MSCT, which is a limitation. 
Furthermore, surgical data was not systematically available in all patients with FMR, precluding 
us to confi rm prospectively the value of MSCT in the surgical treatment decision. Future stud-
ies, assessing both the anatomical and the functional aspects of the mitral valve with MSCT 
and with larger populations including patients with several grades of FMR, may provide more 
insight in this issue. Finally, radiation dose (currently 10-15 mSv) is one of the general disad-
vantages of MSCT and adjustments in imaging protocols are warranted to keep the radiation 
exposure within limits.
CONCLUSIONS
The present study shows that MSCT allows detailed assessment of mitral valve anatomy and 
geometry. In patients with moderate to severe FMR, an asymmetrical remodeling of the mitral 
valve was observed, with tethering of the mitral leafl ets at the central and posteromedial levels 
of the mitral valve. MSCT provides the anatomical and geometric analysis of the mitral valve 
apparatus and may be of value to guide surgical treatment of FMR. 
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Degenerative aortic stenosis (AS) accounts for the majority of native valve disease (1). Surgical 
aortic valve (AV) replacement is a treatment option that provides good outcome in the majority 
of the patients, with good durability of the prosthetic valve (2). However, a large proportion of 
patients with severe AS are not referred for, or denied surgery. The Euro Heart Survey on valvu-
luar heart disease demonstrated that up to 33% of the patients with severe AS did not undergo 
surgery, although there was an indication (3). Patient’s age and (multiple) co-morbidities were 
the main reasons for denial of surgery (4). Therefore, there is a need for a less invasive treatment 
option in older patients with severe AS. 
In the past few years, new percutaneous AV implantation procedures have been introduced 
(5). Two diff erent types of percutaneous AV prostheses now have CE mark approval in Europe. In 
addition, European (6) and American (7,8) recommendations on percutaneous AV implantation 
have been published. In the present manuscript, the clinical experience with the two diff erent 
percutaneous AVs will be reviewed. In addition, the role of diff erent imaging modalities in the 
selection of patients, guidance during percutaneous AV implantation and follow-up will be 
discussed. 
PROSTHESES AND CLINICAL EXPERIENCE 
Currently, two diff erent types of percutaneous AV devices are commercially available. The 
balloon-expandable Edwards SAPIEN valve (Edwards Lifesciences Inc., Irvine, California, USA) 
and the self-expanding CoreValve Revalving prosthesis (CoreValve Inc., Irvine, California, 
USA). At present, more than 2500 patients worldwide have been treated with percutaneous 
AV implantation, and the number of studies reporting the clinical experience and results with 
percutaneous AV procedures is rapidly growing (Table 1). In the following paragraphs, technical 
aspects of the diff erent prostheses and clinical experience with percutaneous AV implantations 
will be reviewed.
Balloon-expandable valve
Andersen et al. fi rst tested the balloon-expandable percutaneous AV in an animal model in 1992 
(9). Subsequently, Cribier et al. performed the fi rst human implantation in 2002 (10). The fi rst 
generation balloon-expandable valve was entitled Cribier-Edwards valve (Edwards Lifesciences 
Inc.), whereas at present the Edwards SAPIEN valve (Edwards Lifesciences Inc.) is commercially 
available (Figure 1). This prosthesis incorporates a balloon-expandable stainless steel stent, 
fabric sealing cuff  and bovine pericardial leafl ets. At present, available prosthesis sizes are 23 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the fi rst studies, an antegrade implantation of the valve was performed, using transseptal 
access to the left atrium and passage through the mitral valve to reach the AV (10). However, at 
present a retrograde approach through the femoral artery is used (11). During the procedure, 
a balloon valvuloplasty is fi rst performed to facilitate passage of the native AV. During rapid 
right ventricular pacing, the prosthesis is positioned and deployed under fl uoroscopy and 
echocardiographic guidance. Alternatively, in patients with diffi  cult vascular access because of 
extensive calcifi cations or tortuosity of the femoral artery or aorta, a transapical approach can 
be used. After a partial thoracotomy, direct puncture of the apical portion of the left ventricular 
free wall is performed to gain catheter access to the left ventricle and AV. The prosthesis is 
subsequently positioned and deployed, similar to the antegrade approach (12). 
Clinical experience: Cribier-Edwards and Edwards SAPIEN valve A single center Phase 1 
project was started in 2003 for compassionate use of the Cribier-Edwards valve in patients with 
end-stage AS after the fi rst successful animal and human studies. In the Initial Registry of Endo-
Vascular Implantation of Valves in Europe (I-REVIVE) trial, followed by the Registry of Endovas-
cular Critical Aortic Stenosis Treatment (RECAST) trial, a total of 36 patients (mean EuroSCORE 
12 ± 2) were included (13,14). Twenty seven patients underwent successful percutaneous AV 
implantation (23 antegrade, 4 retrograde). The 30-day mortality was 22% (6 of 27 patients), 
and mean aortic valve area (AVA) increased from 0.60 ± 0.11 cm2 to 1.70 ± 0.10 cm2 (p<0.001). 
Importantly, this improvement in AVA was maintained up to 24 months follow-up (14). 
After these fi rst trials, the Cribier-Edwards prosthesis and the Edwards SAPIEN prosthesis 
have been used in numerous studies (Table 1). Overall, acute procedural success is achieved 
in 75 to 100% of the procedures, and 30-day mortality ranges between 8 and 50% in the 
published studies. In a large study using the retrograde approach, Webb et al. treated 50 AS 
patients (mean age 82 ± 7 years, 45 patients in New York Heart Association (NYHA) functional 
class III or IV) (15). A Cribier-Edwards valve was successfully implanted in 43 of the 50 patients 
(86%). Interestingly, a clear learning curve was observed when comparing the fi rst 25 patients 
with the second 25 patients. Procedural success increased from 76% in the fi rst 25 patients 
Figure 1. Currently commercially available prostheses for percutaneous AV implantation. Panel A shows the balloon-expandable Edwards-
SAPIEN valve. Panel B shows the self-expanding CoreValve prosthesis.
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to 96% in the second 25, and 30-day mortality fell from 16% to 8% (15). Recently, Walther 
et al. reported their initial single-center experience with the transapical implantation of the 
Edwards SAPIEN valve in 50 high-risk AS patients (16). Via an anterolateral minithoracotomy, 
the prosthesis was successfully implanted in 47 patients (94%); early conversion to conven-
tional sternotomy had to be performed in 3 patients. Cardiopulmonary bypass was used in 
16 patients (32%). After implantation, all prostheses showed good valvular function, with only 
mild aortic incompentence (mean aortic regurgitation grade 0.5 ± 0.5). During the fi rst 30 days 
post-operative 4 patients died and during follow-up another 10 patients died (overall survival 
at 12 months 71.4%). A post-hoc analysis of the fi rst 25 patients versus the second 25 patients 
did not show a diff erence in long-term survival after AV implantation (16). 
Importantly, a randomized trial using the Edwards SAPIEN valve is currently comparing 
percutaneous AV implantation against surgical AV replacement (objective: demonstrating 
non-inferiority of the percutaneous prosthesis) and medical therapy (objective: demonstrating 
superiority of the prosthesis) (Figure 2). The primary endpoint in the two arms is mortality at 12 
months follow-up, with secondary endpoints that focus on long-term adverse cardiovascular 
events composite, valve performance and quality-of-life indicators (17). The results of this fi rst 
randomized trial with percutaneous AV implantations are eagerly awaited. 
Self-expanding valve
The CoreValve Revalving systemTM (CoreValve Inc.) consists of a tri-leafl et bioprosthetic porcine 






Predicted mortality risk 15% 
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Figure 2. Flowchart of the randomized Placement of AoRTic traNscathetER valves (PARTNER) trial. In the fi rst treatment arm (surgical) the 
Edwards SAPIEN prosthesis is compared against standard surgical AV replacement in 350 patients. The second arm (medical management) compares 
the Edwards SAPIEN valve against medical therapy and/or balloon valvuloplasty in 250 patients. The primary endpoint in the two arms is mortality 
at 12 months follow-up. Secondary endpoints include an adverse cardiovascular events composite, valve performance and quality-of-life indicators.
346
The device is constrained within a delivery sheath, and expands to its predetermined shape 
when the sheath is withdrawn. It has a specifi c design consisting of three distinct parts: The 
lower portion of the prosthesis has high radial force to expand and avoid recoil. The middle 
portion includes the pericardial tissue valve and is constrained to avoid coronary occlusion. The 
upper part is fl ared to center and fi x the prosthesis in the ascending aorta. At present, the third 
generation CoreValve Revalving system is commercially available. The size of the delivery system 
has gradually declined from a 25F and 21F system (fi rst- and second-generation, respectively) 
to the currently available third-generation 18F system. Two diff erent sizes are currently avail-
able: a 26 mm prosthesis (aortic annulus diameter 20 – 24 mm) and a 29 mm prosthesis (aortic 
annulus diameter 24 – 27 mm). The CoreValve prosthesis is implanted retrograde through the 
femoral artery. While in the fi rst series the prosthesis was implanted under general anesthesia 
with a cardiac assist device, extracorporal membrane oxygenation or a full-bypass support 
(18), at present local anesthesia combined with mild systemic sedative/analgesic medication is 
used without cardiac assist or full-bypass support (19). After balloon valvuloplasty, the device is 
positioned under fl uoroscopy guidance. Retraction of the outer sheath allows deployment of the 
self-expanding prosthesis. Postdilatation of the prosthesis can be performed if deemed neces-
sary, depending on the position of the prosthesis and the presence of aortic regurgitation (19). 
Clinical experience: CoreValve Revalving system. After the fi rst implantation of the CoreValve 
prosthesis in a patient in 2005 (20), a large number of patients have been treated with this 
device to date (Table 1). In the fi rst pilot study, Grube et al. treated 25 patients with severe AS 
deemed unsuitable for open-heart surgery using fi rst- and second-generation prostheses (21). 
Acute procedural success was achieved in 21 of 25 patients (84%). Major in-hospital cardiovas-
cular and cerebral events occurred in 8 patients (32%) whereas major bleeding occurred in 5 of 
10 patients (50%) treated with the fi rst-generation device and in 1 of 15 patients (7%) treated 
with the second-generation prosthesis. At 30-days follow-up, mean AV gradient decreased 
from 44.2 ± 10.8 mmHg to 11.8 ± 3.4 mmHg (p<0.001), and NYHA class improved from 2.9 ± 0.2 
to 1.7 ± 0.5 (p<0.001) (21). 
Recently, Grube et al have reported the results with the three diff erent generations Core-
Valve Revalving system (19). In this nonrandomized, prospective study, a total of 136 patients 
were included. Ten patients were treated with fi rst-generation devices, 24 patients with second-
generation and 102 patients with third-generation devices. At baseline, mean AVA was 0.67 
± 0.9 cm2 and mean logistic EuroSCORE was 23.1 ± 15.0 % in the overall study population. 
Overall procedural success rate increased signifi cantly with the new generation devices from 
70.0% and 70.8% to 91.2% for fi rst-, second- and third-generation prostheses, respectively 
(p=0.003). Interestingly, periprocedural mortality decreased using newer devices from 10% 
(fi rst-generation) to 8.3% (second-generation) to 0% (third-generation). Overall 30-day mortal-
ity for the three generations was 40%, 8.3% and 10.8%, respectively. Pooled data demonstrated 
a signifi cant improvement in NYHA functional class (from 3.3 ± 0.5 to 1.7 ± 0.7, p<0.001), 
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without a diff erence between the 3 generations. Importantly, NYHA functional class and mean 
pressure gradient remained stable up to 12 months follow-up in all 3 generations. This largest 
single-center experience with three generations CoreValve prostheses demonstrates that the 
use of the latest generation prosthesis is associated with an improved procedural and mid-term 
outcome (19). 
In addition, the results of a multi-center registry with the third-generation CoreValve 
Revalving system have recently been reported (22). A total of 646 patients from 51 centers were 
included in the registry. It was a high risk elderly population (mean age 81 ± 7 years) with a 
poor functional class (85% of the patients in NYHA class III or IV), and a high logistic EuroSCORE 
(mean 23.1 ± 13.8%). Procedural success was achieved in 628 of the 646 patients (97.2%). 
All-cause 30-day mortality was 8%, and the combined end-point of procedural-related death, 
stroke or myocardial infarction was reached in 60 patients (9.3%). After successful implantation, 
mean pressure gradient decreased from 49 ± 14 mmHg to 3 ± 2 mmHg (22). This large registry 
confi rms the results of earlier studies, and demonstrates the safety, feasibility and effi  cacy of 
the CoreValve Revalving system.
Valve-in-valve procedure
The concept of a percutaneous AV implantation in an existing AV prosthesis (‘valve-in-valve’) 
has recently been introduced. The feasibility was demonstrated in an animal model by Walther 
et al. (23). Afterwards, the valve-in-valve concept has been successfully applied in patients 
with degenerated aortic bioprostheses (24,25). It may be of great value in these patients, since 
re-operation for degenerated xenografts is challenging, and is associated with an increased 
mortality risk as compared with fi rst isolated AV replacement (26). 
Furthermore, the valve-in-valve concept can be used during fi rst percutaneous CoreValve 
prosthesis implantation, in case of suboptimal implantation of the prosthesis (19). Good func-
tion of the prostheses and durability of the valve-in-valve has been demonstrated up to three 
years follow-up (27). Recently, a multi-center study demonstrated that in up to 2.6% of fi rst 
CoreValve prosthesis implantation procedures, a valve-in-valve procedure is performed (22). 
However, it should be performed with caution because future access to the coronary ostia may 
be limited by the two overlying nitinol frames of the prostheses. 
SELECTION OF PATIENTS
The selection of patients for percutaneous AV implantation involves several critical steps. In 
general, a multi-disciplinary team, including cardiologists, surgeons, anesthesiologists and 
imaging specialists, should decide if patients are eligible for percutaneous AV implantation. 
Recently, two position statements on the use of percutaneous AV procedures have been pub-
lished, that provide important information on the patient selection procedure (6,8). A summary 
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of the European statement (endorsed by the European Association of Cardio-Thoracic Surgery 
and the European Society of Cardiology) is provided in Table 2. 
One of the fi rst steps in the selection procedure is the assessment of AS severity. At present, 
percutaneous AV implantation is only recommended in symptomatic patients with severe AS. The 
surgical risk, life expectancy, and quality of life should also be assessed. Preferably, the surgical 
risk is determined using a combination of clinical judgement and multiple risk scores, such as the 
logistic EuroSCORE, the STS Predicted Risk of Mortality score, or Ambler score (6). When patients 
are deemed inoperable due to a high surgical risk, a percutaneous procedure can be considered. 
Finally, the feasibility of a percutaneous procedure and contraindications should be 
assessed in the potential candidates (Table 2). Typically, coronary anatomy, the aortic annulus 
and the peripheral vessels are evaluated. For this purpose, various imaging modalities are avail-
able. These modalities and their relative merits will be reviewed in the following paragraphs. 
Table 2. Recommendations on patient selection for percutaneous AV implantation (adapted from Vahanian et al. ref # (6))
Patient selection steps Recommendation on patient 
selection
Comment
1. Confi rmation of AS severity Only in severe AS Echocardiography is preferred tool
2. Clinical evaluation Only in patients with severe 
symptoms related to AS
3A. Evaluation of surgical risk Only in high-risk patients or 
patients with contra-indications for 
surgery
Clinical judgement and the use 
of a combination of risk scores 
(EuroSCORE, STS Predicted Risk of 
Mortality score, Ambler score) is 
preferred
3B. Evaluation of life expectancy 
/ quality of life
Not in patients with life expectancy 
< 1 year (conservative treatment)
4A. Assessment of feasibility of 
procedure
Evaluation should include:
   Coronary anatomy assessment Coronary angiography or MSCT 
should be used to assess:
   Coronary artery disease
   Position of coronary arteries relative 
to aortic cusps
   Aortic annulus assessment Echocardiography/ MSCT/ MRI/ 
Aortography should be used to assess 
aortic annulus size
   Peripheral arteries assessment Angiography/ MSCT/ MRI should 
be used to assess size, tortuosity, 
calcifi cations. 
4B. Assessment of 
contraindications
Contraindications are:
   Aortic annulus <18 or >25 mm 
(Edwards-SAPIEN) and <20 or >27 
mm (CoreValve)
   Bicuspid AV
   Asymmetric heavy valvular 
calcifi cation
   Aortic root dimension >45 mm
   Presence of LV apical thrombus
AS = aortic stenosis; AV = aortic valve; MRI = magnetic resonance imaging; MSCT = multi-slice computed tomography
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IMAGING IN PERCUTANEOUS AORTIC VALVE IMPLANTATION 
Various imaging modalities are available for the selection of patients, performing percutane-
ous AV implantation, and for follow-up after the procedure. An overview on the role of various 
imaging modalities in percutaneous AV implantation procedures is provided in Table 3. Whereas 
transthoracic echocardiography (TTE), multi-slice computed tomography (MSCT), and magnetic 
resonance imaging (MRI) are valuable imaging techniques before and after the procedure, trans-
esophageal echocardiography (TEE) is mainly used during the actual implantation procedure. 
The various processes and imaging modalities will be reviewed in the following paragraphs
Patient selection
The selection of candidates for percutaneous AV implantation involves a number of critical 
steps. The diff erent imaging modalities can assist in the selection process by providing impor-
tant information on the AV, coronary arteries and vascular structures. First, the severity of AS 
should be assessed. Both TTE and TEE are the preferred tools to assess the severity of AS (1). 
However, recent reports have suggested a good correlation between echocardiography and 
both MSCT (28) and MRI (29) to assess AVA with planimetry. 
In addition, the exact anatomy of the AV should be assessed. Echocardiography, MSCT and 
MRI all can help to distinguish between a bicuspid and a tricuspid AV. It has been suggested that 
a bicuspid AV may result in a higher incidence of stent misdeployment and peri-stent leakage 
Table 3. The role of imaging in percutaneous AV implantation procedures
Process Preferred imaging modality
Patient selection
   AS severity TTE or TEE
   AV anatomy TTE or TEE
   AV calcifi cations (severity, location)  MSCT
   Coronary anatomy (CAD, relation with annulus) Angiography or MSCT
   Aortic annulus diameter All modalities can be used
   Aortic arch (angulation, atheroma) MSCT
   Peripheral arteries (calcifi cations, tortuosity) Angiography or MSCT
   Atrial or ventricular thrombus TTE or TEE
   LV ejection fraction All modalities can be used
AV implantation
   Vascular access Fluoroscopy and/or TEE
   Prosthesis sizing Fluoroscopy and/or TEE
   Prosthesis positioning and deployment Fluoroscopy and/or TEE
   Assessment of valve competence Fluoroscopy and/or TEE
   Assessment of coronary patency Fluoroscopy and/or TEE
   Detection of complications Fluoroscopy and/or TEE
Follow-up
   Assessment of prosthesis function TTE or TEE
   Assessment of prosthesis position TTE, TEE or MSCT
   Detection of complications All modalities can be used
AS = aortic stenosis; AV = aortic valve; CAD = coronary artery disease; LV = left ventricular; MSCT = multi-slice computed tomography; TEE = 
transesophageal echocardiography; TTE = transthoracic echocardiography.
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(30). Therefore, at present it is not recommended to perform percutaneous AV implantation 
in bicuspid AV (6). Furthermore, the exact location and severity of AV calcifi cations and the 
presence of bulky AV leafl ets should be assessed. Before the implantation procedure, MSCT 
may be the preferred tool to identify AV calcifi cations (19). A severely calcifi ed AV may result 
in the inability to cross the native valve with the catheter. Bulky leafl ets and calcifi cations on 
the free edge of the leafl ets may increase the risk of occlusion of the coronary ostia during AV 
implantation (15). Therefore, the extent and exact location of calcifi cations should be carefully 
assessed before the implantation procedure (Figure 3). 
The assessment of coronary anatomy is also important in the selection process. Conven-
tional coronary angiography should be performed to exclude the presence of signifi cant 
coronary artery disease (6). Although conventional angiography remains the ‘gold standard’, 
non-invasive evaluation of coronary artery disease may be performed with MSCT as well. This 
technique also allows detailed, three-dimensional evaluation of the relation between the coro-
nary ostia and the AV leafl ets. This may be important to avoid coronary occlusion during AV 
implantation. It has been demonstrated that the relation between the aortic annulus, the coro-
nary ostia and leafl ets is highly variable. In a cohort of 169 patients undergoing MSCT scanning, 
Figure 3. Before the percutaneous valve procedure, MSCT can depict the extent and exact location of calcifi cations. During percutaneous 
AV replacement, extensive calcifi cations may hamper the ability to cross the native valve. On transverse reconstructions through the plane of 
the AV, the calcifi cations can be quantifi ed. Panel A shows small isolated spots (mildly calcifi ed AV). In contrast, panel B shows multiple larger 
spots, predominantly at the base of the leafl ets (moderately calcifi ed AV). Panel C shows a heavily calcifi ed AV, mainly located at the tips of the 
leafl ets. In panel D, a sagittal view through the AV is shown, demonstrating bulky calcifi cations at the tip of the AV leafl ets.
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it was noted that the distance between the aortic annulus and the coronary ostia was smaller 
than the length of the AV leafl ets in up to 49% of the patients (31). In these patients, the risk of 
coronary occlusion during percutaneous AV implantation may be increased. Therefore, both 
invasive and non-invasive evaluation of coronary anatomy can provide important information 
for the selection of candidates for percutaneous AV implantation. 
The assessment of aortic annulus diameters is of utmost importance for correct prosthesis 
sizing. Various prosthesis sizes for the balloon-expandable and self-expanding prostheses are 
available for a wide range of annulus diameters. However, at present no gold-standard is avail-
able for the exact measurement of the aortic annulus diameter. Typically, TTE is used to assess 
the aortic annulus diameter (Figure 4, panel A). However, it may underestimate the diameter 
when compared with TEE (32). Importantly, with both techniques the basal attachments of the 
leafl ets are used as landmark points, potentially underestimating the true/ full aortic annulus 
diameter (33). In contrast, three-dimensional echocardiography, MRI and MSCT allow a three-
dimensional, multi-planar reconstruction of the aortic annulus (Figure 4, panels B and C). This 
may result in a more accurate measurement of the aortic annulus diameter. 
Furthermore, the anatomy of the aorta and peripheral vasculature should be assessed. 
Conventional angiography is the preferred imaging modality. However, MSCT and MRI may also 
provide the necessary information. A transapical approach is preferred over the transfemoral 
approach in patients with a severe angulation of the aortic arch, or the presence of atheroma in 
the aorta. In patients with severe calcifi cations and/or tortuosity of the femoral vessels, or small 
vessel diameters (typically < 6 to 9 mm), a transfemoral approach is contraindicated, because of 
the high risk of vascular complications. Finally, contraindications such as the presence of atrial 
or ventricular thrombi, and a very poor left ventricular ejection fraction should be assessed. 
Aortic valve implantation
During the AV implantation procedure, a combination of fl uoroscopy/ angiography and TEE 
is typically used (8). Rather than replacing each other, these techniques are complimentary 
during the AV implantation. Contrast aortagraphy can be used for fi nal assessment of the aortic 
Figure 4. Before percutaneous AV implantation, the aortic annulus diameter should be assessed. For this purpose, diff erent imaging 
modalities are available. Panel A demonstrates conventional TTE, where the annulus diameter is assessed at the ventricular aspect of the leafl et 
insertion. In panel B, three-dimensional TEE is shown. Panel C demonstrates a sagittal reconstruction through the AV. The dotted arrow indicates 
the measurement of the aortic annulus.
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annulus diameter and prosthesis sizing. However, similar to echocardiography, it is limited by 
its two-dimensional nature. 
Positioning and fi nal deployment of the prosthesis is performed under fl uoroscopy and/or 
TEE guidance (Figure 5, panel A and B). In patients with severely calcifi ed AS, fl uoroscopy allows 
easy localization of the prosthesis in relation to the aortic annulus and leafl ets. Conversely, in 
patients without severe calcifi cations, TEE may be more helpful for exact prosthesis position-
ing. Typically, a long-axis (130°) transesophageal view is used (32). Critical assessment of the 
exact location of the undeployed prosthesis, in relation to the native AV is important. When the 
correct positioning is confi rmed with fl uoroscopy and/or echocardiography, the prosthesis is 
deployed under rapid right ventricular pacing. 
Immediately after the stent deployment, valve competence should be assessed. A trans-
esophageal short-axis view is the best view to diff erentiate between valvular and paravalvular 
aortic regurgitation. The severity of paravalvular aortic regurgitation can be used as an indica-
tor of procedural success, and can help to decide if balloon (re-)dilatation is necessary. In 32 
patients undergoing TEE guided balloon-expandable AV implantation, Moss et al. noted some 
degree of aortic regurgitation in 88% of the patients (32). In the majority of the patients (84%) 
paravalvular aortic regurgitation was present. Thirteen patients underwent subsequent re-
dilatation of the prosthesis, with an improvement in aortic regurgitation of more than 1 grade 
in 7 of the 13 patients. Mild valvular regurgitation typically resolves during the fi rst days after 
implantation (32). 
For the assessment of coronary patency, coronary angiography should be performed after 
prosthesis implantation (Figure 5, panel C). Acute coronary occlusion is a serious, but rare 
complication. Interestingly, it has been demonstrated that correct positioning of the prosthesis 
even allows coronary intervention after percutaneous AV implantation (34). 
Various complications have been reported after percutaneous AV implantation, mainly 
related to vascular access and thromboembolic complications. In addition, new atrioventricular 
block may occur in up to 6% of the patients (35). In addition to fl uoroscopy, TEE may help in the 
Figure 5. Imaging during a percutaneous implantation procedure of a balloon-expandable valve. Panel A demonstrates a long-axis 3D 
TEE view during balloon infl ation. Panel B demonstrates the fi nal deployment of the prosthesis. After the implantation, coronary angiography 
should be performed to confi rm coronary patency (Panel C). LAD = left anterior descending artery; RCA = right coronary artery
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recognition of complications during percutaneous AV implantation. In a study of 11 patients 
(median logistic EuroScore 36%) undergoing self-expanding CoreValve implantation, it was 
noted that routine TEE enabled the early detection of complications (a thrombus in the left 
ventricular outfl ow tract and pericardial eff usion) (36). 
Finally, intracardiac echocardiography and novel three-dimensional TEE may be helpful in 
guidance of percutaneous AV implantation. Three-dimensional TEE may allow a more precise 
evaluation of the AV, and may improve spatial orientation and prosthesis positioning (37). 
However, more studies are needed to fully understand the exact value of these techniques in 
percutaneous AV implantations. 
Follow-up 
In addition to complications and conventional outcome parameters (such as mortality, stroke, 
major cardiac events), prosthesis function and position should be assessed during follow-up 
(38). For this purpose, TTE is the most commonly used technique (39). In most studies, the 
AVA and mean pressure gradient are used to quantify AV function (Table 1). In addition, aortic 
regurgitation should be assessed. 
The exact position of the prosthesis and the relation between the stent and the coronary 
arteries can be assessed with MSCT. This technique may be preferred over TTE because it is less 
hampered by artifacts, and has a high spatial resolution. In addition, it allows a more precise 
evaluation of prosthesis deployment and diameters (40). Examples of MSCT images after per-
cutaneous AV implantation are shown in Figure 6. 
Figure 6. With the use of MSCT, the exact location of the prosthesis can be assessed, and the relation with the coronary ostia. In panels A 
and B, an example is demonstrated where the prosthesis extents beyond the coronary ostia (white arrows). During the implantation procedure, 
good patency of the coronary arteries was demonstrated. In panels C and D, an example is demonstrated where the prosthesis is positioned 
below the coronary ostia (black arrows).
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CONCLUSIONS
Percutaneous AV implantation is a promising technique for highly symptomatic patients with 
severe AS. Several studies have demonstrated good results for both the balloon-expandable 
and self-expanding valves. A critical selection of potential candidates, including clinical evalu-
ation, assessment of surgical risk and feasibility of the procedure is needed. Several imaging 
modalities are available for patient selection, procedural assistance and follow-up. 
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ABSTRACT
Background: Transcatheter aortic valve replacement has been proposed as an alternative 
to surgery in high-risk patients with severe aortic stenosis (AS). For this procedure, detailed 
knowledge on aortic annulus diameters and the relation between the annulus and the coro-
nary arteries is needed. 
Objectives: In the present study, the anatomy of the aortic root was assessed non-invasively 
with Multislice Computed Tomography (MSCT). 
Methods: In 169 patients (111 men, age 54 ± 11 years) a 64-slice MSCT scan was performed 
for evaluation of coronary artery disease. Nineteen patients with moderate-severe AS were 
included. Reconstructed coronal and sagittal views were used for assessment of the aortic annu-
lus diameter in two directions. In addition, the distance between the annulus and the ostium of 
the right and left coronary artery and the length of the coronary leafl ets were assessed. 
Results: The diameter of the aortic annulus was 26.3 ± 2.8 mm on the coronal view, and 23.5 
± 2.7 mm on the sagittal view. Mean diff erence between the two diameters was 2.9 ± 1.8 mm, 
indicating an oval shape of the aortic annulus. Mean distance between the aortic annulus and 
the ostium of the right coronary artery was 17.2 ± 3.3 mm, and mean distance between the 
annulus and the ostium of the left coronary artery was 14.4 ± 2.9 mm. In 82 patients (49%) the 
length of the left coronary leafl et exceeded the distance between the annulus and the ostium 
of the left coronary artery. 
Conclusions: MSCT can provide detailed information on the shape of the aortic annulus, and 
the relation between the annulus and the ostia of the coronary arteries. Thereby, MSCT may be 
helpful for avoiding paravalvular leakage and coronary occlusion and may facilitate the selec-
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INTRODUCTION
Degenerative aortic stenosis (AS) is the most common native valve disease (1). Although surgi-
cal aortic valve replacement provides good long-term results and symptom relief, it is complex 
in high-risk patients with extensive co-morbidity (2). In patients with severe, symptomatic 
AS and a very high risk of morbidity or mortality with conventional surgery, a percutaneous 
transcatheter aortic valve replacement may be preferred. 
Several studies have shown the feasibility of transcatheter aortic valve replacement (3-5). 
Diffi  culties with accurate positioning of the prosthesis in the aortic annulus, prosthesis sizing, 
the covering of the coronary ostia by the upper part of the prosthesis (5) and even occlusion 
of the left coronary artery (4) are important issues in transcatheter aortic valve replacement. 
Therefore, detailed information on the anatomy of the aortic annulus and the relation of the 
annulus with the coronary arteries is important for performing these procedures. Fluoroscopy 
and transesophageal echocardiography are helpful imaging modalities during percutaneous 
valve replacement procedures (3-5). However, these modalities are limited by their two-dimen-
sional character. Multislice computed tomography (MSCT) can provide three-dimensional 
images with a high spatial resolution, and may therefore be of great value for percutaneous 
valve replacement procedures. 
The purpose of the present study was to assess the anatomy of the aortic root non-invasively 
with 64-slice MSCT. We sought to determine standardized measurements on the aortic annulus 
and the relation with the left coronary artery in a large cohort of patients, including patients 
with moderate-severe AS.  
METHODS
The study population comprised 169 patients referred for MSCT coronary angiography in the 
period from February 2005 until January 2007 at the Leiden University Medical Center. In all 
patients, the aortic root could be analyzed on the acquired MSCT scan. To detect diff erences in 
aortic root anatomy between patients with and without AS, the study population was divided into 
2 groups: patients with no or mild AS (n=150) and patients with moderate to severe AS (n=19). 
Multislice Computed Tomography
The MSCT examinations were performed with a Toshiba Multislice Aquilion 64 system (Toshiba 
Medical Systems, Tokyo, Japan). Before MSCT angiography, a prospective coronary calcium scan 
was performed (collimation 4 × 3.0 mm, rotation time 500 ms, tube voltage 120 kV, and tube 
current 200 mA). The temporal window was set at 75% after the R wave for electrocardiographi-
cally triggered prospective reconstruction. 
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For the MSCT coronary angiogram, a collimation of 64 x 0.5 mm and a rotation time of 400 
ms were used. A multi-segment reconstruction algorithm was used, resulting in a temporal 
resolution of < 200 ms depending on heart rate and pitch. The tube current was 300 mA, at 120 
kV. Non-ionic contrast material (Iomeron 400, Bracco, Altana Pharma, Konstanz, Germany) was 
administered in the antecubital vein, in an amount of 80 to 110 ml depending on the total scan 
time, and a fl ow rate of 5.0 ml/sec. 
Automated peak enhancement detection in the descending aorta was used for timing of 
the scan. After the threshold level of +100 Hounsfi eld units was reached, data acquisition was 
automatically initiated. Data acquisition was performed during an inspiratory breathhold of 
approximately 8 to 10 seconds, while the ECG was recorded simultaneously to allow retrospec-
tive gating of the data. 
The data set of the contrast enhanced scan was reconstructed at 30% and 75% of the RR 
interval for the systolic and diastolic phases, respectively. All images were reconstructed with 
a slice thickness of 0.5 mm and a reconstruction interval of 0.3 mm. Axial data sets were then 
transferred to a remote workstation (Vitrea 2, Vital Images, Plymouth, Minn) for post-processing 
and subsequent image analysis.
Image analysis
All images were analyzed by two experienced observers blinded to the clinical and echocardio-
graphic information. An overview of the measured variables is shown in Table 1. 
Table 1. Anatomical analysis of the aortic root
Variable MSCT view
Aortic valve
   Aspect (bicuspid/tricuspid) Double oblique transverse *
   Calcifi cation (grade 1-4) Double oblique transverse
   Agatston calcium score Prospective calcium scan
   Calcium volume Prospective calcium scan
Aortic annulus
   Diameter (diastole / systole) Coronal †
Single oblique sagittal ‡
Sinus of Valsalva
   Diameter Coronal
   Distance between annulus and sinus of Valsalva Coronal
Relation Aortic annulus, coronary leafl et, ostium coronary artery
   Distance between annulus and ostium coronary artery (left and right) Coronal
   Length of coronary leafl et (left and right) Coronal




   Diameter Coronal
   Distance between annulus and sinotubular junction Coronal
* The double oblique transverse view is perpendicular to the aortic axis; † The coronal view has the same orientation as the anterior posterior 
view on aortic root angiography; ‡ The single oblique sagittal view has the same orientation as the parasternal long axis view on transthoracic 
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Aortic valve anatomy and calcifi cation The aspect of the aortic valve (tricuspid or bicuspid) 
and the presence of aortic valve calcifi cations were assessed on double oblique transverse 
reconstructions of the MSCT coronary angiogram. Aortic valve calcifi cations were then graded 
subjectively as previously described (6,7). The degree of aortic valve calcifi cation was graded 
as follows: grade 1: no calcifi cation; grade 2: mildly calcifi ed (small isolated spots); grade 3: 
moderately calcifi ed (multiple larger spots); grade 4: heavily calcifi ed (extensive calcifi cation 
of all cusps). Examples of the diff erent calcifi cation grades are shown in Figure 1. In addition, 
an Agatston calcium score (8) and the calcium volume for the aortic valve was obtained from 
the prospective calcium scan using dedicated Calcium scoring software (Vitrea 2, Vital Images, 
Plymouth, Minn). 
Anatomical analysis of the aortic root Standard orthogonal axial and sagittal views were 
used for initial orientation on the aortic valve. Since the aortic valve is oriented oblique to the 
standard axial view, a coronal and a single oblique sagittal view through the aortic valve were 
reconstructed. The anatomy of the aortic root and the relationship of the aortic annulus, the 
coronary leafl ets and the ostia of the coronary arteries was assessed on the coronal view and 
the reconstructed single oblique sagittal view, both in the systolic and diastolic phases. The 
coronal view is similar to the anterior-posterior view on aortic root angiography. The recon-
structed single oblique sagittal view has the same orientation as the parasternal long-axis view 
Figure 1. The degree of aortic valve calcifi cation was graded as follows: grade 1: no calcifi cation; grade 2: mildly calcifi ed (small isolated 
spots); grade 3: moderately calcifi ed (multiple larger spots); grade 4: heavily calcifi ed (extensive calcifi cation of all cusps).
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on transthoracic echocardiogram and the mid oesophageal long-axis view on transesopha-
geal echocardiogram. Care was taken for correct orientation of both views by reviewing the 
reconstructed double oblique transverse view at the level of the aortic valve. Examples of the 
coronal, single oblique sagittal and double oblique transversal views are shown in Figure 2. 
The diameter of the annulus was assessed in the systolic and diastolic phases. The ori-
entation of the views was similar to those used for percutaneous aortic valve replacement 
procedures (4). In addition, the maximal diameter of the sinus of Valsalva and the sinotubular 
junction, and their respective distance to the level of the aortic annulus was assessed (Figure 3). 
These variables are important to assess, since they may have implications for prosthesis sizing 
during transcatheter aortic valve replacement and paravalvular leakage after the procedure.
Furthermore, the distance between the annulus and the ostium of the left and the right coro-
nary artery, and the coronary leafl et length were assessed. An example of these measurements 
for the left coronary artery is shown in Figure 4. In addition, the distance between the tip of 
the left coronary leafl et and the ostium of the left coronary artery was assessed in diastole and 
systole (Figure 5). These variables may have implications for transcatheter aortic valve replace-
ment, since they may determine the risk of coronary artery occlusion during the procedure, as 
previously described (4). 
Finally, the left ventricular outfl ow tract and the interventricular septum were analyzed on 
the single oblique sagittal view at end-diastole. The diameter of the left ventricular outfl ow tract 
was assessed, parallel to the aortic valve annulus plane. The largest diameter of the interven-
tricular septum was assessed, and the aspect of the interventricular septum was subjectively 
graded as normal or sigmoid. An example of a sigmoid septum is shown in Figure 6. 
Figure 2. The anatomy of the aortic root was assessed on three reconstructed views. The coronal view (A) is similar to the anterior-posterior 
view on aortic root angiography. The reconstructed single oblique sagittal (B) view has the same orientation as the parasternal long-axis view 
on transthoracic echocardiogram and the mid oesophageal long-axis view on transesophageal echocardiogram. The reconstructed double 
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Echocardiography
Two-dimensional echocardiograms were obtained with patients in the left lateral decubitus 
position using a commercially available system (Vingmed Vivid 7, General Electric-Vingmed, 
Milwaukee, Wisconsin, USA). Images were obtained using a 3.5-MHz transducer at a depth of 
16 cm in the parasternal (long- and short-axis) and apical (two-chamber and four-chamber) 
views. Standard two-dimensional images and color Doppler data were digitally stored in cine-
loop format. Left ventricular ejection fraction was calculated from apical two-chamber and 
four-chamber images using the biplane Simpson’s rule (9). The diameter of the aortic annulus 
was assessed from the parasternal long-axis view. Aortic stenosis was graded according to the 
ACC/AHA guidelines (2): ‘Mild’: area 1.5 cm2, mean gradient less than 25 mm Hg, or jet velocity 
less than 3.0 m per second; ‘Moderate’: area 1.0 to 1.5 cm2, mean gradient 25 to 40 mm Hg, 
or jet velocity 3.0 to 4.0 m per second; ‘Severe’: area less than 1.0 cm2, mean gradient greater 
than 40 mm Hg, or jet velocity greater than 4.0 m per second. To detect diff erences in anatomi-
cal variables between patients with and without AS, the study population was divided into 2 
groups: patients with no or mild AS (n=150) and patients with moderate to severe AS (n=19). 
Figure 3. On the coronal view, the maximal diameter of the sinus of Valsalva was assessed (indicated by the double arrow). In addition, 




All continuous variables had normal distribution (as evaluated by Kolmogorov-Smirnov tests). 
Summary statistics for these variables are therefore presented as mean values ± one standard 
deviation (SD). Categorical data are summarized as frequencies and percentages. Diff erences 
in aortic annulus diameter in the diff erent views were evaluated with paired Student t-tests. 
The agreement between echocardiography and MSCT for the aortic annulus measurement 
was assessed with Bland-Altman analysis. Diff erences in anatomical variables between patients 
with and without AS are evaluated using unpaired Student t-tests (continuous variables) or 
Chi-square tests (dichotomous variables), as appropriate. All analyses were performed using 
SPSS software (version 12.0, SPSS Inc. Chicago, Illinois, USA). All statistical tests were two-sided, 
and a p-value <0.05 was considered signifi cant. 
RESULTS
A total of 169 patients were studied. Baseline characteristics of the study population are listed 
in Table 2. In all patients, adequate images for evaluation of the aortic root were available. 
Figure 4. With the use of a coronal view, the distance between the annulus and the ostia of the coronary arteries, and the length of the 
coronary leafl ets were assessed. This fi gure demonstrates the measurements of the distance between the annulus and the ostium of the left 
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Aortic valve anatomy and calcifi cation
In 167 patients a tricuspid aortic valve was present, whereas 2 patients had a bicuspid aortic 
valve. The 2 patients with a bicuspid aortic valve were excluded from the anatomical analysis. 
Calcifi cations of the aortic valve were graded subjectively as previously described (6,7). In 123 
patients (73%), no calcifi cations were present (grade 1). In 29 patients (17%) calcifi cations were 
characterized as grade 2; whereas 11 patients (6%) had calcifi cations grade 3, and 6 patients 
(4%) had calcifi cations grade 4. Calcifi cations were present on the left coronary cusp in 36 of 
the 46 patients (78%) with aortic valve calcifi cations, and on the right coronary cusp in 30 of the 
46 patients (65%). Mean Agatston score was 819 ± 1245 and mean calcium volume of the aortic 
valve calcifi cations was 663 ± 960 mm3. 
Aortic root diameter and geometry
In the diastolic phase, mean diameter of the aortic annulus on the coronal view was 26.3 ± 2.8 
mm; whereas the mean diameter on the reconstructed single oblique sagittal view was 23.5 ± 
2.7 mm. The mean diff erence between the coronal and the sagittal diameter was 2.9 ± 1.8 mm. 
Figure 5. On the coronal view, the distance between the tip of the left coronary leafl et and the ostium of the left coronary artery was 
assessed in diastole and systole.
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In 78 patients (47%), the diff erence between the two diameters was ≥ 3 mm, indicating an oval 
shape of the aortic annulus. In the systolic phase, the diameter of the aortic annulus on the 
coronal view was 26.5 ± 2.9 mm and the diameter on the single oblique sagittal view was 24.2 
± 2.6 mm. The mean diff erence between the coronal and the sagittal diameter in the systolic 
phase was 2.4 ± 1.9 mm. The mean diameter of the aortic annulus assessed with echocardiog-
Figure 6. A single oblique sagittal view was used to assess the largest diameter of the interventricular septum, and to grade the aspect of 
the interventricular septum as normal or sigmoid. In this patient, accurate positioning of the percutaneous aortic valve may be hampered by 
the small diameter of the left ventricular outfl ow tract (indicated by the double arrow). Also note the post-stenotic dilatation of the ascending 
aorta, indicated by the dotted arrow in this patient.
Table 2. Baseline characteristics of the study population
Study population (n=169)
Age, years 54 ± 11
Gender, M/F 111 / 58
Previous myocardial infarction, n (%) 40 (24)
Previous CABG, n (%) 12 (7)
LVEF, % 57 ±17
Risk factors, n (%)
   Diabetes mellitus 51 (30)
   Hypertension 81 (48)
   Hypercholesterolemia 71 (42)
   Smoking 50 (30)
   Positive family history 59 (35)




T of the aortic root
369
raphy was 21.6 ± 2.6 mm. There was a good agreement between MSCT and echocardiography, 
as assessed with Bland-Altman analysis (Figure 7). 
The maximal diameter of the sinus of Valsalva in diastole on the coronal view was 32.4 ± 
4.0 mm. The mean distance between the level of the annulus and the maximal diameter of the 
sinus of Valsalva was 17.2 ± 2.9 mm. The maximal diameter of the sinotubular junction was 28.2 
± 3.2 mm. The mean distance between the level of the annulus and the sinotubular junction 
was 20.3 ± 3.3 mm. 
Relation aortic annulus, leafl et and coronary artery
The relation of the aortic annulus, the coronary leafl ets and the ostia of the coronary arteries 
was assessed on the coronal view. The mean distance between the aortic annulus and the 
ostium of the left coronary artery was 14.4 ± 2.9 mm, with a range of 7.1 to 22.7 mm. The length 
of the left coronary leafl et was 14.2 ± 1.8 mm (range 10.0 – 21.3 mm). In 82 patients (49%) the 
left coronary leafl et was longer than the distance between the annulus and the ostium of the 
left coronary artery (mean diff erence 2.1 ± 1.7 mm). In the remaining 85 patients (51%), the 
length of the left coronary leafl et was shorter than the distance between the annulus and the 
ostium of the left coronary artery (mean diff erence 2.4 ± 1.5 mm). Similar, the mean distance 
between the aortic annulus and the ostium of the right coronary artery was 17.2 ± 3.3 mm, 
with a range of 9.2 to 26.3 mm. The length of the right coronary leafl et was 13.2 ± 1.9 mm 
(range 9.0 – 19.6 mm). In 17 patients (10%) the length of the coronary leafl et was longer than 
Figure 7. Bland-Altman analysis revealed a good agreement between MSCT and echocardiography for the assessment of aortic annulus 
diameter. The diff erence between each pair (Y axis) is plotted against the average value of the same pair (X axis). Mean diff erence was 1.9 mm 
(solid line), 95% confi dence interval -2.8 – 6.6 mm (dotted lines).
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the distance between the annulus and the ostium of the right coronary artery (mean diff erence 
1.5 ± 1.2 mm). In the remaining 150 patients (90%) the length of the right coronary leafl et was 
shorter than the distance between the annulus and the ostium of the right coronary artery 
(mean diff erence 4.7 ± 2.7 mm). 
The minimal distance from the tip of the left coronary leafl et to the left coronary ostium 
was measured in the diastolic and systolic phases. In diastole the distance between the leafl et 
tip and the coronary ostium was 17.6 ± 2.7 mm, whereas in systole this distance was 12.1 ± 3.4 
mm (p<0.001). 
Left ventricular outfl ow tract and interventricular septum 
The left ventricular outfl ow tract and the interventricular septum were analyzed on the single 
oblique sagittal view at end-diastole. Mean diameter of the left ventricular outfl ow tract was 
21.2 ± 2.6 mm. Mean end-diastolic diameter of the interventricular septum was 12.4 ± 2.6 mm 
(range 7.9 – 20.9 mm). In 12 patients (7%), a sigmoid aspect of the interventricular septum was 
observed (Figure 6). End-diastolic diameter in these 12 patients was 16.2 ± 1.8 mm. 
Anatomic observations in aortic stenosis
Of the 169 patients, 19 patients had moderate-severe AS. In these patients, mean pressure 
gradient was 50 ± 21 mmHg and mean aortic valve area was 0.8 ± 0.2 cm2. In the 19 patients 
with AS, aortic valve calcifi cation was characterized as grade 2 in 3 patients, as grade 3 in 10 
patients and 6 patients had calcifi cations grade 4. The severity of calcifi cation was signifi cantly 
diff erent between the patients with and the patients without AS (p<0.001).To detect possible 
diff erences in aortic root anatomy between patients with and patients without AS, the patients 
with a bicuspid aortic valve were excluded and subsequently, the study population was divided 
in two groups: patients with no or mild AS (n=150) and patients with moderate to severe AS 
(n=17). There were no signifi cant diff erences in the diameter of the annulus, the diameter of the 
sinus of Valsalva, or the distance between the annulus and the sinus of Valsalva between the 
patients with and the patients without AS (Table 3). In addition, no diff erences in the distance 
between the annulus, the left coronary leafl et and the ostium of the left coronary artery were 
detected between the two groups (Table 3). 
In 13 of the 17 patients with AS (76%), the left coronary leafl et was longer than the distance 
between the annulus and the ostium of the left coronary artery (mean diff erence 2.5 ± 2.2 
mm). Of interest, the percentage of patients in which the left coronary leafl et was longer than 
the distance between the annulus and the ostium of the left coronary artery was signifi cantly 
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DISCUSSION
In the present study, the anatomy of the aortic root was assessed with the use of 64-slice MSCT 
in 169 patients, including 19 patients with AS. It was noted that the annulus of the aorta has an 
oval shape, with a larger diameter on the coronal view than on the sagittal view. In addition, a 
wide variability in the distance between the annulus and the ostium of the left coronary artery 
and a wide variability in the leafl et length was observed. MSCT of the aortic root may be help-
ful in planning and performing transcatheter aortic valve replacement procedures, and in the 
selection of potential candidates for these procedures. 
Aortic root diameter and geometry
In the present study, the diameter of the aortic annulus was assessed on a coronal and a 
sagittal view (similar to the anterior-posterior and the parasternal long-axis view, respectively). 
The diameter of the annulus on the coronal view was consistently larger than on the sagit-
tal view, indicating an oval shape of the aortic annulus. From previous anatomical studies, 
it has become apparent that the annulus of the aorta is not a circular structure, but rather a 
three-pronged coronet (10). In addition, at the base of the right and left coronary sinuses, a 
Table 3. Anatomical analysis of the aortic root in patients with and without AS






   Coronal view, diastole, mm 26.3 ± 2.6 26.7 ± 3.9 0.6
   Sagittal view, diastole, mm 23.4 ± 2.7 24.2 ± 3.0 0.2
   Coronal view, systole, mm 26.4 ± 2.8 27.3 ± 3.7 0.3
   Sagittal view, systole, mm 24.0 ± 2.6 24.7 ± 3.0 0.4
Sinus of Valsalva 
   Diameter, mm 32.3 ± 3.9 33.4 ± 4.6 0.2
   Distance between annulus and sinus of Valsalva, mm 17.2 ± 2.7 17.3 ± 3.9 0.9
Relation Aortic annulus, coronary leafl et, ostium 
coronary artery
   Distance between annulus and ostium left coronary artery, 
mm
14.4 ± 2.8 14.0 ± 3.3 0.6
   Length of left coronary leafl et, mm 14.1 ± 1.7 14.7 ± 2.4 0.3
   Distance between annulus and ostium right coronary 
artery, mm
17.2 ± 3.3 17.2 ± 3.6 0.9
   Length of right coronary leafl et, mm 13.1 ± 1.7 14.1 ± 2.9 0.2
   Distance between tip of left coronary leafl et and ostium 
left coronary artery, diastole, mm
17.6 ± 2.7 17.1 ± 2.9 0.4
   Distance between tip of left coronary leafl et and ostium 
left coronary artery, systole, mm
11.9 ± 3.1 12.1 ± 2.4 0.9
Sinotubular junction
   Diameter, mm 28.1 ± 3.1 28.9 ± 4.2 0.3
   Distance between annulus and sinotubular junction, mm 20.3 ± 3.1 20.7 ± 4.6 0.8
* 2 patients with a bicuspid aortic valve were excluded from the anatomical analysis;. AS = aortic stenosis.
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crescent of ventricular musculature is incorporated, in contrast to the non-coronary sinus that 
is exclusively fi brous (11). These anatomical observations may explain the variations in aortic 
annulus diameter as found in the present study. 
Detailed, non-invasive information on the aortic annulus diameter, as provided by MSCT, 
may be of great value in transcatheter aortic valve replacement. Kazui et al (12) studied the 
anatomy of the aortic root in 25 patients without signifi cant valvular disease using 16-slice CT. 
The reported diameter of the aortic annulus in the diastolic phase was 22.1 ± 2.2 mm (12). Similar 
to the results of the present study, no diff erences in annulus diameter were found between dias-
tole and systole. Unfortunately, no patients with AS were studied in the study by Kazui et al (12). 
Recently, Willmann et al (7) studied 25 patients with severe AS prior to surgical aortic valve 
replacement. With the use of 4-slice CT, the smallest diameter of the annulus was assessed on 
a reconstructed double oblique view. The mean diameter was 2.4 ± 0.2 cm, and a good agree-
ment between non-invasive assessment of the aortic annulus with CT and the measurement 
during aortic valve replacement was noted (mean diff erence 0.7 mm) (7). In the present study, 
similar results for the annulus diameter were observed (mean diameters were 26.3 ± 2.8 mm 
and 23.5 ± 2.7 mm on the coronal and the sagittal view, respectively). The use of a 64-slice scan-
ner in the current study, and the use of diff erent reconstructions may explain the subtle diff er-
ences between the previously reported results (7) and the present study. By providing detailed 
information on variations in aortic annulus diameter, MSCT may be of great value for prosthesis 
sizing and avoidance of paravalvular leakage in percutaneous aortic valve replacement. 
Relation aortic annulus, leafl et and left coronary artery
In the present study, a large variability in the relation between the aortic annulus and the left 
coronary artery was found, with important implications for transcatheter aortic valve replace-
ment. Jatene et al (13) evaluated the anatomy of the aortic root in an autopsy study of 100 
structural normal hearts. The mean distance between the ostium of the left coronary artery 
and the base of the sinus of Valsalva was 13.3 mm (13). Unfortunately, no range in distances 
was reported in that study. In another anatomical study, McAlpine et al (14) studied 100 human 
hearts. The mean distance between the annulus and the right and left coronary orifi ces was 
18.5 ± 2.5 mm (14). Abedin et al (15) studied 54 patients undergoing coronary angiography. 
Average distance from the base of the left coronary sinus to the origin of the left main coronary 
artery was 19.4 ± 2.7 mm (15). Of interest, this distance showed a large variability, and was inde-
pendent of the patient’s height. In the present study, mean distance between the ostium and 
the annulus was 14.4 ± 2.9 mm. Importantly, a wide variation in distance was found, ranging 
from 7.1 to 22.7 mm. In 49% of the patients, the distance between the ostium and the annulus 
was smaller than the left coronary leafl et length. This may increase the risk of coronary occlu-
sion when a transcatheter aortic valve replacement is performed (4). Of note, the percentage 
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and the ostium of the left coronary artery was signifi cantly greater in the patients with AS than 
in the remaining patients. 
Implications for transcatheter aortic valve replacement
The present study demonstrates that there is a wide variability in the anatomy of the aortic 
root. These fi ndings have important implications for percutaneous aortic valve replacement 
procedures (Figure 8). From the fi rst human experience with the self-expanding aortic valve 
prosthesis (CoreValve, Paris, France), it has become apparent that diffi  culties with positioning 
of the device in the aortic annulus were responsible for failure of half of the procedures (5). In 
addition, correct prosthesis sizing is of great importance in percutaneous valve procedures. 
At present, prosthesis diameters range between 21 and 26 mm (3-5). Annulus-prosthesis mis-
match as a consequence of inaccurate sizing of the prosthesis may result in severe paravalvular 
leakage. MSCT provides detailed non-invasive information on the aortic annulus diameter 
before the procedure, and may thereby be helpful in planning and performing of percutaneous 
aortic valve replacement. 
Furthermore, in the present study, a variable distance between the level of the aortic annu-
lus and the ostium of the left coronary artery was observed, ranging from 7.1 to 22.7 mm. At 
present, the height of the aortic valve prostheses ranges between 14.5 mm (Edwards, Irvine, 
California) and 50 mm (CoreValve, Paris, France). To avoid interference of the coronary ostia by 
the prosthesis stent struts, the Edwards prosthesis is preferably positioned under the level of 
the coronary ostia. However, occlusion of the coronary ostia with this prosthesis may still occur 
(4). The larger CoreValve has a design feature with a waist in the middle part to protect the 
coronary ostia. Cribier and co-workers did not observe problems accessing the coronary ostia 
after percutaneous aortic valve replacement (16). However, if the distance between the annulus 
Figure 8. Representative examples of patients in which diffi  culties with transcatheter aortic valve replacement may be encountered. Panel 
A and B demonstrate an example of a patient with an oval shape of the aortic annulus. The diameter of the aortic annulus on the coronal view 
(panel A) was 27.3 mm, whereas the annulus diameter on the sagittal view (panel B) was 20.3 mm. A signifi cant oval shape of the aortic annulus 
may increase the risk of paravalvular leakage after percutaneous aortic valve replacement. Panel C demonstrates a patient in which the length of 
the coronary leafl et exceeded the distance between the aortic annulus and the ostium of the left coronary leafl et (distances were 13.4 and 11.6 
mm, respectively). There is an increased risk of coronary occlusion by the coronary leafl et or the prosthesis sealing annular cuff  in these patients.
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and the left coronary ostium is small, it may be diffi  cult to access the coronary ostia after trans-
catheter aortic valve replacement. Furthermore, the lower part of the currently available aortic 
prostheses incorporates a sealing annular cuff . If the distance between the annulus and the 
coronary ostium is smaller than the lower two-third of the prosthesis, coronary occlusion may 
occur. With the use of MSCT, the distance between the aortic annulus and the ostium of the left 
coronary artery can accurately be assessed. 
In addition, MSCT can provide accurate quantifi cation of the severity and the exact loca-
tion of aortic valve calcifi cation. Heavily calcifi ed aortic valves may hamper the ability of the 
prosthesis to cross the native valve in percutaneous valve replacement (5). In contrast to 
transthoracic and transesophageal echo and magnetic resonance imaging, MSCT allows for 
an accurate, non-invasive evaluation of aortic valve calcifi cation. Finally, MSCT can also provide 
detailed, non-invasive information on the tortuosity, diameter and calcifi cation of the descend-
ing aorta and femoral arteries, which is of great importance for the advancement of the sheath 
during transcatheter aortic valve replacement procedures (4). Therefore, MSCT may help in the 
selection of potential candidates for transcatheter aortic valve replacement. 
Study limitations
Some limitations of the present study need to be addressed. First, the study population of the 
present study does not comprise AS patients referred for percutaneous aortic valve replace-
ment. Future studies are needed to assess the value of noninvasive evaluation of the aortic 
root with MSCT in these patients. Second, the use of MSCT before percutaneous aortic valve 
replacement may be optimized by recent technical advances and newer generation MSCT 
scanners. The use of dual-source technology allows for a signifi cant improvement in temporal 
resolution. Furthermore, radiation exposure may be signifi cantly reduced by the use of dose 
modulation during scanning. 
CONCLUSIONS 
The anatomy of the aortic root can be assessed non-invasively with MSCT. A large variability in 
the aortic annulus diameter and the relation between the annulus, the left coronary leafl et and 
left coronary artery exists. MSCT may provide useful information for the selection of potential 
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ABSTRACT
Transcatheter aortic valve replacement (TAVR) requires precise knowledge of the anatomic 
dimensions and physical characteristics of the aortic valve, annulus and aortic root. Most 
groups currently utilize angiography, transthoracic echocardiography (TTE) or transesophageal 
echocardiography (TEE) to assess aortic annulus dimensions and anatomy. However, multislice 
computed tomography (MSCT) may allow more detailed 3-dimensional assessment of the 
aortic root. Twenty-six patients referred for TAVR underwent MSCT. Scans were also performed 
in 18 patients following TAVR. All patients underwent pre- and post-procedural aortic root 
angiograms, TTE and TEE. Mean diff erences in measured aortic annular diameters were 1.1 mm 
(95% CI 0.5, 1.8 mm) for calibrated angiography and TTE, 0.9 mm (95% CI -1.7, -0.1 mm) for TTE 
and TEE, 0.3 mm (95% CI -1.1, 0.6 mm) for MSCT (sagittal) and TTE, 1.2 mm (95% CI -2.2, -0.2 mm) 
for MSCT (sagittal) and TEE. The coronal systolic measurements on MSCT, which correspond 
to the angiographic orientation, were 3.2 mm (1st and 3rd quartiles 2.6, 3.9) larger than the 
sagittal systolic measurements, which are in the same anatomic plane as standard TTE and TEE 
views. There was no signifi cant association between either the shape of the aortic annulus or 
the amount of AV calcium and the development of perivalvular aortic regurgitation. Following 
TAVR the prosthesis extended to or beyond the inferior border of the left main ostium in 9 of 18 
patients (50%) and in 11 patients (61%) valvular calcium was <5mm from the left main ostium. 
In conclusion, MSCT identifi ed that the aortic annulus is commonly eccentric and often oval. 
This may, in part, explain the small but clinically insignifi cant diff erences in measured aortic 
annular diameters with other imaging modalities. MSCT following TAVR demonstrated the 
close proximity of both the prosthesis and displaced valvular calcium to the left main ostium in 
most patients. Neither eccentricity nor calcifi c deposits appeared to contribute signifi cantly to 








Transcatheter aortic valve replacement (TAVR) shows promise as an alternative  to conventional 
open heart surgery for selected patients with severe symptomatic aortic stenosis (AS) (1-7). 
Transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and calibrated 
aortic angiography are commonly used to determine aortic annular size to assist in prosthesis 
selection (8). Recent work with multislice computed tomography (MSCT) provided detailed 
information on the shape of the aortic annulus and the relation between the annulus and the 
ostia of the coronary arteries (9). MSCT identifi ed that the aortic annulus is oval, rather than 
circular, which might help explain the diff erences in measured aortic annular diameters with 
TTE, TEE, and calibrated angiography. We sought to determine if MSCT could provide clinically 
useful information beyond that available from angiographic and echocardiographic assess-
ment that might infl uence patient selection and procedural issues during TAVR. 
METHODS
Patients with severe symptomatic AS were referred to St. Paul’s Hospital, University of Brit-
ish Columbia, Vancouver, Canada for TAVR due to a high risk of morbidity or mortality with 
conventional valve surgery. As part of their assessment 26 patients underwent screening 
MSCT in Vancouver between June 2005 and January 2007. These patients represent the study 
population. It was the consensus of a group of senior cardiac surgeons and cardiologists that 
the patients were unsuitable for conventional AVR due to excessive surgical risk. Of the initial 26 
patients screened with MSCT, 23 subsequently underwent TAVR, 2 were determined not to be 
candidates for TAVR for technical reasons, and 1 patient was subsequently accepted for conven-
tional surgery (Table 1). Of the 23 patients who underwent TAVR, 18 subsequently underwent 
evaluation with MSCT at a median of 4 (1st and 3rd quartiles 3, 6) months after TAVR. During this 
period an additional 52 patients underwent TAVR but did not undergo MSCT assessment due 
to renal dysfunction, poorly controlled arrhythmias or logistical issues. 
All MSCT scans were obtained using a cardiac gated Siemens Sensation 64 slice scanner 
(Siemens Medical Solutions, Erlangen, Germany) during suspended full inspiration. An initial 
non contrast enhanced coronary calcium scoring scan was performed using the following 
specifi cations: 120kVp, 123 eff ective mAs, ECG modulation on, pitch 0.2, rotation time 164 
msec, detector aperture 0.6 mm, 180 degree B25f cardiac gated reconstruction algorithm at 
75% R-R, 3 mm slice thickness, 3 mm spacing. A contrast enhanced bolus timing scan was 
performed at the level of the carina using a scan delay of 10 seconds. Twenty ml of Isovue 
370 (Bracco Diagnostics, Mississauga, Ontario) contrast media was followed by 50 ml of normal 
saline delivered at 5 ml per second through an 18 gauge catheter in the antecubital fossa. 
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the subsequent diagnostic cardiac CT scan. This scan of the entire heart was acquired during 
the injection of 100 ml of 370 Isovue contrast media followed by 50 ml of normal saline at 5 
ml per second. The scan acquisition used the following parameters: 120 kVp, 830-870 eff ective 
mAs, EKG modulation off , pitch 0.2, rotation time 330 msec, detector aperture 0.6 mm. Image 
reconstruction parameters included: 180 degree cardiac gated B30f  reconstruction algorithm, 
165 msec temporal resolution, timed to 30% and 70% of the R-R interval, 0.75 mm slice thick-
ness, 0.4 mm spacing. 
Non-contrast and contrast-enhanced images were transferred over the hospital’s imaging 
network to the Multi Modality Workplace workstation (Version VE22A, Siemens Medical Solu-
tions, Erlangen, Germany). Agatston method (10) aortic valve calcium scoring was performed 
using the Calcium Scoring software package (Syngo 2007C VE27B, Siemens Medical Solutions, 
Erlangen, Germany). Aortic valve measurements were made using electronic calipers within the 
Circulation software package (Syngo 2007C VE27B, Siemens Medical Solutions, Erlangen, Ger-
many). Pre-implantation images were evaluated using window width of 1000 Hounsfi eld units 
(HU) and level of 150 HU. Due to artifact arising from the struts of the aortic valve prosthesis, 
post implantation images were evaluated using window width of 2500 HU and level of 1000 HU. 
Images were analyzed using the workstation by consensus of two observers. The largest 
transverse diameter of the aortic annulus was measured in coronal and single oblique sagittal 
projections using the 30% (systole, or R-R with maximum leafl et excursion) and 70% (diastole) 
images. These proved to be the longest and shortest annular measurements in all patients. The 
correct orientation of these two orthogonal images was confi rmed by inspection of the double 
oblique transverse (DOT) images of the aortic valve, which allowed confi rmation of the level 
of insertion of the aortic valve leafl ets (Figure 1). The single oblique sagittal view has the same 
orientation as both the parasternal long axis view on TTE and the midesophageal long axis 
view on TEE (11) (Figure 2). The coronal view has the same orientation as the anterior posterior 
view on aortic root angiography (Figure 3). The coronal view in diastole was used to measure 
the diameter of the sinus of Valsalva, the distance from the annulus to the inferior border of the 
left main coronary artery, and the length of the left coronary cusp leafl et (9). The coronal view 
in systole was used to measure the above leafl et length as well as the distance from the leafl et 
tip to the inferior border of the left main coronary artery (Figure 4). The DOT view was used to 
measure the maximum diameter of the sinus of Valsalva at the level of the inferior border of the 
left main coronary artery. 
We subjectively graded the AV calcium using the scoring system of Willmann et al (12), 
which was adapted from Rosenhek et al. (13). Agatston method (10) calcium scores were 
obtained from the aortic valve leafl ets using the Calcium Scoring program on the Siemens 
workstation from the non contrast enhanced images. Areas of AV calcium were highlighted 
and surrounding areas of calcium were excluded to generate a composite score for each valve. 
MSCT scans performed post TAVR were analyzed using the same orthogonal viewing planes. 
Stent diameter was measured in systole in the single oblique sagittal and coronal planes at the 
382
level of the aortic annulus (Figure 5). The coronal view was used to measure the distance from 
the inferior border of the left main coronary artery to both the native valve calcifi cation and the 
stent wall (Figure 6A). The distance from the superior edge of the stent to the inferior edge of 
the left main coronary artery was measured on an oblique coronal image that was rotated to 
pass through the origin of the left main artery and the centre of the stent (Figure 6A).
Standard 2 dimensional TTE was performed as part of our screening assessment. Images 
were obtained with patients in the left lateral decubitus position with a commercially available 
system (Sonos 5500, Philips Medical Systems) interfaced with an S3 compound probe and stored 
on a digital archive system. The diameter of the aortic annulus was measured by an independent 
viewer in systole in the parasternal long axis view at the site of leafl et attachment (Figure 2B). 
TEE was performed immediately before and after TAVR. Images were obtained with patients 
intubated and sedated in the supine position with the same system interfaced with a T6210 
omniplane probe. The diameter of the aortic annulus was measured by an independent viewer 
in systole in the midesophageal long axis view at the site of leafl et attachment (Figure 2C). 
Aortic regurgitation (AR) severity immediately post implantation and at hospital discharge 
was the consensus grade of two senior echocardiographers using the ratio of regurgitation 
jet to left ventricular outfl ow tract height and regurgitation pressure half-time determination 
(8,14,15). The site of AR was judged to be either valvular (through the valve) or perivalvular 
(around the valve). 
Figure 1. Double oblique transverse (DOT) view is used to derive the other standard orthogonal planes (single oblique sagittal and coronal 
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Calibrated angiographic annular measurements were performed by two independent view-
ers as part of the screening assessment. The diameter at the leafl et hinge point at the presumed 
level of the aortic annulus was measured in systole in the anterior posterior view (Figure 3B). 
Continuous data are presented as mean values ± standard deviation (SD) or median values 
with 1st and 3rd quartiles, as appropriate. Categorical data are presented as percentages. 
Bland-Altman plots were used to compare annular measurements obtained using diff erent 
techniques (angiographic, echocardiographic and MSCT) (16). All statistical analyses were 
performed with SPSS TM software (version 13.0, SPSS Inc., Chicago, Illinois). All statistical tests 
were 2 sided. A p value of < 0.05 was considered statistically signifi cant.
RESULTS
Mean age of the 26 patients was 82 ± 9 years. A balloon expandable valve was implanted in 
23 patients, utilizing the femoral approach in 21 and the apical approach in 2 due to the pres-
ence of femoral artery disease. Coronary artery disease was present in 83%, with 30% having 
Figure 2. The (A) single oblique sagittal view on MSCT is equivalent to the (B) parasternal long axis-view on TTE and the (C) midesophageal 
long-axis view on TEE. The aortic annular measurements for this patient were 23, 23, and 24 mm respectively.
Figure 3. The (A) coronal view on MSCT has the same orientation as the (B) anterior posterior view on aortic root angiogram. Images from 
the same patient as Figure 2 are displayed with aortic annular measurements of 25 and 26 mm respectively.
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undergone prior percutaneous intervention and 39% having had prior coronary artery bypass 
graft surgery. The logistic EuroSCORE (17,18) estimate of operative mortality was 31.5 ± 19.7%. 
Screening MSCT measurements were applied to our 26 patients with severe AS. The aver-
age left coronary cusp leafl et length in systole, from leafl et insertion to leafl et tip, was 14.8 ± 1.3 
mm. The mean distance from the aortic annulus to the inferior border of the left main coronary 
artery was 15 ± 3.0 mm. The maximum diameter of the sinus of Valsalva in the DOT view was 
32.5 ± 3.0 mm. 
The diff erences in aortic annular dimensions for calibrated angiography, TTE, TEE, and 
MSCT are listed in Table 1 and selected Bland-Altman plots are shown in Figure 7. The mean dif-
ferences in measured aortic annular diameters were 1.1 mm (95% CI 0.5, 1.8 mm) for calibrated 
angiography and TTE, 0.9 mm (95% CI -1.7, -0.1 mm) for TTE and TEE, 0.3 mm (95% CI -1.1, 0.6 
mm) for MSCT (sagittal) and TTE, 1.2 mm (95% CI -2.2, -0.2 mm) for MSCT (sagittal) and TEE 
(Figure 7). In the systolic phase, the mean diameter of the aortic annulus on the coronal view 
was 25.7 ± 1.5 mm and 22.4 ± 1.3 mm in the sagittal view. The mean diff erence between the 
coronal and sagittal diameters was 3.2 mm (95% CI 2.6, 3.9). In the diastolic phase, the mean 
diameter of the aortic annulus on the coronal view was 25.5 ± 2.5 mm and 21.5 ± 2.1 mm in 
the sagittal view. The mean diff erence between the coronal and sagittal diameters was 4.0 mm 
(95% CI 3.1, 4.8). 
Patients were considered to have an oval annulus if the diff erence between their coronal 
and sagittal annular measurements was ≥ 3 mm (9). Twenty patients (77 %) had an oval annu-
lus. Eight patients had ≥ moderate perivalvular AR on TEE immediately post implantation. There 
was no signifi cant association between the shape of the aortic annulus and the proportion of 
Figure 4. The coronal view in systole on MSCT was used to measure the distance from the left coronary cusp leafl et tip to the inferior border 
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patients that developed moderate perivalvular AR (Fisher’s exact test, p=1.0). Seven of these 
patients went on to have successful re-dilation of their balloon expandable aortic valve imme-
diately following implantation with a reduction in perivalvular leak. 
Seventeen patients had grade 4, 6 grade 3, and none grade 1 or 2 AV calcifi c deposits. There 
was no signifi cant association between the grade of calcium and the proportion of patients 
that developed moderate perivalvular AR (Fisher’s exact test, p=0.35). AV calcium scores were 
also stratifi ed above and below 3500, corresponding to subjective AV calcium scores of 3 or 4. 
There was no signifi cant association between the stratifi ed objective calcium scores and the 
proportion of patients that developed moderate perivalvular AR (Fisher’s exact test, p=0.37). 
Post TAVR the prosthesis was observed to extend above the inferior border of the left main 
coronary artery in 50% of patients (n=9) (Figure 6A); extending a median of 0.5 mm (1st and 
3rd quartiles 0, 8) above the left main ostium. The median distance from the left main coronary 
artery to the displaced native valve calcium was 4 mm (1st and 3rd quartiles 3, 5). Eleven patients 
(61%) had displaced calcium that was <5mm from the left main ostium (Figure 6A). 
The stent diameter was measured at the level of the aortic annulus (Figure 5). The implanted 
stent was considered circular if the diff erence between the coronal and sagittal annular 
measurements was <3 mm. By this defi nition, 14 patients (78%) had a circular annulus post 
implantation and 4 (22%) had a non-circular annulus. Of those with a non-circular annulus, 3 of 
the 4 patients had an oval annulus prior to TAVR.
Figure 5. The coronal view in systole on MSCT was used to measure the stent diameter at the level of the aortic annulus.
386
DISCUSSION
Anderson et al. fi rst noted that the site of attachment of the three aortic valvar leafl ets is not 
circular, as the term “annulus” implies (19). Recently, studies using both MSCT and magnetic 
resonance imaging have supported these observations (9,20). The word “annulus” is actually 
a misnomer as the aortic valvar complex consists of several small rings within the aortic root 
that do not all correspond to discrete anatomic structures. We have used the term “annulus” for 
simplicity. The mean diff erence between the coronal and sagittal annular diameters was 3.2 
mm (95% CI 2.6, 3.9) during the systolic phase and 4.0 mm (95% CI 3.1, 4.8) during the diastolic 
phase and is similar to the results we obtained with a larger cohort (169 patients) with and with-
out AS (9). There was no signifi cant diff erence between the systolic and diastolic measurements 
in either study. An oval aortic annulus helps explain the diff erences in annular measurements 
seen with imaging modalities that are restricted to a single plane or a limited fi eld of view (Table 
1). The current practice of routinely oversizing the prosthesis by 10 to 20% makes the small 
Figure 6. The (A) coronal view in systole on MSCT was used to measure the distance from the inferior border of the left main coronary 
artery to both the native valve calcium and the stent wall. The distance the stent was placed above or below the inferior border of the left 
main coronary artery was also recorded. Panel B: A digital picture of a 23 mm balloon expandable prosthesis (Cribier-EdwardsTM , Edwards 
Lifesciences Inc., Irvine, CA) demonstrates the fabric cuff  that covers the bottom third of the stent.
Figure 7. Bland-Altman plots comparing (A) annular measurements using angiography and TTE, (B) the coronal view obtained in systole on 
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diff erences in measured aortic annular diameters with TTE, TEE, and calibrated angiography 
clinically insignifi cant. An oval annulus also has important implications for echocardiography 
as the parasternal short axis view assumes a circular annulus as a point of reference. Physicians 
should be aware of this potential limitation. 
There was no signifi cant association between the shape of the aortic annulus and the pro-
portion of patients that developed moderate perivalvular AR. It is possible that an association 
may become apparent with a larger cohort over a longer time period although this has not 
been observed (7). Our routine practice of oversizing the prosthesis by 10 to 20% may have also 
obscured any potential association (4,8). 
There was no signifi cant association between either the calcium grade or the AV calcium 
score and the proportion of patients that developed moderate perivalvular AR. It is possible 
that an association may become apparent with a larger cohort although this does not appear 
to be a major concern in the majority of patients. This is consistent with the clinical impression 
that severe native AV calcium is not a major contraindication to TAVR (3). 
In one half of the current cohort (n=9) the prosthesis was observed to extend to or beyond 
the level of the ostium of the left main coronary artery (Figure 6A). Currently available balloon 
expandable transcatheter valves incorporate a sealing cuff  in the portion of the prosthesis that 
lies within the annulus. The portion of the valve extending to or beyond the left main typically 
consists of an open mesh that does not interfere with coronary perfusion (Figure 6B). Cell size is 
suffi  ciently large to permit catheter access to the coronaries although a leafl et support strut may 
be problematic. However, obstruction of the left main ostium due to a displaced bulky native 
valve leafl et has been an infrequent occurrence (3,4). Our fi nding of native calcifi ed tissue in 
relatively close proximity to the left main ostium argues for careful screening and surveillance. 
CONCLUSIONS
MSCT prior to TAVR may be useful to assess aortic valve morphology, annular dimensions, assist 
in prosthesis selection and assess the potential for coronary compromise. That the annulus is 
commonly oval rather than circular has implications with regards to the interpretation of other 
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SUMMARY
In recent years, a number of new cardiac interventional procedures have been introduced. For 
atrial fi brillation (AF), catheter ablation procedures have been refi ned and are now considered a 
good treatment option in patients with drug-refractory AF. In cardiac pacing, cardiac resynchro-
nization therapy (CRT) is now standard of care in patients with drug-refractory heart failure. 
At the same time, CRT may also be benefi cial in patients with heart failure after long-term RV 
apical pacing. Finally, new percutaneous procedures for valvular heart disease have been intro-
duced for patients that are deemed inoperable. At the same time, various imaging modalities 
have been further developed and important advances have been made in the integration of 
diff erent imaging modalities. 
The aim of the present thesis was to explore the role of multimodality imaging in cardiac 
interventional procedures. In Part I, the integration of diff erent imaging modalities during 
catheter ablation procedures for AF was studied. In addition, the eff ects of these procedures on 
left atrial (LA) and left ventricular (LV) size and function were investigated. Part II studied the 
eff ects of right ventricular (RV) apical pacing on LV dyssynchrony and mechanics, and the eff ect 
of upgrade to CRT. Finally, in Part III the role of imaging in new percutaneous procedures for 
valvular heart disease was explored. 
PART I: Catheter ablation for atrial fi brillation
The fi rst part of the thesis focused on catheter ablation procedures for AF. These procedures 
are performed in an increasing number of patients worldwide. For these procedures, accurate 
visualization of the LA and pulmonary veins (PVs) is of critical importance. Chapter 2 reviews 
the diff erent imaging modalities that are available for the assessment of LA and PV anatomy. 
In daily clinical practice, conventional transthoracic echocardiography is most frequently 
used to assess LA size and volumes. Three-dimensional imaging techniques such as magnetic 
resonance imaging and multi-slice computed tomography (MSCT) are mainly used to assess 
PV anatomy before catheter ablation of AF. In addition, intracardiac echocardiography may be 
a valuable tool during these procedures. Finally, the integration of MSCT and electroanatomic 
mapping during catheter ablation procedures is discussed. 
Chapter 3 is a clinically oriented review on the use of imaging in the work-up of patients with 
AF, and provides an overview on the role of imaging in catheter ablation procedures. In the 
evaluation of patients with AF, associated conditions such as coronary artery disease, valvular 
heart disease and heart failure should carefully be analyzed. The various imaging modalities 
that are available for this are reviewed in this chapter. In addition, relevant issues before cath-
eter ablation (detection of thrombi, assessment of LA and PV anatomy) and available imaging 
techniques are discussed. Finally, an overview of the diff erent imaging modalities that can be 
integrated to guide catheter ablation procedures is provided. 
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In Chapter 4, the feasibility of the integration of MSCT images and electroanatomic mapping 
was tested in 16 patients undergoing catheter ablation for drug-refractory AF. The fusion of 
pre-procedural acquired MSCT images and electroanatomic maps may facilitate catheter abla-
tion procedures by improved visualization of critical structures such as the PVs. A new image 
integration module (CartoMergeTM) was used to merge the two imaging modalities using 
dedicated registration algorithms. After fusion of the two images, the mean distance between 
all mapping points and the MSCT image was 2.1 ± 0.2 mm (range 1.7 – 2.8). The integrated 
image was subsequently used to guide the catheter ablation. This study demonstrates that it is 
feasible to integrate MSCT images and electroanatomic maps. Image integration can facilitate 
catheter ablation procedures by improved visualization of important anatomical structures. 
The fi ndings of the previous study were extended in Chapter 5. In this study, the feasibility 
of the integration of intracardiac echocardiography, electroanatomic mapping and MSCT 
was tested. For this purpose, a newly developed intracardiac echocardiography probe, with 
an incorporated CartoTM navigation sensor located at its tip, was used. After positioning of 
the catheter in the right atrium, electroanatomic maps were created by drawing endocardial 
contours on the real-time intracardiac echocardiography images. Seventeen patients (13 men, 
mean age 56 ± 8 years) referred for catheter ablation for AF were studied. 
A mean of 31.1 ± 8.5 contours were used to create the 3D maps of the LA and PVs, and the 
mean distance between the contours and the MSCT image (registration accuracy) was 2.2 ± 0.3 
mm. Furthermore, a good agreement between intracardiac echocardiography and MSCT for 
the assessment of PV anatomy and PV diameters was noted. In conclusion, the feasibility of the 
integration of intracardiac echocardiography, electroanatomic mapping and MSCT was clearly 
demonstrated in this study. 
Chapter 6 focused on PV anatomy assessment with MSCT before catheter ablation, and its 
impact on the outcome of the ablation procedures. A total of 100 patients undergoing catheter 
ablation for AF were evaluated with MSCT. Pulmonary vein anatomy was classifi ed as ‘normal’ or 
‘complex’ based on the absence or presence of additional PVs or common ostia (single insertion 
of PVs). Furthermore, LA dimensions were assessed in three directions. Complex PV anatomy of 
the left-sided and right-sided PVs was present in 26% and 22% of patients, respectively. Mean 
LA diameter in the anterior-posterior direction was 41 ± 7 mm. Interestingly, the presence of 
right-sided complex PV anatomy was associated with an improved outcome of the catheter 
ablation procedure (OR = 0.149 [0.038-0.576], p=0.006), whereas LA dilatation was associated 
with a worse outcome (OR = 1.083 [1.009-1.162], p=0.027). This study underlines the impor-
tance of pre-procedural PV and LA anatomy assessment. Favorable anatomy may have impact 
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In the following studies, the eff ect of catheter ablation procedures on LA and LV size and func-
tion were investigated. We hypothesized that successful elimination of AF results in reverse 
remodeling of the LA. The study described in Chapter 7 included 57 patients treated with 
catheter ablation for AF. At baseline and after three months follow-up LA size and volumes were 
assessed with conventional 2D echocardiography. In patients who maintained sinus rhythm 
during follow-up (n=39), LA size signifi cantly decreased, whereas in patients with recurrence 
of AF (n=18) LA size increased. In addition, a decrease in LA end-diastolic volume (from 37 ± 
9 ml to 31 ± 7 ml, p<0.01) and LA end-systolic volume (from 59 ± 12 ml to 50 ± 11 ml, p<0.01) 
was noted in patients who maintained sinus rhythm during follow-up. These fi ndings were 
confi rmed in Chapter 8. In this study, real-time 3D echocardiography was used to assess LA 
size and volumes. This technique may be more accurate and reproducible than conventional 
2D echocardiography for assessment of LA volumes. In addition to LA size and volumes, LA 
function was assessed at baseline and follow-up (mean 7.9 ± 2.7 months). Based on minimum 
and maximum LA volume, and LA volume just before atrial active contraction, LA function 
(total emptying fraction, active emptying fraction and passive emptying fraction) was assessed. 
Signifi cant improvements in LA active function (from 22 ± 8% to 33 ± 9%, p<0.01) and LA res-
ervoir function (from 116 ± 45% to 152 ± 54%, p<0.01) were noted in patients who maintained 
sinus rhythm. In contrast, LA function showed a trend towards deterioration in patients who 
had recurrence of AF. 
From the abovementioned studies, it appears that LA reverse remodeling may occur after cath-
eter ablation for AF. The following study aimed to elucidate the clinical and echocardiographic 
determinants of LA reverse remodeling (Chapter 9). Reverse remodeling was defi ned as ≥15% 
reduction in maximum LA volume at follow-up. Tissue Doppler imaging was used to assess LA 
systolic and end-diastolic strain, representing LA expansion function and LA active contraction 
function, respectively. The study population (n=148) was divided according to the presence or 
absence of LA reverse remodeling at follow-up (‘responders’ [n=93] or ‘non-responders’ [n=55]). 
In the responders, a signifi cant increase in LA systolic strain was noted from baseline to follow-
up (from 19 ± 8% to 22 ± 9%, p<0.05), whereas no change was noted in the non-responders 
(from 14 ± 6% to 15 ± 8%, p=NS). Interestingly, LA systolic strain at baseline was the strongest 
predictor of LA reverse remodeling (OR 1.089; 95% CI 1.014-1.169, p=0.019). This study suggests 
a close association between LA reverse remodeling after catheter ablation and LA strain. 
Finally, in Chapter 10 the long-term eff ects of catheter ablation on LV function were studied. 
In this study, speckle-tracking echocardiography was used to assess LV strain in 3 directions 
(radial, circumferential and longitudinal). This technique may detect more subtle abnormalities 
in LV systolic function, as compared with conventional parameters such as LV ejection fraction. 
A total of 78 patients (mean LV ejection fraction 60 ± 7%) were included in the study. After 
13.8 ± 4.7 months follow-up, 54 patients maintained sinus rhythm, whereas 24 patients had 
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recurrence of AF. In the patients who maintained sinus rhythm, LV circumferential strain and LV 
longitudinal strain signifi cantly improved from baseline to follow-up (from -18.3 ± 3.2% to -20.4 
± 3.8%, p<0.001 and from -18.8 ± 2.7% to -19.6 ± 2.6%, p<0.001, respectively). In contrast, LV 
circumferential strain remained unchanged and LV longitudinal strain signifi cantly deteriorated 
in patients with recurrence of AF. This study demonstrates that LV strain improves in patients 
with preserved LV ejection fraction that are successfully treated with catheter ablation for AF. 
PART II: Ventricular pacing and dyssynchrony
The second part of this thesis focused on cardiac pacing and mechanical dyssynchrony. In 
Chapter 11, an extensive review of the available evidence on the eff ects of RV apical pacing on 
LV function and dyssynchrony is provided. Large randomized trials on the selection of pacing 
mode have demonstrated an association between long-term RV pacing and deterioration of 
LV systolic function and heart failure. These negative eff ects may be related to the presence of 
LV dyssynchrony. Several studies have demonstrated that the upgrade from RV apical pacing 
to biventricular pacing results in (partly) reversal of the detrimental eff ects of RV pacing. In 
addition, there is increasing evidence that ‘de novo’ CRT may be preferred over RV apical pacing 
in patients requiring high amounts of ventricular pacing. 
The long-term eff ects of RV apical pacing on LV function, LV dyssynchrony and heart failure 
symptoms were studied in Chapter 12. For this purpose, 55 patients were studied 3.8 ± 1.7 
years after atrio-ventricular node ablation and pacemaker implantation. Left ventricular dys-
synchrony was assessed with conventional 2D echocardiography: with the use of M-mode 
echocardiography the septal-to-posterior wall motion delay was assessed as a measure of intra-
ventricular dyssynchrony. A delay ≥130 ms was used to defi ne signifi cant LV dyssynchrony. In 
addition, tissue Doppler imaging was used to assess the septal-to-lateral delay at follow-up. 
At baseline, none of the patients exhibited ventricular dyssynchrony. However, in 27 patients 
(49%) LV dyssynchrony was present at long-term follow-up. Importantly, LV ejection fraction 
signifi cantly decreased in patients with LV dyssynchrony (from 48 ± 7% to 43 ± 7%, p<0.05), 
whereas it remained unchanged in patients without LV dyssynchrony (from 49 ± 6% to 49 ± 8%, 
p=NS). In addition, NYHA functional class deteriorated in patients with LV dyssynchrony (from 
1.8 ± 0.6 to 2.2 ± 0.7, p<0.05), whereas it improved in patients without LV dyssynchrony (from 
1.7 ± 0.7 to 1.4 ± 0.5, p<0.01). This study demonstrates that patients may develop signifi cant LV 
dyssynchrony after long-term permanent RV apical pacing. Importantly, the development of LV 
dyssynchrony is associated with a deterioration of LV function and functional class. 
After these fi ndings, a subsequent study was conducted to investigate if LV dyssynchrony is 
induced acutely (Chapter 13). For this purpose, 25 patients undergoing electrophysiological 
testing for supraventricular arrhythmias, and 25 control subjects were studied. At baseline 
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Speckle-tracking echocardiography was used to assess global LV longitudinal strain, LV dys-
synchrony and LV twist. At baseline, the 25 patients and 25 control subjects were comparable 
with regard to LV function and LV synchrony (median 21 ms vs. 20 ms, p=NS). However, during 
RV apical pacing, a signifi cant decrease in LV ejection fraction was noted (from 56 ± 8% to 48 
± 9%, p=0.001). In addition, the time diff erence between the earliest and the latest activated 
segments (representing LV dyssynchrony) signifi cantly increased in the study population (from 
21 ms [10, 53] to 91 ms [40, 204], p<0.001). In 36% of the patients signifi cant LV dyssynchrony 
(≥130 ms) was present. In addition, deterioration in LV global longitudinal strain and LV twist 
was noted after onset of RV apical pacing. Thus, the detrimental eff ects of RV apical pacing may 
(partly) occur immediately after onset of pacing. 
In patients with signifi cant LV dyssynchrony immediately after onset of pacing or at long-term 
follow-up, ventricular synchrony may be restored with biventricular pacing (or CRT). For opti-
mal benefi t of CRT, the site of latest activation (maximum dyssynchrony) should be identifi ed. 
Speckle-tracking echocardiography was used in 58 patients with permanent RV apical pacing 
to detect the site of latest activation in the study described in Chapter 14. Furthermore, the 
eff ect of upgrade from RV apical pacing to CRT was studied in a subset of patients. Before RV 
pacing, similar time-to-peak strain was noted among six LV segments (mean 371 ± 114 ms). 
However, after long-term RV apical pacing, heterogeneity in time-to-peak strain was noted. 
Most frequently, the lateral and posterior segments of the LV wall were the site of latest activa-
tion (31% and 25%, respectively). This delay resulted in signifi cant LV dyssynchrony in 57% of 
the patients. Unfortunately, no clinical parameters at baseline could predict LV dyssynchrony. 
Importantly, 11 patients underwent an upgrade from RV apical pacing to biventricular pacing. 
In these patients, LV dyssynchrony disappeared and LV ejection fraction signifi cantly improved 
from 30 ± 8% to 39 ± 7% (p<0.001) after upgrade to CRT. Thus, the detrimental eff ects of RV 
apical pacing may (partly) be reversed by CRT. 
In Chapter 15 the eff ect of RV pacing on myocardial oxidative metabolism and effi  ciency 
was studied. A total of 10 pacemaker patients (mean age 62 ± 17 years) were studied with 
the use of echocardiography and positron emission tomography during pacing-OFF (sinus 
rhythm or atrial pacing) and pacing-ON (RV pacing). Left ventricular dyssynchrony was studied 
with tissue Doppler imaging and speckle-tracking echocardiography. Myocardial blood fl ow, 
oxidative metabolism and myocardial effi  ciency were derived from the positron emission 
tomography images. During RV pacing, global myocardial blood fl ow and oxidative metabo-
lism did not change signifi cantly in the overall study population. However, diff erent eff ects on 
cardiac metabolism and effi  ciency were observed according to the presence or absence of LV 
dyssynchrony during RV pacing. In patients with LV dyssynchrony during pacing-ON (n=6) a 
signifi cant decrease in myocardial effi  ciency was noted (from 78.11 ± 25.35 mmHg·l/g to 60.40 
± 13.93 mmHg·l/g, p<0.05), whereas in patients without LV dyssynchrony (n=4) no signifi cant 
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change was noted (from 73.55 ± 24.78 mmHg·l/g to 75.32 ± 31.33 mmHg·l/g, p=NS). The 
presence of LV dyssynchrony during RV pacing appears to be associated with a worsening of 
LV oxidative metabolism and effi  ciency. From the abovementioned studies, it becomes clear 
that assessment of ventricular dyssynchrony in patients with RV pacing has important clinical 
implications. The presence of LV dyssynchrony is associated with deterioration of LV function, 
impaired oxidative metabolism and functional status. 
Finally, in Chapter 16 the prevalence of ventricular dyssynchrony in patients with arrhyth-
mogenic right ventricular dysplasia (ARVD) was studied. Arrhythmogenic right ventricular 
dysplasia is an inherited disease characterized by fi brofatty infi ltration of the myocardium. This 
infi ltration may result in electrical conduction delay and mechanical dyssynchrony. However, 
the prevalence of mechanical dyssynchrony in ARVD has not been studied yet. A total of 52 
patients (mean age 41 ± 12 years, 22 men) with ARVD and 25 healthy controls were studied. 
Transthoracic echocardiography was used to assess ventricular volumes and tissue Doppler 
imaging was used to determine the extent of mechanical dyssynchrony using time-to-peak sys-
tolic velocity (TSV) of the RV free wall, the interventricular septum and the LV lateral wall. Signifi -
cant RV dyssynchrony was defi ned as a diff erence between the RV free wall and interventricular 
septum, >2 SD above the mean value for control subjects. Mean diff erence in TSV between the 
septum and RV free wall was 26 ± 15 ms in the controls (resulting in a cut-off  value of ≥56 ms 
for RV dyssynchrony) and 55 ± 34 ms in the ARVD patients (p<0.001). In 26 ARVD patients (50%) 
signifi cant RV dyssynchrony was present. Interestingly, no diff erences in QRS duration, preva-
lence in T-wave inversion or right bundle branch block were noted between ARVD patients with 
and without signifi cant RV dyssynchrony. However, RV fractional area change was signifi cantly 
lower (29 ± 8% vs. 34 ± 8%, p<0.05) and RV peak systolic strain was signifi cantly lower (-16 ± 
6% vs. -22 ± 7%, p<0.01) in ARVD patients with RV dyssynchrony compared with ARVD patients 
without RV dyssynchrony. The present study demonstrates that signifi cant RV dyssynchrony 
may be present in up to 50% of ARVD patients. The presence of RV dyssynchrony is associated 
with RV remodeling rather than electrocardiographic abnormalities. 
PART III: Percutaneous valve procedures
The third part of this thesis focused on percutaneous valve procedures. In recent years, a num-
ber of new transcatheter procedures have been introduced to treat severe mitral regurgitation 
(MR) and aortic stenosis (AS). Various imaging modalities may be of great value for these pro-
cedures, in particular in the selection of patients. The various percutaneous valve procedures, 
the available evidence and the role of imaging in these procedures are reviewed in Chapter 17. 
In Chapter 18, MSCT was used in 105 patients to assess coronary sinus anatomy. The relation 
between the coronary sinus, the mitral valve annulus and the coronary arteries is of critical 
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the mitral valve annulus. Unfavorable anatomy may result in ineffi  cient remodeling and may 
impair coronary blood fl ow. In the present study, a highly variable relation between the coro-
nary sinus and the mitral valve annulus was noted. The coronary sinus was located along the LA 
wall in the majority of the patients (mean distance 5.1 ± 2.9 mm). Importantly, the circumfl ex 
artery coursed between the coronary sinus and the mitral valve annulus in 68% of the patients. 
In addition, it was noted that the minimal distance between the coronary sinus and the mitral 
valve annulus was signifi cantly larger in patients with MR as compared with patients without 
MR (mean 7.3 ± 3.9 mm vs. 4.8 ± 2.5 mm, p<0.05). In patients with large distance between 
the coronary sinus and mitral valve annulus, or in patients where the circumfl ex artery courses 
between the two structures, percutaneous mitral valve procedures may not be feasible. There-
fore, MSCT provides important information for the selection of patients for these procedures.
The evaluation of the mitral valve with MSCT was further explored in Chapter 19. The 
subvalvular apparatus and mitral valve geometry (mitral valve tenting height and leafl et teth-
ering) was evaluated in 151 patients, including 29 patients with moderate to severe MR. An 
asymmetric deformation of the mitral valve was observed in patients with MR. In these patients, 
an increased posterior leafl et angle was noted at the central (44.4 ± 11.9°) and the posterome-
dial (35.9 ± 10.6°) levels. In addition, mitral valve tenting height was signifi cantly increased in 
patients with MR, compared with patients without MR at these levels (central level: 6.6 ± 1.4 
mm/m2 vs. 5.3 ± 1.3 mm/m2, p<0.001; posteromedial level: 5.4 ± 1.6 mm/m2 vs. 4.1 ± 1.2 mm/
m2, p<0.001). This study demonstrates the value of MSCT in the evaluation of anatomical and 
geometric characteristics of the mitral valve. 
The remaining of the studies focused on percutaneous aortic valve procedures. In Chapter 
20, an extensive review of the available studies on percutaneous aortic valve procedures is 
provided. The majority of these studies clearly demonstrate high procedural success rates, low 
30-day mortality and good prosthesis function during follow-up. In addition, the recommenda-
tions on selection of patients for percutaneous aortic valve procedures are reviewed in this 
chapter. At present, these procedures are only recommended in patients with symptomatic, 
severe AS that are deemed inoperable. Finally, the use of various imaging modalities in the 
selection of patients, performing aortic valve procedures and follow-up is reviewed.  
Multi-slice computed tomography is one of the imaging modalities that may provide important 
information on aortic valve anatomy before percutaneous valve procedures. Therefore, the 
anatomy of the aortic root was assessed with MSCT in 169 patients referred for non-invasive 
coronary angiography (including 19 patients with moderate to severe AS) in Chapter 21. In 
addition to the extent and location of valvular calcifi cations, standardized measurements of 
the aortic root were performed. Reconstructed MSCT images were used to assess the aortic 
annulus diameter in two directions. The orientation of the reconstructions was similar to the 
image orientation that is used during the actual percutaneous valve implantation. Furthermore, 
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the distance between the aortic annulus and the ostia of the coronary arteries was measured. 
These parameters may have great impact on prosthesis sizing and on the feasibility of the 
procedure. Interestingly, an oval shape of the aortic annulus was noted, with a mean diameter 
of 26.3 ± 2.8 mm on the coronal view, and 23.5 ± 2.7 mm on the sagittal view. Large variation 
in the distance between the aortic annulus and the left coronary ostium (mean 14.4 ± 2.9 mm, 
range 7.1 to 22.7 mm) and the right coronary ostium (mean 17.2 ± 3.3 mm, range 9.2 to 26.3 
mm) was noted. Importantly, the length of the coronary leafl et exceeded this distance in up 
to 49% of the patients. This may increase the risk of coronary occlusion during percutaneous 
valve procedures. Thus, MSCT may provide important information for the selection of patients 
for percutaneous aortic valve replacement. 
These fi ndings were confi rmed in a group of 26 patients with severe AS referred for percutane-
ous aortic valve replacement (Chapter 22). Before the percutaneous valve implantation and 
after 4 months follow-up, MSCT images were analyzed using the same measurements as in 
the previous study. Measurements of aortic annulus diameters with MSCT, echocardiography 
and fl uoroscopy were compared. In addition, the stent diameter and the distance between 
the left coronary artery and the stent wall were assessed. Mean distance between the aortic 
annulus and the left coronary ostium was 15.0 ± 3.0 mm. Comparable results for aortic annulus 
diameters were noted with diff erent imaging modalities: mean diff erence between MSCT and 
transthoracic echocardiography was -0.3 mm (95% confi dence interval -1.1 to 0.6 mm). After 
percutaneous aortic valve replacement, the prosthesis extended above the coronary ostia in 
50% of the patients. In addition, in 78% of the patients a circular deployment of the prosthesis 
was noted. Importantly, no association was found between the aortic annulus shape and the 
proportion of patients who developed perivalvular aortic regurgitation. This study clearly 
demonstrates the value of MSCT in the pre-procedural assessment and follow-up of patients 
with severe AS referred for percutaneous aortic valve replacement. 
CONCLUSIONS AND FUTURE PERSPECTIVES
The studies described in the present thesis explore the role of multimodality imaging in cardiac 
interventional procedures. In recent years, exciting advances have been made in the invasive 
treatment of AF, cardiac pacing and the percutaneous treatment of valvular heart disease. The 
selection of patients for these procedures, the procedures themselves and the follow-up of 
patients may be greatly facilitated by the use of imaging modalities. Importantly, the integra-
tion of diff erent imaging techniques may enhance visualization of critical anatomic structures 
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Catheter ablation for atrial fi brillation
Careful identifi cation of LA and PV anatomy is of critical importance for successful catheter 
ablation of AF. Importantly, the anatomy of the PVs and LA has impact on the outcome of 
the catheter ablation procedure. Diff erent imaging modalities are available for assessment 
of LA and PV anatomy. Unfortunately, each imaging modality also has its drawbacks. Image 
integration may overcome the limitations of each separate imaging modality by combining 
the diff erent techniques. The studies in the present thesis demonstrate that the integration 
of diff erent imaging modalities is feasible, and provides additional information during the 
catheter ablation procedure. Future studies are needed to further explore image integration 
in the electrophysiology laboratory. Large randomized trials are needed to assess the impact 
of image integration on the outcome of AF ablation procedures. In addition, in the near future 
new imaging techniques such as rotational angiography (providing real-time 3D fl uoroscopic 
images comparable to MSCT) and real-time magnetic resonance imaging (in a hybrid suite) 
may have great impact on AF ablation procedures. 
Furthermore, the present studies demonstrate that successful catheter ablation of AF results 
in reverse remodeling of the LA and improvement of LA and LV function. Unfortunately, the 
exact pathophysiologic mechanism remains to be determined. Furthermore, it remains unclear 
whether the maintenance of sinus rhythm results in reverse remodeling, or vice versa (‘chicken 
or egg’). Additional studies are therefore needed to fi nd predictors of reverse remodeling, and 
pre-clinical studies may contribute to a better understanding of this phenomenon. It may well 
be that the amount of fi brosis in the LA plays an important role in the outcome of catheter 
ablation procedures. Pre-procedural evaluation of LA scar with dedicated imaging techniques 
may then be of great value. Finally, assessment of LA scar and ablation lesions using magnetic 
resonance imaging after the procedure may provide important information on the eff ect of 
catheter ablation procedures on LA and LV function. 
Ventricular pacing and dyssynchrony
The detrimental eff ects of long-term RV apical pacing as demonstrated in large pacing mode 
trials and smaller observational studies may be related to the induction of LV dyssynchrony. The 
present studies demonstrate that about half of the patients with long-term RV apical pacing 
develop signifi cant LV dyssynchrony and exhibit deterioration of LV function. The presence 
of LV dyssynchrony during RV pacing is also associated with worsening of cardiac oxidative 
metabolism and effi  ciency. By restoration of synchronous contraction, CRT may (partly) reverse 
the detrimental eff ects of long-term permanent RV apical pacing. Importantly, LV dyssynchrony 
may be present immediately after onset of RV apical pacing. Finally, from the present studies 
it has become apparent that signifi cant ventricular dyssynchrony is also present in up to 50% 
of patients with ARVD. More studies are needed to clarify the underlying mechanism, and the 
clinical implications of these fi ndings. 
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With regard to RV pacing and ventricular dyssynchrony, a number of important questions 
remain unanswered, and need to be addressed in future studies. For example, why do some 
patients develop signifi cant LV dyssynchrony with RV pacing, while others do not? Both 
patient- and pacemaker-related parameters that may predict the development of mechanical 
dyssynchrony and deterioration of cardiac function need to be identifi ed. Is acutely induced 
LV dyssynchrony associated with deterioration of LV function during follow-up? Should future 
studies confi rm that there is a relation between acutely induced LV dyssynchrony and worsen-
ing of LV function and functional class at long-term follow-up, assessment of LV dyssynchrony 
at pacemaker implantation may have important implications. Biventricular pacing may then 
be considered in patients with signifi cant LV dyssynchrony immediately after onset of pacing. 
Furthermore, screening for LV dyssynchrony on a regular basis in patients with conventional RV 
pacing may identify patients that may benefi t from upgrade to CRT. 
Percutaneous valve procedures
In recent years, a number of exciting procedures and prostheses have been introduced for the 
percutaneous treatment of severe valvular heart disease. The present studies demonstrate that 
cardiac imaging provides critical information for percutaneous valve procedures. In particular, 
MSCT plays an important role in the selection of patients referred for these procedures. This 
3D imaging technique clearly visualizes the relation between the coronary arteries, coronary 
veins and aff ected valves. Both for percutaneous mitral valve procedures using coronary sinus 
annuloplasty and transcatheter aortic valve replacement, this relation is of utmost importance. 
Furthermore, MSCT allows visualization of the prosthesis, and the relation with surrounding 
structures, after implantation. 
Future studies will need to address a number of important issues. The long-term durability 
of the prostheses and favorable long-term clinical outcome needs to be demonstrated. At the 
same time, more studies comparing percutaneous and surgical treatment of valvular heart 
disease are warranted. The results of the PARTNER trial (The Placement of AoRTic TraNscathetER 
Valve Trial) comparing percutaneous and surgical aortic valve replacement in 350 patients are 
eagerly awaited. This trial may add important evidence on the role of percutaneous valve pro-
cedures in the treatment of patients with severe AS. Should future studies demonstrate equal or 
superior effi  cacy and long-term durability, it may well be that the indication for percutaneous 
valve procedures is expanded. This is of particular interest when considering the percutane-
ous ‘valve-in-valve’ concept in patients with degenerated aortic bioprostheses. Finally, more 
studies are needed to examine the ability of diff erent imaging modalities to improve the safety 
of percutaneous valve procedures. In particular, the feasibility of image integration during 
percutaneous valve procedures needs to the studied.









Dit proefschrift behandelt twee belangrijke deelgebieden van de klinische cardiologie: Cardiale 
beeldvorming (‘multimodality imaging’) en cardiale interventies (‘interventional procedures’). 
In de afgelopen jaren heeft een aantal belangrijke ontwikkelingen plaatsvonden op het gebied 
van cardiale beeldvorming en cardiale interventie procedures. Een aantal nieuwe beeldvor-
mende technieken zoals multi-slice computer tomografi e (MSCT) scan is geïntroduceerd. 
Daarnaast zijn andere beeldvormende technieken (zoals echocardiografi e) verfi jnd zodat nu 
een meer gedetailleerde analyse van cardiale anatomie en functie mogelijk is. Verder is er 
grote vooruitgang geboekt op het gebied van integratie van verschillende beeldvormende 
technieken. 
Tegelijkertijd is een aantal nieuwe interventie procedures beschikbaar gekomen voor de 
behandeling van hartritmestoornissen en hartkleplijden. Catheter ablatie procedures worden 
tegenwoordig beschouwd als een goede behandeloptie voor patiënten met therapieresistent 
atriumfi brilleren (AF). Bij deze procedures wordt via de liesader en de grote aders een catheter 
in het linker atrium (LA) van het hart gebracht. Hiermee worden vervolgens de pulmonaalve-
nen (PV) elektrisch geïsoleerd met behulp van radiofrequente energie (Figuur 2 in Hoofdstuk 
1). Zodoende wordt de hartritmestoornis verholpen. Op het gebied van pacemakers is de 
laatste jaren duidelijk geworden dat conventioneel rechter ventrikel (RV) stimulatie (of ‘pacen’) 
negatieve eff ecten heeft op de functie van het linker ventrikel (LV) van het hart. Een deel van 
de patiënten die een pacemaker krijgt, bijvoorbeeld vanwege een traag hartritme, ontwik-
kelt op de lange termijn hartfalen. Dit hangt mogelijk samen met het abnormale activatie 
patroon van de ventrikels tijdens het pacen. Het abnormale activatie patroon resulteert in 
een niet-synchroon samentrekken van de verschillende delen van de ventrikels van het hart 
(ofwel: ‘dyssynchronie’, Figuur 6 in Hoofdstuk 1). Cardiale resynchronisatie therapie (CRT) is een 
speciale vorm van pacen die zorgt voor het herstel van het synchroon samentrekken van de 
ventrikels. Wellicht dat CRT ook een goede optie is voor patiënten met een gewone pacemaker 
en dyssynchronie. Ten slotte zijn er nieuwe procedures en protheses geïntroduceerd voor de 
behandeling van patiënten met ernstig hartkleplijden die niet in aanmerking komen voor een 
open-hart operatie. Bij deze procedures wordt via de lies en de grote (slag)aders een catheter 
in het hart gebracht, waarmee een nieuwe hartklep of een andere prothese wordt geplaatst 
(Figuur 8 in Hoofdstuk 1). 
In dit proefschrift wordt de rol van verschillende beeldvormende technieken bij cardiale 
interventie procedures bestudeerd. In Deel I werd gekeken naar catheter ablatie procedures 
voor AF. Het doel van het onderzoek was te kijken of het mogelijk is om deze procedures te 
verbeteren door verschillende beeldvormende technieken te integreren. Daarnaast werd het 
eff ect van deze procedures op de functie van het LA en LV bestudeerd. Het doel van de studies 
in Deel II was om de eff ecten van RV pacen op LV dyssynchronie en LV functie te bekijken. 
Daarnaast werd het eff ect van CRT bij patiënten met dyssynchronie na lange termijn RV pacen 
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onderzocht. Deel III behandelt de rol van beeldvormende technieken bij nieuwe percutane 
procedures voor ernstige hartklepafwijkingen. 
Deel I: Catheter ablatie voor atriumfi brilleren 
Het eerste deel van dit proefschrift gaat over catheter ablatie procedures voor AF. Steeds meer 
patiënten met therapieresistent AF ondergaan dergelijke procedures. Het is belangrijk om 
voorafgaand en tijdens de procedure het LA en de PV goed in beeld te brengen. Hoofdstuk 2 
geeft een uitgebreide beschrijving van de verschillende beeldvormende technieken die hier-
voor gebruikt kunnen worden. In de dagelijkse praktijk is transthoracale echocardiografi e de 
meest gebruikte techniek om het LA in beeld te brengen. Driedimensionale technieken zoals 
MSCT en magnetic resonance imaging (MRI) worden vaak gebruikt om voorafgaand aan een 
catheter ablatie procedure de PV te visualiseren. Tijdens de ablatie procedure kan intracardiale 
echocardiografi e gebruikt worden. Ten slotte wordt de integratie van de verschillende technie-
ken in dit hoofdstuk besproken. 
Hoofdstuk 3 is een klinisch georiënteerd overzichtsartikel waarin de rol van beeldvormende 
technieken bij de evaluatie van patiënten met AF, en de rol van deze technieken bij catheter 
ablatie procedures wordt behandeld. Wanneer een patiënt met AF voor de eerste maal wordt 
beoordeeld, moet een aantal geassocieerde ziektebeelden (zoals kransslaglijden, hartkleplij-
den en hartfalen) zorgvuldig worden bestudeerd. De diverse beeldvormende technieken die 
hiervoor beschikbaar zijn, worden in dit hoofdstuk beschreven. Verder wordt een overzicht 
gegeven van de aandachtspunten die belangrijk zijn voorafgaand en tijdens catheter ablatie 
procedures en wordt beschreven hoe de verschillende beeldvormende technieken hiervoor 
gebruikt kunnen worden. 
Tijdens catheter ablatie procedures wordt veelvuldig gebruik gemaakt van ‘elektroanatomische 
maps’. Dit zijn reconstructies van het LA die zowel informatie over anatomie als over elektrische 
geleiding bevatten. Deze maps worden gemaakt met behulp van de ablatie catheters. In 
Hoofdstuk 4 werd de integratie van MSCT en deze elektroanatomische maps bestudeerd bij 
16 patiënten die een catheter ablatie procedure voor AF ondergingen. Hiervoor werd gebruik 
gemaakt van een nieuwe ‘image integration module’ (CartoMergeTM), uitgerust met speciale 
algoritmes. Na de integratie van de MSCT beelden en de elektroanatomische maps was de 
gemiddelde afstand tussen deze twee beelden 2.1 ± 0.2 mm (range 1.7 – 2.8). Het geïntegreerde 
beeld werd vervolgens gebruikt om de catheter ablatie procedure te sturen (Figuur 3 in Hoofd-
stuk 4). Deze studie laat zien dat het mogelijk is om MSCT beelden en elektroanatomische maps 
te integreren en vervolgens te gebruiken voor catheter ablatie procedures. 
Deze bevindingen worden verder uitgewerkt in Hoofdstuk 5. In deze studie werd de integratie 
van intracardiale echocardiografi e, elektroanatomische maps en MSCT beelden bestudeerd. 
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Hiervoor werd gebruik gemaakt van een nieuwe intracardiale echocardiografi e ‘camera’ (probe) 
die uitgerust is met een speciale sensor van het CartoTM elektroanatomische mapping systeem. 
Hiermee kunnen vanuit het rechter atrium elektroanatomische maps van het LA worden 
gemaakt door contouren te trekken op de echocardiografi sche beelden (Figuur 1 in Hoofdstuk 
5). Zeventien patiënten (13 mannen, gemiddelde leeftijd 56 ± 8 jaar) werden bestudeerd. 
Gemiddeld waren 31.1 ± 8.5 contouren nodig om een driedimensionale reconstructie van het 
LA en de PV te maken. De gemiddelde afstand tussen de contouren en de MSCT beelden (als 
maat voor de nauwkeurigheid van de integratie) was 2.2 ± 0.3 mm. Verder werd een goede 
overeenkomst gevonden tussen intracardiale echocardiografi e en MSCT voor het vaststellen 
van de anatomie en diameters van de PV. 
Het in beeld brengen van de anatomie van de PV met behulp van MSCT, en het eff ect van PV 
anatomie op de uitkomst van catheter ablatie procedures waren de doelen van Hoofdstuk 6. 
Bij 100 patiënten met AF die een catheter ablatie procedure ondergingen werd een MSCT scan 
gemaakt. Gebaseerd op de aan- of afwezigheid van additionele PV of ‘common ostia’ (één enkele 
PV uitmonding aan een zijde van het LA, zie ook Figuur 3 in Hoofdstuk 6), werd de anatomie van 
de PV geduid als ‘normaal’ of ‘complex’. Verder werd de diameter van het LA in drie verschillende 
richtingen gemeten. Complexe PV anatomie aan de linker zijde was aanwezig bij 26% van de 
patiënten, en aan de rechter zijde bij 22%. De gemiddelde voorachterwaartse diameter van het 
LA was 41 ± 7 mm. Complexe PV anatomie aan de rechter zijde was geassocieerd met een ver-
beterde uitkomst van de catheter ablatie procedure (OR = 0.149 [0.038-0.576], p=0.006), terwijl 
LA dilatatie was geassocieerd met een slechtere uitkomst (OR = 1.083 [1.009-1.162], p=0.027). 
Deze studie benadrukt de relevantie van het beoordelen van LA en PV anatomie voorafgaand 
aan catheter ablatie procedures. 
In de volgende studies werd gekeken naar het eff ect van catheter ablatie procedures op de 
grootte en functie van het LA en LV. Onze hypothese was dat een geslaagde ablatie procedure 
een gunstig eff ect heeft op zowel de grootte als de functie van het LA en LV. De studie in 
Hoofdstuk 7 bevatte 57 patiënten die werden behandeld met catheter ablatie voor AF. Vooraf-
gaand aan, en drie maanden na de ablatie procedure werden de volumes van het LA berekend 
met tweedimensionale echocardiografi e. Bij patiënten die normaal sinusritme behielden 
(geslaagde procedure, n=39) werd het LA signifi cant kleiner, terwijl bij patiënten die opnieuw 
AF kregen (niet geslaagde procedure, n=18) het LA groter werd. Daarnaast werd zowel het LA 
einddiastolisch volume kleiner (van 37 ± 9 ml naar 31 ± 7 ml, p<0.01), als het LA eindsystolisch 
volume (van 59 ± 12 ml naar 50 ± 11 ml, p<0.01) bij patiënten die sinusritme behielden. Deze 
bevindingen worden bevestigd in Hoofdstuk 8. In deze studie werd gebruik gemaakt van 
driedimensionale echocardiografi e (Figuur 1 in Hoofdstuk 8). Deze nieuwe techniek is mogelijk 
nauwkeuriger voor het bepalen van LA grootte en volumes en beter reproduceerbaar dan 
tweedimensionale echocardiografi e. In deze studie werd naast de grootte en volumes ook 
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gekeken naar de functie van het LA. De functie van het LA kan ingedeeld worden in drie fases: 
de expansie functie, de reservoir functie en de actieve contractie functie. Bij patiënten die 
sinusritme behielden na de catheter ablatie procedure werden signifi cante verbeteringen in de 
actieve functie van het LA (van 22 ± 8% naar 33 ± 9%, p<0.01) en de reservoir functie van het 
LA (van 116 ± 45% naar 152 ± 54%, p<0.01) gevonden. Deze verbeteringen werden echter niet 
gezien bij patiënten die opnieuw AF kregen gedurende follow-up. 
De voorafgaande studies laten zien dat er sprake is van ‘LA reverse remodeling’ na een suc-
cesvolle ablatie procedure voor AF, waarbij er sprake is van een afname van de LA grootte en 
een verbetering van LA functie. In Hoofdstuk 9 werd gezocht naar de klinische en echocardio-
grafi sche determinanten van LA reverse remodeling. Reverse remodeling werd gedefi nieerd 
als een afname van ≥15% in het maximale LA volume. Tissue Doppler echocardiografi e werd 
gebruikt om LA systolische strain (als een maat voor LA expansie functie) en LA diastolische 
strain (als een maat voor LA actieve contractie functie) te berekenen (Figuur 1 in Hoofdstuk 
9). Aan de hand van de aan- of afwezigheid van reverse remodeling tijdens follow-up werd 
de studie populatie verdeeld in ‘responders’ (n=93) of ‘non-responders’ (n=55). De responders 
lieten een signifi cante toename van LA systolische strain gezien (van 19 ± 8% naar 22 ± 9%, 
p<0.05), terwijl er geen signifi cante verandering was bij de non-responders (van 14 ± 6% naar 
15 ± 8%, p=NS). De belangrijkste voorspeller van LA reverse remodeling was LA systolische 
strain op baseline (OR 1.089; 95% CI 1.014-1.169, p=0.019). Deze studie laat een sterke relatie 
zien tussen LA reverse remodeling en LA strain. 
In Hoofdstuk 10 wordt het eff ect van catheter ablatie procedures op de LV functie onderzocht. 
Hiervoor werd gebruik gemaakt van ‘speckle-tracking’ echocardiografi e, dat akoestische mar-
kers die aanwezig zijn op standaard echocardiografi sche beelden analyseert. Hiermee werd LV 
strain in drie richtingen (radiaal, circumferentieel en longitudinaal, zie ook Figuur 1 in Hoofd-
stuk 10) berekend op baseline en gedurende follow-up bij 78 patiënten (gemiddelde LV ejectie 
fractie 60 ± 7%). Na 13.8 ± 4.7 maanden hadden 54 patiënten sinusritme behouden, terwijl 25 
patiënten opnieuw AF kregen. Bij de patiënten met behoud van sinusritme was er sprake van 
een signifi cante toename in LV strain in de circumferentiële richting (van -18.3 ± 3.2% naar 
-20.4 ± 3.8%, p<0.001) en LV strain in de longitudinale richting (van -18.8 ± 2.7% naar -19.6 ± 
2.6%, p<0.001). Deze verbeteringen werden niet gezien bij patiënten die opnieuw AF kregen 
gedurende follow-up. Deze studie laat zien dat LV functie alleen verbetert na een succesvolle 
catheter ablatie procedure voor AF. 
Deel II: Ventriculair pacen en dyssynchronie
In het tweede deel van het proefschrift staan pacemakers en mechanische dyssynchronie 
centraal. In Hoofdstuk 11 wordt een overzicht gegeven van de eff ecten van RV pacen op 
LV functie en LV dyssynchronie. Grote gerandomiseerde studies die de optimale pacemaker 
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modus onderzochten, lieten een associatie zien tussen langdurig RV pacen en verslechtering 
van LV functie en hartfalen. De negatieve eff ecten op lange termijn zijn mogelijk gerelateerd 
aan het induceren van LV dyssynchronie door RV pacen, als gevolg van het abnormale activatie 
patroon. Meerdere studies hebben laten zien dat de upgrade van RV pacen naar CRT een gun-
stig eff ect heeft op LV functie. Wellicht dat CRT ook van betekenis kan zijn voor patiënten die 
een normale pacemaker nodig hebben, maar waarvan verwacht wordt dat ze langdurig pacen 
nodig hebben. 
De eff ecten van RV pacen op LV functie, LV dyssynchronie en symptomen van hartfalen staan 
centraal in Hoofdstuk 12. Bij 55 patiënten werd een pacemaker geïmplanteerd na ablatie 
van de atrioventriculaire knoop (elektrische verbinding tussen de atria en de ventrikels). 
Voorafgaand aan de pacemaker implantatie, en na gemiddeld 3.8 ± 1.7 jaar werd een echo-
cardiogram verricht. Linker ventrikel dyssynchronie werd onderzocht met tweedimensionale 
echocardiografi e. Een verschil van ≥130 ms tussen de systolische beweging van het septum en 
de achterwand van het LV werd gebruikt voor de defi nitie van LV dyssynchronie. Voorafgaand 
aan de pacemaker implantatie had geen van de patiënten LV dyssynchronie. Echter na lang-
durig RV pacen was er sprake van signifi cante LV dyssynchronie bij 27 patiënten (49%). Bij die 
patiënten was er sprake van een signifi cante verslechtering van de LV ejectie fractie (van 48 ± 
7% naar 43 ± 7%, p<0.05), terwijl deze gelijk bleef bij patiënten zonder LV dyssynchronie (van 
49 ± 6% naar 49 ± 8%, p=NS). Daarnaast was er een verslechtering in hartfalen symptomen bij 
patiënten met LV dyssynchronie (NYHA klasse van 1.8 ± 0.6 naar 2.2 ± 0.7, p<0.05), terwijl de 
symptomen verbeterden bij patiënten zonder LV dyssynchronie (NYHA klasse van 1.7 ± 0.7 naar 
1.4 ± 0.5, p<0.01). Deze studie laat zien dat patiënten signifi cante LV dyssynchronie kunnen 
ontwikkelen na langdurig RV pacen. Het ontwikkelen van LV dyssynchronie is geassocieerd met 
verslechtering van de LV functie en hartfalen symptomen. 
Na deze bevindingen werd een studie opgezet om te onderzoeken of LV dyssynchronie direct 
na het starten van RV pacen optreedt (Hoofdstuk 13). Hiervoor werden 25 patiënten die een 
elektrofysiologisch onderzoek ondergingen vanwege hartritmestoornissen, en 25 controle 
patiënten bestudeerd. Op baseline en na ten minste 5 minuten RV pacen werden LV functie en 
dyssynchronie gekwantifi ceerd. Speckle-tracking echocardiografi e werd gebruikt om LV strain 
in longitudinale richting, LV dyssynchronie en LV twist (berekend met behulp van de rotatie van 
de LV tijdens systole) te berekenen. Op baseline waren er geen verschillen tussen de 25 studie 
patiënten en de 25 controle patiënten wat LV functie en LV dyssynchronie (mediaan 21 ms vs. 
20 ms, p=NS) betreft. Echter, na het starten van RV pacen verslechterde de LV ejectie fractie bij 
de 25 studie patiënten (van 56 ± 8% naar 48 ± 9%, p=0.001). Tegelijkertijd was er sprake van 
een toename van LV dyssynchronie (van 21 ms [10, 53] naar 91 ms [40, 204], p<0.001). Bij 36% 
van de patiënten was er sprake van signifi cante LV dyssynchronie (≥130 ms). Daarnaast werd 
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er een verslechtering van LV strain en LV twist geconstateerd na het starten van RV pacen. Dus, 
de negatieve eff ecten van RV pacen ontstaan (gedeeltelijk) direct na aanvang van RV pacen. 
Bij patiënten met signifi cante LV dyssynchronie direct na aanvang of na langdurig RV pacen, 
kan een synchroon contractie patroon van de LV hersteld worden met behulp van biventricu-
lair pacen (CRT). Voor een optimaal resultaat van CRT moet dat deel van de LV dat het laatste 
wordt geactiveerd (langste ‘time-to-peak’ strain), en waar dus maximale LV dyssynchronie is, 
worden bepaald. Hiervoor werd in Hoofdstuk 14 speckle-tracking echocardiografi e gebruikt 
bij 58 patiënten met een pacemaker. Daarnaast werd het eff ect van de upgrade van RV pacen 
naar CRT bestudeerd bij een deel van deze patiënten. Voor aanvang van RV pacen waren er ver-
gelijkbare waarden voor time-to-peak strain in 6 mid-ventriculaire LV segmenten (gemiddeld 
371 ± 114 ms). Echter na langdurig RV pacen was er sprake van heterogeniteit in time-to-peak 
strain van de 6 segmenten. De laterale en de achterwand segmenten waren meestal de delen 
van de LV met de laatste activatie (Figuur 1 in Hoofdstuk 14). Dit resulteerde in signifi cante 
LV dyssynchronie bij 57% van de patiënten. Bij 11 patiënten werd een upgrade van RV pacen 
naar CRT verricht. Bij deze patiënten verdween de LV dyssynchronie, en de LV ejectie fractie 
verbeterde van 30 ± 8% naar 39 ± 7% (p<0.001). De negatieve eff ecten van RV pacen kunnen 
dus (gedeeltelijk) worden verbeterd met CRT. 
Hoofdstuk 15 gaat in op het eff ect van RV pacen op het oxidatieve metabolisme van het 
myocard. Tien patiënten met een pacemaker (gemiddelde leeftijd 62 ± 17 jaar) ondergingen 
echocardiografi e en een ‘positron emission tomography’ scan tijdens pacing-OFF (normaal 
sinusritme of atriaal pacen) en pacing-ON (RV pacen). Linker ventrikel dyssynchronie werd 
bestudeerd met tissue Doppler en speckle-tracking echocardiografi e. Verschillende parameters 
werden onderzocht middels de positron emission tomography scan, zoals de bloedstroom van 
het myocard, het oxidatieve metabolisme en de effi  ciëntie van het myocard. Tijdens RV pacen 
vond er geen verandering plaats in globale bloedstroom van het myocard en het oxidatieve 
metabolisme in de studie populatie als geheel. Echter, bij patiënten met signifi cante LV dys-
synchronie tijdens RV pacing-ON (n=6) werd een verslechtering in effi  ciëntie van het myocard 
gezien (van 78.11 ± 25.35 mmHg·l/g naar 60.40 ± 13.93 mmHg·l/g, p<0.05), terwijl bij patiënten 
zonder LV dyssynchrony (n=4) geen verandering werd gezien (van 73.55 ± 24.78 mmHg·l/g 
naar 75.32 ± 31.33 mmHg·l/g, p=NS). Er is dus een associatie tussen LV dyssynchronie tijdens RV 
pacen, en een verslechtering van het oxidatieve metabolisme en de effi  ciëntie van het LV. De 
bovenstaande studies laten het belang van het bestuderen van LV dyssynchronie bij patiënten 
met een pacemaker zien. De aanwezigheid van LV dyssynchronie tijdens RV pacen is geasso-
cieerd met een verslechtering van LV functie, het oxidatieve metabolisme en de functionele 
status van de patiënt. 
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Ten slotte werd in Hoofdstuk 16 de prevalentie van dyssynchronie bij patiënten met aritmo-
gene rechterventrikeldysplasie (ARVD) bestudeerd. ARVD is een erfelijke cardiomyopathie, en 
wordt gekenmerkt door vervanging van normaal myocardweefsel door vetweefsel (voorna-
melijk in het RV). Dit resulteert in ritme- en geleidingsstoornissen en mogelijk mechanische 
dyssynchronie. De prevalentie van dyssynchronie is echter nooit onderzocht bij deze patiënten 
populatie. Bij 52 ARVD patiënten (gemiddelde leeftijd 41 ± 12 jaar, 22 mannen) en 25 gezonde 
controles (vrijwilligers) werd de mate van mechanische dyssynchronie bestudeerd met behulp 
van tissue Doppler echocardiografi e. De time-to-peak systolische snelheid (TSV) van de RV 
vrije wand, het interventriculaire septum en de LV laterale wand werden gemeten, en zo werd 
ventriculaire dyssynchronie berekend (Figuur 1 in Hoofdstuk 16). Signifi cante RV dyssynchronie 
werd gedefi nieerd als het verschil tussen TSV van de RV vrije wand en het interventriculaire 
septum, >2 standaard deviaties boven het gemiddelde van de controle groep. Het gemiddelde 
verschil tussen TSV van het septum en de RV vrije wand was 26 ± 15 ms in de controle groep 
(resulterend in een cut-off  waarde van ≥56 ms voor signifi cante RV dyssynchronie), en 55 ± 34 
ms bij de ARVD patiënten (p<0.001). Bij 26 ARVD patiënten (50%) was er sprake van signifi cante 
RV dyssynchronie. Er werden geen verschillen gevonden in QRS duur, mate van T golf inversie 
of rechter bundeltakblok tussen ARVD patiënten met en zonder RV dyssynchronie. Echter, RV 
‘fractional area change’ (als maat voor RV functie) was signifi cant lager (29 ± 8% vs. 34 ± 8%, 
p<0.05) en RV systolische strain was signifi cant lager (-16 ± 6% vs. -22 ± 7%, p<0.01) bij ARVD 
patiënten met RV dyssynchronie, vergeleken met ARVD patiënten zonder RV dyssynchronie. 
Samenvattend werd in deze studie aangetoond dat tot wel 50% van de ARVD patiënten signi-
fi cante RV dyssynchronie kan hebben. De aanwezigheid van RV dyssynchronie is geassocieerd 
met verslechtering van RV functie. 
DEEL III: Percutane hartklep procedures
Het derde deel van dit proefschrift gaat over percutane procedures voor hartklepafwijkingen. 
In de afgelopen jaren zijn er nieuwe (percutane) procedures ontwikkeld om met behulp 
van catheters via de lies ernstige mitralisklepinsuffi  ciëntie (MI) en aortaklepstenose (AS) te 
behandelen bij patiënten die geen open-hart operatie kunnen ondergaan. Verschillende 
beeldvormende technieken spelen een grote rol bij dergelijke procedures, voornamelijk in 
de selectie van patiënten. De verschillende percutane hartklep procedures en de rol van de 
diverse beeldvormende technieken wordt uitgebreid besproken in Hoofdstuk 17. 
In Hoofdstuk 18 werden MSCT scans gemaakt bij 105 patiënten om de anatomie van de sinus 
coronarius (een ader van het hart) te evalueren. De relatie tussen de sinus coronarius, de annulus 
(klepring) van de mitralisklep, en de kransslagvaten is van belang voor percutane mitralisklep 
procedures. Deze maken namelijk gebruik van protheses die in de sinus coronarius worden 
geplaatst om MI te behandelen. Een ongunstige relatie tussen de voornoemde structuren kan 
resulteren in een niet effi  ciënte procedure en zelfs afsluiting van de kransslagvaten. In deze 
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studie werd een grote variatie in de relatie tussen de sinus coronarius en de annulus van de 
mitralisklep geconstateerd (Figuur 3 in Hoofdstuk 18). In het merendeel van de patiënten was 
de sinus coronarius gelokaliseerd langs het LA, in plaats van langs de annulus van de mitralis-
klep. Bij 68% van de patiënten liep de circumfl ex coronair arterie tussen de sinus coronarius en 
de annulus; dit vergroot de kans op afsluiting van dit kransslagvat tijdens percutane behande-
ling van MI. Daarnaast werd gezien dat de minimale afstand tussen de sinus coronarius en de 
annulus van de mitralisklep signifi cant groter was bij patiënten met ernstige MI, in vergelijking 
met patiënten zonder ernstige MI (gemiddelde afstand 7.3 ± 3.9 mm vs. 4.8 ± 2.5 mm, p<0.05). 
Patiënten met een grote afstand tussen deze twee structuren hebben mogelijk geen baat bij 
de percutane behandeling van MI. Dus, MSCT kan belangrijke informatie geven bij de selectie 
van patiënten voor deze procedures. 
De evaluatie van de mitralisklep met behulp van MSCT werd verder uitgediept in Hoofdstuk 
19. Het subvalvulaire apparaat en de geometrie van de mitralisklep (mitralisklep ‘tenting 
heigth’ en ‘leafl et tethering’, Figuur 3 in Hoofdstuk 19) werden bestudeerd bij 151 patiënten, 
inclusief 29 patiënten met matig tot ernstige MI. Er werd geconstateerd dat patiënten met MI 
een asymmetrische geometrie van de mitralisklep hebben. Bij deze patiënten werd een ver-
grote hoek van het achterste mitralisklepblad gevonden op het centrale (44.4 ± 11.9°) en het 
posteromediale (35.9 ± 10.6°) niveau. Daarnaast was de mitralisklep ‘tenting heigth’ signifi cant 
vergroot in deze patiënten, in vergelijking met patiënten zonder MI (centrale niveau: 6.6 ± 1.4 
mm/m2 vs. 5.3 ± 1.3 mm/m2, p<0.001; posteromediale niveau: 5.4 ± 1.6 mm/m2 vs. 4.1 ± 1.2 
mm/m2, p<0.001). Deze studie laat zien dat MSCT belangrijke informatie kan geven over de 
anatomie en geometrie van de mitralisklep, en dat er sprake is van asymmetrische geometrie 
bij patiënten met matig tot ernstige MI. 
De rest van de studies betrof percutane procedures voor ernstige AS. In Hoofdstuk 20 wordt 
een uitgebreid overzicht gegeven van de tot nu toe verrichte studies naar percutane behande-
ling van AS. Het merendeel van deze studies laten een hoog slagingspercentage van de proce-
dure zien, een lage mortaliteit na 30 dagen, en een goede functie van de prothese gedurende 
follow-up. Daarnaast worden in dit hoofdstuk de recente aanbevelingen voor de percutane 
behandeling van AS besproken. Op dit moment worden deze procedures alleen aanbevolen 
voor patiënten met ernstige, symptomatische AS die in een te slechte conditie zijn voor een 
open-hart operatie. Verder wordt stilgestaan bij de verschillende beeldvormende technieken 
die gebruikt worden voor de selectie van patiënten, het begeleiden van de procedure, en de 
follow-up van patiënten. 
MSCT is één van de technieken die belangrijke informatie voor de selectie van patiënten ver-
schaft. Deze techniek werd dan ook gebruikt om de anatomie van de aortaklep te bestuderen bij 
169 patiënten (inclusief 19 patiënten met matig ernstige AS) in Hoofdstuk 21. De hoeveelheid 
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en exacte locatie van aortaklep calcifi caties werden beoordeeld, naast gestandaardiseerde 
metingen van de aortawortel (Figuur 1 t/m 5 in Hoofdstuk 21). De oriëntatie van de gerecon-
strueerde MSCT beelden is gelijk aan de oriëntatie van de echocardiografi e en doorlichting 
beelden die normaliter tijdens percutane aortaklep procedures worden gebruikt. De diameter 
van de annulus van de aortaklep werd in twee richtingen gemeten. Daarnaast werd de afstand 
tussen de annulus en de kransslagvaten gemeten. Deze metingen zijn belangrijk voor het 
beoordelen van de diameter van de te plaatsen prothese, en het beoordelen van het risico op 
afsluiting van de kransslagvaten tijdens de implantatie procedure. In deze studie werd een ovale 
vorm van de annulus van de aortaklep gevonden; de gemiddelde diameter van de annulus was 
26.3 ± 2.8 mm op de coronale beelden, en 23.5 ± 2.7 mm op de sagittale beelden. Daarnaast 
werd een grote variatie in de afstand tussen de annulus en het linker kransslagvat (gemiddeld 
14.4 ± 2.9 mm, van 7.1 tot 22.7 mm) en tussen de annulus en het rechter kransslagvat (gemid-
deld 17.2 ± 3.3 mm, van 9.2 tot 26.3 mm) gevonden. Belangrijk hierbij is dat de lengte van het 
aortaklepblad groter was dan deze afstand in 49% van de patiënten. Dit vergroot de kans op 
afsluiting van het kransslagvat tijdens de percutane aortaklep implantatie. Dus, MSCT verschaft 
belangrijke informatie voor de selectie van patiënten voor deze procedures. 
Deze bevindingen werden bevestigd bij 26 patiënten met ernstige AS die werden verwezen 
voor percutane aortaklep implantatie (Hoofdstuk 22). Voorafgaand aan de procedure en na 4 
maanden follow-up werd een MSCT scan gemaakt, en geanalyseerd zoals eerder beschreven. 
De metingen op de MSCT beelden werden vergeleken met echocardiografi e en doorlichting. 
Op de follow-up scans werd de stent diameter en de afstand tussen de stent en het linker 
kransslagvat bepaald. De gemiddelde afstand tussen de annulus van de aortaklep en het 
linker kransslagvat was 15.0 ± 3.0 mm. Een goede overeenkomst werd gevonden tussen MSCT, 
echocardiografi e en doorlichting voor de bepaling van de annulus van de aortaklep. Na de 
percutane implantatie van de aortaklep was bij 50% van de patiënten de prothese gelegen 
boven het linker kransslagvat. Bij 78% van de patiënten was er sprake van een goede circulaire 
ontplooiing van de prothese. Deze studie laat de waarde zien van MSCT voor de selectie en de 
follow-up van patiënten die worden verwezen voor percutane aortaklep implantatie. 
CONCLUSIES EN TOEKOMSTPERSPECTIEVEN
De studies in dit proefschrift bestuderen de rol van beeldvormende technieken bij cardiale 
interventie procedures. In de afgelopen jaren zijn er belangrijke stappen gezet in de invasieve 
behandeling van AF, pacemakers en de percutane behandeling van ernstig hartkleplijden. De 
selectie van patiënten voor deze procedures, de procedures zelf en de follow-up van patiën-
ten kunnen geoptimaliseerd worden met behulp van diverse beeldvormende technieken. 
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Daarnaast kan de integratie van diverse technieken het in beeld brengen van de belangrijkste 
anatomische structuren tijdens de procedures aanzienlijk vergemakkelijken. 
Catheter ablatie voor atriumfi brilleren
Het nauwkeurig in beeld brengen van het LA en de PV is van groot belang voor het slagen 
van catheter ablatie procedures voor AF. Daarnaast is uit één van de huidige studies geble-
ken dat PV anatomie ook een prognostische waarde heeft. Verschillende beeldvormende 
technieken zijn beschikbaar voor het visualiseren van het LA en de PV. Echter, elke techniek 
heeft ook beperkingen. Integratie van verschillende technieken overwint de beperkingen van 
de individuele technieken door ze te combineren. De studies in dit proefschrift laten zien dat 
het mogelijk is om verschillende beeldvormende technieken te integreren, en dat dit meer-
waarde heeft voor catheter ablatie procedures voor AF. Meer studies zijn nu nodig om verdere 
integratie van verschillende technieken tijdens elektrofysiologische procedures te exploreren. 
Daarnaast zijn grote gerandomiseerde studies nodig om te onderzoeken of het integreren van 
de verschillende technieken ook eff ect heeft op het resultaat van de ablatie procedure. Verder 
moet bekeken worden wat de rol is van recent geïntroduceerde beeldvormende technieken 
zoals ‘rotational angiography’ (waarbij doorlichting CT-achtige beelden geeft), en ‘real-time 
MRI’ (in een hybride catheterisatie kamer). 
Verder lieten de studies in dit proefschrift zien dat de functie van het LA en LV kan verbe-
teren na succesvolle catheter ablatie voor AF. Helaas kan uit deze studies het onderliggende 
pathofysiologische proces niet duidelijk worden gemaakt. Verder blijft het onduidelijk of het 
behoud van sinusritme resulteert in ‘reverse remodeling’, of vice versa (‘de kip of het ei’….). 
Daarom zijn meer studies nodig om de doorslaggevende factoren voor reverse remodeling te 
vinden, en preklinische studies kunnen wellicht het onderliggende proces ophelderen. Het kan 
goed zijn dat de hoeveelheid littekenweefsel in het LA een belangrijke rol speelt in het slagen 
van catheter ablatie procedures, en reverse remodeling erna. Het in beeld brengen van de hoe-
veelheid littekenweefsel in het LA met behulp van beeldvormende technieken voorafgaand 
aan de ablatie procedure kan dan van grote waarde zijn. Ten slotte kan het kwantifi ceren van de 
hoeveelheid littekenweefsel na de ablatie procedure met behulp van MRI meer duidelijkheid 
geven over de eff ecten van dergelijke procedures op de grootte en de functie van het LA. 
Ventriculair pacen en dyssynchronie
De negatieve eff ecten van RV pacen, zoals aangetoond in grote gerandomiseerde studies, 
is mogelijk gerelateerd aan de aanwezigheid van LV dyssynchronie. In dit proefschrift wordt 
aangetoond dat ongeveer de helft van de patiënten die langdurig RV pacen ondergaan, 
signifi cante LV dyssynchronie ontwikkelen en verslechtering van LV functie laten zien. De aan-
wezigheid van LV dyssynchronie tijdens RV pacen is ook geassocieerd met een verslechtering 
van het oxidatieve metabolisme en effi  ciëntie van het myocard. Door het corrigeren van het 
asynchrone contractie patroon kan CRT deze negatieve eff ecten gedeeltelijk herstellen. Verder 
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werd aangetoond dat LV dyssynchronie vrijwel direct na het starten van RV pacen aanwezig kan 
zijn. Ten slotte liet een studie in dit proefschrift zien dat signifi cante RV dyssynchronie aanwezig 
is in ongeveer 50% van de patiënten met ARVD. Meer studies zijn nodig om het onderliggende 
mechanisme te verhelderen, en om de klinische relevantie van deze bevinding te verduidelijken. 
Met betrekking tot RV pacen en ventriculaire dyssynchronie blijft een aantal belangrijke 
vragen onbeantwoord, en moeten dus worden behandeld in toekomstige studies. Waarom 
ontwikkelen sommige patiënten signifi cante LV dyssynchronie en zelfs hartfalen tijdens RV 
pacen, en andere patiënten niet? Zowel patiënt- als pacemakergerelateerde factoren die het 
ontwikkelen van dyssynchronie en verslechtering van LV functie zouden kunnen voorspellen, 
moeten onderzocht worden. Is het ontstaan van LV dyssynchronie in de acute fase geassoci-
eerd met een verslechtering van LV functie tijdens follow-up? Als toekomstige studies deze 
relatie laten zien, dan moet ten tijde van de pacemaker implantatie de aanwezigheid van LV 
dyssynchronie worden onderzocht. Dan kan vervolgens CRT worden overwogen bij patiënten 
met signifi cante LV dyssynchronie bij pacemaker implantatie. Verder kan een regelmatige 
screening op LV dyssynchronie bij patiënten met een gewone pacemaker, de patiënten die 
baat hebben bij een CRT pacemaker identifi ceren. 
Percutane hartklep procedures
In de afgelopen jaren is een aantal interessante, nieuwe percutane procedures geïntroduceerd 
voor de behandeling van patiënten met ernstige hartklepafwijkingen. Dit proefschrift laat 
zien dat beeldvormende technieken (en in het bijzonder MSCT scans) belangrijke informatie 
kunnen verschaff en voor de selectie van patiënten voor dergelijke procedures. MSCT is een 
driedimensionale beeldvormende techniek die uitstekend de relatie tussen de kransslagvaten, 
de sinus coronarius en de betreff ende hartklep in beeld kan brengen. Deze relatie is van belang 
voor zowel percutane procedures voor ernstige MI die gebruik maken van de sinus coronarius, 
als voor percutane implantatie van een aortaklep. Verder kan MSCT de prothese en de relatie 
met omgevende structuren in beeld brengen na de percutane procedure. Voor percutane 
hartklep procedures moet nog een aantal belangrijke zaken onderzocht worden in toekom-
stige studies, zoals de lange termijn veiligheid en eff ectiviteit van de prothesen. Tegelijkertijd 
moeten meer studies de percutane benadering vergelijken met de chirurgische benadering. Er 
wordt momenteel uitgekeken naar de resultaten van de PARTNER trial (The Placement of AoRTic 
TraNscathetER Valve Trial) die bij 350 patiënten deze vergelijking onderzoekt. Als toekomstige 
studies vergelijkbare of betere resultaten van de percutane benadering laten zien, dan worden 
de indicaties voor een percutane procedure waarschijnlijk uitgebreid. Dit is voornamelijk 
interessant voor patiënten die eerder een aortakunstklep kregen, die nu aan vervanging toe 
is. Dit zou dan niet een nieuwe operatie betekenen, maar een percutane ingreep (‘valve-in-
valve’). Ten slotte, meer studies zijn nodig om te onderzoeken of beeldvormende technieken de 
veiligheid en eff ectiviteit van de procedures kunnen verbeteren. In het bijzonder moet worden 
gekeken naar de integratie van de verschillende technieken tijdens de implantatie procedure.
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